data_5y95_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5y95 _Structure_validation_residue.Date_analyzed 2017-09-29 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 109.854 -0.424 . . . . 10.0 109.854 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.2 m -92.59 157.73 16.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.461 -0.336 . . . . 10.0 110.637 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.2 82.67 1.12 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.95 -0.643 . . . . 10.0 113.142 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.6 m -88.75 173.37 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.906 -0.405 . . . . 10.0 109.906 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -95.6 176.77 6.03 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.74 -0.209 . . . . 10.0 110.678 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.5 m -67.22 -23.41 30.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-O 120.881 0.372 . . . . 10.0 111.43 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -133.1 87.9 2.45 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.445 -0.576 . . . . 10.0 109.445 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -93.58 13.78 20.9 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.677 -0.692 . . . . 10.0 110.857 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.96 -42.79 94.28 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.767 -0.651 . . . . 10.0 111.412 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.05 -25.8 62.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.257 -0.428 . . . . 10.0 111.526 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.4 m -61.24 -60.35 3.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.22 -0.445 . . . . 10.0 111.519 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -66.22 -31.88 72.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.35 -0.386 . . . . 10.0 111.168 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.09 -52.72 62.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.426 . . . . 10.0 111.48 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -74.74 -27.17 60.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.302 -0.408 . . . . 10.0 111.272 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -58.18 -38.89 77.56 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.251 -0.431 . . . . 10.0 111.662 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.2 t -62.77 -34.83 67.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.122 0.487 . . . . 10.0 110.632 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.7 ttpm? -70.41 -34.74 72.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.857 -0.611 . . . . 10.0 110.762 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 35.1 mt -76.75 -35.57 25.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.701 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -71.21 -43.38 67.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.209 -0.45 . . . . 10.0 111.104 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -106.94 44.18 1.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.184 0.516 . . . . 10.0 110.901 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.55 -30.75 78.18 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.882 -0.675 . . . . 10.0 112.291 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.1 m -92.73 -6.28 49.43 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 122.759 -0.26 . . . . 10.0 111.304 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -123.13 85.03 51.3 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 120.794 0.33 . . . . 10.0 110.847 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.42 -26.32 41.01 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.479 2.119 . . . . 10.0 112.812 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.79 -44.48 93.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.653 -0.249 . . . . 10.0 111.087 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.2 m -65.88 -40.79 91.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.063 -0.517 . . . . 10.0 111.034 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -69.06 -37.73 78.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.547 -0.297 . . . . 10.0 110.835 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -61.23 -43.22 99.23 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.856 0.36 . . . . 10.0 110.616 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.96 -37.82 95.18 Favored Glycine 0 C--N 1.332 0.33 0 N-CA-C 111.529 -0.628 . . . . 10.0 111.529 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -57.51 -42.21 82.36 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.974 0.416 . . . . 10.0 110.181 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 26.6 mt -67.12 -38.04 84.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.811 -0.631 . . . . 10.0 110.887 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -61.61 -44.28 97.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.28 -0.418 . . . . 10.0 110.704 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.9 mt -63.7 -35.78 74.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.306 -0.406 . . . . 10.0 110.304 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 82.6 mtp -64.01 -37.11 86.21 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.106 -0.497 . . . . 10.0 110.219 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -62.53 -37.42 86.0 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.008 -0.542 . . . . 10.0 111.153 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -63.45 -36.58 84.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.09 0.471 . . . . 10.0 110.094 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -73.33 -35.63 66.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.048 -0.524 . . . . 10.0 109.747 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -66.73 -23.96 66.17 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.117 -0.492 . . . . 10.0 110.45 178.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.0 m -94.35 2.74 55.8 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.92 -0.582 . . . . 10.0 110.131 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 56.85 31.63 19.95 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.648 -0.706 . . . . 10.0 111.294 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.7 m -82.2 -22.18 36.07 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.563 0.697 . . . . 10.0 109.846 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 17.6 pt -131.99 158.47 43.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.264 -0.88 . . . . 10.0 109.965 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -110.0 -162.46 0.8 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.557 -0.534 . . . . 10.0 109.557 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.474 ' HB ' ' CD ' ' A' ' 73' ' ' PRO . 1.4 m -56.73 -60.17 10.17 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 116.237 -0.438 . . . . 10.0 111.221 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.474 ' CD ' ' HB ' ' A' ' 72' ' ' THR . 25.1 Cg_endo -61.52 -21.73 72.71 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 121.908 1.739 . . . . 10.0 112.594 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.79 -50.31 11.57 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.931 -0.577 . . . . 10.0 112.674 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.545 ' O ' HG22 ' A' ' 79' ' ' VAL . 14.5 p -65.18 -36.85 78.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.89 0.345 . . . . 10.0 110.898 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 60.5 mt -58.64 -38.99 74.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 116.299 -0.409 . . . . 10.0 111.081 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 -60.87 -39.29 88.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.957 -0.565 . . . . 10.0 110.928 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -69.63 -45.56 68.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.805 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 75' ' ' VAL . 13.6 t -61.0 -38.28 79.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.906 -0.588 . . . . 10.0 110.971 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.0 m -65.95 -17.38 64.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.469 . . . . 10.0 111.786 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -102.52 -23.84 13.86 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 111.799 0.296 . . . . 10.0 111.799 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 40.3 tp -85.26 -53.08 5.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.929 0.395 . . . . 10.0 110.348 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -94.96 47.61 1.16 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.025 0.44 . . . . 10.0 110.11 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -66.08 -25.46 67.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.993 -0.549 . . . . 10.0 110.771 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -91.0 -9.54 45.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.114 -0.494 . . . . 10.0 110.583 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -128.97 72.05 81.91 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.289 -0.414 . . . . 10.0 111.214 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -61.8 -26.91 80.0 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.581 2.187 . . . . 10.0 112.587 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -56.27 -38.8 71.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.865 -0.607 . . . . 10.0 111.964 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 97.7 mt -64.36 -42.83 95.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.381 -0.372 . . . . 10.0 111.208 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.3 mt -73.0 -41.01 59.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.088 -0.506 . . . . 10.0 111.03 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.424 ' O ' ' HB2' ' A' ' 94' ' ' ASN . 78.7 t -67.36 -48.35 77.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.973 -0.558 . . . . 10.0 110.597 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.68 -31.19 77.07 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.002 -0.618 . . . . 10.0 112.45 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -63.93 -24.92 67.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.696 0.284 . . . . 10.0 111.17 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' ' 91' ' ' VAL . 2.6 m-80 -63.72 -33.68 76.19 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.031 0.443 . . . . 10.0 110.426 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -95.58 -16.68 21.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.211 0.529 . . . . 10.0 110.343 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -89.35 31.57 0.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.809 -0.632 . . . . 10.0 110.46 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.2 mt -121.35 108.48 35.82 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.4 -0.818 . . . . 10.0 109.178 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -59.7 -49.15 10.82 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.393 2.062 . . . . 10.0 111.849 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.49 118.31 10.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.283 -0.417 . . . . 10.0 110.367 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -168.21 -134.92 1.79 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.55 -0.833 . . . . 10.0 112.53 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -82.83 13.41 2.62 Favored 'Trans proline' 0 CA--C 1.529 0.226 0 C-N-CA 122.88 2.387 . . . . 10.0 113.284 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.2 m -73.65 162.58 29.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.709 0.29 . . . . 10.0 110.261 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.6 m -72.7 104.64 4.0 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.926 0.393 . . . . 10.0 110.532 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.457 0 C-N-CA 120.902 -0.666 . . . . 10.0 112.375 179.698 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 65.7 m . . . . . 0 N--CA 1.453 -0.279 0 CA-C-O 121.102 0.477 . . . . 10.0 110.766 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.56 113.58 24.29 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.947 -0.57 . . . . 10.0 109.907 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 155.08 74.22 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.803 -0.713 . . . . 10.0 111.416 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 28.5 m -84.47 156.54 3.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.094 0.473 . . . . 10.0 111.027 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -112.14 -178.55 3.45 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.585 -0.734 . . . . 10.0 109.321 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.9 m -67.24 -36.27 76.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.721 0.296 . . . . 10.0 111.73 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -115.05 105.72 13.28 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.882 0.372 . . . . 10.0 110.222 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -139.75 3.51 2.06 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.566 0.58 . . . . 10.0 112.566 -178.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.61 -37.73 87.43 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.122 0.487 . . . . 10.0 110.613 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.02 -24.07 67.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.536 -0.756 . . . . 10.0 111.51 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.3 m -68.36 -47.49 67.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.531 -0.304 . . . . 10.0 111.39 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -67.93 -36.56 80.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.922 0.391 . . . . 10.0 110.323 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 59.0 mt -65.08 -28.67 69.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.909 -0.587 . . . . 10.0 110.736 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -76.85 -38.09 54.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.687 -0.688 . . . . 10.0 110.206 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -59.1 -36.4 75.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.769 -0.65 . . . . 10.0 111.168 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 54.0 t -61.1 -40.92 87.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.982 -0.554 . . . . 10.0 110.911 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.1 pttm -71.09 -24.19 62.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.371 -0.377 . . . . 10.0 111.09 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 81.9 mt -78.01 -48.7 22.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 121.014 0.435 . . . . 10.0 110.087 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -63.68 -40.57 97.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.762 -0.653 . . . . 10.0 111.357 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -103.59 40.02 1.5 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.099 0.476 . . . . 10.0 110.428 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -70.82 -29.36 69.43 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.697 -0.763 . . . . 10.0 112.38 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.4 m -81.74 -31.27 32.08 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.407 0.146 . . . . 10.0 111.04 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -113.56 106.67 53.91 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.791 0.329 . . . . 10.0 110.848 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -81.15 -11.62 12.07 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.473 2.115 . . . . 10.0 112.686 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.95 -48.87 64.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.09 -0.504 . . . . 10.0 110.744 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.5 m -66.29 -32.96 74.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 10.0 110.523 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -72.4 -43.3 64.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 10.0 110.241 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -64.55 -37.75 88.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.066 -0.516 . . . . 10.0 110.248 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.65 -26.83 73.65 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.765 -0.652 . . . . 10.0 111.628 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -68.05 -36.81 80.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.267 0.556 . . . . 10.0 109.681 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 60.5 mt -66.06 -36.81 84.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.687 -0.688 . . . . 10.0 110.606 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -66.54 -31.45 72.17 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.064 -0.516 . . . . 10.0 110.788 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.408 HG21 HD11 ' A' ' 61' ' ' ILE . 73.2 mt -65.29 -42.87 94.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.228 0.537 . . . . 10.0 110.577 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.471 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 67.8 mtp -65.8 -33.56 76.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.039 -0.528 . . . . 10.0 110.657 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.39 -34.6 77.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 10.0 111.421 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -67.97 -31.89 71.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.044 0.45 . . . . 10.0 110.566 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -81.13 -29.7 34.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.636 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 62' ' ' MET . 23.7 mtpp -59.0 -41.21 87.13 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.902 0.382 . . . . 10.0 110.771 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.1 m -88.52 8.37 28.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 10.0 110.967 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 58.33 30.57 19.75 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.656 -0.702 . . . . 10.0 111.038 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.3 m -77.14 -24.71 51.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.086 -0.506 . . . . 10.0 110.844 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 36.1 pt -125.31 162.87 27.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.114 -0.494 . . . . 10.0 110.121 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -112.22 -172.4 2.04 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.939 -0.573 . . . . 10.0 110.055 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.562 ' O ' HG11 ' A' ' 75' ' ' VAL . 2.1 m -54.7 -54.39 49.78 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 116.362 -0.381 . . . . 10.0 111.841 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 72' ' ' THR . 28.7 Cg_endo -63.26 -26.12 72.0 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 121.793 1.662 . . . . 10.0 111.994 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.73 -41.93 72.63 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.759 -0.655 . . . . 10.0 112.571 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.562 HG11 ' O ' ' A' ' 72' ' ' THR . 4.2 p -65.51 -29.95 48.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 120.704 0.287 . . . . 10.0 110.372 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 63.6 mt -63.07 -42.73 97.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 10.0 110.209 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -62.02 -40.06 94.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.533 -0.758 . . . . 10.0 109.934 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -66.63 -46.76 74.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.943 -0.572 . . . . 10.0 110.957 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.1 t -66.3 -43.99 91.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.216 -0.447 . . . . 10.0 111.107 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.57 -37.98 83.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.122 -0.49 . . . . 10.0 111.196 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -79.3 -27.09 42.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.708 -0.223 . . . . 10.0 111.363 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 35.5 tp -76.22 -51.94 11.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.879 0.371 . . . . 10.0 110.346 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 -91.5 48.74 1.5 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.206 0.527 . . . . 10.0 110.212 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -68.7 -8.99 47.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.82 -0.627 . . . . 10.0 111.766 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -110.23 -12.03 14.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.836 0.351 . . . . 10.0 111.047 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -130.46 80.87 69.43 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.385 -0.37 . . . . 10.0 111.001 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -62.31 -28.95 79.23 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.597 2.198 . . . . 10.0 112.298 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -58.5 -36.72 74.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.599 -0.728 . . . . 10.0 111.468 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 95.7 mt -75.72 -30.25 59.2 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.408 -0.36 . . . . 10.0 111.125 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.431 HG21 HD12 ' A' ' 90' ' ' ILE . 45.4 mt -69.05 -46.17 78.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.347 0.594 . . . . 10.0 109.459 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.404 ' O ' ' HB2' ' A' ' 94' ' ' ASN . 46.3 t -70.11 -37.33 71.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.318 -0.855 . . . . 10.0 109.751 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.32 -40.63 94.31 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.748 -0.66 . . . . 10.0 112.189 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -60.25 -28.91 68.42 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.754 0.311 . . . . 10.0 110.747 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' A' ' 91' ' ' VAL . 28.4 m-80 -69.78 -17.73 63.44 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.44 -0.345 . . . . 10.0 110.662 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.78 -3.47 24.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.89 0.376 . . . . 10.0 111.024 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -112.86 20.19 16.66 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.064 0.459 . . . . 10.0 110.842 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 17.5 mt -80.22 116.15 59.53 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.815 -0.629 . . . . 10.0 109.831 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.32 -18.41 30.06 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.38 2.054 . . . . 10.0 112.74 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.71 158.27 30.47 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.867 -0.42 . . . . 10.0 109.867 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 169.77 -134.32 3.13 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 121.007 -0.616 . . . . 10.0 111.624 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.57 -9.48 18.58 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.755 2.304 . . . . 10.0 111.533 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 m -66.23 152.11 45.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.673 -0.694 . . . . 10.0 111.373 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.56 133.81 55.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.905 -0.589 . . . . 10.0 111.081 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.222 0 CA-C-N 115.967 -0.56 . . . . 10.0 112.463 179.425 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.1 m . . . . . 0 C--O 1.234 0.248 0 CA-C-O 120.901 0.381 . . . . 10.0 110.78 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.4 m -90.56 150.79 21.6 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.76 0.314 . . . . 10.0 110.425 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.88 91.74 2.22 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.695 -0.764 . . . . 10.0 111.643 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.7 m -91.69 164.57 2.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.654 0.264 . . . . 10.0 110.762 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -119.36 177.05 5.05 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.282 -0.417 . . . . 10.0 110.209 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.3 m -81.98 -12.7 12.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.919 0.39 . . . . 10.0 110.856 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -139.95 87.64 2.17 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.185 -0.461 . . . . 10.0 110.111 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.2 p30 -128.61 12.02 6.31 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.25 -0.432 . . . . 10.0 111.037 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.91 -44.69 96.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.261 0.553 . . . . 10.0 111.072 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -63.24 -31.41 72.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.519 -0.764 . . . . 10.0 111.002 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 m -62.05 -51.42 68.06 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.086 -0.506 . . . . 10.0 111.191 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -70.01 -30.04 67.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.449 -0.341 . . . . 10.0 110.626 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.48 -34.89 78.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.965 0.412 . . . . 10.0 110.528 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -73.87 -32.58 63.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.296 -0.411 . . . . 10.0 110.185 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -60.16 -38.63 83.76 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.092 -0.503 . . . . 10.0 109.782 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 92.9 t -60.35 -39.43 80.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.657 -0.702 . . . . 10.0 109.7 178.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.8 ttpm? -67.04 -38.0 85.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.226 -0.897 . . . . 10.0 110.748 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 57.7 mt -71.0 -43.78 76.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.287 -0.415 . . . . 10.0 110.33 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -62.12 -36.49 81.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 10.0 111.231 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -101.94 36.36 2.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.058 0.456 . . . . 10.0 111.284 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.81 -36.3 89.46 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.855 -0.612 . . . . 10.0 111.984 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.0 m -101.69 13.36 35.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.603 0.24 . . . . 10.0 111.087 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -142.04 74.93 21.18 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.949 0.404 . . . . 10.0 110.752 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -63.71 -26.89 68.36 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.594 2.196 . . . . 10.0 112.476 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.12 -50.03 73.51 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.761 0.315 . . . . 10.0 110.989 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.9 m -63.03 -38.36 90.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.301 -0.409 . . . . 10.0 110.682 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -69.43 -40.11 77.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.412 -0.358 . . . . 10.0 110.791 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -64.65 -41.42 96.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.366 -0.379 . . . . 10.0 110.295 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.83 -27.96 72.77 Favored Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.886 -0.597 . . . . 10.0 111.788 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -64.47 -42.29 95.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.964 0.412 . . . . 10.0 110.393 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.9 mt -64.15 -29.84 70.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.981 -0.554 . . . . 10.0 110.613 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -68.81 -34.2 75.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 10.0 110.259 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.8 mt -67.88 -36.01 74.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.964 -0.562 . . . . 10.0 109.621 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.76 -31.46 72.64 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.591 -0.732 . . . . 10.0 110.156 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -62.36 -39.57 93.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.066 -0.516 . . . . 10.0 111.32 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -63.84 -37.18 86.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.171 -0.468 . . . . 10.0 110.453 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -74.79 -36.5 62.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.123 -0.49 . . . . 10.0 110.474 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -64.28 -41.02 97.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.312 -0.404 . . . . 10.0 110.9 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.7 m -81.8 0.24 40.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.388 -0.369 . . . . 10.0 110.918 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 61.32 32.06 19.24 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.688 -0.687 . . . . 10.0 111.95 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.1 m -78.15 -24.18 47.42 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.193 -0.669 . . . . 10.0 109.193 178.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 45.6 pt -135.91 -179.06 2.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.16 -0.927 . . . . 10.0 109.314 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.447 ' CG ' ' H ' ' A' ' 72' ' ' THR . 6.1 t70 -136.3 -151.2 0.4 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.927 -0.397 . . . . 10.0 109.927 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.447 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 7.1 m -55.72 -57.81 19.29 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 113.167 0.803 . . . . 10.0 113.167 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.433 ' CD ' ' HB ' ' A' ' 72' ' ' THR . 18.8 Cg_endo -61.15 -38.42 67.05 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 121.832 1.688 . . . . 10.0 112.964 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.56 -45.35 93.3 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 116.129 -0.487 . . . . 10.0 113.386 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.414 HG11 ' O ' ' A' ' 72' ' ' THR . 9.9 p -67.45 -39.5 82.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.768 -0.373 . . . . 10.0 111.303 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 81.4 mt -65.57 -43.87 94.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.797 0.332 . . . . 10.0 110.113 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 34.9 ttp-105 -61.58 -37.51 84.14 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.138 -0.483 . . . . 10.0 110.814 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.68 -50.26 58.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.151 -0.477 . . . . 10.0 110.888 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 94.5 t -66.39 -30.95 51.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.111 -0.495 . . . . 10.0 111.869 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 71.0 m -61.19 -27.89 68.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.002 0.429 . . . . 10.0 110.751 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -85.81 -28.97 24.15 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.826 -0.624 . . . . 10.0 110.374 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 25.9 tp -75.67 -45.48 36.78 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.87 -0.604 . . . . 10.0 109.842 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 6.1 m-30 -90.89 41.9 1.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.855 -0.611 . . . . 10.0 109.959 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -65.32 -21.18 66.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.483 -0.326 . . . . 10.0 111.678 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -103.83 5.64 36.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.962 0.411 . . . . 10.0 110.508 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -134.96 69.73 70.74 Favored Pre-proline 0 C--O 1.235 0.341 0 CA-C-N 116.413 -0.358 . . . . 10.0 110.923 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -62.16 -29.74 81.17 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.255 1.97 . . . . 10.0 112.2 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.49 -46.68 83.45 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.009 -0.541 . . . . 10.0 110.703 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 81.0 mt -64.25 -36.29 83.62 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.407 -0.815 . . . . 10.0 111.394 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 94.2 mt -62.57 -47.28 93.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.894 0.378 . . . . 10.0 110.458 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 43.2 t -70.05 -42.72 79.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.293 -0.412 . . . . 10.0 110.649 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.78 -43.84 97.54 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.956 -0.566 . . . . 10.0 112.761 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -62.26 -34.59 76.83 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.699 0.285 . . . . 10.0 111.367 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 -58.59 -38.55 78.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 10.0 111.03 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -91.47 -19.87 22.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.307 -0.406 . . . . 10.0 111.62 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -69.91 -35.32 74.51 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.674 0.274 . . . . 10.0 111.042 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.3 mt -72.01 126.59 91.24 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 120.848 0.356 . . . . 10.0 111.339 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.72 -18.79 11.65 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.829 2.353 . . . . 10.0 111.984 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.42 130.74 43.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.798 -0.637 . . . . 10.0 111.025 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 161.65 -128.26 1.88 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.094 -0.575 . . . . 10.0 111.758 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -89.35 24.8 0.64 Allowed 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.788 2.325 . . . . 10.0 111.99 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.08 166.99 21.15 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.519 -0.764 . . . . 10.0 111.651 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.17 109.27 1.26 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.823 -0.626 . . . . 10.0 111.024 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.486 0 C-N-CA 120.472 -0.871 . . . . 10.0 112.582 179.596 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.2 m . . . . . 0 N--CA 1.452 -0.35 0 CA-C-O 121.239 0.542 . . . . 10.0 110.493 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.6 m -78.26 147.17 34.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.814 -0.63 . . . . 10.0 110.649 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.08 78.96 0.75 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.826 -0.702 . . . . 10.0 111.486 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.4 m -87.93 160.01 2.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.214 0.531 . . . . 10.0 110.97 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -112.9 174.84 5.7 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.95 -0.568 . . . . 10.0 110.193 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.2 m -68.04 -32.57 56.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.166 0.508 . . . . 10.0 109.826 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -113.07 80.47 1.36 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.27 -0.877 . . . . 10.0 109.211 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -123.83 2.4 8.78 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.035 -0.529 . . . . 10.0 111.547 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.51 -49.8 76.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.375 0.607 . . . . 10.0 111.001 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -66.69 -9.33 35.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.607 -0.724 . . . . 10.0 111.833 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.9 m -72.57 -37.44 68.2 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.58 0.228 . . . . 10.0 111.031 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -74.39 -29.55 61.58 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.788 -0.365 . . . . 10.0 110.615 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -58.0 -43.87 86.86 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.767 -0.457 . . . . 10.0 109.767 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.41 ' O ' HG13 ' A' ' 46' ' ' ILE . 36.6 t70 -64.77 -41.88 95.53 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.696 -0.683 . . . . 10.0 110.81 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -61.19 -38.22 85.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.812 -0.631 . . . . 10.0 111.006 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.62 -40.98 89.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.57 -0.53 . . . . 10.0 109.57 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.06 -29.15 68.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.727 -0.67 . . . . 10.0 110.862 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 42' ' ' ASP . 80.6 mt -75.13 -47.25 36.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.529 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 -62.94 -34.26 77.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.22 -0.446 . . . . 10.0 111.398 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -107.19 41.76 1.43 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.15 0.5 . . . . 10.0 110.506 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -70.75 -27.3 72.6 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.938 -0.648 . . . . 10.0 112.538 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.6 t -100.96 5.32 43.14 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.064 0.459 . . . . 10.0 110.473 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -135.64 86.33 28.67 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.815 -0.63 . . . . 10.0 110.105 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -74.32 -15.74 22.39 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.275 1.983 . . . . 10.0 112.644 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.69 -49.58 61.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.316 -0.402 . . . . 10.0 111.114 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.6 m -66.52 -33.31 75.4 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.318 -0.401 . . . . 10.0 110.779 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -67.64 -41.75 83.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.166 -0.47 . . . . 10.0 110.708 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -62.47 -38.59 90.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.935 0.398 . . . . 10.0 110.567 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.27 -33.25 84.52 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.918 -0.658 . . . . 10.0 111.898 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -61.85 -41.94 98.45 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.947 0.403 . . . . 10.0 110.181 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 24.5 mt -66.71 -36.29 82.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.963 -0.562 . . . . 10.0 110.287 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -62.27 -42.43 99.33 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.665 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.2 mt -66.17 -36.62 77.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.533 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 46.2 mtp -62.12 -34.06 75.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 10.0 110.631 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -62.36 -38.57 90.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.292 -0.413 . . . . 10.0 110.613 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -66.37 -36.83 83.87 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.379 -0.6 . . . . 10.0 109.379 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -68.87 -43.82 74.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.43 -0.805 . . . . 10.0 109.981 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -64.16 -37.17 86.51 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.083 -0.508 . . . . 10.0 111.203 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.7 m -82.5 4.38 24.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.302 -0.408 . . . . 10.0 111.336 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 58.97 28.46 17.67 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.874 -0.603 . . . . 10.0 111.449 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.6 m -75.71 -38.52 58.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.18 0.514 . . . . 10.0 110.143 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.2 pt -120.97 157.73 23.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.689 -0.687 . . . . 10.0 110.106 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.405 ' HB3' ' H ' ' A' ' 72' ' ' THR . 2.1 m-20 -106.85 -163.25 0.9 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.173 -0.467 . . . . 10.0 110.399 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.523 ' O ' HG11 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -55.0 -57.05 21.48 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 112.772 0.656 . . . . 10.0 112.772 -179.724 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' A' ' 72' ' ' THR . 20.5 Cg_endo -60.94 -29.45 88.05 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.043 1.828 . . . . 10.0 112.666 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.13 -48.17 20.89 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.625 -0.798 . . . . 10.0 112.017 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.523 HG11 ' O ' ' A' ' 72' ' ' THR . 5.6 p -63.91 -30.39 49.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.565 0.221 . . . . 10.0 110.753 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.5 mt -66.2 -49.22 77.73 Favored 'Isoleucine or valine' 0 C--N 1.337 0.053 0 N-CA-C 109.714 -0.476 . . . . 10.0 109.714 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 60.2 ttp180 -61.44 -42.61 99.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.864 -0.607 . . . . 10.0 110.799 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -56.53 -41.62 77.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.88 -0.6 . . . . 10.0 111.568 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.6 p -84.21 -22.36 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 120.826 -0.349 . . . . 10.0 111.625 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.5 m -64.25 -42.42 96.52 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.022 0.439 . . . . 10.0 110.737 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -77.3 -14.25 59.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.121 -0.49 . . . . 10.0 110.316 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 18.3 tp -86.44 -43.5 12.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.862 -0.608 . . . . 10.0 110.065 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -103.62 37.21 2.08 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.897 -0.592 . . . . 10.0 109.935 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -64.16 -24.56 67.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.321 -0.4 . . . . 10.0 111.595 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -92.55 0.26 57.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.467 -0.333 . . . . 10.0 110.895 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 18.4 m170 -136.34 81.03 38.24 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-O 120.675 0.274 . . . . 10.0 110.857 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -65.1 -27.53 57.21 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.483 2.122 . . . . 10.0 112.343 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -57.62 -42.6 83.65 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.8 -0.636 . . . . 10.0 110.96 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 96.1 mt -68.9 -41.04 78.8 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.127 -0.488 . . . . 10.0 111.184 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 59.3 mt -60.6 -48.01 90.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-O 121.116 0.484 . . . . 10.0 110.972 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.4 t -71.5 -42.8 72.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.985 -0.552 . . . . 10.0 110.834 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.77 -45.38 95.84 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.817 -0.629 . . . . 10.0 112.859 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.401 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 39.5 t80 -63.19 -34.42 77.61 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.729 0.3 . . . . 10.0 111.022 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -62.82 -36.09 82.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.406 -0.361 . . . . 10.0 111.149 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.9 -21.22 26.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.865 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -77.17 -25.14 51.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.903 -0.59 . . . . 10.0 110.908 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 93' ' ' PHE . 57.9 mt -52.34 125.55 34.98 Favored Pre-proline 0 C--O 1.235 0.304 0 CA-C-N 116.126 -0.488 . . . . 10.0 112.172 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -67.75 -30.66 33.75 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.586 2.19 . . . . 10.0 111.57 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.83 145.95 38.09 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.65 -0.705 . . . . 10.0 110.494 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 171.29 -169.02 42.15 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.775 -0.726 . . . . 10.0 111.963 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.37 15.89 0.62 Allowed 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 123.535 2.823 . . . . 10.0 113.125 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.81 179.59 2.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.018 0.437 . . . . 10.0 110.702 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.9 t -78.3 116.96 19.1 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.878 -0.416 . . . . 10.0 109.878 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.146 0 C-N-CA 120.882 -0.675 . . . . 10.0 112.346 179.747 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.235 0.325 0 CA-C-O 121.019 0.438 . . . . 10.0 110.882 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.4 m -81.35 149.35 28.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.122 -0.49 . . . . 10.0 109.816 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.37 74.28 1.07 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.019 -0.61 . . . . 10.0 111.972 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.8 m -82.47 161.29 3.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.775 0.322 . . . . 10.0 111.066 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -101.73 178.07 4.73 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.575 -0.528 . . . . 10.0 109.575 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 32.1 m -81.65 4.99 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.155 0.502 . . . . 10.0 111.235 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -153.52 103.45 2.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.87 -0.605 . . . . 10.0 109.763 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 38.6 p-10 -135.57 17.29 3.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.151 0.5 . . . . 10.0 110.733 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.58 -41.79 99.15 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.755 -0.657 . . . . 10.0 111.147 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -71.17 -30.87 66.96 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.932 -0.577 . . . . 10.0 110.773 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.22 -43.87 93.65 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.209 -0.45 . . . . 10.0 110.876 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -67.45 -38.32 84.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 10.0 110.201 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.64 -41.49 99.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.26 0.552 . . . . 10.0 110.528 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.575 ' O ' HG13 ' A' ' 46' ' ' ILE . 22.1 t70 -66.43 -35.78 81.16 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.369 -0.832 . . . . 10.0 110.874 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -59.53 -45.48 91.64 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.031 0.443 . . . . 10.0 110.712 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 64.7 t -59.51 -35.83 61.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 115.517 -0.765 . . . . 10.0 110.373 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.4 ttpm? -67.51 -35.06 78.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.229 -0.896 . . . . 10.0 110.863 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.575 HG13 ' O ' ' A' ' 42' ' ' ASP . 23.4 mt -76.22 -47.04 32.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.573 -0.285 . . . . 10.0 110.938 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -58.87 -47.14 85.99 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.039 -0.528 . . . . 10.0 111.712 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -104.27 54.65 0.73 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.21 0.528 . . . . 10.0 110.986 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.83 -36.35 29.02 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.709 -0.757 . . . . 10.0 111.521 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.09 4.83 28.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.928 0.394 . . . . 10.0 110.994 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -138.83 87.83 14.25 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.001 -0.545 . . . . 10.0 109.917 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -70.7 -21.0 29.71 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.361 2.041 . . . . 10.0 112.598 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.78 -47.44 83.48 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.499 -0.318 . . . . 10.0 111.328 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.8 m -63.15 -43.27 98.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.077 0.465 . . . . 10.0 110.587 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -65.2 -39.83 93.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.11 -0.495 . . . . 10.0 110.91 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -65.87 -35.97 82.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.985 -0.552 . . . . 10.0 110.705 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -69.53 -33.69 72.52 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.647 -0.706 . . . . 10.0 111.542 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -59.53 -34.82 73.13 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.099 0.476 . . . . 10.0 110.334 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 23.9 mt -62.98 -41.28 99.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.752 -0.658 . . . . 10.0 110.64 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -67.18 -30.39 70.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.97 -0.559 . . . . 10.0 110.637 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.7 mt -65.62 -47.63 85.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.069 -0.514 . . . . 10.0 110.419 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 44.1 mtp -66.07 -27.12 67.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.965 -0.561 . . . . 10.0 111.065 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -63.29 -41.77 99.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.232 -0.44 . . . . 10.0 110.989 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -64.05 -33.32 75.48 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.074 0.464 . . . . 10.0 110.46 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -74.92 -41.27 60.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.7 -0.682 . . . . 10.0 110.466 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -62.63 -34.35 76.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.842 -0.617 . . . . 10.0 111.307 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 68.6 m -82.42 -0.66 47.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.417 -0.356 . . . . 10.0 111.104 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 63.33 23.02 13.58 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.029 -0.532 . . . . 10.0 111.504 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.36 -41.64 39.54 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.845 -0.798 . . . . 10.0 108.845 178.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 31.2 pt -114.87 165.9 9.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.676 -0.693 . . . . 10.0 110.083 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -123.12 -166.48 1.46 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.129 -0.487 . . . . 10.0 109.77 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.474 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 7.1 m -49.02 -55.25 21.6 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 112.029 0.381 . . . . 10.0 112.029 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 72' ' ' THR . 11.5 Cg_endo -55.84 -34.48 91.53 Favored 'Trans proline' 0 C--N 1.358 1.028 0 C-N-CA 122.387 2.058 . . . . 10.0 112.548 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.68 -44.51 62.96 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.778 -0.725 . . . . 10.0 111.939 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.465 ' O ' HG22 ' A' ' 79' ' ' VAL . 82.5 t -60.97 -45.45 98.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.951 -0.388 . . . . 10.0 109.951 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 88.8 mt -55.49 -42.57 68.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.09 -0.504 . . . . 10.0 110.984 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 41.4 ttp180 -59.23 -44.82 92.3 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.137 0.494 . . . . 10.0 109.897 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -63.54 -46.85 84.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.734 -0.666 . . . . 10.0 110.263 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 75' ' ' VAL . 64.3 t -58.46 -43.91 87.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.545 -0.752 . . . . 10.0 111.205 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.408 ' HA ' HD12 ' A' ' 90' ' ' ILE . 9.8 m -66.04 -38.23 87.84 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.182 -0.463 . . . . 10.0 111.59 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -75.84 -20.22 58.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.908 0.385 . . . . 10.0 110.855 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.2 tp -87.55 -53.57 4.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.984 -0.553 . . . . 10.0 110.654 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -97.57 44.52 1.04 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.953 0.406 . . . . 10.0 110.552 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -69.93 -13.59 62.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.321 -0.399 . . . . 10.0 111.424 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -96.95 -12.48 23.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.996 0.426 . . . . 10.0 110.271 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -136.01 77.69 49.11 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 10.0 110.964 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -62.49 -23.41 74.91 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.588 2.192 . . . . 10.0 112.34 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.5 -23.85 67.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.115 -0.493 . . . . 10.0 111.024 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 81.6 mt -87.38 -30.47 20.73 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.459 -0.337 . . . . 10.0 110.49 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.408 HD12 ' HA ' ' A' ' 80' ' ' SER . 55.5 mt -63.48 -51.94 64.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.893 0.378 . . . . 10.0 110.903 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.6 t -63.2 -27.46 43.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.851 -0.613 . . . . 10.0 110.421 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.49 -37.55 92.28 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.431 -0.668 . . . . 10.0 111.431 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -66.67 -39.39 88.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.889 0.376 . . . . 10.0 110.408 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -63.54 -34.87 78.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.585 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -90.24 0.66 57.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.159 -0.473 . . . . 10.0 110.792 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -106.49 2.51 26.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.262 -0.426 . . . . 10.0 110.777 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 53.9 mt -69.96 118.18 61.0 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.276 -0.42 . . . . 10.0 111.069 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -70.79 -41.89 2.69 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.469 2.113 . . . . 10.0 112.536 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.3 m -94.23 149.97 20.74 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 116.321 -0.4 . . . . 10.0 110.232 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -177.9 -141.94 4.41 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.644 -0.789 . . . . 10.0 111.732 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -80.44 0.84 9.73 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.699 2.266 . . . . 10.0 112.424 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.02 157.96 32.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.394 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.2 m -69.19 139.2 54.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.856 0.36 . . . . 10.0 111.426 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.451 0 C-N-CA 120.665 -0.779 . . . . 10.0 112.171 179.912 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.45 -0.434 0 CA-C-O 121.032 0.444 . . . . 10.0 110.529 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.7 m -79.47 134.86 36.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.604 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.58 86.17 1.82 Allowed Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.52 -0.847 . . . . 10.0 112.641 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.9 m -103.62 156.53 5.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 110.068 -0.345 . . . . 10.0 110.068 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -94.63 -164.42 1.17 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.235 -0.438 . . . . 10.0 110.751 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.8 m -78.36 -22.12 13.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.125 0.488 . . . . 10.0 110.929 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -113.59 85.01 2.11 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.414 0.626 . . . . 10.0 110.456 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -113.05 -4.55 13.84 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.541 -0.754 . . . . 10.0 110.402 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.49 -40.13 95.68 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.336 -0.847 . . . . 10.0 112.419 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.15 -9.14 58.81 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.919 0.341 . . . . 10.0 111.919 -178.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.76 -49.55 24.93 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.137 0.494 . . . . 10.0 111.702 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -73.17 -12.9 61.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.07 -0.514 . . . . 10.0 111.499 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.93 -45.81 69.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.007 0.432 . . . . 10.0 110.829 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -69.92 -32.28 70.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.35 -0.386 . . . . 10.0 111.379 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -56.64 -35.13 68.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.929 -0.578 . . . . 10.0 110.885 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 28.7 t -66.02 -42.45 91.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 10.0 110.045 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -63.33 -38.59 91.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.873 -0.603 . . . . 10.0 111.084 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 57.2 mt -73.77 -44.92 51.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 10.0 110.967 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -58.26 -40.96 83.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 10.0 110.894 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -110.13 41.73 1.67 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.335 0.588 . . . . 10.0 110.454 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.87 -28.17 73.41 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.952 -0.642 . . . . 10.0 112.053 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.3 m -96.23 2.38 52.93 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.803 0.335 . . . . 10.0 110.864 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -134.01 86.74 36.62 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 109.591 -0.522 . . . . 10.0 109.591 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -68.27 -17.75 44.77 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.922 2.414 . . . . 10.0 112.582 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.59 -49.28 69.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.058 -0.519 . . . . 10.0 111.122 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.8 m -62.85 -43.19 99.47 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.549 -0.296 . . . . 10.0 111.246 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -65.4 -40.12 93.02 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 110.128 -0.323 . . . . 10.0 110.128 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -60.86 -48.13 83.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 10.0 110.361 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.456 ' O ' HG13 ' A' ' 61' ' ' ILE . . . -60.02 -44.55 97.14 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.93 -0.652 . . . . 10.0 111.828 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -55.78 -43.23 76.59 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.757 0.313 . . . . 10.0 110.891 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 77.8 mt -64.55 -38.03 89.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.932 -0.576 . . . . 10.0 111.26 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -70.71 -39.91 73.13 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.296 -0.411 . . . . 10.0 111.056 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 57' ' ' GLY . 62.4 mt -67.45 -36.5 76.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.024 0.44 . . . . 10.0 110.428 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.93 -31.97 67.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.901 -0.59 . . . . 10.0 111.131 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -63.01 -45.37 92.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.964 -0.562 . . . . 10.0 110.844 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -59.8 -36.34 76.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.916 -0.584 . . . . 10.0 111.663 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -66.73 -42.94 85.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.373 -0.376 . . . . 10.0 110.88 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -74.86 -24.29 58.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.895 -0.593 . . . . 10.0 111.104 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 68.4 m -79.08 5.0 12.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.898 0.38 . . . . 10.0 110.537 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 61.77 33.58 17.75 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.798 -0.637 . . . . 10.0 110.866 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.1 m -93.88 -26.12 17.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.302 -0.408 . . . . 10.0 111.044 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.0 pt -139.85 158.42 26.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.184 -0.462 . . . . 10.0 110.646 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.401 ' HB3' ' H ' ' A' ' 72' ' ' THR . 30.9 m-20 -119.17 -158.93 0.75 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.288 -0.415 . . . . 10.0 110.249 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.401 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -48.21 -59.68 5.58 Favored Pre-proline 0 CA--C 1.542 0.673 0 N-CA-C 112.65 0.611 . . . . 10.0 112.65 -179.6 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.91 -35.07 69.18 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 121.554 1.503 . . . . 10.0 112.722 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.1 -44.31 91.52 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 121.099 -0.572 . . . . 10.0 112.256 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.502 ' O ' HG22 ' A' ' 79' ' ' VAL . 8.9 p -74.89 -35.36 35.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 O-C-N 122.853 -0.204 . . . . 10.0 110.906 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 74.0 mt -62.95 -37.92 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.077 0 N-CA-C 110.172 -0.307 . . . . 10.0 110.172 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -59.86 -29.79 68.53 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.287 0.565 . . . . 10.0 110.193 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -81.61 -42.55 19.9 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.716 -0.675 . . . . 10.0 109.656 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.502 HG22 ' O ' ' A' ' 75' ' ' VAL . 97.6 t -59.3 -46.59 92.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.613 -0.721 . . . . 10.0 110.737 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.6 m -63.04 -28.85 70.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.952 -0.567 . . . . 10.0 111.512 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -84.91 -40.63 16.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.673 0.273 . . . . 10.0 111.366 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 6.6 tp -64.97 -47.45 77.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.235 0.541 . . . . 10.0 111.056 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -101.18 45.59 0.97 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.013 -0.54 . . . . 10.0 110.076 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -63.93 -29.37 70.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.958 -0.565 . . . . 10.0 111.327 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -98.94 6.37 46.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.964 0.411 . . . . 10.0 110.897 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -137.57 71.11 52.18 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 116.36 -0.382 . . . . 10.0 110.438 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.02 -31.44 76.5 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.338 2.025 . . . . 10.0 112.288 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.78 -32.28 70.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 10.0 110.762 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 89.1 mt -72.11 -42.51 65.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.22 -0.446 . . . . 10.0 110.051 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 26.2 mt -65.16 -44.44 95.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 116.036 -0.529 . . . . 10.0 109.805 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 99.1 t -65.11 -37.77 81.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 115.818 -0.628 . . . . 10.0 109.508 178.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -64.18 -38.18 95.58 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.655 -0.783 . . . . 10.0 111.609 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -68.97 -28.1 66.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.96 0.409 . . . . 10.0 110.566 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -62.18 -28.19 69.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.164 0.507 . . . . 10.0 109.926 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.93 8.87 30.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.571 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -117.62 33.35 5.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.831 -0.622 . . . . 10.0 110.072 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.6 mt -106.34 114.68 61.98 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.784 -0.644 . . . . 10.0 110.086 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -71.12 -12.23 30.01 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.626 2.218 . . . . 10.0 112.076 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.3 m -109.93 104.55 13.49 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.029 -0.532 . . . . 10.0 110.563 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -154.49 -149.28 5.21 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.753 -0.737 . . . . 10.0 112.256 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -79.98 39.38 0.83 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.288 2.659 . . . . 10.0 113.232 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 57.9 m -96.35 174.16 7.01 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.147 -0.479 . . . . 10.0 110.228 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.3 m -71.72 95.57 1.49 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.949 0.404 . . . . 10.0 110.252 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.654 0 C-N-CA 120.946 -0.645 . . . . 10.0 111.93 -179.7 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.3 m . . . . . 0 C--O 1.233 0.201 0 N-CA-C 110.055 -0.35 . . . . 10.0 110.055 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.1 m -83.62 99.28 10.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.278 0.561 . . . . 10.0 110.404 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 171.22 66.25 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 111.321 -0.711 . . . . 10.0 111.321 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.4 m -64.85 151.71 9.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.873 0.368 . . . . 10.0 111.294 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 3.2 m170 -116.04 175.68 5.43 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.775 -0.454 . . . . 10.0 109.775 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.7 m -81.26 -23.74 10.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.136 0.493 . . . . 10.0 110.537 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -145.84 88.12 1.81 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.438 0.637 . . . . 10.0 109.936 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -117.87 23.4 11.7 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.682 -0.69 . . . . 10.0 110.254 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.9 -41.95 97.09 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.487 -0.779 . . . . 10.0 110.62 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pp -64.36 -28.47 69.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.534 -0.757 . . . . 10.0 111.303 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.531 ' O ' ' HG2' ' A' ' 43' ' ' GLN . 1.3 m -68.18 -52.78 30.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.068 -0.514 . . . . 10.0 111.358 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -66.38 -28.92 69.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.889 0.376 . . . . 10.0 110.165 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.63 -40.74 96.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.845 -0.616 . . . . 10.0 110.021 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -72.03 -31.27 66.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 10.0 110.554 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.531 ' HG2' ' O ' ' A' ' 39' ' ' THR . 15.9 mm100 -59.21 -40.1 84.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.703 -0.68 . . . . 10.0 110.573 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 92.2 t -59.68 -40.36 82.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.25 0.547 . . . . 10.0 109.863 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.4 ttpm? -62.89 -37.36 86.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.338 -0.846 . . . . 10.0 111.224 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 49.2 mt -73.76 -43.97 52.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.087 0.47 . . . . 10.0 110.795 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -63.66 -37.37 87.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.85 -0.614 . . . . 10.0 111.046 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -110.36 49.81 0.83 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.344 0.592 . . . . 10.0 110.312 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -81.4 -21.67 61.91 Favored Glycine 0 C--O 1.229 -0.156 0 CA-C-N 115.564 -0.744 . . . . 10.0 112.679 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.9 m -86.54 -33.47 20.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.864 0.364 . . . . 10.0 110.522 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -116.85 100.98 53.67 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.067 -0.515 . . . . 10.0 110.71 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -75.12 -15.33 20.54 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.366 2.044 . . . . 10.0 112.256 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.54 -46.83 86.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.7 -0.682 . . . . 10.0 111.067 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.8 m -67.5 -32.61 73.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.008 -0.542 . . . . 10.0 110.331 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -68.74 -43.88 74.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.12 -0.491 . . . . 10.0 110.073 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -62.6 -39.99 95.49 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.845 -0.616 . . . . 10.0 109.972 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.3 -34.19 88.76 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.681 -0.771 . . . . 10.0 111.696 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -63.0 -39.32 94.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.091 0.472 . . . . 10.0 110.657 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 30.1 mt -64.46 -34.61 78.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.877 -0.601 . . . . 10.0 110.433 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -67.39 -37.12 82.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.684 -0.689 . . . . 10.0 110.713 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.7 mt -64.84 -39.96 87.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.166 0.508 . . . . 10.0 110.065 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.73 -31.25 72.37 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.523 -0.762 . . . . 10.0 110.35 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -62.88 -45.15 93.9 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.049 -0.523 . . . . 10.0 109.856 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -61.0 -35.22 76.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.63 -0.714 . . . . 10.0 110.631 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -70.14 -45.61 66.45 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.799 0.333 . . . . 10.0 110.324 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -67.11 -29.83 69.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.013 0.435 . . . . 10.0 110.932 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.83 -3.34 47.39 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.81 -0.632 . . . . 10.0 110.186 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 63.83 31.26 14.17 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.768 -0.651 . . . . 10.0 111.517 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.6 m -91.02 -20.98 21.5 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.1 -0.5 . . . . 10.0 109.75 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 24.3 pt -134.84 150.99 30.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.838 -0.619 . . . . 10.0 109.55 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -107.37 -164.49 0.98 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.878 -0.415 . . . . 10.0 109.878 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -49.12 -56.64 14.69 Favored Pre-proline 0 CA--C 1.537 0.472 0 O-C-N 123.619 0.574 . . . . 10.0 112.502 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.17 -28.59 48.24 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 121.683 1.589 . . . . 10.0 112.733 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.23 -51.99 29.77 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.839 -0.619 . . . . 10.0 113.069 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.9 p -64.52 -40.88 90.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.801 0.334 . . . . 10.0 111.1 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 91.6 mt -62.37 -45.35 98.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.475 -0.33 . . . . 10.0 110.644 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 11.4 ttp180 -61.61 -45.65 93.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.395 -0.366 . . . . 10.0 110.936 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -57.87 -49.33 77.05 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.997 0.427 . . . . 10.0 111.095 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 86.2 t -68.36 -34.81 68.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.006 -0.543 . . . . 10.0 111.011 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.9 t -61.83 -30.57 70.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.483 -0.326 . . . . 10.0 111.475 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -82.36 -28.97 31.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.009 0.433 . . . . 10.0 110.698 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 23.2 tp -81.96 -40.99 21.42 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.097 -0.501 . . . . 10.0 111.326 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -97.08 32.24 2.21 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.167 -0.469 . . . . 10.0 110.637 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -65.67 -17.65 64.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.895 0.378 . . . . 10.0 111.749 -179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -88.33 -7.78 56.15 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.014 0.435 . . . . 10.0 110.466 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -134.69 71.64 70.31 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.864 -0.607 . . . . 10.0 109.491 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.38 -27.48 84.93 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.953 2.436 . . . . 10.0 112.746 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.07 -31.26 72.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.239 -0.437 . . . . 10.0 110.871 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 67.7 mt -75.21 -35.67 61.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 10.0 110.67 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 58.3 mt -65.41 -52.79 47.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.944 -0.571 . . . . 10.0 110.48 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.1 t -65.49 -38.98 83.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.052 -0.522 . . . . 10.0 109.706 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.98 -36.16 86.92 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.488 -0.778 . . . . 10.0 111.908 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -64.1 -44.03 93.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.716 0.293 . . . . 10.0 110.387 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -60.47 -42.86 97.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.121 -0.49 . . . . 10.0 110.191 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.31 -22.0 59.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.109 -0.496 . . . . 10.0 111.257 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -83.04 -11.6 57.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.258 -0.428 . . . . 10.0 111.171 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 60.2 mt -69.63 119.47 71.13 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.42 -0.355 . . . . 10.0 110.429 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -67.18 -42.59 7.56 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.642 2.228 . . . . 10.0 112.012 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.2 m -79.82 145.32 32.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.71 -0.677 . . . . 10.0 109.967 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 179.92 -131.92 1.73 Allowed Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.563 -0.615 . . . . 10.0 111.563 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -92.26 17.56 1.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.916 2.411 . . . . 10.0 112.16 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.4 m -82.77 176.57 9.22 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.941 -0.572 . . . . 10.0 111.305 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.48 113.97 3.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.994 -0.548 . . . . 10.0 111.598 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.479 0 C-N-CA 121.036 -0.602 . . . . 10.0 112.391 179.404 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.0 m . . . . . 0 N--CA 1.451 -0.425 0 N-CA-C 110.0 -0.371 . . . . 10.0 110.0 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.8 m -105.01 136.08 45.15 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.31 -0.404 . . . . 10.0 110.97 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.92 105.23 2.97 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.637 -0.792 . . . . 10.0 112.207 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 17.0 m -115.45 164.56 11.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 110.12 -0.326 . . . . 10.0 110.12 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -104.3 -175.77 2.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.374 -0.376 . . . . 10.0 110.506 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.5 m -79.9 -4.19 6.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.189 0.518 . . . . 10.0 110.869 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -109.56 25.75 11.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.662 -0.699 . . . . 10.0 110.349 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.0 p-10 -68.07 -26.35 65.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.887 -0.597 . . . . 10.0 111.332 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.36 -51.3 62.91 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.586 0.587 . . . . 10.0 112.586 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pp -80.75 -0.87 40.45 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 122.067 -0.396 . . . . 10.0 111.86 -178.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 m -84.25 -34.99 23.72 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.942 0.401 . . . . 10.0 110.46 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -70.58 -21.92 62.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.342 -0.39 . . . . 10.0 111.214 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.54 -47.23 86.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 10.0 110.814 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -64.62 -35.91 82.55 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.957 -0.565 . . . . 10.0 110.61 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -58.41 -48.42 80.72 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.09 -0.505 . . . . 10.0 110.839 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.2 t -64.08 -35.86 75.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 115.65 -0.704 . . . . 10.0 110.549 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.7 tttm -67.77 -35.97 79.65 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.412 -0.813 . . . . 10.0 111.242 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 94.8 mt -77.16 -43.24 31.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.693 0.282 . . . . 10.0 111.295 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -58.3 -36.93 74.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.417 -0.356 . . . . 10.0 111.282 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -110.93 48.05 0.95 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.342 0.591 . . . . 10.0 109.987 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.47 -29.86 74.52 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.642 -0.708 . . . . 10.0 112.788 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.7 m -101.52 1.82 38.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.877 0.339 . . . . 10.0 111.383 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -124.68 94.55 44.26 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 120.908 0.385 . . . . 10.0 110.344 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -77.63 -11.38 17.02 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.481 2.121 . . . . 10.0 112.325 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.44 -51.55 23.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.215 -0.448 . . . . 10.0 110.919 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.5 m -64.48 -31.66 72.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.397 0.618 . . . . 10.0 110.039 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -66.27 -44.44 83.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.657 -0.702 . . . . 10.0 110.265 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -64.36 -37.5 87.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.509 . . . . 10.0 110.828 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.25 -39.45 97.89 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.71 -0.677 . . . . 10.0 112.891 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -60.75 -38.33 84.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.86 0.362 . . . . 10.0 110.702 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.427 ' O ' ' HG3' ' A' ' 63' ' ' LYS . 67.0 mt -65.89 -37.83 87.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.102 -0.499 . . . . 10.0 110.722 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -62.98 -40.38 97.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.114 0.483 . . . . 10.0 109.928 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.3 mt -62.75 -44.66 99.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.786 -0.643 . . . . 10.0 110.198 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.412 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -61.65 -35.75 78.84 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.691 -0.686 . . . . 10.0 110.773 179.853 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 59' ' ' LEU . 92.8 mttt -60.62 -47.22 87.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.753 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -59.58 -40.58 87.85 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.925 0.393 . . . . 10.0 110.885 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -68.24 -42.03 80.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.295 -0.411 . . . . 10.0 110.649 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 62' ' ' MET . 43.8 mtpt -66.12 -33.05 74.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.432 -0.349 . . . . 10.0 111.107 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.1 m -84.67 3.84 35.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.498 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 60.69 32.69 20.3 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.819 -0.628 . . . . 10.0 111.947 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.2 m -81.44 -25.72 35.91 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.329 0.585 . . . . 10.0 109.576 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 15.6 pt -137.84 164.88 27.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.365 -0.834 . . . . 10.0 109.904 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.35 -165.55 1.02 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.935 -0.395 . . . . 10.0 109.935 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.409 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 2.3 m -51.97 -55.57 29.47 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 112.502 0.556 . . . . 10.0 112.502 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 72' ' ' THR . 24.6 Cg_endo -62.35 -22.23 73.8 Favored 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 121.908 1.739 . . . . 10.0 112.59 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -83.26 -44.78 6.85 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.757 -0.735 . . . . 10.0 111.904 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.5 p -64.79 -34.69 71.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-O 120.817 0.342 . . . . 10.0 110.921 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 77.5 mt -70.11 -41.57 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 110.063 -0.347 . . . . 10.0 110.063 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 26.3 ttp180 -63.62 -40.11 96.06 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.339 -0.391 . . . . 10.0 110.253 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.6 mmt180 -57.76 -43.9 85.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.397 0.618 . . . . 10.0 110.18 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 45.9 t -72.9 -29.51 29.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.461 -0.79 . . . . 10.0 111.082 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.7 m -61.08 -29.87 70.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.079 0.466 . . . . 10.0 110.785 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.8 mm-40 -87.82 -26.77 22.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.917 -0.583 . . . . 10.0 110.45 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 29.5 tp -76.53 -53.6 7.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.031 -0.531 . . . . 10.0 110.284 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 18.9 m-30 -93.11 45.27 1.17 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.953 0.406 . . . . 10.0 110.447 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -68.35 -13.01 61.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.035 -0.529 . . . . 10.0 110.948 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -102.99 -10.89 18.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.009 -0.541 . . . . 10.0 110.761 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -133.36 79.53 60.57 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 120.737 0.303 . . . . 10.0 110.855 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.44 ' O ' HG22 ' A' ' 91' ' ' VAL . 18.1 Cg_endo -61.55 -31.47 87.35 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.741 2.294 . . . . 10.0 111.981 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -60.6 -31.81 70.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.744 -0.662 . . . . 10.0 110.987 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.2 mt -74.48 -25.33 59.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.031 -0.532 . . . . 10.0 111.162 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 46.1 mt -80.73 -44.56 21.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.125 -0.489 . . . . 10.0 110.023 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 87' ' ' PRO . 17.4 t -67.87 -31.1 50.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.83 -0.623 . . . . 10.0 110.288 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.22 -39.4 97.64 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.805 -0.712 . . . . 10.0 111.759 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.444 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 59.2 t80 -64.28 -36.44 84.13 Favored 'General case' 0 C--O 1.227 -0.117 0 CA-C-O 121.007 0.432 . . . . 10.0 110.216 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -62.63 -27.88 69.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.816 -0.629 . . . . 10.0 110.756 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -93.16 -19.96 20.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.287 -0.415 . . . . 10.0 111.149 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -97.26 44.5 1.05 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.299 -0.41 . . . . 10.0 110.643 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 93' ' ' PHE . 40.9 mt -113.01 102.92 55.48 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.083 -0.508 . . . . 10.0 110.444 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 97' ' ' LEU . 18.7 Cg_endo -62.19 -42.92 26.23 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.37 2.047 . . . . 10.0 111.873 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.7 94.53 7.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.921 -0.581 . . . . 10.0 110.039 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -134.31 -151.15 6.33 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.559 -0.829 . . . . 10.0 112.55 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -83.11 25.22 0.69 Allowed 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 122.939 2.426 . . . . 10.0 112.385 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.89 171.77 14.72 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.938 -0.574 . . . . 10.0 111.106 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.5 m -61.38 125.44 23.79 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.049 0.452 . . . . 10.0 111.171 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.652 0 C-N-CA 120.814 -0.708 . . . . 10.0 111.806 -179.951 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.2 m . . . . . 0 C--O 1.235 0.322 0 CA-C-O 120.866 0.365 . . . . 10.0 110.222 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.0 m -106.43 127.07 53.01 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.227 -0.442 . . . . 10.0 110.628 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.07 55.12 0.1 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.72 -0.753 . . . . 10.0 111.996 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.8 m -68.78 155.02 7.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-O 121.154 0.502 . . . . 10.0 111.351 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -99.07 -176.14 3.23 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.201 -0.454 . . . . 10.0 110.571 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.0 m -65.33 -20.11 26.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 121.197 0.522 . . . . 10.0 110.673 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -102.6 56.75 0.78 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.285 0.564 . . . . 10.0 109.812 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -90.44 -12.23 38.04 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.53 -0.759 . . . . 10.0 111.23 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.2 -48.7 80.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.609 -0.723 . . . . 10.0 111.355 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 pp -71.2 -22.5 62.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.161 -0.472 . . . . 10.0 111.993 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.491 ' O ' ' HG2' ' A' ' 43' ' ' GLN . 1.1 m -65.45 -60.1 3.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.356 -0.384 . . . . 10.0 111.421 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -67.4 -27.94 67.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.639 -0.255 . . . . 10.0 111.244 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -58.39 -35.24 71.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.281 -0.418 . . . . 10.0 111.511 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -91.06 -24.61 19.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.394 -0.366 . . . . 10.0 111.44 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 39' ' ' THR . 15.9 mm100 -56.47 -36.12 68.72 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.905 0.383 . . . . 10.0 110.856 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.524 HG22 ' CZ ' ' A' ' 58' ' ' PHE . 11.0 t -66.7 -36.84 78.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 10.0 110.615 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.7 ttpm? -65.91 -35.4 80.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.886 -0.597 . . . . 10.0 110.449 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 46.0 mt -74.61 -40.92 48.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.717 -0.674 . . . . 10.0 109.98 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 -63.23 -51.76 64.92 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.345 -0.843 . . . . 10.0 111.514 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -102.35 54.03 0.79 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.282 0.563 . . . . 10.0 110.433 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.74 -41.28 89.3 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.701 -0.681 . . . . 10.0 112.874 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.3 m -92.96 7.93 41.95 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.842 0.321 . . . . 10.0 111.583 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -129.14 89.07 49.38 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.86 0.362 . . . . 10.0 111.241 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.9 -17.66 17.47 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.218 1.946 . . . . 10.0 112.311 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.83 -54.8 22.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.959 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.6 m -69.04 -27.51 65.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.024 0.44 . . . . 10.0 111.049 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -70.19 -41.99 72.99 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.858 0.361 . . . . 10.0 110.677 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -62.57 -42.11 99.35 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.201 -0.454 . . . . 10.0 110.322 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.12 -33.23 86.69 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.933 -0.651 . . . . 10.0 111.723 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.524 ' CZ ' HG22 ' A' ' 44' ' ' VAL . 88.4 t80 -62.2 -37.02 83.71 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.071 0.462 . . . . 10.0 110.07 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 22.7 mt -72.3 -35.87 68.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.68 -0.691 . . . . 10.0 110.901 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -62.04 -34.86 77.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.925 -0.58 . . . . 10.0 111.071 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.4 mt -66.22 -34.31 69.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.114 -0.493 . . . . 10.0 110.959 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.5 mtp -64.5 -33.79 76.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.371 -0.377 . . . . 10.0 110.52 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -61.64 -37.56 84.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.973 -0.558 . . . . 10.0 110.615 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -64.23 -37.92 89.2 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.111 -0.495 . . . . 10.0 110.808 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -78.6 -42.3 29.36 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.728 -0.389 . . . . 10.0 111.15 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -63.25 -34.33 77.44 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.589 -0.278 . . . . 10.0 111.661 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.9 m -84.22 5.38 26.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.733 0.301 . . . . 10.0 111.117 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 63.7 31.92 14.08 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.974 -0.557 . . . . 10.0 111.736 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.4 m -87.71 -48.29 7.98 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.999 0.428 . . . . 10.0 110.303 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 47.9 pt -104.72 146.43 11.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 110.03 -0.359 . . . . 10.0 110.03 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -99.48 -175.54 3.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.802 -0.636 . . . . 10.0 109.956 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.543 ' O ' HG11 ' A' ' 75' ' ' VAL . 0.9 OUTLIER -55.08 -54.09 54.13 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 111.707 0.262 . . . . 10.0 111.707 -179.77 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' A' ' 72' ' ' THR . 24.2 Cg_endo -63.26 -24.71 72.1 Favored 'Trans proline' 0 C--N 1.358 1.067 0 C-N-CA 121.833 1.689 . . . . 10.0 112.324 178.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.85 -39.26 28.99 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.018 -0.61 . . . . 10.0 112.679 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.543 HG11 ' O ' ' A' ' 72' ' ' THR . 4.9 p -68.71 -29.86 45.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 O-C-N 122.715 -0.285 . . . . 10.0 111.105 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 72' ' ' THR . 68.0 mt -59.86 -41.37 85.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-O 120.912 0.387 . . . . 10.0 110.052 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -62.13 -40.03 94.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.753 -0.658 . . . . 10.0 109.71 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.2 mmt180 -63.22 -44.89 93.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.754 -0.657 . . . . 10.0 110.739 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 75' ' ' VAL . 47.4 t -61.84 -46.3 96.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.758 -0.655 . . . . 10.0 110.855 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.9 m -65.59 -24.32 67.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.893 -0.594 . . . . 10.0 111.661 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -87.43 -24.53 24.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.748 0.309 . . . . 10.0 111.023 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 14.8 tp -86.0 -45.54 11.35 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.08 0.467 . . . . 10.0 110.418 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -103.82 43.77 1.07 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.739 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 13.5 p80 -63.6 -20.12 65.4 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.001 -0.545 . . . . 10.0 111.491 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -101.36 -0.21 35.91 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.962 0.411 . . . . 10.0 110.613 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -135.27 77.05 55.46 Favored Pre-proline 0 C--O 1.236 0.38 0 CA-C-N 116.246 -0.434 . . . . 10.0 110.208 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.434 ' O ' HG23 ' A' ' 91' ' ' VAL . 18.0 Cg_endo -60.92 -29.25 87.7 Favored 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.301 2.001 . . . . 10.0 112.631 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -62.85 -37.58 87.4 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 116.115 -0.493 . . . . 10.0 110.667 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.1 mt -66.15 -41.34 90.55 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.144 -0.48 . . . . 10.0 110.545 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.2 mt -66.02 -46.07 89.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.031 -0.532 . . . . 10.0 109.983 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 87' ' ' PRO . 73.8 t -62.38 -43.91 98.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.637 -0.711 . . . . 10.0 110.383 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.93 -40.62 99.11 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.685 -0.689 . . . . 10.0 112.235 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -66.14 -43.18 87.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.706 0.289 . . . . 10.0 110.726 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -61.79 -32.76 73.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.929 0.395 . . . . 10.0 111.36 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.23 -25.06 27.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.821 0.343 . . . . 10.0 111.365 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.45 -31.59 72.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.014 -0.539 . . . . 10.0 111.511 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 36.4 mt -58.16 115.62 11.94 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.526 -0.306 . . . . 10.0 111.688 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -82.25 -24.82 3.59 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.689 2.259 . . . . 10.0 112.125 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.4 m -91.41 99.82 12.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.157 -0.474 . . . . 10.0 110.58 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -151.55 -115.27 0.66 Allowed Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.955 -0.858 . . . . 10.0 110.955 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -82.32 6.86 5.46 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.407 2.071 . . . . 10.0 111.201 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.33 154.44 23.93 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.408 -0.815 . . . . 10.0 111.765 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.45 126.12 29.07 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.74 -0.664 . . . . 10.0 110.173 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 C-N-CA 120.768 -0.729 . . . . 10.0 112.463 179.682 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 56.3 m . . . . . 0 C--O 1.235 0.3 0 CA-C-O 121.028 0.442 . . . . 10.0 110.258 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.9 m -67.39 148.39 51.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.985 -0.552 . . . . 10.0 111.224 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.49 83.34 1.56 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.742 -0.742 . . . . 10.0 112.42 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 29.5 m -108.14 156.23 8.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 110.159 -0.312 . . . . 10.0 110.159 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -102.35 -177.77 3.5 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.344 -0.389 . . . . 10.0 110.203 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.2 m -65.19 -27.1 41.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.812 0.339 . . . . 10.0 111.485 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -99.53 93.41 5.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.465 -0.334 . . . . 10.0 110.396 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -107.09 -11.56 15.61 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.348 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.09 -50.76 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.649 -0.705 . . . . 10.0 112.404 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.12 -10.99 60.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.129 -0.487 . . . . 10.0 112.052 -178.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.54 -58.46 2.52 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.049 0.452 . . . . 10.0 111.695 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.495 ' O ' HG23 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -67.88 -30.78 70.22 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.896 0.702 . . . . 10.0 112.896 -177.633 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.1 -38.83 73.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.749 0.309 . . . . 10.0 111.59 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.4 ' O ' HG13 ' A' ' 46' ' ' ILE . 12.5 t0 -78.92 -35.49 43.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.83 0.348 . . . . 10.0 110.642 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -57.72 -39.9 78.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.981 -0.554 . . . . 10.0 111.383 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 40' ' ' TYR . 26.8 t -65.44 -37.11 79.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.077 0.465 . . . . 10.0 110.207 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.1 ttpm? -69.15 -33.26 73.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.638 -0.71 . . . . 10.0 110.634 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 42' ' ' ASP . 62.8 mt -73.59 -43.07 55.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.855 -0.612 . . . . 10.0 110.224 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -65.74 -42.24 91.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.864 -0.607 . . . . 10.0 111.203 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -107.4 58.94 0.62 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.33 0.586 . . . . 10.0 110.57 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.62 -43.78 9.94 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.457 -0.792 . . . . 10.0 111.938 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 39.3 m -85.21 -11.05 55.83 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.861 0.362 . . . . 10.0 110.838 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -114.66 92.74 30.35 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.149 -0.478 . . . . 10.0 110.824 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -76.42 -15.84 17.49 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.233 1.956 . . . . 10.0 111.757 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.32 -54.49 32.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.507 -0.77 . . . . 10.0 111.634 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.7 m -65.95 -34.0 77.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.402 -0.363 . . . . 10.0 111.0 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -65.34 -44.23 88.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 10.0 110.719 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -64.6 -41.8 95.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.169 -0.469 . . . . 10.0 110.569 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.61 -39.09 96.91 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 115.948 -0.569 . . . . 10.0 112.09 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -57.98 -40.61 81.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.146 0.498 . . . . 10.0 110.463 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 27.3 mt -71.7 -30.01 65.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.791 -0.641 . . . . 10.0 111.127 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -68.93 -38.65 79.64 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.022 0.439 . . . . 10.0 110.876 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.1 mt -67.74 -30.84 49.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.784 -0.644 . . . . 10.0 110.606 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 33.1 mmt -64.94 -28.11 69.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.181 -0.463 . . . . 10.0 110.588 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -63.08 -41.26 99.37 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.154 -0.476 . . . . 10.0 110.26 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -65.31 -42.25 93.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.761 -0.654 . . . . 10.0 110.487 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -65.15 -42.59 93.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.112 -0.495 . . . . 10.0 110.634 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -67.82 -18.56 64.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.89 0.376 . . . . 10.0 111.054 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.1 m -95.92 2.19 53.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.067 -0.515 . . . . 10.0 110.453 178.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 64.79 23.05 12.65 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.714 -0.676 . . . . 10.0 110.758 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.2 m -77.74 -29.34 51.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.508 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 37.8 pt -128.48 153.37 37.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 10.0 111.008 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -105.3 -164.35 1.02 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.902 -0.59 . . . . 10.0 110.432 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.437 ' HB ' ' HD3' ' A' ' 73' ' ' PRO . 24.5 m -55.05 -56.48 27.52 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-N 116.502 -0.317 . . . . 10.0 111.212 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.437 ' HD3' ' HB ' ' A' ' 72' ' ' THR . 36.8 Cg_endo -66.41 -21.77 53.24 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 121.647 1.565 . . . . 10.0 111.822 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.07 -48.15 73.96 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.616 -0.72 . . . . 10.0 112.077 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.436 ' O ' HG22 ' A' ' 79' ' ' VAL . 9.5 p -72.77 -31.88 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 120.882 -0.327 . . . . 10.0 110.161 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 47.0 mt -59.95 -40.82 84.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 109.7 -0.482 . . . . 10.0 109.7 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 30.0 ttp180 -59.28 -42.32 90.97 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.112 -0.699 . . . . 10.0 109.112 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -67.4 -45.73 75.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.376 -0.829 . . . . 10.0 110.439 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 75' ' ' VAL . 62.7 t -55.64 -43.41 73.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.973 -0.558 . . . . 10.0 111.239 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.9 m -64.69 -30.33 71.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.036 -0.529 . . . . 10.0 112.006 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -87.93 -36.26 17.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.695 0.283 . . . . 10.0 111.381 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 24.1 tp -73.55 -54.14 8.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.92 0.391 . . . . 10.0 111.056 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -91.29 38.9 0.98 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.382 0.611 . . . . 10.0 109.651 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -59.38 -34.39 72.37 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.299 -0.864 . . . . 10.0 112.57 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -94.19 7.0 46.86 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.499 0.185 . . . . 10.0 111.499 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -133.59 72.48 74.03 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-O 120.754 0.311 . . . . 10.0 110.25 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.483 ' O ' HG23 ' A' ' 91' ' ' VAL . 33.4 Cg_exo -60.44 -32.78 94.23 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.026 2.484 . . . . 10.0 111.939 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -58.28 -38.4 76.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.591 -0.731 . . . . 10.0 110.433 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 60.1 mt -73.58 -31.69 63.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.915 -0.584 . . . . 10.0 111.306 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.0 mt -68.88 -45.53 80.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.12 0.486 . . . . 10.0 110.107 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 87' ' ' PRO . 19.4 t -69.34 -35.11 65.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.753 -0.658 . . . . 10.0 110.326 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.39 -46.39 94.42 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.787 -0.72 . . . . 10.0 112.47 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.439 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 64.2 t80 -62.01 -32.11 72.56 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.761 0.315 . . . . 10.0 111.18 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -61.37 -38.03 85.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.099 -0.501 . . . . 10.0 111.781 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.38 -8.25 32.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.895 0.378 . . . . 10.0 111.657 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.46 -19.69 35.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.823 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 93' ' ' PHE . 86.9 mt -58.02 121.66 52.32 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.939 -0.573 . . . . 10.0 111.533 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -77.57 -13.63 16.36 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.708 2.272 . . . . 10.0 112.451 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.7 m -106.45 110.77 23.08 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.336 -0.393 . . . . 10.0 110.651 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -142.05 -146.66 4.7 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.694 -0.765 . . . . 10.0 111.671 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -74.25 -5.99 17.76 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.635 2.223 . . . . 10.0 112.549 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 m -66.92 153.47 43.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.857 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.2 t -59.22 128.83 39.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.243 -0.435 . . . . 10.0 110.556 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.419 0 C-N-CA 120.435 -0.888 . . . . 10.0 112.351 -179.893 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.043 -0.423 . . . . 10.0 112.043 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.99 150.47 36.09 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.771 0.32 . . . . 10.0 110.68 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.7 t -83.47 84.58 7.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.271 0.558 . . . . 10.0 110.523 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -144.28 138.15 7.77 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.698 -0.763 . . . . 10.0 112.264 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.1 m -132.87 108.13 8.76 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.854 -0.424 . . . . 10.0 109.854 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.2 m -92.59 157.73 16.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.461 -0.336 . . . . 10.0 110.637 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.2 82.67 1.12 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.95 -0.643 . . . . 10.0 113.142 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.6 m -88.75 173.37 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.906 -0.405 . . . . 10.0 109.906 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -95.6 176.77 6.03 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.74 -0.209 . . . . 10.0 110.678 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.5 m -67.22 -23.41 30.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-O 120.881 0.372 . . . . 10.0 111.43 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -133.1 87.9 2.45 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.445 -0.576 . . . . 10.0 109.445 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -93.58 13.78 20.9 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.677 -0.692 . . . . 10.0 110.857 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.96 -42.79 94.28 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.767 -0.651 . . . . 10.0 111.412 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.05 -25.8 62.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.257 -0.428 . . . . 10.0 111.526 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.4 m -61.24 -60.35 3.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.22 -0.445 . . . . 10.0 111.519 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.515 ' HB3' ' C4 ' ' A' ' 201' ' ' 8TL . 42.9 t80 -66.22 -31.88 72.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.35 -0.386 . . . . 10.0 111.168 -179.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.09 -52.72 62.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.426 . . . . 10.0 111.48 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -74.74 -27.17 60.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.302 -0.408 . . . . 10.0 111.272 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -58.18 -38.89 77.56 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.251 -0.431 . . . . 10.0 111.662 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.2 t -62.77 -34.83 67.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.122 0.487 . . . . 10.0 110.632 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.7 ttpm? -70.41 -34.74 72.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.857 -0.611 . . . . 10.0 110.762 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 35.1 mt -76.75 -35.57 25.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.701 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -71.21 -43.38 67.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.209 -0.45 . . . . 10.0 111.104 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -106.94 44.18 1.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.184 0.516 . . . . 10.0 110.901 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.55 -30.75 78.18 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.882 -0.675 . . . . 10.0 112.291 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.1 m -92.73 -6.28 49.43 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 122.759 -0.26 . . . . 10.0 111.304 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -123.13 85.03 51.3 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 120.794 0.33 . . . . 10.0 110.847 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.42 -26.32 41.01 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.479 2.119 . . . . 10.0 112.812 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.79 -44.48 93.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.653 -0.249 . . . . 10.0 111.087 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.2 m -65.88 -40.79 91.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.063 -0.517 . . . . 10.0 111.034 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -69.06 -37.73 78.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.547 -0.297 . . . . 10.0 110.835 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -61.23 -43.22 99.23 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.856 0.36 . . . . 10.0 110.616 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.96 -37.82 95.18 Favored Glycine 0 C--N 1.332 0.33 0 N-CA-C 111.529 -0.628 . . . . 10.0 111.529 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -57.51 -42.21 82.36 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.974 0.416 . . . . 10.0 110.181 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 26.6 mt -67.12 -38.04 84.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.811 -0.631 . . . . 10.0 110.887 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -61.61 -44.28 97.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.28 -0.418 . . . . 10.0 110.704 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.9 mt -63.7 -35.78 74.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.306 -0.406 . . . . 10.0 110.304 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 82.6 mtp -64.01 -37.11 86.21 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.106 -0.497 . . . . 10.0 110.219 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -62.53 -37.42 86.0 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.008 -0.542 . . . . 10.0 111.153 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -63.45 -36.58 84.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.09 0.471 . . . . 10.0 110.094 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -73.33 -35.63 66.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.048 -0.524 . . . . 10.0 109.747 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -66.73 -23.96 66.17 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.117 -0.492 . . . . 10.0 110.45 178.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.0 m -94.35 2.74 55.8 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.92 -0.582 . . . . 10.0 110.131 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 56.85 31.63 19.95 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.648 -0.706 . . . . 10.0 111.294 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.7 m -82.2 -22.18 36.07 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.563 0.697 . . . . 10.0 109.846 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 17.6 pt -131.99 158.47 43.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.264 -0.88 . . . . 10.0 109.965 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -110.0 -162.46 0.8 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.557 -0.534 . . . . 10.0 109.557 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.474 ' HB ' ' CD ' ' A' ' 73' ' ' PRO . 1.4 m -56.73 -60.17 10.17 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 116.237 -0.438 . . . . 10.0 111.221 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.474 ' CD ' ' HB ' ' A' ' 72' ' ' THR . 25.1 Cg_endo -61.52 -21.73 72.71 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 121.908 1.739 . . . . 10.0 112.594 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.79 -50.31 11.57 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.931 -0.577 . . . . 10.0 112.674 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.545 ' O ' HG22 ' A' ' 79' ' ' VAL . 14.5 p -65.18 -36.85 78.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.89 0.345 . . . . 10.0 110.898 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 60.5 mt -58.64 -38.99 74.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 116.299 -0.409 . . . . 10.0 111.081 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 -60.87 -39.29 88.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.957 -0.565 . . . . 10.0 110.928 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -69.63 -45.56 68.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.805 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 75' ' ' VAL . 13.6 t -61.0 -38.28 79.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.906 -0.588 . . . . 10.0 110.971 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.0 m -65.95 -17.38 64.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.469 . . . . 10.0 111.786 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -102.52 -23.84 13.86 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 111.799 0.296 . . . . 10.0 111.799 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 40.3 tp -85.26 -53.08 5.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.929 0.395 . . . . 10.0 110.348 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -94.96 47.61 1.16 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.025 0.44 . . . . 10.0 110.11 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -66.08 -25.46 67.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.993 -0.549 . . . . 10.0 110.771 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -91.0 -9.54 45.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.114 -0.494 . . . . 10.0 110.583 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -128.97 72.05 81.91 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.289 -0.414 . . . . 10.0 111.214 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -61.8 -26.91 80.0 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.581 2.187 . . . . 10.0 112.587 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -56.27 -38.8 71.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.865 -0.607 . . . . 10.0 111.964 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 97.7 mt -64.36 -42.83 95.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.381 -0.372 . . . . 10.0 111.208 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.3 mt -73.0 -41.01 59.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.088 -0.506 . . . . 10.0 111.03 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.424 ' O ' ' HB2' ' A' ' 94' ' ' ASN . 78.7 t -67.36 -48.35 77.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.973 -0.558 . . . . 10.0 110.597 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.68 -31.19 77.07 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.002 -0.618 . . . . 10.0 112.45 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -63.93 -24.92 67.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.696 0.284 . . . . 10.0 111.17 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' ' 91' ' ' VAL . 2.6 m-80 -63.72 -33.68 76.19 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.031 0.443 . . . . 10.0 110.426 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -95.58 -16.68 21.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.211 0.529 . . . . 10.0 110.343 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -89.35 31.57 0.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.809 -0.632 . . . . 10.0 110.46 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.2 mt -121.35 108.48 35.82 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.4 -0.818 . . . . 10.0 109.178 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -59.7 -49.15 10.82 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.393 2.062 . . . . 10.0 111.849 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.49 118.31 10.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.283 -0.417 . . . . 10.0 110.367 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -168.21 -134.92 1.79 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.55 -0.833 . . . . 10.0 112.53 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -82.83 13.41 2.62 Favored 'Trans proline' 0 CA--C 1.529 0.226 0 C-N-CA 122.88 2.387 . . . . 10.0 113.284 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.2 m -73.65 162.58 29.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.709 0.29 . . . . 10.0 110.261 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.6 m -72.7 104.64 4.0 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.926 0.393 . . . . 10.0 110.532 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.457 0 C-N-CA 120.902 -0.666 . . . . 10.0 112.375 179.698 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' 8TL . . . . . 0.779 ' O3 ' ' C11' ' A' ' 201' ' ' 8TL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.573 0 N-CA-C 112.241 -0.344 . . . . 10.0 112.241 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.8 m -139.27 129.8 25.78 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.852 0.358 . . . . 10.0 110.536 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.9 m -87.86 104.71 16.86 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.405 -0.361 . . . . 10.0 110.422 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -176.81 166.97 38.09 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.113 -0.565 . . . . 10.0 111.965 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 65.7 m -151.74 93.09 1.82 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.102 0.477 . . . . 10.0 110.766 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.56 113.58 24.29 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.947 -0.57 . . . . 10.0 109.907 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 155.08 74.22 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.803 -0.713 . . . . 10.0 111.416 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 28.5 m -84.47 156.54 3.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.094 0.473 . . . . 10.0 111.027 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -112.14 -178.55 3.45 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.585 -0.734 . . . . 10.0 109.321 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.9 m -67.24 -36.27 76.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.721 0.296 . . . . 10.0 111.73 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -115.05 105.72 13.28 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.882 0.372 . . . . 10.0 110.222 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -139.75 3.51 2.06 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.566 0.58 . . . . 10.0 112.566 -178.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.61 -37.73 87.43 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.122 0.487 . . . . 10.0 110.613 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.02 -24.07 67.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.536 -0.756 . . . . 10.0 111.51 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.3 m -68.36 -47.49 67.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.531 -0.304 . . . . 10.0 111.39 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -67.93 -36.56 80.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.922 0.391 . . . . 10.0 110.323 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 59.0 mt -65.08 -28.67 69.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.909 -0.587 . . . . 10.0 110.736 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -76.85 -38.09 54.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.687 -0.688 . . . . 10.0 110.206 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -59.1 -36.4 75.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.769 -0.65 . . . . 10.0 111.168 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 54.0 t -61.1 -40.92 87.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.982 -0.554 . . . . 10.0 110.911 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.1 pttm -71.09 -24.19 62.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.371 -0.377 . . . . 10.0 111.09 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 81.9 mt -78.01 -48.7 22.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 121.014 0.435 . . . . 10.0 110.087 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -63.68 -40.57 97.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.762 -0.653 . . . . 10.0 111.357 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -103.59 40.02 1.5 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.099 0.476 . . . . 10.0 110.428 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -70.82 -29.36 69.43 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.697 -0.763 . . . . 10.0 112.38 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.4 m -81.74 -31.27 32.08 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.407 0.146 . . . . 10.0 111.04 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -113.56 106.67 53.91 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.791 0.329 . . . . 10.0 110.848 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -81.15 -11.62 12.07 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.473 2.115 . . . . 10.0 112.686 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.95 -48.87 64.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.09 -0.504 . . . . 10.0 110.744 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.5 m -66.29 -32.96 74.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 10.0 110.523 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -72.4 -43.3 64.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 10.0 110.241 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -64.55 -37.75 88.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.066 -0.516 . . . . 10.0 110.248 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.65 -26.83 73.65 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.765 -0.652 . . . . 10.0 111.628 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -68.05 -36.81 80.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.267 0.556 . . . . 10.0 109.681 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 60.5 mt -66.06 -36.81 84.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.687 -0.688 . . . . 10.0 110.606 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -66.54 -31.45 72.17 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.064 -0.516 . . . . 10.0 110.788 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.408 HG21 HD11 ' A' ' 61' ' ' ILE . 73.2 mt -65.29 -42.87 94.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.228 0.537 . . . . 10.0 110.577 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.471 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 67.8 mtp -65.8 -33.56 76.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.039 -0.528 . . . . 10.0 110.657 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.39 -34.6 77.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 10.0 111.421 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -67.97 -31.89 71.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.044 0.45 . . . . 10.0 110.566 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -81.13 -29.7 34.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.636 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 62' ' ' MET . 23.7 mtpp -59.0 -41.21 87.13 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.902 0.382 . . . . 10.0 110.771 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.1 m -88.52 8.37 28.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 10.0 110.967 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 58.33 30.57 19.75 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.656 -0.702 . . . . 10.0 111.038 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.3 m -77.14 -24.71 51.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.086 -0.506 . . . . 10.0 110.844 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 36.1 pt -125.31 162.87 27.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.114 -0.494 . . . . 10.0 110.121 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -112.22 -172.4 2.04 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.939 -0.573 . . . . 10.0 110.055 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.562 ' O ' HG11 ' A' ' 75' ' ' VAL . 2.1 m -54.7 -54.39 49.78 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 116.362 -0.381 . . . . 10.0 111.841 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 72' ' ' THR . 28.7 Cg_endo -63.26 -26.12 72.0 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 121.793 1.662 . . . . 10.0 111.994 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.73 -41.93 72.63 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.759 -0.655 . . . . 10.0 112.571 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.562 HG11 ' O ' ' A' ' 72' ' ' THR . 4.2 p -65.51 -29.95 48.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 120.704 0.287 . . . . 10.0 110.372 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 63.6 mt -63.07 -42.73 97.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 10.0 110.209 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -62.02 -40.06 94.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.533 -0.758 . . . . 10.0 109.934 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -66.63 -46.76 74.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.943 -0.572 . . . . 10.0 110.957 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.1 t -66.3 -43.99 91.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.216 -0.447 . . . . 10.0 111.107 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.57 -37.98 83.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.122 -0.49 . . . . 10.0 111.196 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -79.3 -27.09 42.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.708 -0.223 . . . . 10.0 111.363 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 35.5 tp -76.22 -51.94 11.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.879 0.371 . . . . 10.0 110.346 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 -91.5 48.74 1.5 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.206 0.527 . . . . 10.0 110.212 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -68.7 -8.99 47.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.82 -0.627 . . . . 10.0 111.766 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -110.23 -12.03 14.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.836 0.351 . . . . 10.0 111.047 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -130.46 80.87 69.43 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.385 -0.37 . . . . 10.0 111.001 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -62.31 -28.95 79.23 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.597 2.198 . . . . 10.0 112.298 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -58.5 -36.72 74.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.599 -0.728 . . . . 10.0 111.468 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 95.7 mt -75.72 -30.25 59.2 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.408 -0.36 . . . . 10.0 111.125 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.431 HG21 HD12 ' A' ' 90' ' ' ILE . 45.4 mt -69.05 -46.17 78.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.347 0.594 . . . . 10.0 109.459 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.404 ' O ' ' HB2' ' A' ' 94' ' ' ASN . 46.3 t -70.11 -37.33 71.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.318 -0.855 . . . . 10.0 109.751 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.32 -40.63 94.31 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.748 -0.66 . . . . 10.0 112.189 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -60.25 -28.91 68.42 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.754 0.311 . . . . 10.0 110.747 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' A' ' 91' ' ' VAL . 28.4 m-80 -69.78 -17.73 63.44 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.44 -0.345 . . . . 10.0 110.662 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.78 -3.47 24.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.89 0.376 . . . . 10.0 111.024 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -112.86 20.19 16.66 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.064 0.459 . . . . 10.0 110.842 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 17.5 mt -80.22 116.15 59.53 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.815 -0.629 . . . . 10.0 109.831 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.32 -18.41 30.06 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.38 2.054 . . . . 10.0 112.74 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.71 158.27 30.47 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.867 -0.42 . . . . 10.0 109.867 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 169.77 -134.32 3.13 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 121.007 -0.616 . . . . 10.0 111.624 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.57 -9.48 18.58 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.755 2.304 . . . . 10.0 111.533 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 m -66.23 152.11 45.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.673 -0.694 . . . . 10.0 111.373 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.56 133.81 55.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.905 -0.589 . . . . 10.0 111.081 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.222 0 CA-C-N 115.967 -0.56 . . . . 10.0 112.463 179.425 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' 8TL . . . . . 0.761 ' O3 ' ' C11' ' A' ' 201' ' ' 8TL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.382 0 N-CA-C 112.051 -0.419 . . . . 10.0 112.051 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -115.56 137.88 51.61 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.753 0.277 . . . . 10.0 110.572 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 19.0 m -101.12 73.17 1.5 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.105 0.478 . . . . 10.0 110.716 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -155.44 137.86 5.79 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.022 -0.609 . . . . 10.0 111.71 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.1 m -106.65 105.25 15.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.901 0.381 . . . . 10.0 110.78 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.4 m -90.56 150.79 21.6 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.76 0.314 . . . . 10.0 110.425 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.88 91.74 2.22 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.695 -0.764 . . . . 10.0 111.643 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.7 m -91.69 164.57 2.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.654 0.264 . . . . 10.0 110.762 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -119.36 177.05 5.05 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.282 -0.417 . . . . 10.0 110.209 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.3 m -81.98 -12.7 12.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.919 0.39 . . . . 10.0 110.856 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -139.95 87.64 2.17 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.185 -0.461 . . . . 10.0 110.111 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.2 p30 -128.61 12.02 6.31 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.25 -0.432 . . . . 10.0 111.037 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.91 -44.69 96.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.261 0.553 . . . . 10.0 111.072 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -63.24 -31.41 72.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.519 -0.764 . . . . 10.0 111.002 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 m -62.05 -51.42 68.06 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.086 -0.506 . . . . 10.0 111.191 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -70.01 -30.04 67.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.449 -0.341 . . . . 10.0 110.626 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.48 -34.89 78.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.965 0.412 . . . . 10.0 110.528 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -73.87 -32.58 63.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.296 -0.411 . . . . 10.0 110.185 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -60.16 -38.63 83.76 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.092 -0.503 . . . . 10.0 109.782 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 92.9 t -60.35 -39.43 80.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.657 -0.702 . . . . 10.0 109.7 178.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.8 ttpm? -67.04 -38.0 85.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.226 -0.897 . . . . 10.0 110.748 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 57.7 mt -71.0 -43.78 76.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.287 -0.415 . . . . 10.0 110.33 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -62.12 -36.49 81.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 10.0 111.231 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -101.94 36.36 2.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.058 0.456 . . . . 10.0 111.284 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.81 -36.3 89.46 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.855 -0.612 . . . . 10.0 111.984 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.0 m -101.69 13.36 35.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.603 0.24 . . . . 10.0 111.087 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -142.04 74.93 21.18 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.949 0.404 . . . . 10.0 110.752 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -63.71 -26.89 68.36 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.594 2.196 . . . . 10.0 112.476 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.12 -50.03 73.51 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.761 0.315 . . . . 10.0 110.989 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.9 m -63.03 -38.36 90.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.301 -0.409 . . . . 10.0 110.682 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -69.43 -40.11 77.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.412 -0.358 . . . . 10.0 110.791 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -64.65 -41.42 96.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.366 -0.379 . . . . 10.0 110.295 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.83 -27.96 72.77 Favored Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.886 -0.597 . . . . 10.0 111.788 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -64.47 -42.29 95.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.964 0.412 . . . . 10.0 110.393 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.9 mt -64.15 -29.84 70.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.981 -0.554 . . . . 10.0 110.613 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -68.81 -34.2 75.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 10.0 110.259 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.8 mt -67.88 -36.01 74.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.964 -0.562 . . . . 10.0 109.621 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.76 -31.46 72.64 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.591 -0.732 . . . . 10.0 110.156 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -62.36 -39.57 93.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.066 -0.516 . . . . 10.0 111.32 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -63.84 -37.18 86.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.171 -0.468 . . . . 10.0 110.453 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -74.79 -36.5 62.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.123 -0.49 . . . . 10.0 110.474 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -64.28 -41.02 97.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.312 -0.404 . . . . 10.0 110.9 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.7 m -81.8 0.24 40.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.388 -0.369 . . . . 10.0 110.918 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 61.32 32.06 19.24 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.688 -0.687 . . . . 10.0 111.95 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.1 m -78.15 -24.18 47.42 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.193 -0.669 . . . . 10.0 109.193 178.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 45.6 pt -135.91 -179.06 2.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.16 -0.927 . . . . 10.0 109.314 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.447 ' CG ' ' H ' ' A' ' 72' ' ' THR . 6.1 t70 -136.3 -151.2 0.4 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.927 -0.397 . . . . 10.0 109.927 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.447 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 7.1 m -55.72 -57.81 19.29 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 113.167 0.803 . . . . 10.0 113.167 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.433 ' CD ' ' HB ' ' A' ' 72' ' ' THR . 18.8 Cg_endo -61.15 -38.42 67.05 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 121.832 1.688 . . . . 10.0 112.964 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.56 -45.35 93.3 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 116.129 -0.487 . . . . 10.0 113.386 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.414 HG11 ' O ' ' A' ' 72' ' ' THR . 9.9 p -67.45 -39.5 82.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.768 -0.373 . . . . 10.0 111.303 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 81.4 mt -65.57 -43.87 94.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.797 0.332 . . . . 10.0 110.113 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 34.9 ttp-105 -61.58 -37.51 84.14 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.138 -0.483 . . . . 10.0 110.814 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.68 -50.26 58.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.151 -0.477 . . . . 10.0 110.888 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 94.5 t -66.39 -30.95 51.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.111 -0.495 . . . . 10.0 111.869 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 71.0 m -61.19 -27.89 68.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.002 0.429 . . . . 10.0 110.751 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -85.81 -28.97 24.15 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.826 -0.624 . . . . 10.0 110.374 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 25.9 tp -75.67 -45.48 36.78 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.87 -0.604 . . . . 10.0 109.842 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 6.1 m-30 -90.89 41.9 1.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.855 -0.611 . . . . 10.0 109.959 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -65.32 -21.18 66.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.483 -0.326 . . . . 10.0 111.678 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -103.83 5.64 36.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.962 0.411 . . . . 10.0 110.508 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -134.96 69.73 70.74 Favored Pre-proline 0 C--O 1.235 0.341 0 CA-C-N 116.413 -0.358 . . . . 10.0 110.923 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -62.16 -29.74 81.17 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.255 1.97 . . . . 10.0 112.2 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.49 -46.68 83.45 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.009 -0.541 . . . . 10.0 110.703 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 81.0 mt -64.25 -36.29 83.62 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.407 -0.815 . . . . 10.0 111.394 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 94.2 mt -62.57 -47.28 93.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.894 0.378 . . . . 10.0 110.458 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 43.2 t -70.05 -42.72 79.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.293 -0.412 . . . . 10.0 110.649 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.78 -43.84 97.54 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.956 -0.566 . . . . 10.0 112.761 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -62.26 -34.59 76.83 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.699 0.285 . . . . 10.0 111.367 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 -58.59 -38.55 78.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 10.0 111.03 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -91.47 -19.87 22.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.307 -0.406 . . . . 10.0 111.62 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -69.91 -35.32 74.51 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.674 0.274 . . . . 10.0 111.042 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.3 mt -72.01 126.59 91.24 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 120.848 0.356 . . . . 10.0 111.339 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.72 -18.79 11.65 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.829 2.353 . . . . 10.0 111.984 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.42 130.74 43.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.798 -0.637 . . . . 10.0 111.025 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 161.65 -128.26 1.88 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.094 -0.575 . . . . 10.0 111.758 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -89.35 24.8 0.64 Allowed 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.788 2.325 . . . . 10.0 111.99 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.08 166.99 21.15 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.519 -0.764 . . . . 10.0 111.651 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.17 109.27 1.26 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.823 -0.626 . . . . 10.0 111.024 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.486 0 C-N-CA 120.472 -0.871 . . . . 10.0 112.582 179.596 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' 8TL . . . . . 0.77 ' O3 ' ' C11' ' A' ' 201' ' ' 8TL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.406 0 N-CA-C 112.023 -0.431 . . . . 10.0 112.023 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.67 136.63 32.94 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 117.05 0.425 . . . . 10.0 109.988 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.3 m -82.55 93.47 7.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.856 0.36 . . . . 10.0 110.457 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -150.8 135.99 5.4 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.636 -0.792 . . . . 10.0 112.372 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.2 m -117.98 84.06 2.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.239 0.542 . . . . 10.0 110.493 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.6 m -78.26 147.17 34.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.814 -0.63 . . . . 10.0 110.649 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.08 78.96 0.75 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.826 -0.702 . . . . 10.0 111.486 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.4 m -87.93 160.01 2.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.214 0.531 . . . . 10.0 110.97 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -112.9 174.84 5.7 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.95 -0.568 . . . . 10.0 110.193 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.2 m -68.04 -32.57 56.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.166 0.508 . . . . 10.0 109.826 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -113.07 80.47 1.36 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.27 -0.877 . . . . 10.0 109.211 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -123.83 2.4 8.78 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.035 -0.529 . . . . 10.0 111.547 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.51 -49.8 76.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.375 0.607 . . . . 10.0 111.001 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -66.69 -9.33 35.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.607 -0.724 . . . . 10.0 111.833 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.9 m -72.57 -37.44 68.2 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.58 0.228 . . . . 10.0 111.031 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -74.39 -29.55 61.58 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.788 -0.365 . . . . 10.0 110.615 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -58.0 -43.87 86.86 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.767 -0.457 . . . . 10.0 109.767 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.41 ' O ' HG13 ' A' ' 46' ' ' ILE . 36.6 t70 -64.77 -41.88 95.53 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.696 -0.683 . . . . 10.0 110.81 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -61.19 -38.22 85.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.812 -0.631 . . . . 10.0 111.006 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.62 -40.98 89.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.57 -0.53 . . . . 10.0 109.57 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.06 -29.15 68.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.727 -0.67 . . . . 10.0 110.862 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 42' ' ' ASP . 80.6 mt -75.13 -47.25 36.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.529 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 -62.94 -34.26 77.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.22 -0.446 . . . . 10.0 111.398 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -107.19 41.76 1.43 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.15 0.5 . . . . 10.0 110.506 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -70.75 -27.3 72.6 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.938 -0.648 . . . . 10.0 112.538 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.6 t -100.96 5.32 43.14 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.064 0.459 . . . . 10.0 110.473 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -135.64 86.33 28.67 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.815 -0.63 . . . . 10.0 110.105 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -74.32 -15.74 22.39 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.275 1.983 . . . . 10.0 112.644 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.69 -49.58 61.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.316 -0.402 . . . . 10.0 111.114 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.6 m -66.52 -33.31 75.4 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.318 -0.401 . . . . 10.0 110.779 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -67.64 -41.75 83.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.166 -0.47 . . . . 10.0 110.708 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -62.47 -38.59 90.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.935 0.398 . . . . 10.0 110.567 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.27 -33.25 84.52 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.918 -0.658 . . . . 10.0 111.898 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -61.85 -41.94 98.45 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.947 0.403 . . . . 10.0 110.181 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 24.5 mt -66.71 -36.29 82.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.963 -0.562 . . . . 10.0 110.287 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -62.27 -42.43 99.33 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.665 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.2 mt -66.17 -36.62 77.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.533 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 46.2 mtp -62.12 -34.06 75.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 10.0 110.631 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -62.36 -38.57 90.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.292 -0.413 . . . . 10.0 110.613 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -66.37 -36.83 83.87 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.379 -0.6 . . . . 10.0 109.379 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -68.87 -43.82 74.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.43 -0.805 . . . . 10.0 109.981 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -64.16 -37.17 86.51 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.083 -0.508 . . . . 10.0 111.203 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.7 m -82.5 4.38 24.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.302 -0.408 . . . . 10.0 111.336 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 58.97 28.46 17.67 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.874 -0.603 . . . . 10.0 111.449 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.6 m -75.71 -38.52 58.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.18 0.514 . . . . 10.0 110.143 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.2 pt -120.97 157.73 23.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.689 -0.687 . . . . 10.0 110.106 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.405 ' HB3' ' H ' ' A' ' 72' ' ' THR . 2.1 m-20 -106.85 -163.25 0.9 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.173 -0.467 . . . . 10.0 110.399 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.523 ' O ' HG11 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -55.0 -57.05 21.48 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 112.772 0.656 . . . . 10.0 112.772 -179.724 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' A' ' 72' ' ' THR . 20.5 Cg_endo -60.94 -29.45 88.05 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.043 1.828 . . . . 10.0 112.666 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.13 -48.17 20.89 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.625 -0.798 . . . . 10.0 112.017 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.523 HG11 ' O ' ' A' ' 72' ' ' THR . 5.6 p -63.91 -30.39 49.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.565 0.221 . . . . 10.0 110.753 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.5 mt -66.2 -49.22 77.73 Favored 'Isoleucine or valine' 0 C--N 1.337 0.053 0 N-CA-C 109.714 -0.476 . . . . 10.0 109.714 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 60.2 ttp180 -61.44 -42.61 99.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.864 -0.607 . . . . 10.0 110.799 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -56.53 -41.62 77.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.88 -0.6 . . . . 10.0 111.568 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.6 p -84.21 -22.36 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 120.826 -0.349 . . . . 10.0 111.625 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.5 m -64.25 -42.42 96.52 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.022 0.439 . . . . 10.0 110.737 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -77.3 -14.25 59.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.121 -0.49 . . . . 10.0 110.316 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 18.3 tp -86.44 -43.5 12.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.862 -0.608 . . . . 10.0 110.065 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -103.62 37.21 2.08 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.897 -0.592 . . . . 10.0 109.935 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -64.16 -24.56 67.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.321 -0.4 . . . . 10.0 111.595 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -92.55 0.26 57.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.467 -0.333 . . . . 10.0 110.895 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 18.4 m170 -136.34 81.03 38.24 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-O 120.675 0.274 . . . . 10.0 110.857 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -65.1 -27.53 57.21 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.483 2.122 . . . . 10.0 112.343 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -57.62 -42.6 83.65 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.8 -0.636 . . . . 10.0 110.96 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 96.1 mt -68.9 -41.04 78.8 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.127 -0.488 . . . . 10.0 111.184 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 59.3 mt -60.6 -48.01 90.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-O 121.116 0.484 . . . . 10.0 110.972 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.4 t -71.5 -42.8 72.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.985 -0.552 . . . . 10.0 110.834 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.77 -45.38 95.84 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.817 -0.629 . . . . 10.0 112.859 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.401 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 39.5 t80 -63.19 -34.42 77.61 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.729 0.3 . . . . 10.0 111.022 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -62.82 -36.09 82.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.406 -0.361 . . . . 10.0 111.149 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.9 -21.22 26.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.865 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -77.17 -25.14 51.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.903 -0.59 . . . . 10.0 110.908 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 93' ' ' PHE . 57.9 mt -52.34 125.55 34.98 Favored Pre-proline 0 C--O 1.235 0.304 0 CA-C-N 116.126 -0.488 . . . . 10.0 112.172 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -67.75 -30.66 33.75 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.586 2.19 . . . . 10.0 111.57 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.83 145.95 38.09 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.65 -0.705 . . . . 10.0 110.494 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 171.29 -169.02 42.15 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.775 -0.726 . . . . 10.0 111.963 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.37 15.89 0.62 Allowed 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 123.535 2.823 . . . . 10.0 113.125 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.81 179.59 2.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.018 0.437 . . . . 10.0 110.702 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.9 t -78.3 116.96 19.1 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.878 -0.416 . . . . 10.0 109.878 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.146 0 C-N-CA 120.882 -0.675 . . . . 10.0 112.346 179.747 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' 8TL . . . . . 0.751 ' O3 ' ' C11' ' A' ' 201' ' ' 8TL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.139 0 N-CA-C 112.47 -0.252 . . . . 10.0 112.47 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.87 117.9 16.38 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.966 -0.383 . . . . 10.0 109.966 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.1 m -68.46 123.47 20.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 10.0 110.792 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 161.27 129.45 1.03 Allowed Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.846 -0.693 . . . . 10.0 111.594 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.57 94.46 5.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.019 0.438 . . . . 10.0 110.882 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.4 m -81.35 149.35 28.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.122 -0.49 . . . . 10.0 109.816 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.37 74.28 1.07 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.019 -0.61 . . . . 10.0 111.972 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.8 m -82.47 161.29 3.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.775 0.322 . . . . 10.0 111.066 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -101.73 178.07 4.73 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.575 -0.528 . . . . 10.0 109.575 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 32.1 m -81.65 4.99 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.155 0.502 . . . . 10.0 111.235 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -153.52 103.45 2.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.87 -0.605 . . . . 10.0 109.763 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 38.6 p-10 -135.57 17.29 3.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.151 0.5 . . . . 10.0 110.733 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.58 -41.79 99.15 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.755 -0.657 . . . . 10.0 111.147 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -71.17 -30.87 66.96 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.932 -0.577 . . . . 10.0 110.773 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.22 -43.87 93.65 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.209 -0.45 . . . . 10.0 110.876 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -67.45 -38.32 84.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 10.0 110.201 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.64 -41.49 99.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.26 0.552 . . . . 10.0 110.528 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.575 ' O ' HG13 ' A' ' 46' ' ' ILE . 22.1 t70 -66.43 -35.78 81.16 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.369 -0.832 . . . . 10.0 110.874 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -59.53 -45.48 91.64 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.031 0.443 . . . . 10.0 110.712 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 64.7 t -59.51 -35.83 61.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 115.517 -0.765 . . . . 10.0 110.373 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.4 ttpm? -67.51 -35.06 78.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.229 -0.896 . . . . 10.0 110.863 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.575 HG13 ' O ' ' A' ' 42' ' ' ASP . 23.4 mt -76.22 -47.04 32.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.573 -0.285 . . . . 10.0 110.938 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -58.87 -47.14 85.99 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.039 -0.528 . . . . 10.0 111.712 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -104.27 54.65 0.73 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.21 0.528 . . . . 10.0 110.986 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.83 -36.35 29.02 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.709 -0.757 . . . . 10.0 111.521 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.09 4.83 28.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.928 0.394 . . . . 10.0 110.994 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -138.83 87.83 14.25 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.001 -0.545 . . . . 10.0 109.917 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -70.7 -21.0 29.71 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.361 2.041 . . . . 10.0 112.598 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.78 -47.44 83.48 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.499 -0.318 . . . . 10.0 111.328 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.8 m -63.15 -43.27 98.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.077 0.465 . . . . 10.0 110.587 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -65.2 -39.83 93.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.11 -0.495 . . . . 10.0 110.91 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -65.87 -35.97 82.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.985 -0.552 . . . . 10.0 110.705 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -69.53 -33.69 72.52 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.647 -0.706 . . . . 10.0 111.542 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -59.53 -34.82 73.13 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.099 0.476 . . . . 10.0 110.334 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 23.9 mt -62.98 -41.28 99.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.752 -0.658 . . . . 10.0 110.64 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -67.18 -30.39 70.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.97 -0.559 . . . . 10.0 110.637 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.7 mt -65.62 -47.63 85.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.069 -0.514 . . . . 10.0 110.419 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 44.1 mtp -66.07 -27.12 67.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.965 -0.561 . . . . 10.0 111.065 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -63.29 -41.77 99.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.232 -0.44 . . . . 10.0 110.989 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -64.05 -33.32 75.48 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.074 0.464 . . . . 10.0 110.46 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -74.92 -41.27 60.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.7 -0.682 . . . . 10.0 110.466 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -62.63 -34.35 76.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.842 -0.617 . . . . 10.0 111.307 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 68.6 m -82.42 -0.66 47.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.417 -0.356 . . . . 10.0 111.104 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 63.33 23.02 13.58 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.029 -0.532 . . . . 10.0 111.504 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.36 -41.64 39.54 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.845 -0.798 . . . . 10.0 108.845 178.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 31.2 pt -114.87 165.9 9.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.676 -0.693 . . . . 10.0 110.083 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -123.12 -166.48 1.46 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.129 -0.487 . . . . 10.0 109.77 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.474 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 7.1 m -49.02 -55.25 21.6 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 112.029 0.381 . . . . 10.0 112.029 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 72' ' ' THR . 11.5 Cg_endo -55.84 -34.48 91.53 Favored 'Trans proline' 0 C--N 1.358 1.028 0 C-N-CA 122.387 2.058 . . . . 10.0 112.548 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.68 -44.51 62.96 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.778 -0.725 . . . . 10.0 111.939 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.465 ' O ' HG22 ' A' ' 79' ' ' VAL . 82.5 t -60.97 -45.45 98.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.951 -0.388 . . . . 10.0 109.951 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 88.8 mt -55.49 -42.57 68.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.09 -0.504 . . . . 10.0 110.984 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 41.4 ttp180 -59.23 -44.82 92.3 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.137 0.494 . . . . 10.0 109.897 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -63.54 -46.85 84.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.734 -0.666 . . . . 10.0 110.263 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 75' ' ' VAL . 64.3 t -58.46 -43.91 87.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.545 -0.752 . . . . 10.0 111.205 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.408 ' HA ' HD12 ' A' ' 90' ' ' ILE . 9.8 m -66.04 -38.23 87.84 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.182 -0.463 . . . . 10.0 111.59 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -75.84 -20.22 58.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.908 0.385 . . . . 10.0 110.855 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.2 tp -87.55 -53.57 4.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.984 -0.553 . . . . 10.0 110.654 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -97.57 44.52 1.04 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.953 0.406 . . . . 10.0 110.552 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -69.93 -13.59 62.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.321 -0.399 . . . . 10.0 111.424 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -96.95 -12.48 23.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.996 0.426 . . . . 10.0 110.271 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -136.01 77.69 49.11 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 10.0 110.964 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -62.49 -23.41 74.91 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.588 2.192 . . . . 10.0 112.34 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.5 -23.85 67.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.115 -0.493 . . . . 10.0 111.024 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 81.6 mt -87.38 -30.47 20.73 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.459 -0.337 . . . . 10.0 110.49 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.408 HD12 ' HA ' ' A' ' 80' ' ' SER . 55.5 mt -63.48 -51.94 64.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.893 0.378 . . . . 10.0 110.903 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.6 t -63.2 -27.46 43.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.851 -0.613 . . . . 10.0 110.421 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.49 -37.55 92.28 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.431 -0.668 . . . . 10.0 111.431 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -66.67 -39.39 88.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.889 0.376 . . . . 10.0 110.408 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -63.54 -34.87 78.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.585 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -90.24 0.66 57.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.159 -0.473 . . . . 10.0 110.792 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -106.49 2.51 26.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.262 -0.426 . . . . 10.0 110.777 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 53.9 mt -69.96 118.18 61.0 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.276 -0.42 . . . . 10.0 111.069 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -70.79 -41.89 2.69 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.469 2.113 . . . . 10.0 112.536 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.3 m -94.23 149.97 20.74 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 116.321 -0.4 . . . . 10.0 110.232 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -177.9 -141.94 4.41 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.644 -0.789 . . . . 10.0 111.732 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -80.44 0.84 9.73 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.699 2.266 . . . . 10.0 112.424 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.02 157.96 32.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.394 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.2 m -69.19 139.2 54.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.856 0.36 . . . . 10.0 111.426 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.451 0 C-N-CA 120.665 -0.779 . . . . 10.0 112.171 179.912 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' 8TL . . . . . 0.777 ' O3 ' ' C11' ' A' ' 201' ' ' 8TL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.265 0 N-CA-C 112.03 -0.428 . . . . 10.0 112.03 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.39 138.43 50.36 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 110.127 -0.323 . . . . 10.0 110.127 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.0 m -105.3 101.55 11.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.989 0.423 . . . . 10.0 110.368 -179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -161.32 126.28 1.56 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 121.06 -0.59 . . . . 10.0 112.09 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.75 82.47 2.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.032 0.444 . . . . 10.0 110.529 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.7 m -79.47 134.86 36.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.604 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.58 86.17 1.82 Allowed Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.52 -0.847 . . . . 10.0 112.641 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.9 m -103.62 156.53 5.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 110.068 -0.345 . . . . 10.0 110.068 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -94.63 -164.42 1.17 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.235 -0.438 . . . . 10.0 110.751 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.8 m -78.36 -22.12 13.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.125 0.488 . . . . 10.0 110.929 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -113.59 85.01 2.11 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.414 0.626 . . . . 10.0 110.456 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -113.05 -4.55 13.84 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.541 -0.754 . . . . 10.0 110.402 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.49 -40.13 95.68 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.336 -0.847 . . . . 10.0 112.419 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.15 -9.14 58.81 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.919 0.341 . . . . 10.0 111.919 -178.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.76 -49.55 24.93 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.137 0.494 . . . . 10.0 111.702 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.41 ' HB3' ' C5 ' ' A' ' 201' ' ' 8TL . 64.6 t80 -73.17 -12.9 61.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.07 -0.514 . . . . 10.0 111.499 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.93 -45.81 69.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.007 0.432 . . . . 10.0 110.829 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -69.92 -32.28 70.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.35 -0.386 . . . . 10.0 111.379 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -56.64 -35.13 68.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.929 -0.578 . . . . 10.0 110.885 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 28.7 t -66.02 -42.45 91.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 10.0 110.045 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -63.33 -38.59 91.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.873 -0.603 . . . . 10.0 111.084 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 57.2 mt -73.77 -44.92 51.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 10.0 110.967 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -58.26 -40.96 83.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 10.0 110.894 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -110.13 41.73 1.67 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.335 0.588 . . . . 10.0 110.454 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.87 -28.17 73.41 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.952 -0.642 . . . . 10.0 112.053 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.3 m -96.23 2.38 52.93 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.803 0.335 . . . . 10.0 110.864 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -134.01 86.74 36.62 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 109.591 -0.522 . . . . 10.0 109.591 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -68.27 -17.75 44.77 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.922 2.414 . . . . 10.0 112.582 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.59 -49.28 69.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.058 -0.519 . . . . 10.0 111.122 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.8 m -62.85 -43.19 99.47 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.549 -0.296 . . . . 10.0 111.246 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -65.4 -40.12 93.02 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 110.128 -0.323 . . . . 10.0 110.128 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -60.86 -48.13 83.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 10.0 110.361 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.456 ' O ' HG13 ' A' ' 61' ' ' ILE . . . -60.02 -44.55 97.14 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.93 -0.652 . . . . 10.0 111.828 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -55.78 -43.23 76.59 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.757 0.313 . . . . 10.0 110.891 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 77.8 mt -64.55 -38.03 89.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.932 -0.576 . . . . 10.0 111.26 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -70.71 -39.91 73.13 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.296 -0.411 . . . . 10.0 111.056 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 57' ' ' GLY . 62.4 mt -67.45 -36.5 76.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.024 0.44 . . . . 10.0 110.428 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.93 -31.97 67.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.901 -0.59 . . . . 10.0 111.131 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -63.01 -45.37 92.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.964 -0.562 . . . . 10.0 110.844 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -59.8 -36.34 76.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.916 -0.584 . . . . 10.0 111.663 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -66.73 -42.94 85.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.373 -0.376 . . . . 10.0 110.88 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -74.86 -24.29 58.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.895 -0.593 . . . . 10.0 111.104 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 68.4 m -79.08 5.0 12.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.898 0.38 . . . . 10.0 110.537 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 61.77 33.58 17.75 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.798 -0.637 . . . . 10.0 110.866 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.1 m -93.88 -26.12 17.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.302 -0.408 . . . . 10.0 111.044 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.0 pt -139.85 158.42 26.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.184 -0.462 . . . . 10.0 110.646 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.401 ' HB3' ' H ' ' A' ' 72' ' ' THR . 30.9 m-20 -119.17 -158.93 0.75 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.288 -0.415 . . . . 10.0 110.249 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.401 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -48.21 -59.68 5.58 Favored Pre-proline 0 CA--C 1.542 0.673 0 N-CA-C 112.65 0.611 . . . . 10.0 112.65 -179.6 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.91 -35.07 69.18 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 121.554 1.503 . . . . 10.0 112.722 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.1 -44.31 91.52 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 121.099 -0.572 . . . . 10.0 112.256 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.502 ' O ' HG22 ' A' ' 79' ' ' VAL . 8.9 p -74.89 -35.36 35.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 O-C-N 122.853 -0.204 . . . . 10.0 110.906 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 74.0 mt -62.95 -37.92 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.077 0 N-CA-C 110.172 -0.307 . . . . 10.0 110.172 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -59.86 -29.79 68.53 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.287 0.565 . . . . 10.0 110.193 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -81.61 -42.55 19.9 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.716 -0.675 . . . . 10.0 109.656 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.502 HG22 ' O ' ' A' ' 75' ' ' VAL . 97.6 t -59.3 -46.59 92.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.613 -0.721 . . . . 10.0 110.737 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.6 m -63.04 -28.85 70.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.952 -0.567 . . . . 10.0 111.512 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -84.91 -40.63 16.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.673 0.273 . . . . 10.0 111.366 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 6.6 tp -64.97 -47.45 77.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.235 0.541 . . . . 10.0 111.056 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -101.18 45.59 0.97 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.013 -0.54 . . . . 10.0 110.076 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -63.93 -29.37 70.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.958 -0.565 . . . . 10.0 111.327 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -98.94 6.37 46.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.964 0.411 . . . . 10.0 110.897 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -137.57 71.11 52.18 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 116.36 -0.382 . . . . 10.0 110.438 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.02 -31.44 76.5 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.338 2.025 . . . . 10.0 112.288 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.78 -32.28 70.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 10.0 110.762 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 89.1 mt -72.11 -42.51 65.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.22 -0.446 . . . . 10.0 110.051 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 26.2 mt -65.16 -44.44 95.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 116.036 -0.529 . . . . 10.0 109.805 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 99.1 t -65.11 -37.77 81.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 115.818 -0.628 . . . . 10.0 109.508 178.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -64.18 -38.18 95.58 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.655 -0.783 . . . . 10.0 111.609 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -68.97 -28.1 66.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.96 0.409 . . . . 10.0 110.566 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -62.18 -28.19 69.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.164 0.507 . . . . 10.0 109.926 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.93 8.87 30.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.571 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -117.62 33.35 5.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.831 -0.622 . . . . 10.0 110.072 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.6 mt -106.34 114.68 61.98 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.784 -0.644 . . . . 10.0 110.086 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -71.12 -12.23 30.01 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.626 2.218 . . . . 10.0 112.076 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.3 m -109.93 104.55 13.49 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.029 -0.532 . . . . 10.0 110.563 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -154.49 -149.28 5.21 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.753 -0.737 . . . . 10.0 112.256 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -79.98 39.38 0.83 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.288 2.659 . . . . 10.0 113.232 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 57.9 m -96.35 174.16 7.01 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.147 -0.479 . . . . 10.0 110.228 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.3 m -71.72 95.57 1.49 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.949 0.404 . . . . 10.0 110.252 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.654 0 C-N-CA 120.946 -0.645 . . . . 10.0 111.93 -179.7 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' 8TL . . . . . 0.75 ' O3 ' ' C11' ' A' ' 201' ' ' 8TL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 111.862 -0.495 . . . . 10.0 111.862 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.2 m -118.21 154.65 31.86 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.02 -0.363 . . . . 10.0 110.02 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.3 m -102.26 111.61 23.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.995 0.426 . . . . 10.0 111.0 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -157.04 160.58 30.52 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 121.036 -0.602 . . . . 10.0 111.916 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.3 m -133.98 83.64 2.06 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.055 -0.35 . . . . 10.0 110.055 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.1 m -83.62 99.28 10.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.278 0.561 . . . . 10.0 110.404 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 171.22 66.25 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 111.321 -0.711 . . . . 10.0 111.321 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.4 m -64.85 151.71 9.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.873 0.368 . . . . 10.0 111.294 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 3.2 m170 -116.04 175.68 5.43 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.775 -0.454 . . . . 10.0 109.775 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.7 m -81.26 -23.74 10.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.136 0.493 . . . . 10.0 110.537 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -145.84 88.12 1.81 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.438 0.637 . . . . 10.0 109.936 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -117.87 23.4 11.7 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.682 -0.69 . . . . 10.0 110.254 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.9 -41.95 97.09 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.487 -0.779 . . . . 10.0 110.62 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pp -64.36 -28.47 69.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.534 -0.757 . . . . 10.0 111.303 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.531 ' O ' ' HG2' ' A' ' 43' ' ' GLN . 1.3 m -68.18 -52.78 30.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.068 -0.514 . . . . 10.0 111.358 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.453 ' HB3' ' C4 ' ' A' ' 201' ' ' 8TL . 4.1 t80 -66.38 -28.92 69.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.889 0.376 . . . . 10.0 110.165 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.63 -40.74 96.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.845 -0.616 . . . . 10.0 110.021 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -72.03 -31.27 66.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 10.0 110.554 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.531 ' HG2' ' O ' ' A' ' 39' ' ' THR . 15.9 mm100 -59.21 -40.1 84.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.703 -0.68 . . . . 10.0 110.573 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 92.2 t -59.68 -40.36 82.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.25 0.547 . . . . 10.0 109.863 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.4 ttpm? -62.89 -37.36 86.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.338 -0.846 . . . . 10.0 111.224 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 49.2 mt -73.76 -43.97 52.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.087 0.47 . . . . 10.0 110.795 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -63.66 -37.37 87.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.85 -0.614 . . . . 10.0 111.046 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -110.36 49.81 0.83 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.344 0.592 . . . . 10.0 110.312 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -81.4 -21.67 61.91 Favored Glycine 0 C--O 1.229 -0.156 0 CA-C-N 115.564 -0.744 . . . . 10.0 112.679 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.9 m -86.54 -33.47 20.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.864 0.364 . . . . 10.0 110.522 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -116.85 100.98 53.67 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.067 -0.515 . . . . 10.0 110.71 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -75.12 -15.33 20.54 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.366 2.044 . . . . 10.0 112.256 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.54 -46.83 86.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.7 -0.682 . . . . 10.0 111.067 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.8 m -67.5 -32.61 73.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.008 -0.542 . . . . 10.0 110.331 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -68.74 -43.88 74.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.12 -0.491 . . . . 10.0 110.073 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -62.6 -39.99 95.49 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.845 -0.616 . . . . 10.0 109.972 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.3 -34.19 88.76 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.681 -0.771 . . . . 10.0 111.696 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -63.0 -39.32 94.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.091 0.472 . . . . 10.0 110.657 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 30.1 mt -64.46 -34.61 78.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.877 -0.601 . . . . 10.0 110.433 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -67.39 -37.12 82.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.684 -0.689 . . . . 10.0 110.713 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.7 mt -64.84 -39.96 87.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.166 0.508 . . . . 10.0 110.065 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.73 -31.25 72.37 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.523 -0.762 . . . . 10.0 110.35 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -62.88 -45.15 93.9 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.049 -0.523 . . . . 10.0 109.856 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -61.0 -35.22 76.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.63 -0.714 . . . . 10.0 110.631 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -70.14 -45.61 66.45 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.799 0.333 . . . . 10.0 110.324 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -67.11 -29.83 69.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.013 0.435 . . . . 10.0 110.932 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.83 -3.34 47.39 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.81 -0.632 . . . . 10.0 110.186 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 63.83 31.26 14.17 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.768 -0.651 . . . . 10.0 111.517 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.6 m -91.02 -20.98 21.5 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.1 -0.5 . . . . 10.0 109.75 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 24.3 pt -134.84 150.99 30.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.838 -0.619 . . . . 10.0 109.55 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -107.37 -164.49 0.98 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.878 -0.415 . . . . 10.0 109.878 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -49.12 -56.64 14.69 Favored Pre-proline 0 CA--C 1.537 0.472 0 O-C-N 123.619 0.574 . . . . 10.0 112.502 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.17 -28.59 48.24 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 121.683 1.589 . . . . 10.0 112.733 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.23 -51.99 29.77 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.839 -0.619 . . . . 10.0 113.069 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.9 p -64.52 -40.88 90.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.801 0.334 . . . . 10.0 111.1 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 91.6 mt -62.37 -45.35 98.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.475 -0.33 . . . . 10.0 110.644 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 11.4 ttp180 -61.61 -45.65 93.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.395 -0.366 . . . . 10.0 110.936 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -57.87 -49.33 77.05 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.997 0.427 . . . . 10.0 111.095 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.433 HG21 ' C8 ' ' A' ' 201' ' ' 8TL . 86.2 t -68.36 -34.81 68.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.006 -0.543 . . . . 10.0 111.011 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.9 t -61.83 -30.57 70.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.483 -0.326 . . . . 10.0 111.475 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -82.36 -28.97 31.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.009 0.433 . . . . 10.0 110.698 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 23.2 tp -81.96 -40.99 21.42 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.097 -0.501 . . . . 10.0 111.326 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -97.08 32.24 2.21 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.167 -0.469 . . . . 10.0 110.637 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -65.67 -17.65 64.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.895 0.378 . . . . 10.0 111.749 -179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -88.33 -7.78 56.15 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.014 0.435 . . . . 10.0 110.466 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -134.69 71.64 70.31 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.864 -0.607 . . . . 10.0 109.491 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.38 -27.48 84.93 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.953 2.436 . . . . 10.0 112.746 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.07 -31.26 72.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.239 -0.437 . . . . 10.0 110.871 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 67.7 mt -75.21 -35.67 61.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 10.0 110.67 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 58.3 mt -65.41 -52.79 47.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.944 -0.571 . . . . 10.0 110.48 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.1 t -65.49 -38.98 83.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.052 -0.522 . . . . 10.0 109.706 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.98 -36.16 86.92 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.488 -0.778 . . . . 10.0 111.908 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -64.1 -44.03 93.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.716 0.293 . . . . 10.0 110.387 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -60.47 -42.86 97.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.121 -0.49 . . . . 10.0 110.191 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.31 -22.0 59.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.109 -0.496 . . . . 10.0 111.257 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -83.04 -11.6 57.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.258 -0.428 . . . . 10.0 111.171 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 60.2 mt -69.63 119.47 71.13 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.42 -0.355 . . . . 10.0 110.429 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -67.18 -42.59 7.56 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.642 2.228 . . . . 10.0 112.012 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.2 m -79.82 145.32 32.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.71 -0.677 . . . . 10.0 109.967 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 179.92 -131.92 1.73 Allowed Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.563 -0.615 . . . . 10.0 111.563 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -92.26 17.56 1.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.916 2.411 . . . . 10.0 112.16 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.4 m -82.77 176.57 9.22 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.941 -0.572 . . . . 10.0 111.305 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.48 113.97 3.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.994 -0.548 . . . . 10.0 111.598 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.479 0 C-N-CA 121.036 -0.602 . . . . 10.0 112.391 179.404 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' 8TL . . . . . 0.764 ' O3 ' ' C11' ' A' ' 201' ' ' 8TL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.425 0 N-CA-C 112.438 -0.265 . . . . 10.0 112.438 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.0 m -69.55 125.69 27.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.642 0.258 . . . . 10.0 110.767 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.0 t -79.21 137.27 37.35 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.981 -0.554 . . . . 10.0 110.158 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 137.37 176.76 14.6 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 121.096 -0.574 . . . . 10.0 111.794 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.0 m -152.62 133.77 14.24 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 110.0 -0.371 . . . . 10.0 110.0 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.8 m -105.01 136.08 45.15 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.31 -0.404 . . . . 10.0 110.97 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.92 105.23 2.97 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.637 -0.792 . . . . 10.0 112.207 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 17.0 m -115.45 164.56 11.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 110.12 -0.326 . . . . 10.0 110.12 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -104.3 -175.77 2.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.374 -0.376 . . . . 10.0 110.506 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.5 m -79.9 -4.19 6.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.189 0.518 . . . . 10.0 110.869 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -109.56 25.75 11.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.662 -0.699 . . . . 10.0 110.349 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.0 p-10 -68.07 -26.35 65.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.887 -0.597 . . . . 10.0 111.332 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.36 -51.3 62.91 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.586 0.587 . . . . 10.0 112.586 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pp -80.75 -0.87 40.45 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 122.067 -0.396 . . . . 10.0 111.86 -178.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 m -84.25 -34.99 23.72 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.942 0.401 . . . . 10.0 110.46 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -70.58 -21.92 62.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.342 -0.39 . . . . 10.0 111.214 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.54 -47.23 86.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 10.0 110.814 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -64.62 -35.91 82.55 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.957 -0.565 . . . . 10.0 110.61 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -58.41 -48.42 80.72 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.09 -0.505 . . . . 10.0 110.839 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.2 t -64.08 -35.86 75.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 115.65 -0.704 . . . . 10.0 110.549 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.7 tttm -67.77 -35.97 79.65 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.412 -0.813 . . . . 10.0 111.242 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 94.8 mt -77.16 -43.24 31.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.693 0.282 . . . . 10.0 111.295 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -58.3 -36.93 74.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.417 -0.356 . . . . 10.0 111.282 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -110.93 48.05 0.95 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.342 0.591 . . . . 10.0 109.987 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.47 -29.86 74.52 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.642 -0.708 . . . . 10.0 112.788 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.7 m -101.52 1.82 38.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.877 0.339 . . . . 10.0 111.383 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -124.68 94.55 44.26 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 120.908 0.385 . . . . 10.0 110.344 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -77.63 -11.38 17.02 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.481 2.121 . . . . 10.0 112.325 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.44 -51.55 23.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.215 -0.448 . . . . 10.0 110.919 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.5 m -64.48 -31.66 72.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.397 0.618 . . . . 10.0 110.039 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -66.27 -44.44 83.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.657 -0.702 . . . . 10.0 110.265 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -64.36 -37.5 87.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.509 . . . . 10.0 110.828 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.25 -39.45 97.89 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.71 -0.677 . . . . 10.0 112.891 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -60.75 -38.33 84.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.86 0.362 . . . . 10.0 110.702 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.427 ' O ' ' HG3' ' A' ' 63' ' ' LYS . 67.0 mt -65.89 -37.83 87.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.102 -0.499 . . . . 10.0 110.722 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -62.98 -40.38 97.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.114 0.483 . . . . 10.0 109.928 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.3 mt -62.75 -44.66 99.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.786 -0.643 . . . . 10.0 110.198 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.412 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -61.65 -35.75 78.84 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.691 -0.686 . . . . 10.0 110.773 179.853 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 59' ' ' LEU . 92.8 mttt -60.62 -47.22 87.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.753 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -59.58 -40.58 87.85 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.925 0.393 . . . . 10.0 110.885 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -68.24 -42.03 80.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.295 -0.411 . . . . 10.0 110.649 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 62' ' ' MET . 43.8 mtpt -66.12 -33.05 74.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.432 -0.349 . . . . 10.0 111.107 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.1 m -84.67 3.84 35.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.498 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 60.69 32.69 20.3 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.819 -0.628 . . . . 10.0 111.947 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.2 m -81.44 -25.72 35.91 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.329 0.585 . . . . 10.0 109.576 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 15.6 pt -137.84 164.88 27.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.365 -0.834 . . . . 10.0 109.904 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.35 -165.55 1.02 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.935 -0.395 . . . . 10.0 109.935 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.409 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 2.3 m -51.97 -55.57 29.47 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 112.502 0.556 . . . . 10.0 112.502 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 72' ' ' THR . 24.6 Cg_endo -62.35 -22.23 73.8 Favored 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 121.908 1.739 . . . . 10.0 112.59 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -83.26 -44.78 6.85 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.757 -0.735 . . . . 10.0 111.904 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.5 p -64.79 -34.69 71.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-O 120.817 0.342 . . . . 10.0 110.921 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 77.5 mt -70.11 -41.57 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 110.063 -0.347 . . . . 10.0 110.063 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 26.3 ttp180 -63.62 -40.11 96.06 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.339 -0.391 . . . . 10.0 110.253 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.6 mmt180 -57.76 -43.9 85.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.397 0.618 . . . . 10.0 110.18 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.415 HG23 ' C8 ' ' A' ' 201' ' ' 8TL . 45.9 t -72.9 -29.51 29.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.461 -0.79 . . . . 10.0 111.082 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.7 m -61.08 -29.87 70.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.079 0.466 . . . . 10.0 110.785 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.8 mm-40 -87.82 -26.77 22.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.917 -0.583 . . . . 10.0 110.45 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 29.5 tp -76.53 -53.6 7.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.031 -0.531 . . . . 10.0 110.284 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 18.9 m-30 -93.11 45.27 1.17 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.953 0.406 . . . . 10.0 110.447 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -68.35 -13.01 61.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.035 -0.529 . . . . 10.0 110.948 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -102.99 -10.89 18.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.009 -0.541 . . . . 10.0 110.761 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -133.36 79.53 60.57 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 120.737 0.303 . . . . 10.0 110.855 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.44 ' O ' HG22 ' A' ' 91' ' ' VAL . 18.1 Cg_endo -61.55 -31.47 87.35 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.741 2.294 . . . . 10.0 111.981 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -60.6 -31.81 70.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.744 -0.662 . . . . 10.0 110.987 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.2 mt -74.48 -25.33 59.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.031 -0.532 . . . . 10.0 111.162 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 46.1 mt -80.73 -44.56 21.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.125 -0.489 . . . . 10.0 110.023 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 87' ' ' PRO . 17.4 t -67.87 -31.1 50.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.83 -0.623 . . . . 10.0 110.288 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.22 -39.4 97.64 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.805 -0.712 . . . . 10.0 111.759 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.444 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 59.2 t80 -64.28 -36.44 84.13 Favored 'General case' 0 C--O 1.227 -0.117 0 CA-C-O 121.007 0.432 . . . . 10.0 110.216 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -62.63 -27.88 69.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.816 -0.629 . . . . 10.0 110.756 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -93.16 -19.96 20.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.287 -0.415 . . . . 10.0 111.149 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -97.26 44.5 1.05 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.299 -0.41 . . . . 10.0 110.643 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 93' ' ' PHE . 40.9 mt -113.01 102.92 55.48 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.083 -0.508 . . . . 10.0 110.444 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 97' ' ' LEU . 18.7 Cg_endo -62.19 -42.92 26.23 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.37 2.047 . . . . 10.0 111.873 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.7 94.53 7.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.921 -0.581 . . . . 10.0 110.039 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -134.31 -151.15 6.33 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.559 -0.829 . . . . 10.0 112.55 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -83.11 25.22 0.69 Allowed 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 122.939 2.426 . . . . 10.0 112.385 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.89 171.77 14.72 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.938 -0.574 . . . . 10.0 111.106 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.5 m -61.38 125.44 23.79 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.049 0.452 . . . . 10.0 111.171 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.652 0 C-N-CA 120.814 -0.708 . . . . 10.0 111.806 -179.951 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' 8TL . . . . . 0.783 ' O3 ' ' C11' ' A' ' 201' ' ' 8TL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.423 0 N-CA-C 112.223 -0.351 . . . . 10.0 112.223 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 m -124.8 124.12 41.44 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.591 0.234 . . . . 10.0 110.393 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.1 156.68 33.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.991 -0.55 . . . . 10.0 110.59 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.09 85.26 0.52 Allowed Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.534 -0.841 . . . . 10.0 112.465 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.2 m -73.09 114.97 11.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.866 0.365 . . . . 10.0 110.222 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.0 m -106.43 127.07 53.01 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.227 -0.442 . . . . 10.0 110.628 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.07 55.12 0.1 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.72 -0.753 . . . . 10.0 111.996 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.8 m -68.78 155.02 7.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-O 121.154 0.502 . . . . 10.0 111.351 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -99.07 -176.14 3.23 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.201 -0.454 . . . . 10.0 110.571 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.0 m -65.33 -20.11 26.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 121.197 0.522 . . . . 10.0 110.673 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -102.6 56.75 0.78 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.285 0.564 . . . . 10.0 109.812 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -90.44 -12.23 38.04 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.53 -0.759 . . . . 10.0 111.23 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.2 -48.7 80.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.609 -0.723 . . . . 10.0 111.355 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 pp -71.2 -22.5 62.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.161 -0.472 . . . . 10.0 111.993 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.491 ' O ' ' HG2' ' A' ' 43' ' ' GLN . 1.1 m -65.45 -60.1 3.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.356 -0.384 . . . . 10.0 111.421 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -67.4 -27.94 67.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.639 -0.255 . . . . 10.0 111.244 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -58.39 -35.24 71.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.281 -0.418 . . . . 10.0 111.511 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -91.06 -24.61 19.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.394 -0.366 . . . . 10.0 111.44 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 39' ' ' THR . 15.9 mm100 -56.47 -36.12 68.72 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.905 0.383 . . . . 10.0 110.856 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.524 HG22 ' CZ ' ' A' ' 58' ' ' PHE . 11.0 t -66.7 -36.84 78.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 10.0 110.615 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.7 ttpm? -65.91 -35.4 80.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.886 -0.597 . . . . 10.0 110.449 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 46.0 mt -74.61 -40.92 48.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.717 -0.674 . . . . 10.0 109.98 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 -63.23 -51.76 64.92 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.345 -0.843 . . . . 10.0 111.514 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -102.35 54.03 0.79 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.282 0.563 . . . . 10.0 110.433 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.74 -41.28 89.3 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.701 -0.681 . . . . 10.0 112.874 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.3 m -92.96 7.93 41.95 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.842 0.321 . . . . 10.0 111.583 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -129.14 89.07 49.38 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.86 0.362 . . . . 10.0 111.241 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.9 -17.66 17.47 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.218 1.946 . . . . 10.0 112.311 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.83 -54.8 22.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.959 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.6 m -69.04 -27.51 65.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.024 0.44 . . . . 10.0 111.049 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -70.19 -41.99 72.99 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.858 0.361 . . . . 10.0 110.677 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -62.57 -42.11 99.35 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.201 -0.454 . . . . 10.0 110.322 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.12 -33.23 86.69 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.933 -0.651 . . . . 10.0 111.723 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.524 ' CZ ' HG22 ' A' ' 44' ' ' VAL . 88.4 t80 -62.2 -37.02 83.71 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.071 0.462 . . . . 10.0 110.07 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 22.7 mt -72.3 -35.87 68.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.68 -0.691 . . . . 10.0 110.901 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -62.04 -34.86 77.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.925 -0.58 . . . . 10.0 111.071 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.4 mt -66.22 -34.31 69.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.114 -0.493 . . . . 10.0 110.959 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.5 mtp -64.5 -33.79 76.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.371 -0.377 . . . . 10.0 110.52 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -61.64 -37.56 84.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.973 -0.558 . . . . 10.0 110.615 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -64.23 -37.92 89.2 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.111 -0.495 . . . . 10.0 110.808 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -78.6 -42.3 29.36 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.728 -0.389 . . . . 10.0 111.15 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -63.25 -34.33 77.44 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.589 -0.278 . . . . 10.0 111.661 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.9 m -84.22 5.38 26.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.733 0.301 . . . . 10.0 111.117 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 63.7 31.92 14.08 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.974 -0.557 . . . . 10.0 111.736 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.4 m -87.71 -48.29 7.98 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.999 0.428 . . . . 10.0 110.303 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 47.9 pt -104.72 146.43 11.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 110.03 -0.359 . . . . 10.0 110.03 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -99.48 -175.54 3.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.802 -0.636 . . . . 10.0 109.956 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.543 ' O ' HG11 ' A' ' 75' ' ' VAL . 0.9 OUTLIER -55.08 -54.09 54.13 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 111.707 0.262 . . . . 10.0 111.707 -179.77 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' A' ' 72' ' ' THR . 24.2 Cg_endo -63.26 -24.71 72.1 Favored 'Trans proline' 0 C--N 1.358 1.067 0 C-N-CA 121.833 1.689 . . . . 10.0 112.324 178.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.85 -39.26 28.99 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.018 -0.61 . . . . 10.0 112.679 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.543 HG11 ' O ' ' A' ' 72' ' ' THR . 4.9 p -68.71 -29.86 45.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 O-C-N 122.715 -0.285 . . . . 10.0 111.105 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 72' ' ' THR . 68.0 mt -59.86 -41.37 85.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-O 120.912 0.387 . . . . 10.0 110.052 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -62.13 -40.03 94.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.753 -0.658 . . . . 10.0 109.71 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.2 mmt180 -63.22 -44.89 93.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.754 -0.657 . . . . 10.0 110.739 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 75' ' ' VAL . 47.4 t -61.84 -46.3 96.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.758 -0.655 . . . . 10.0 110.855 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.9 m -65.59 -24.32 67.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.893 -0.594 . . . . 10.0 111.661 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -87.43 -24.53 24.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.748 0.309 . . . . 10.0 111.023 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 14.8 tp -86.0 -45.54 11.35 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.08 0.467 . . . . 10.0 110.418 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -103.82 43.77 1.07 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.739 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 13.5 p80 -63.6 -20.12 65.4 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.001 -0.545 . . . . 10.0 111.491 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -101.36 -0.21 35.91 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.962 0.411 . . . . 10.0 110.613 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -135.27 77.05 55.46 Favored Pre-proline 0 C--O 1.236 0.38 0 CA-C-N 116.246 -0.434 . . . . 10.0 110.208 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.434 ' O ' HG23 ' A' ' 91' ' ' VAL . 18.0 Cg_endo -60.92 -29.25 87.7 Favored 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.301 2.001 . . . . 10.0 112.631 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -62.85 -37.58 87.4 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 116.115 -0.493 . . . . 10.0 110.667 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.1 mt -66.15 -41.34 90.55 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.144 -0.48 . . . . 10.0 110.545 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.2 mt -66.02 -46.07 89.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.031 -0.532 . . . . 10.0 109.983 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 87' ' ' PRO . 73.8 t -62.38 -43.91 98.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.637 -0.711 . . . . 10.0 110.383 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.93 -40.62 99.11 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.685 -0.689 . . . . 10.0 112.235 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -66.14 -43.18 87.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.706 0.289 . . . . 10.0 110.726 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -61.79 -32.76 73.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.929 0.395 . . . . 10.0 111.36 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.23 -25.06 27.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.821 0.343 . . . . 10.0 111.365 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.45 -31.59 72.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.014 -0.539 . . . . 10.0 111.511 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 36.4 mt -58.16 115.62 11.94 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.526 -0.306 . . . . 10.0 111.688 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -82.25 -24.82 3.59 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.689 2.259 . . . . 10.0 112.125 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.4 m -91.41 99.82 12.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.157 -0.474 . . . . 10.0 110.58 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -151.55 -115.27 0.66 Allowed Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.955 -0.858 . . . . 10.0 110.955 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -82.32 6.86 5.46 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.407 2.071 . . . . 10.0 111.201 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.33 154.44 23.93 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.408 -0.815 . . . . 10.0 111.765 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.45 126.12 29.07 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.74 -0.664 . . . . 10.0 110.173 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 C-N-CA 120.768 -0.729 . . . . 10.0 112.463 179.682 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' 8TL . . . . . 0.774 ' O3 ' ' C11' ' A' ' 201' ' ' 8TL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.498 0 N-CA-C 112.093 -0.403 . . . . 10.0 112.093 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.23 140.47 23.13 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.039 -0.356 . . . . 10.0 110.039 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.0 m -74.42 145.18 43.91 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.712 0.291 . . . . 10.0 110.43 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 151.33 151.49 5.61 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.811 -0.709 . . . . 10.0 112.186 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 56.3 m -151.41 85.57 1.33 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.028 0.442 . . . . 10.0 110.258 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.9 m -67.39 148.39 51.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.985 -0.552 . . . . 10.0 111.224 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.49 83.34 1.56 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.742 -0.742 . . . . 10.0 112.42 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 29.5 m -108.14 156.23 8.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 110.159 -0.312 . . . . 10.0 110.159 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -102.35 -177.77 3.5 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.344 -0.389 . . . . 10.0 110.203 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.2 m -65.19 -27.1 41.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.812 0.339 . . . . 10.0 111.485 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -99.53 93.41 5.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.465 -0.334 . . . . 10.0 110.396 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -107.09 -11.56 15.61 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.348 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.09 -50.76 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.649 -0.705 . . . . 10.0 112.404 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.12 -10.99 60.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.129 -0.487 . . . . 10.0 112.052 -178.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.54 -58.46 2.52 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.049 0.452 . . . . 10.0 111.695 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.495 ' O ' HG23 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -67.88 -30.78 70.22 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.896 0.702 . . . . 10.0 112.896 -177.633 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.1 -38.83 73.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.749 0.309 . . . . 10.0 111.59 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.4 ' O ' HG13 ' A' ' 46' ' ' ILE . 12.5 t0 -78.92 -35.49 43.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.83 0.348 . . . . 10.0 110.642 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -57.72 -39.9 78.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.981 -0.554 . . . . 10.0 111.383 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 40' ' ' TYR . 26.8 t -65.44 -37.11 79.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.077 0.465 . . . . 10.0 110.207 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.1 ttpm? -69.15 -33.26 73.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.638 -0.71 . . . . 10.0 110.634 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 42' ' ' ASP . 62.8 mt -73.59 -43.07 55.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.855 -0.612 . . . . 10.0 110.224 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -65.74 -42.24 91.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.864 -0.607 . . . . 10.0 111.203 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -107.4 58.94 0.62 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.33 0.586 . . . . 10.0 110.57 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.62 -43.78 9.94 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.457 -0.792 . . . . 10.0 111.938 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 39.3 m -85.21 -11.05 55.83 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.861 0.362 . . . . 10.0 110.838 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -114.66 92.74 30.35 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.149 -0.478 . . . . 10.0 110.824 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -76.42 -15.84 17.49 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.233 1.956 . . . . 10.0 111.757 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.32 -54.49 32.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.507 -0.77 . . . . 10.0 111.634 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.7 m -65.95 -34.0 77.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.402 -0.363 . . . . 10.0 111.0 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -65.34 -44.23 88.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 10.0 110.719 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -64.6 -41.8 95.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.169 -0.469 . . . . 10.0 110.569 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.61 -39.09 96.91 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 115.948 -0.569 . . . . 10.0 112.09 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -57.98 -40.61 81.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.146 0.498 . . . . 10.0 110.463 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 27.3 mt -71.7 -30.01 65.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.791 -0.641 . . . . 10.0 111.127 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -68.93 -38.65 79.64 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.022 0.439 . . . . 10.0 110.876 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.1 mt -67.74 -30.84 49.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.784 -0.644 . . . . 10.0 110.606 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 33.1 mmt -64.94 -28.11 69.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.181 -0.463 . . . . 10.0 110.588 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -63.08 -41.26 99.37 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.154 -0.476 . . . . 10.0 110.26 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -65.31 -42.25 93.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.761 -0.654 . . . . 10.0 110.487 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -65.15 -42.59 93.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.112 -0.495 . . . . 10.0 110.634 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -67.82 -18.56 64.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.89 0.376 . . . . 10.0 111.054 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.1 m -95.92 2.19 53.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.067 -0.515 . . . . 10.0 110.453 178.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 64.79 23.05 12.65 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.714 -0.676 . . . . 10.0 110.758 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.2 m -77.74 -29.34 51.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.508 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 37.8 pt -128.48 153.37 37.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 10.0 111.008 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -105.3 -164.35 1.02 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.902 -0.59 . . . . 10.0 110.432 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.437 ' HB ' ' HD3' ' A' ' 73' ' ' PRO . 24.5 m -55.05 -56.48 27.52 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-N 116.502 -0.317 . . . . 10.0 111.212 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.437 ' HD3' ' HB ' ' A' ' 72' ' ' THR . 36.8 Cg_endo -66.41 -21.77 53.24 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 121.647 1.565 . . . . 10.0 111.822 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.07 -48.15 73.96 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.616 -0.72 . . . . 10.0 112.077 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.436 ' O ' HG22 ' A' ' 79' ' ' VAL . 9.5 p -72.77 -31.88 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 120.882 -0.327 . . . . 10.0 110.161 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 47.0 mt -59.95 -40.82 84.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 109.7 -0.482 . . . . 10.0 109.7 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 30.0 ttp180 -59.28 -42.32 90.97 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.112 -0.699 . . . . 10.0 109.112 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -67.4 -45.73 75.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.376 -0.829 . . . . 10.0 110.439 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 75' ' ' VAL . 62.7 t -55.64 -43.41 73.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.973 -0.558 . . . . 10.0 111.239 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.9 m -64.69 -30.33 71.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.036 -0.529 . . . . 10.0 112.006 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -87.93 -36.26 17.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.695 0.283 . . . . 10.0 111.381 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 24.1 tp -73.55 -54.14 8.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.92 0.391 . . . . 10.0 111.056 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -91.29 38.9 0.98 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.382 0.611 . . . . 10.0 109.651 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -59.38 -34.39 72.37 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.299 -0.864 . . . . 10.0 112.57 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -94.19 7.0 46.86 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.499 0.185 . . . . 10.0 111.499 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -133.59 72.48 74.03 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-O 120.754 0.311 . . . . 10.0 110.25 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.483 ' O ' HG23 ' A' ' 91' ' ' VAL . 33.4 Cg_exo -60.44 -32.78 94.23 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.026 2.484 . . . . 10.0 111.939 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -58.28 -38.4 76.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.591 -0.731 . . . . 10.0 110.433 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 60.1 mt -73.58 -31.69 63.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.915 -0.584 . . . . 10.0 111.306 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.0 mt -68.88 -45.53 80.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.12 0.486 . . . . 10.0 110.107 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 87' ' ' PRO . 19.4 t -69.34 -35.11 65.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.753 -0.658 . . . . 10.0 110.326 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.39 -46.39 94.42 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.787 -0.72 . . . . 10.0 112.47 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.439 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 64.2 t80 -62.01 -32.11 72.56 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.761 0.315 . . . . 10.0 111.18 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -61.37 -38.03 85.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.099 -0.501 . . . . 10.0 111.781 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.38 -8.25 32.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.895 0.378 . . . . 10.0 111.657 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.46 -19.69 35.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.823 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 93' ' ' PHE . 86.9 mt -58.02 121.66 52.32 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.939 -0.573 . . . . 10.0 111.533 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -77.57 -13.63 16.36 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.708 2.272 . . . . 10.0 112.451 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.7 m -106.45 110.77 23.08 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.336 -0.393 . . . . 10.0 110.651 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -142.05 -146.66 4.7 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.694 -0.765 . . . . 10.0 111.671 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -74.25 -5.99 17.76 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.635 2.223 . . . . 10.0 112.549 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 m -66.92 153.47 43.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.857 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.2 t -59.22 128.83 39.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.243 -0.435 . . . . 10.0 110.556 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.419 0 C-N-CA 120.435 -0.888 . . . . 10.0 112.351 -179.893 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' 8TL . . . . . 0.76 ' O3 ' ' C11' ' A' ' 201' ' ' 8TL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 109.854 -0.424 . . . . 10.0 109.854 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.2 m -92.59 157.73 16.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.461 -0.336 . . . . 10.0 110.637 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.2 82.67 1.12 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.95 -0.643 . . . . 10.0 113.142 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.6 m -88.75 173.37 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.906 -0.405 . . . . 10.0 109.906 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -95.6 176.77 6.03 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.74 -0.209 . . . . 10.0 110.678 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.5 m -67.22 -23.41 30.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-O 120.881 0.372 . . . . 10.0 111.43 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -133.1 87.9 2.45 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.445 -0.576 . . . . 10.0 109.445 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -93.58 13.78 20.9 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.677 -0.692 . . . . 10.0 110.857 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.96 -42.79 94.28 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.767 -0.651 . . . . 10.0 111.412 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.05 -25.8 62.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.257 -0.428 . . . . 10.0 111.526 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.4 m -61.24 -60.35 3.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.22 -0.445 . . . . 10.0 111.519 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -66.22 -31.88 72.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.35 -0.386 . . . . 10.0 111.168 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.09 -52.72 62.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.426 . . . . 10.0 111.48 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -74.74 -27.17 60.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.302 -0.408 . . . . 10.0 111.272 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -58.18 -38.89 77.56 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.251 -0.431 . . . . 10.0 111.662 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.2 t -62.77 -34.83 67.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.122 0.487 . . . . 10.0 110.632 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.7 ttpm? -70.41 -34.74 72.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.857 -0.611 . . . . 10.0 110.762 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 35.1 mt -76.75 -35.57 25.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.701 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -71.21 -43.38 67.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.209 -0.45 . . . . 10.0 111.104 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -106.94 44.18 1.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.184 0.516 . . . . 10.0 110.901 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.55 -30.75 78.18 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.882 -0.675 . . . . 10.0 112.291 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.1 m -92.73 -6.28 49.43 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 122.759 -0.26 . . . . 10.0 111.304 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -123.13 85.03 51.3 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 120.794 0.33 . . . . 10.0 110.847 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.42 -26.32 41.01 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.479 2.119 . . . . 10.0 112.812 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.79 -44.48 93.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.653 -0.249 . . . . 10.0 111.087 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.2 m -65.88 -40.79 91.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.063 -0.517 . . . . 10.0 111.034 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -69.06 -37.73 78.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.547 -0.297 . . . . 10.0 110.835 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -61.23 -43.22 99.23 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.856 0.36 . . . . 10.0 110.616 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.96 -37.82 95.18 Favored Glycine 0 C--N 1.332 0.33 0 N-CA-C 111.529 -0.628 . . . . 10.0 111.529 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -57.51 -42.21 82.36 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.974 0.416 . . . . 10.0 110.181 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 26.6 mt -67.12 -38.04 84.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.811 -0.631 . . . . 10.0 110.887 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -61.61 -44.28 97.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.28 -0.418 . . . . 10.0 110.704 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.9 mt -63.7 -35.78 74.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.306 -0.406 . . . . 10.0 110.304 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 82.6 mtp -64.01 -37.11 86.21 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.106 -0.497 . . . . 10.0 110.219 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -62.53 -37.42 86.0 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.008 -0.542 . . . . 10.0 111.153 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -63.45 -36.58 84.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.09 0.471 . . . . 10.0 110.094 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -73.33 -35.63 66.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.048 -0.524 . . . . 10.0 109.747 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -66.73 -23.96 66.17 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.117 -0.492 . . . . 10.0 110.45 178.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.0 m -94.35 2.74 55.8 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.92 -0.582 . . . . 10.0 110.131 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 56.85 31.63 19.95 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.648 -0.706 . . . . 10.0 111.294 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.7 m -82.2 -22.18 36.07 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.563 0.697 . . . . 10.0 109.846 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 17.6 pt -131.99 158.47 43.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.264 -0.88 . . . . 10.0 109.965 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -110.0 -162.46 0.8 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.557 -0.534 . . . . 10.0 109.557 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.483 ' HB ' ' CD ' ' A' ' 73' ' ' PRO . 1.4 m -56.73 -60.17 10.17 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 116.237 -0.438 . . . . 10.0 111.221 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.483 ' CD ' ' HB ' ' A' ' 72' ' ' THR . 25.1 Cg_endo -61.52 -21.73 72.71 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 121.908 1.739 . . . . 10.0 112.594 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.79 -50.31 11.57 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.931 -0.577 . . . . 10.0 112.674 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.602 ' O ' HG23 ' A' ' 79' ' ' VAL . 14.5 p -65.18 -36.85 78.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.89 0.345 . . . . 10.0 110.898 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.441 HD12 ' HA ' ' A' ' 73' ' ' PRO . 60.5 mt -58.64 -38.99 74.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 116.299 -0.409 . . . . 10.0 111.081 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 -60.87 -39.29 88.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.957 -0.565 . . . . 10.0 110.928 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -69.63 -45.56 68.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.805 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.61 HG12 HG12 ' A' ' 90' ' ' ILE . 13.6 t -61.0 -38.28 79.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.906 -0.588 . . . . 10.0 110.971 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.481 ' HA ' HD13 ' A' ' 90' ' ' ILE . 23.0 m -65.95 -17.38 64.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.469 . . . . 10.0 111.786 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -102.52 -23.84 13.86 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 111.799 0.296 . . . . 10.0 111.799 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 40.3 tp -85.26 -53.08 5.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.929 0.395 . . . . 10.0 110.348 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -94.96 47.61 1.16 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.025 0.44 . . . . 10.0 110.11 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.502 ' CD2' ' HG2' ' A' ' 85' ' ' GLU . 29.2 p-80 -66.08 -25.46 67.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.993 -0.549 . . . . 10.0 110.771 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.502 ' HG2' ' CD2' ' A' ' 84' ' ' HIS . 53.0 mm-40 -91.0 -9.54 45.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.114 -0.494 . . . . 10.0 110.583 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -128.97 72.05 81.91 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.289 -0.414 . . . . 10.0 111.214 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -61.8 -26.91 80.0 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.581 2.187 . . . . 10.0 112.587 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -56.27 -38.8 71.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.865 -0.607 . . . . 10.0 111.964 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 97.7 mt -64.36 -42.83 95.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.381 -0.372 . . . . 10.0 111.208 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.61 HG12 HG12 ' A' ' 79' ' ' VAL . 3.3 mt -73.0 -41.01 59.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.088 -0.506 . . . . 10.0 111.03 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.435 ' O ' ' HB2' ' A' ' 94' ' ' ASN . 78.7 t -67.36 -48.35 77.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.973 -0.558 . . . . 10.0 110.597 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.68 -31.19 77.07 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.002 -0.618 . . . . 10.0 112.45 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -63.93 -24.92 67.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.696 0.284 . . . . 10.0 111.17 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' A' ' 91' ' ' VAL . 2.6 m-80 -63.72 -33.68 76.19 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.031 0.443 . . . . 10.0 110.426 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -95.58 -16.68 21.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.211 0.529 . . . . 10.0 110.343 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -89.35 31.57 0.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.809 -0.632 . . . . 10.0 110.46 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.2 mt -121.35 108.48 35.82 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.4 -0.818 . . . . 10.0 109.178 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -59.7 -49.15 10.82 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.393 2.062 . . . . 10.0 111.849 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.49 118.31 10.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.283 -0.417 . . . . 10.0 110.367 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -168.21 -134.92 1.79 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.55 -0.833 . . . . 10.0 112.53 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -82.83 13.41 2.62 Favored 'Trans proline' 0 CA--C 1.529 0.226 0 C-N-CA 122.88 2.387 . . . . 10.0 113.284 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.2 m -73.65 162.58 29.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.709 0.29 . . . . 10.0 110.261 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.6 m -72.7 104.64 4.0 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.926 0.393 . . . . 10.0 110.532 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.457 0 C-N-CA 120.902 -0.666 . . . . 10.0 112.375 179.698 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 65.7 m . . . . . 0 N--CA 1.453 -0.279 0 CA-C-O 121.102 0.477 . . . . 10.0 110.766 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.56 113.58 24.29 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.947 -0.57 . . . . 10.0 109.907 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 155.08 74.22 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.803 -0.713 . . . . 10.0 111.416 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 28.5 m -84.47 156.54 3.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.094 0.473 . . . . 10.0 111.027 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -112.14 -178.55 3.45 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.585 -0.734 . . . . 10.0 109.321 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.405 HG22 ' H ' ' A' ' 34' ' ' VAL . 1.9 m -67.24 -36.27 76.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.721 0.296 . . . . 10.0 111.73 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -115.05 105.72 13.28 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.882 0.372 . . . . 10.0 110.222 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -139.75 3.51 2.06 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.566 0.58 . . . . 10.0 112.566 -178.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.61 -37.73 87.43 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.122 0.487 . . . . 10.0 110.613 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.493 ' H ' ' HG ' ' A' ' 38' ' ' LEU . 0.7 OUTLIER -64.02 -24.07 67.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.536 -0.756 . . . . 10.0 111.51 179.738 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.3 m -68.36 -47.49 67.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.531 -0.304 . . . . 10.0 111.39 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -67.93 -36.56 80.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.922 0.391 . . . . 10.0 110.323 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 59.0 mt -65.08 -28.67 69.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.909 -0.587 . . . . 10.0 110.736 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -76.85 -38.09 54.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.687 -0.688 . . . . 10.0 110.206 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -59.1 -36.4 75.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.769 -0.65 . . . . 10.0 111.168 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 54.0 t -61.1 -40.92 87.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.982 -0.554 . . . . 10.0 110.911 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.1 pttm -71.09 -24.19 62.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.371 -0.377 . . . . 10.0 111.09 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 81.9 mt -78.01 -48.7 22.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 121.014 0.435 . . . . 10.0 110.087 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -63.68 -40.57 97.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.762 -0.653 . . . . 10.0 111.357 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -103.59 40.02 1.5 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.099 0.476 . . . . 10.0 110.428 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -70.82 -29.36 69.43 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.697 -0.763 . . . . 10.0 112.38 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.4 m -81.74 -31.27 32.08 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.407 0.146 . . . . 10.0 111.04 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -113.56 106.67 53.91 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.791 0.329 . . . . 10.0 110.848 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -81.15 -11.62 12.07 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.473 2.115 . . . . 10.0 112.686 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.95 -48.87 64.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.09 -0.504 . . . . 10.0 110.744 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.5 m -66.29 -32.96 74.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 10.0 110.523 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -72.4 -43.3 64.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 10.0 110.241 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -64.55 -37.75 88.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.066 -0.516 . . . . 10.0 110.248 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.65 -26.83 73.65 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.765 -0.652 . . . . 10.0 111.628 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -68.05 -36.81 80.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.267 0.556 . . . . 10.0 109.681 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 60.5 mt -66.06 -36.81 84.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.687 -0.688 . . . . 10.0 110.606 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -66.54 -31.45 72.17 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.064 -0.516 . . . . 10.0 110.788 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.2 mt -65.29 -42.87 94.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.228 0.537 . . . . 10.0 110.577 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.471 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 67.8 mtp -65.8 -33.56 76.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.039 -0.528 . . . . 10.0 110.657 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.39 -34.6 77.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 10.0 111.421 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -67.97 -31.89 71.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.044 0.45 . . . . 10.0 110.566 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -81.13 -29.7 34.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.636 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 62' ' ' MET . 23.7 mtpp -59.0 -41.21 87.13 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.902 0.382 . . . . 10.0 110.771 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.1 m -88.52 8.37 28.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 10.0 110.967 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 58.33 30.57 19.75 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.656 -0.702 . . . . 10.0 111.038 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.3 m -77.14 -24.71 51.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.086 -0.506 . . . . 10.0 110.844 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 36.1 pt -125.31 162.87 27.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.114 -0.494 . . . . 10.0 110.121 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -112.22 -172.4 2.04 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.939 -0.573 . . . . 10.0 110.055 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.609 ' O ' HG12 ' A' ' 75' ' ' VAL . 2.1 m -54.7 -54.39 49.78 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 116.362 -0.381 . . . . 10.0 111.841 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 72' ' ' THR . 28.7 Cg_endo -63.26 -26.12 72.0 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 121.793 1.662 . . . . 10.0 111.994 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.73 -41.93 72.63 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.759 -0.655 . . . . 10.0 112.571 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.609 HG12 ' O ' ' A' ' 72' ' ' THR . 4.2 p -65.51 -29.95 48.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 120.704 0.287 . . . . 10.0 110.372 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 63.6 mt -63.07 -42.73 97.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 10.0 110.209 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -62.02 -40.06 94.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.533 -0.758 . . . . 10.0 109.934 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -66.63 -46.76 74.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.943 -0.572 . . . . 10.0 110.957 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.1 t -66.3 -43.99 91.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.216 -0.447 . . . . 10.0 111.107 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.554 ' HA ' HD13 ' A' ' 90' ' ' ILE . 0.4 OUTLIER -60.57 -37.98 83.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.122 -0.49 . . . . 10.0 111.196 -179.506 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -79.3 -27.09 42.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.708 -0.223 . . . . 10.0 111.363 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 35.5 tp -76.22 -51.94 11.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.879 0.371 . . . . 10.0 110.346 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 -91.5 48.74 1.5 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.206 0.527 . . . . 10.0 110.212 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -68.7 -8.99 47.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.82 -0.627 . . . . 10.0 111.766 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -110.23 -12.03 14.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.836 0.351 . . . . 10.0 111.047 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -130.46 80.87 69.43 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.385 -0.37 . . . . 10.0 111.001 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -62.31 -28.95 79.23 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.597 2.198 . . . . 10.0 112.298 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -58.5 -36.72 74.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.599 -0.728 . . . . 10.0 111.468 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 95.7 mt -75.72 -30.25 59.2 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.408 -0.36 . . . . 10.0 111.125 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.554 HD13 ' HA ' ' A' ' 80' ' ' SER . 45.4 mt -69.05 -46.17 78.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.347 0.594 . . . . 10.0 109.459 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.411 ' O ' ' HB2' ' A' ' 94' ' ' ASN . 46.3 t -70.11 -37.33 71.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.318 -0.855 . . . . 10.0 109.751 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.32 -40.63 94.31 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.748 -0.66 . . . . 10.0 112.189 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -60.25 -28.91 68.42 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.754 0.311 . . . . 10.0 110.747 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' A' ' 91' ' ' VAL . 28.4 m-80 -69.78 -17.73 63.44 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.44 -0.345 . . . . 10.0 110.662 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.78 -3.47 24.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.89 0.376 . . . . 10.0 111.024 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -112.86 20.19 16.66 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.064 0.459 . . . . 10.0 110.842 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 17.5 mt -80.22 116.15 59.53 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.815 -0.629 . . . . 10.0 109.831 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.32 -18.41 30.06 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.38 2.054 . . . . 10.0 112.74 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.71 158.27 30.47 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.867 -0.42 . . . . 10.0 109.867 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 169.77 -134.32 3.13 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 121.007 -0.616 . . . . 10.0 111.624 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.57 -9.48 18.58 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.755 2.304 . . . . 10.0 111.533 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 m -66.23 152.11 45.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.673 -0.694 . . . . 10.0 111.373 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.56 133.81 55.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.905 -0.589 . . . . 10.0 111.081 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.222 0 CA-C-N 115.967 -0.56 . . . . 10.0 112.463 179.425 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.1 m . . . . . 0 C--O 1.234 0.248 0 CA-C-O 120.901 0.381 . . . . 10.0 110.78 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.4 m -90.56 150.79 21.6 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.76 0.314 . . . . 10.0 110.425 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.88 91.74 2.22 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.695 -0.764 . . . . 10.0 111.643 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.7 m -91.69 164.57 2.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.654 0.264 . . . . 10.0 110.762 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -119.36 177.05 5.05 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.282 -0.417 . . . . 10.0 110.209 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.3 m -81.98 -12.7 12.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.919 0.39 . . . . 10.0 110.856 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -139.95 87.64 2.17 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.185 -0.461 . . . . 10.0 110.111 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.2 p30 -128.61 12.02 6.31 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.25 -0.432 . . . . 10.0 111.037 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.91 -44.69 96.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.261 0.553 . . . . 10.0 111.072 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.541 HD23 ' H ' ' A' ' 38' ' ' LEU . 1.8 pt? -63.24 -31.41 72.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.519 -0.764 . . . . 10.0 111.002 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 m -62.05 -51.42 68.06 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.086 -0.506 . . . . 10.0 111.191 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -70.01 -30.04 67.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.449 -0.341 . . . . 10.0 110.626 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.48 -34.89 78.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.965 0.412 . . . . 10.0 110.528 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -73.87 -32.58 63.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.296 -0.411 . . . . 10.0 110.185 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -60.16 -38.63 83.76 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.092 -0.503 . . . . 10.0 109.782 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 92.9 t -60.35 -39.43 80.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.657 -0.702 . . . . 10.0 109.7 178.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.8 ttpm? -67.04 -38.0 85.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.226 -0.897 . . . . 10.0 110.748 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 57.7 mt -71.0 -43.78 76.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.287 -0.415 . . . . 10.0 110.33 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -62.12 -36.49 81.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 10.0 111.231 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -101.94 36.36 2.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.058 0.456 . . . . 10.0 111.284 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.81 -36.3 89.46 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.855 -0.612 . . . . 10.0 111.984 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.0 m -101.69 13.36 35.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.603 0.24 . . . . 10.0 111.087 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -142.04 74.93 21.18 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.949 0.404 . . . . 10.0 110.752 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -63.71 -26.89 68.36 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.594 2.196 . . . . 10.0 112.476 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.12 -50.03 73.51 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.761 0.315 . . . . 10.0 110.989 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.9 m -63.03 -38.36 90.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.301 -0.409 . . . . 10.0 110.682 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -69.43 -40.11 77.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.412 -0.358 . . . . 10.0 110.791 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -64.65 -41.42 96.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.366 -0.379 . . . . 10.0 110.295 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.83 -27.96 72.77 Favored Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.886 -0.597 . . . . 10.0 111.788 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -64.47 -42.29 95.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.964 0.412 . . . . 10.0 110.393 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.9 mt -64.15 -29.84 70.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.981 -0.554 . . . . 10.0 110.613 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -68.81 -34.2 75.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 10.0 110.259 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.8 mt -67.88 -36.01 74.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.964 -0.562 . . . . 10.0 109.621 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.76 -31.46 72.64 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.591 -0.732 . . . . 10.0 110.156 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -62.36 -39.57 93.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.066 -0.516 . . . . 10.0 111.32 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -63.84 -37.18 86.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.171 -0.468 . . . . 10.0 110.453 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -74.79 -36.5 62.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.123 -0.49 . . . . 10.0 110.474 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -64.28 -41.02 97.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.312 -0.404 . . . . 10.0 110.9 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.7 m -81.8 0.24 40.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.388 -0.369 . . . . 10.0 110.918 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 61.32 32.06 19.24 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.688 -0.687 . . . . 10.0 111.95 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.1 m -78.15 -24.18 47.42 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.193 -0.669 . . . . 10.0 109.193 178.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 45.6 pt -135.91 -179.06 2.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.16 -0.927 . . . . 10.0 109.314 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -136.3 -151.2 0.4 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.927 -0.397 . . . . 10.0 109.927 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.459 ' HB ' ' HD3' ' A' ' 73' ' ' PRO . 7.1 m -55.72 -57.81 19.29 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 113.167 0.803 . . . . 10.0 113.167 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.459 ' HD3' ' HB ' ' A' ' 72' ' ' THR . 18.8 Cg_endo -61.15 -38.42 67.05 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 121.832 1.688 . . . . 10.0 112.964 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.56 -45.35 93.3 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 116.129 -0.487 . . . . 10.0 113.386 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.45 -39.5 82.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.768 -0.373 . . . . 10.0 111.303 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 81.4 mt -65.57 -43.87 94.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.797 0.332 . . . . 10.0 110.113 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 34.9 ttp-105 -61.58 -37.51 84.14 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.138 -0.483 . . . . 10.0 110.814 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.68 -50.26 58.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.151 -0.477 . . . . 10.0 110.888 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 94.5 t -66.39 -30.95 51.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.111 -0.495 . . . . 10.0 111.869 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 71.0 m -61.19 -27.89 68.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.002 0.429 . . . . 10.0 110.751 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -85.81 -28.97 24.15 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.826 -0.624 . . . . 10.0 110.374 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 25.9 tp -75.67 -45.48 36.78 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.87 -0.604 . . . . 10.0 109.842 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 6.1 m-30 -90.89 41.9 1.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.855 -0.611 . . . . 10.0 109.959 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -65.32 -21.18 66.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.483 -0.326 . . . . 10.0 111.678 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -103.83 5.64 36.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.962 0.411 . . . . 10.0 110.508 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -134.96 69.73 70.74 Favored Pre-proline 0 C--O 1.235 0.341 0 CA-C-N 116.413 -0.358 . . . . 10.0 110.923 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -62.16 -29.74 81.17 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.255 1.97 . . . . 10.0 112.2 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.49 -46.68 83.45 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.009 -0.541 . . . . 10.0 110.703 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 81.0 mt -64.25 -36.29 83.62 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.407 -0.815 . . . . 10.0 111.394 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 94.2 mt -62.57 -47.28 93.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.894 0.378 . . . . 10.0 110.458 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 43.2 t -70.05 -42.72 79.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.293 -0.412 . . . . 10.0 110.649 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.78 -43.84 97.54 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.956 -0.566 . . . . 10.0 112.761 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -62.26 -34.59 76.83 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.699 0.285 . . . . 10.0 111.367 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 -58.59 -38.55 78.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 10.0 111.03 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -91.47 -19.87 22.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.307 -0.406 . . . . 10.0 111.62 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -69.91 -35.32 74.51 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.674 0.274 . . . . 10.0 111.042 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 97' ' ' LEU . 9.3 mt -72.01 126.59 91.24 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 120.848 0.356 . . . . 10.0 111.339 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.72 -18.79 11.65 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.829 2.353 . . . . 10.0 111.984 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.42 130.74 43.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.798 -0.637 . . . . 10.0 111.025 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 161.65 -128.26 1.88 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.094 -0.575 . . . . 10.0 111.758 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -89.35 24.8 0.64 Allowed 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.788 2.325 . . . . 10.0 111.99 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.08 166.99 21.15 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.519 -0.764 . . . . 10.0 111.651 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.17 109.27 1.26 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.823 -0.626 . . . . 10.0 111.024 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.486 0 C-N-CA 120.472 -0.871 . . . . 10.0 112.582 179.596 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.2 m . . . . . 0 N--CA 1.452 -0.35 0 CA-C-O 121.239 0.542 . . . . 10.0 110.493 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.6 m -78.26 147.17 34.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.814 -0.63 . . . . 10.0 110.649 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.08 78.96 0.75 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.826 -0.702 . . . . 10.0 111.486 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.4 m -87.93 160.01 2.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.214 0.531 . . . . 10.0 110.97 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -112.9 174.84 5.7 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.95 -0.568 . . . . 10.0 110.193 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.2 m -68.04 -32.57 56.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.166 0.508 . . . . 10.0 109.826 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -113.07 80.47 1.36 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.27 -0.877 . . . . 10.0 109.211 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -123.83 2.4 8.78 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.035 -0.529 . . . . 10.0 111.547 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.51 -49.8 76.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.375 0.607 . . . . 10.0 111.001 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -66.69 -9.33 35.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.607 -0.724 . . . . 10.0 111.833 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.9 m -72.57 -37.44 68.2 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.58 0.228 . . . . 10.0 111.031 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -74.39 -29.55 61.58 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.788 -0.365 . . . . 10.0 110.615 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -58.0 -43.87 86.86 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.767 -0.457 . . . . 10.0 109.767 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.408 ' O ' HG13 ' A' ' 46' ' ' ILE . 36.6 t70 -64.77 -41.88 95.53 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.696 -0.683 . . . . 10.0 110.81 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -61.19 -38.22 85.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.812 -0.631 . . . . 10.0 111.006 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.62 -40.98 89.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.57 -0.53 . . . . 10.0 109.57 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.06 -29.15 68.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.727 -0.67 . . . . 10.0 110.862 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 42' ' ' ASP . 80.6 mt -75.13 -47.25 36.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.529 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 -62.94 -34.26 77.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.22 -0.446 . . . . 10.0 111.398 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -107.19 41.76 1.43 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.15 0.5 . . . . 10.0 110.506 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -70.75 -27.3 72.6 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.938 -0.648 . . . . 10.0 112.538 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.6 t -100.96 5.32 43.14 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.064 0.459 . . . . 10.0 110.473 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -135.64 86.33 28.67 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.815 -0.63 . . . . 10.0 110.105 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -74.32 -15.74 22.39 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.275 1.983 . . . . 10.0 112.644 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.69 -49.58 61.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.316 -0.402 . . . . 10.0 111.114 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.6 m -66.52 -33.31 75.4 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.318 -0.401 . . . . 10.0 110.779 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -67.64 -41.75 83.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.166 -0.47 . . . . 10.0 110.708 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -62.47 -38.59 90.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.935 0.398 . . . . 10.0 110.567 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.27 -33.25 84.52 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.918 -0.658 . . . . 10.0 111.898 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -61.85 -41.94 98.45 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.947 0.403 . . . . 10.0 110.181 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 24.5 mt -66.71 -36.29 82.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.963 -0.562 . . . . 10.0 110.287 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -62.27 -42.43 99.33 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.665 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.2 mt -66.17 -36.62 77.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.533 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 46.2 mtp -62.12 -34.06 75.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 10.0 110.631 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -62.36 -38.57 90.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.292 -0.413 . . . . 10.0 110.613 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -66.37 -36.83 83.87 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.379 -0.6 . . . . 10.0 109.379 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -68.87 -43.82 74.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.43 -0.805 . . . . 10.0 109.981 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -64.16 -37.17 86.51 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.083 -0.508 . . . . 10.0 111.203 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.7 m -82.5 4.38 24.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.302 -0.408 . . . . 10.0 111.336 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 58.97 28.46 17.67 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.874 -0.603 . . . . 10.0 111.449 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.6 m -75.71 -38.52 58.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.18 0.514 . . . . 10.0 110.143 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.2 pt -120.97 157.73 23.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.689 -0.687 . . . . 10.0 110.106 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -106.85 -163.25 0.9 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.173 -0.467 . . . . 10.0 110.399 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.486 ' O ' HG12 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -55.0 -57.05 21.48 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 112.772 0.656 . . . . 10.0 112.772 -179.724 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 72' ' ' THR . 20.5 Cg_endo -60.94 -29.45 88.05 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.043 1.828 . . . . 10.0 112.666 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.13 -48.17 20.89 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.625 -0.798 . . . . 10.0 112.017 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.486 HG12 ' O ' ' A' ' 72' ' ' THR . 5.6 p -63.91 -30.39 49.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.565 0.221 . . . . 10.0 110.753 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.5 mt -66.2 -49.22 77.73 Favored 'Isoleucine or valine' 0 C--N 1.337 0.053 0 N-CA-C 109.714 -0.476 . . . . 10.0 109.714 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 60.2 ttp180 -61.44 -42.61 99.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.864 -0.607 . . . . 10.0 110.799 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -56.53 -41.62 77.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.88 -0.6 . . . . 10.0 111.568 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.6 p -84.21 -22.36 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 120.826 -0.349 . . . . 10.0 111.625 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.5 m -64.25 -42.42 96.52 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.022 0.439 . . . . 10.0 110.737 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -77.3 -14.25 59.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.121 -0.49 . . . . 10.0 110.316 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 18.3 tp -86.44 -43.5 12.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.862 -0.608 . . . . 10.0 110.065 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -103.62 37.21 2.08 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.897 -0.592 . . . . 10.0 109.935 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -64.16 -24.56 67.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.321 -0.4 . . . . 10.0 111.595 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -92.55 0.26 57.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.467 -0.333 . . . . 10.0 110.895 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 18.4 m170 -136.34 81.03 38.24 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-O 120.675 0.274 . . . . 10.0 110.857 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -65.1 -27.53 57.21 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.483 2.122 . . . . 10.0 112.343 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -57.62 -42.6 83.65 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.8 -0.636 . . . . 10.0 110.96 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 96.1 mt -68.9 -41.04 78.8 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.127 -0.488 . . . . 10.0 111.184 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 59.3 mt -60.6 -48.01 90.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-O 121.116 0.484 . . . . 10.0 110.972 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.4 t -71.5 -42.8 72.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.985 -0.552 . . . . 10.0 110.834 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.77 -45.38 95.84 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.817 -0.629 . . . . 10.0 112.859 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.413 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 39.5 t80 -63.19 -34.42 77.61 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.729 0.3 . . . . 10.0 111.022 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -62.82 -36.09 82.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.406 -0.361 . . . . 10.0 111.149 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.9 -21.22 26.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.865 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -77.17 -25.14 51.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.903 -0.59 . . . . 10.0 110.908 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 93' ' ' PHE . 57.9 mt -52.34 125.55 34.98 Favored Pre-proline 0 C--O 1.235 0.304 0 CA-C-N 116.126 -0.488 . . . . 10.0 112.172 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -67.75 -30.66 33.75 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.586 2.19 . . . . 10.0 111.57 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.83 145.95 38.09 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.65 -0.705 . . . . 10.0 110.494 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 171.29 -169.02 42.15 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.775 -0.726 . . . . 10.0 111.963 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.37 15.89 0.62 Allowed 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 123.535 2.823 . . . . 10.0 113.125 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.81 179.59 2.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.018 0.437 . . . . 10.0 110.702 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.9 t -78.3 116.96 19.1 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.878 -0.416 . . . . 10.0 109.878 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.146 0 C-N-CA 120.882 -0.675 . . . . 10.0 112.346 179.747 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.235 0.325 0 CA-C-O 121.019 0.438 . . . . 10.0 110.882 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.4 m -81.35 149.35 28.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.122 -0.49 . . . . 10.0 109.816 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.37 74.28 1.07 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.019 -0.61 . . . . 10.0 111.972 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.8 m -82.47 161.29 3.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.775 0.322 . . . . 10.0 111.066 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -101.73 178.07 4.73 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.575 -0.528 . . . . 10.0 109.575 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 32.1 m -81.65 4.99 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.155 0.502 . . . . 10.0 111.235 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -153.52 103.45 2.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.87 -0.605 . . . . 10.0 109.763 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 38.6 p-10 -135.57 17.29 3.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.151 0.5 . . . . 10.0 110.733 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.58 -41.79 99.15 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.755 -0.657 . . . . 10.0 111.147 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.584 HD23 ' H ' ' A' ' 38' ' ' LEU . 2.2 pt? -71.17 -30.87 66.96 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.932 -0.577 . . . . 10.0 110.773 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.22 -43.87 93.65 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.209 -0.45 . . . . 10.0 110.876 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -67.45 -38.32 84.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 10.0 110.201 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.64 -41.49 99.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.26 0.552 . . . . 10.0 110.528 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.579 ' O ' HG13 ' A' ' 46' ' ' ILE . 22.1 t70 -66.43 -35.78 81.16 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.369 -0.832 . . . . 10.0 110.874 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -59.53 -45.48 91.64 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.031 0.443 . . . . 10.0 110.712 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 64.7 t -59.51 -35.83 61.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 115.517 -0.765 . . . . 10.0 110.373 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.4 ttpm? -67.51 -35.06 78.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.229 -0.896 . . . . 10.0 110.863 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.579 HG13 ' O ' ' A' ' 42' ' ' ASP . 23.4 mt -76.22 -47.04 32.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.573 -0.285 . . . . 10.0 110.938 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -58.87 -47.14 85.99 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.039 -0.528 . . . . 10.0 111.712 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -104.27 54.65 0.73 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.21 0.528 . . . . 10.0 110.986 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.83 -36.35 29.02 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.709 -0.757 . . . . 10.0 111.521 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.09 4.83 28.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.928 0.394 . . . . 10.0 110.994 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -138.83 87.83 14.25 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.001 -0.545 . . . . 10.0 109.917 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -70.7 -21.0 29.71 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.361 2.041 . . . . 10.0 112.598 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.78 -47.44 83.48 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.499 -0.318 . . . . 10.0 111.328 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.8 m -63.15 -43.27 98.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.077 0.465 . . . . 10.0 110.587 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -65.2 -39.83 93.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.11 -0.495 . . . . 10.0 110.91 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -65.87 -35.97 82.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.985 -0.552 . . . . 10.0 110.705 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -69.53 -33.69 72.52 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.647 -0.706 . . . . 10.0 111.542 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -59.53 -34.82 73.13 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.099 0.476 . . . . 10.0 110.334 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 23.9 mt -62.98 -41.28 99.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.752 -0.658 . . . . 10.0 110.64 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -67.18 -30.39 70.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.97 -0.559 . . . . 10.0 110.637 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.7 mt -65.62 -47.63 85.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.069 -0.514 . . . . 10.0 110.419 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 44.1 mtp -66.07 -27.12 67.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.965 -0.561 . . . . 10.0 111.065 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -63.29 -41.77 99.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.232 -0.44 . . . . 10.0 110.989 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -64.05 -33.32 75.48 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.074 0.464 . . . . 10.0 110.46 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -74.92 -41.27 60.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.7 -0.682 . . . . 10.0 110.466 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -62.63 -34.35 76.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.842 -0.617 . . . . 10.0 111.307 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 68.6 m -82.42 -0.66 47.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.417 -0.356 . . . . 10.0 111.104 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 63.33 23.02 13.58 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.029 -0.532 . . . . 10.0 111.504 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.36 -41.64 39.54 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.845 -0.798 . . . . 10.0 108.845 178.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 31.2 pt -114.87 165.9 9.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.676 -0.693 . . . . 10.0 110.083 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -123.12 -166.48 1.46 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.129 -0.487 . . . . 10.0 109.77 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.478 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 7.1 m -49.02 -55.25 21.6 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 112.029 0.381 . . . . 10.0 112.029 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 72' ' ' THR . 11.5 Cg_endo -55.84 -34.48 91.53 Favored 'Trans proline' 0 C--N 1.358 1.028 0 C-N-CA 122.387 2.058 . . . . 10.0 112.548 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.68 -44.51 62.96 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.778 -0.725 . . . . 10.0 111.939 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.595 ' O ' HG23 ' A' ' 79' ' ' VAL . 82.5 t -60.97 -45.45 98.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.951 -0.388 . . . . 10.0 109.951 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 88.8 mt -55.49 -42.57 68.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.09 -0.504 . . . . 10.0 110.984 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 41.4 ttp180 -59.23 -44.82 92.3 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.137 0.494 . . . . 10.0 109.897 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -63.54 -46.85 84.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.734 -0.666 . . . . 10.0 110.263 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 75' ' ' VAL . 64.3 t -58.46 -43.91 87.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.545 -0.752 . . . . 10.0 111.205 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.429 ' HA ' HD13 ' A' ' 90' ' ' ILE . 9.8 m -66.04 -38.23 87.84 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.182 -0.463 . . . . 10.0 111.59 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -75.84 -20.22 58.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.908 0.385 . . . . 10.0 110.855 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.2 tp -87.55 -53.57 4.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.984 -0.553 . . . . 10.0 110.654 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -97.57 44.52 1.04 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.953 0.406 . . . . 10.0 110.552 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 32.9 p-80 -69.93 -13.59 62.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.321 -0.399 . . . . 10.0 111.424 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -96.95 -12.48 23.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.996 0.426 . . . . 10.0 110.271 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -136.01 77.69 49.11 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 10.0 110.964 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -62.49 -23.41 74.91 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.588 2.192 . . . . 10.0 112.34 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.5 -23.85 67.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.115 -0.493 . . . . 10.0 111.024 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 81.6 mt -87.38 -30.47 20.73 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.459 -0.337 . . . . 10.0 110.49 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.429 HD13 ' HA ' ' A' ' 80' ' ' SER . 55.5 mt -63.48 -51.94 64.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.893 0.378 . . . . 10.0 110.903 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.6 t -63.2 -27.46 43.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.851 -0.613 . . . . 10.0 110.421 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.49 -37.55 92.28 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.431 -0.668 . . . . 10.0 111.431 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -66.67 -39.39 88.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.889 0.376 . . . . 10.0 110.408 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -63.54 -34.87 78.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.585 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -90.24 0.66 57.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.159 -0.473 . . . . 10.0 110.792 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -106.49 2.51 26.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.262 -0.426 . . . . 10.0 110.777 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 53.9 mt -69.96 118.18 61.0 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.276 -0.42 . . . . 10.0 111.069 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -70.79 -41.89 2.69 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.469 2.113 . . . . 10.0 112.536 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.3 m -94.23 149.97 20.74 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 116.321 -0.4 . . . . 10.0 110.232 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -177.9 -141.94 4.41 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.644 -0.789 . . . . 10.0 111.732 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -80.44 0.84 9.73 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.699 2.266 . . . . 10.0 112.424 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.02 157.96 32.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.394 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.2 m -69.19 139.2 54.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.856 0.36 . . . . 10.0 111.426 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.451 0 C-N-CA 120.665 -0.779 . . . . 10.0 112.171 179.912 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.45 -0.434 0 CA-C-O 121.032 0.444 . . . . 10.0 110.529 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.7 m -79.47 134.86 36.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.604 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.58 86.17 1.82 Allowed Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.52 -0.847 . . . . 10.0 112.641 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.9 m -103.62 156.53 5.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 110.068 -0.345 . . . . 10.0 110.068 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -94.63 -164.42 1.17 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.235 -0.438 . . . . 10.0 110.751 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.8 m -78.36 -22.12 13.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.125 0.488 . . . . 10.0 110.929 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -113.59 85.01 2.11 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.414 0.626 . . . . 10.0 110.456 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -113.05 -4.55 13.84 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.541 -0.754 . . . . 10.0 110.402 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.49 -40.13 95.68 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.336 -0.847 . . . . 10.0 112.419 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.15 -9.14 58.81 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.919 0.341 . . . . 10.0 111.919 -178.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.76 -49.55 24.93 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.137 0.494 . . . . 10.0 111.702 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -73.17 -12.9 61.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.07 -0.514 . . . . 10.0 111.499 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.93 -45.81 69.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.007 0.432 . . . . 10.0 110.829 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -69.92 -32.28 70.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.35 -0.386 . . . . 10.0 111.379 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -56.64 -35.13 68.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.929 -0.578 . . . . 10.0 110.885 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 28.7 t -66.02 -42.45 91.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 10.0 110.045 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -63.33 -38.59 91.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.873 -0.603 . . . . 10.0 111.084 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 57.2 mt -73.77 -44.92 51.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 10.0 110.967 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -58.26 -40.96 83.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 10.0 110.894 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -110.13 41.73 1.67 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.335 0.588 . . . . 10.0 110.454 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.87 -28.17 73.41 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.952 -0.642 . . . . 10.0 112.053 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.3 m -96.23 2.38 52.93 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.803 0.335 . . . . 10.0 110.864 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -134.01 86.74 36.62 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 109.591 -0.522 . . . . 10.0 109.591 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -68.27 -17.75 44.77 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.922 2.414 . . . . 10.0 112.582 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.59 -49.28 69.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.058 -0.519 . . . . 10.0 111.122 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.8 m -62.85 -43.19 99.47 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.549 -0.296 . . . . 10.0 111.246 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -65.4 -40.12 93.02 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 110.128 -0.323 . . . . 10.0 110.128 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -60.86 -48.13 83.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 10.0 110.361 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.457 ' O ' HG13 ' A' ' 61' ' ' ILE . . . -60.02 -44.55 97.14 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.93 -0.652 . . . . 10.0 111.828 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -55.78 -43.23 76.59 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.757 0.313 . . . . 10.0 110.891 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 77.8 mt -64.55 -38.03 89.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.932 -0.576 . . . . 10.0 111.26 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -70.71 -39.91 73.13 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.296 -0.411 . . . . 10.0 111.056 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 57' ' ' GLY . 62.4 mt -67.45 -36.5 76.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.024 0.44 . . . . 10.0 110.428 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.93 -31.97 67.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.901 -0.59 . . . . 10.0 111.131 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -63.01 -45.37 92.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.964 -0.562 . . . . 10.0 110.844 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -59.8 -36.34 76.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.916 -0.584 . . . . 10.0 111.663 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -66.73 -42.94 85.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.373 -0.376 . . . . 10.0 110.88 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -74.86 -24.29 58.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.895 -0.593 . . . . 10.0 111.104 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 68.4 m -79.08 5.0 12.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.898 0.38 . . . . 10.0 110.537 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 61.77 33.58 17.75 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.798 -0.637 . . . . 10.0 110.866 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.1 m -93.88 -26.12 17.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.302 -0.408 . . . . 10.0 111.044 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.0 pt -139.85 158.42 26.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.184 -0.462 . . . . 10.0 110.646 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.416 ' HB3' ' H ' ' A' ' 72' ' ' THR . 30.9 m-20 -119.17 -158.93 0.75 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.288 -0.415 . . . . 10.0 110.249 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.428 ' HB ' ' HD3' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -48.21 -59.68 5.58 Favored Pre-proline 0 CA--C 1.542 0.673 0 N-CA-C 112.65 0.611 . . . . 10.0 112.65 -179.6 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.428 ' HD3' ' HB ' ' A' ' 72' ' ' THR . 28.7 Cg_endo -62.91 -35.07 69.18 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 121.554 1.503 . . . . 10.0 112.722 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.1 -44.31 91.52 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 121.099 -0.572 . . . . 10.0 112.256 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.506 ' O ' HG23 ' A' ' 79' ' ' VAL . 8.9 p -74.89 -35.36 35.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 O-C-N 122.853 -0.204 . . . . 10.0 110.906 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 74.0 mt -62.95 -37.92 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.077 0 N-CA-C 110.172 -0.307 . . . . 10.0 110.172 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -59.86 -29.79 68.53 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.287 0.565 . . . . 10.0 110.193 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -81.61 -42.55 19.9 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.716 -0.675 . . . . 10.0 109.656 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 75' ' ' VAL . 97.6 t -59.3 -46.59 92.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.613 -0.721 . . . . 10.0 110.737 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.464 ' HA ' HD13 ' A' ' 90' ' ' ILE . 49.6 m -63.04 -28.85 70.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.952 -0.567 . . . . 10.0 111.512 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -84.91 -40.63 16.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.673 0.273 . . . . 10.0 111.366 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 6.6 tp -64.97 -47.45 77.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.235 0.541 . . . . 10.0 111.056 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -101.18 45.59 0.97 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.013 -0.54 . . . . 10.0 110.076 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -63.93 -29.37 70.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.958 -0.565 . . . . 10.0 111.327 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -98.94 6.37 46.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.964 0.411 . . . . 10.0 110.897 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -137.57 71.11 52.18 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 116.36 -0.382 . . . . 10.0 110.438 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.02 -31.44 76.5 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.338 2.025 . . . . 10.0 112.288 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.78 -32.28 70.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 10.0 110.762 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 89.1 mt -72.11 -42.51 65.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.22 -0.446 . . . . 10.0 110.051 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.464 HD13 ' HA ' ' A' ' 80' ' ' SER . 26.2 mt -65.16 -44.44 95.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 116.036 -0.529 . . . . 10.0 109.805 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 99.1 t -65.11 -37.77 81.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 115.818 -0.628 . . . . 10.0 109.508 178.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -64.18 -38.18 95.58 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.655 -0.783 . . . . 10.0 111.609 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -68.97 -28.1 66.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.96 0.409 . . . . 10.0 110.566 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -62.18 -28.19 69.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.164 0.507 . . . . 10.0 109.926 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.93 8.87 30.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.571 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -117.62 33.35 5.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.831 -0.622 . . . . 10.0 110.072 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.6 mt -106.34 114.68 61.98 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.784 -0.644 . . . . 10.0 110.086 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -71.12 -12.23 30.01 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.626 2.218 . . . . 10.0 112.076 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.3 m -109.93 104.55 13.49 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.029 -0.532 . . . . 10.0 110.563 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -154.49 -149.28 5.21 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.753 -0.737 . . . . 10.0 112.256 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -79.98 39.38 0.83 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.288 2.659 . . . . 10.0 113.232 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 57.9 m -96.35 174.16 7.01 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.147 -0.479 . . . . 10.0 110.228 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.3 m -71.72 95.57 1.49 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.949 0.404 . . . . 10.0 110.252 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.654 0 C-N-CA 120.946 -0.645 . . . . 10.0 111.93 -179.7 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.3 m . . . . . 0 C--O 1.233 0.201 0 N-CA-C 110.055 -0.35 . . . . 10.0 110.055 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.1 m -83.62 99.28 10.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.278 0.561 . . . . 10.0 110.404 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 171.22 66.25 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 111.321 -0.711 . . . . 10.0 111.321 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.4 m -64.85 151.71 9.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.873 0.368 . . . . 10.0 111.294 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 3.2 m170 -116.04 175.68 5.43 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.775 -0.454 . . . . 10.0 109.775 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.7 m -81.26 -23.74 10.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.136 0.493 . . . . 10.0 110.537 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -145.84 88.12 1.81 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.438 0.637 . . . . 10.0 109.936 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -117.87 23.4 11.7 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.682 -0.69 . . . . 10.0 110.254 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.9 -41.95 97.09 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.487 -0.779 . . . . 10.0 110.62 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pp -64.36 -28.47 69.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.534 -0.757 . . . . 10.0 111.303 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.542 ' O ' ' HG2' ' A' ' 43' ' ' GLN . 1.3 m -68.18 -52.78 30.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.068 -0.514 . . . . 10.0 111.358 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -66.38 -28.92 69.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.889 0.376 . . . . 10.0 110.165 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.63 -40.74 96.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.845 -0.616 . . . . 10.0 110.021 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -72.03 -31.27 66.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 10.0 110.554 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.542 ' HG2' ' O ' ' A' ' 39' ' ' THR . 15.9 mm100 -59.21 -40.1 84.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.703 -0.68 . . . . 10.0 110.573 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 92.2 t -59.68 -40.36 82.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.25 0.547 . . . . 10.0 109.863 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.4 ttpm? -62.89 -37.36 86.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.338 -0.846 . . . . 10.0 111.224 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 49.2 mt -73.76 -43.97 52.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.087 0.47 . . . . 10.0 110.795 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -63.66 -37.37 87.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.85 -0.614 . . . . 10.0 111.046 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -110.36 49.81 0.83 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.344 0.592 . . . . 10.0 110.312 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -81.4 -21.67 61.91 Favored Glycine 0 C--O 1.229 -0.156 0 CA-C-N 115.564 -0.744 . . . . 10.0 112.679 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.9 m -86.54 -33.47 20.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.864 0.364 . . . . 10.0 110.522 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -116.85 100.98 53.67 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.067 -0.515 . . . . 10.0 110.71 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -75.12 -15.33 20.54 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.366 2.044 . . . . 10.0 112.256 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.54 -46.83 86.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.7 -0.682 . . . . 10.0 111.067 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.8 m -67.5 -32.61 73.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.008 -0.542 . . . . 10.0 110.331 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -68.74 -43.88 74.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.12 -0.491 . . . . 10.0 110.073 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -62.6 -39.99 95.49 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.845 -0.616 . . . . 10.0 109.972 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.3 -34.19 88.76 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.681 -0.771 . . . . 10.0 111.696 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -63.0 -39.32 94.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.091 0.472 . . . . 10.0 110.657 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 30.1 mt -64.46 -34.61 78.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.877 -0.601 . . . . 10.0 110.433 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -67.39 -37.12 82.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.684 -0.689 . . . . 10.0 110.713 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.7 mt -64.84 -39.96 87.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.166 0.508 . . . . 10.0 110.065 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.73 -31.25 72.37 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.523 -0.762 . . . . 10.0 110.35 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -62.88 -45.15 93.9 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.049 -0.523 . . . . 10.0 109.856 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -61.0 -35.22 76.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.63 -0.714 . . . . 10.0 110.631 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -70.14 -45.61 66.45 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.799 0.333 . . . . 10.0 110.324 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -67.11 -29.83 69.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.013 0.435 . . . . 10.0 110.932 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.83 -3.34 47.39 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.81 -0.632 . . . . 10.0 110.186 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 63.83 31.26 14.17 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.768 -0.651 . . . . 10.0 111.517 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.6 m -91.02 -20.98 21.5 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.1 -0.5 . . . . 10.0 109.75 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 24.3 pt -134.84 150.99 30.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.838 -0.619 . . . . 10.0 109.55 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -107.37 -164.49 0.98 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.878 -0.415 . . . . 10.0 109.878 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.427 ' HB ' ' HD3' ' A' ' 73' ' ' PRO . 0.6 OUTLIER -49.12 -56.64 14.69 Favored Pre-proline 0 CA--C 1.537 0.472 0 O-C-N 123.619 0.574 . . . . 10.0 112.502 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.427 ' HD3' ' HB ' ' A' ' 72' ' ' THR . 40.8 Cg_endo -66.17 -28.59 48.24 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 121.683 1.589 . . . . 10.0 112.733 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.23 -51.99 29.77 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.839 -0.619 . . . . 10.0 113.069 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.9 p -64.52 -40.88 90.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.801 0.334 . . . . 10.0 111.1 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 91.6 mt -62.37 -45.35 98.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.475 -0.33 . . . . 10.0 110.644 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 77' ' ' ARG . 11.4 ttp180 -61.61 -45.65 93.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.395 -0.366 . . . . 10.0 110.936 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -57.87 -49.33 77.05 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.997 0.427 . . . . 10.0 111.095 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 86.2 t -68.36 -34.81 68.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.006 -0.543 . . . . 10.0 111.011 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.9 t -61.83 -30.57 70.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.483 -0.326 . . . . 10.0 111.475 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -82.36 -28.97 31.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.009 0.433 . . . . 10.0 110.698 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 23.2 tp -81.96 -40.99 21.42 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.097 -0.501 . . . . 10.0 111.326 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -97.08 32.24 2.21 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.167 -0.469 . . . . 10.0 110.637 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -65.67 -17.65 64.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.895 0.378 . . . . 10.0 111.749 -179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -88.33 -7.78 56.15 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.014 0.435 . . . . 10.0 110.466 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -134.69 71.64 70.31 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.864 -0.607 . . . . 10.0 109.491 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.38 -27.48 84.93 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.953 2.436 . . . . 10.0 112.746 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.07 -31.26 72.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.239 -0.437 . . . . 10.0 110.871 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 67.7 mt -75.21 -35.67 61.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 10.0 110.67 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 58.3 mt -65.41 -52.79 47.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.944 -0.571 . . . . 10.0 110.48 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.1 t -65.49 -38.98 83.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.052 -0.522 . . . . 10.0 109.706 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.98 -36.16 86.92 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.488 -0.778 . . . . 10.0 111.908 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -64.1 -44.03 93.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.716 0.293 . . . . 10.0 110.387 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -60.47 -42.86 97.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.121 -0.49 . . . . 10.0 110.191 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.31 -22.0 59.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.109 -0.496 . . . . 10.0 111.257 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -83.04 -11.6 57.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.258 -0.428 . . . . 10.0 111.171 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 60.2 mt -69.63 119.47 71.13 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.42 -0.355 . . . . 10.0 110.429 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -67.18 -42.59 7.56 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.642 2.228 . . . . 10.0 112.012 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.2 m -79.82 145.32 32.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.71 -0.677 . . . . 10.0 109.967 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 179.92 -131.92 1.73 Allowed Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.563 -0.615 . . . . 10.0 111.563 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -92.26 17.56 1.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.916 2.411 . . . . 10.0 112.16 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.4 m -82.77 176.57 9.22 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.941 -0.572 . . . . 10.0 111.305 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.48 113.97 3.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.994 -0.548 . . . . 10.0 111.598 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.479 0 C-N-CA 121.036 -0.602 . . . . 10.0 112.391 179.404 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.0 m . . . . . 0 N--CA 1.451 -0.425 0 N-CA-C 110.0 -0.371 . . . . 10.0 110.0 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.8 m -105.01 136.08 45.15 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.31 -0.404 . . . . 10.0 110.97 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.92 105.23 2.97 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.637 -0.792 . . . . 10.0 112.207 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 17.0 m -115.45 164.56 11.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 110.12 -0.326 . . . . 10.0 110.12 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -104.3 -175.77 2.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.374 -0.376 . . . . 10.0 110.506 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.5 m -79.9 -4.19 6.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.189 0.518 . . . . 10.0 110.869 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -109.56 25.75 11.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.662 -0.699 . . . . 10.0 110.349 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.0 p-10 -68.07 -26.35 65.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.887 -0.597 . . . . 10.0 111.332 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.36 -51.3 62.91 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.586 0.587 . . . . 10.0 112.586 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.453 ' H ' ' HG ' ' A' ' 38' ' ' LEU . 1.4 pp -80.75 -0.87 40.45 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 122.067 -0.396 . . . . 10.0 111.86 -178.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 m -84.25 -34.99 23.72 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.942 0.401 . . . . 10.0 110.46 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -70.58 -21.92 62.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.342 -0.39 . . . . 10.0 111.214 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.54 -47.23 86.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 10.0 110.814 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -64.62 -35.91 82.55 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.957 -0.565 . . . . 10.0 110.61 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -58.41 -48.42 80.72 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.09 -0.505 . . . . 10.0 110.839 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.2 t -64.08 -35.86 75.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 115.65 -0.704 . . . . 10.0 110.549 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.7 tttm -67.77 -35.97 79.65 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.412 -0.813 . . . . 10.0 111.242 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 94.8 mt -77.16 -43.24 31.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.693 0.282 . . . . 10.0 111.295 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -58.3 -36.93 74.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.417 -0.356 . . . . 10.0 111.282 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -110.93 48.05 0.95 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.342 0.591 . . . . 10.0 109.987 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.47 -29.86 74.52 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.642 -0.708 . . . . 10.0 112.788 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.7 m -101.52 1.82 38.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.877 0.339 . . . . 10.0 111.383 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -124.68 94.55 44.26 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 120.908 0.385 . . . . 10.0 110.344 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -77.63 -11.38 17.02 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.481 2.121 . . . . 10.0 112.325 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.44 -51.55 23.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.215 -0.448 . . . . 10.0 110.919 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.5 m -64.48 -31.66 72.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.397 0.618 . . . . 10.0 110.039 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -66.27 -44.44 83.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.657 -0.702 . . . . 10.0 110.265 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -64.36 -37.5 87.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.509 . . . . 10.0 110.828 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.25 -39.45 97.89 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.71 -0.677 . . . . 10.0 112.891 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -60.75 -38.33 84.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.86 0.362 . . . . 10.0 110.702 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.427 ' O ' ' HG3' ' A' ' 63' ' ' LYS . 67.0 mt -65.89 -37.83 87.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.102 -0.499 . . . . 10.0 110.722 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -62.98 -40.38 97.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.114 0.483 . . . . 10.0 109.928 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.3 mt -62.75 -44.66 99.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.786 -0.643 . . . . 10.0 110.198 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.406 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -61.65 -35.75 78.84 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.691 -0.686 . . . . 10.0 110.773 179.853 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 59' ' ' LEU . 92.8 mttt -60.62 -47.22 87.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.753 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -59.58 -40.58 87.85 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.925 0.393 . . . . 10.0 110.885 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -68.24 -42.03 80.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.295 -0.411 . . . . 10.0 110.649 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 62' ' ' MET . 43.8 mtpt -66.12 -33.05 74.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.432 -0.349 . . . . 10.0 111.107 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.1 m -84.67 3.84 35.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.498 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 60.69 32.69 20.3 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.819 -0.628 . . . . 10.0 111.947 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.2 m -81.44 -25.72 35.91 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.329 0.585 . . . . 10.0 109.576 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 15.6 pt -137.84 164.88 27.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.365 -0.834 . . . . 10.0 109.904 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.35 -165.55 1.02 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.935 -0.395 . . . . 10.0 109.935 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.417 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 2.3 m -51.97 -55.57 29.47 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 112.502 0.556 . . . . 10.0 112.502 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 72' ' ' THR . 24.6 Cg_endo -62.35 -22.23 73.8 Favored 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 121.908 1.739 . . . . 10.0 112.59 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -83.26 -44.78 6.85 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.757 -0.735 . . . . 10.0 111.904 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.5 p -64.79 -34.69 71.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-O 120.817 0.342 . . . . 10.0 110.921 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 77.5 mt -70.11 -41.57 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 110.063 -0.347 . . . . 10.0 110.063 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 26.3 ttp180 -63.62 -40.11 96.06 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.339 -0.391 . . . . 10.0 110.253 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.6 mmt180 -57.76 -43.9 85.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.397 0.618 . . . . 10.0 110.18 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 45.9 t -72.9 -29.51 29.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.461 -0.79 . . . . 10.0 111.082 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.404 ' HA ' HD13 ' A' ' 90' ' ' ILE . 69.7 m -61.08 -29.87 70.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.079 0.466 . . . . 10.0 110.785 179.154 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.8 mm-40 -87.82 -26.77 22.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.917 -0.583 . . . . 10.0 110.45 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 29.5 tp -76.53 -53.6 7.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.031 -0.531 . . . . 10.0 110.284 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 18.9 m-30 -93.11 45.27 1.17 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.953 0.406 . . . . 10.0 110.447 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 19.7 p-80 -68.35 -13.01 61.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.035 -0.529 . . . . 10.0 110.948 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -102.99 -10.89 18.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.009 -0.541 . . . . 10.0 110.761 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -133.36 79.53 60.57 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 120.737 0.303 . . . . 10.0 110.855 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.462 ' O ' HG23 ' A' ' 91' ' ' VAL . 18.1 Cg_endo -61.55 -31.47 87.35 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.741 2.294 . . . . 10.0 111.981 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -60.6 -31.81 70.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.744 -0.662 . . . . 10.0 110.987 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.2 mt -74.48 -25.33 59.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.031 -0.532 . . . . 10.0 111.162 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.404 HD13 ' HA ' ' A' ' 80' ' ' SER . 46.1 mt -80.73 -44.56 21.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.125 -0.489 . . . . 10.0 110.023 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 87' ' ' PRO . 17.4 t -67.87 -31.1 50.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.83 -0.623 . . . . 10.0 110.288 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.22 -39.4 97.64 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.805 -0.712 . . . . 10.0 111.759 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.482 ' CZ ' HD21 ' A' ' 97' ' ' LEU . 59.2 t80 -64.28 -36.44 84.13 Favored 'General case' 0 C--O 1.227 -0.117 0 CA-C-O 121.007 0.432 . . . . 10.0 110.216 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -62.63 -27.88 69.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.816 -0.629 . . . . 10.0 110.756 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -93.16 -19.96 20.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.287 -0.415 . . . . 10.0 111.149 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -97.26 44.5 1.05 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.299 -0.41 . . . . 10.0 110.643 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.482 HD21 ' CZ ' ' A' ' 93' ' ' PHE . 40.9 mt -113.01 102.92 55.48 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.083 -0.508 . . . . 10.0 110.444 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -62.19 -42.92 26.23 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.37 2.047 . . . . 10.0 111.873 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.7 94.53 7.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.921 -0.581 . . . . 10.0 110.039 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -134.31 -151.15 6.33 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.559 -0.829 . . . . 10.0 112.55 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -83.11 25.22 0.69 Allowed 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 122.939 2.426 . . . . 10.0 112.385 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.89 171.77 14.72 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.938 -0.574 . . . . 10.0 111.106 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.5 m -61.38 125.44 23.79 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.049 0.452 . . . . 10.0 111.171 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.652 0 C-N-CA 120.814 -0.708 . . . . 10.0 111.806 -179.951 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.2 m . . . . . 0 C--O 1.235 0.322 0 CA-C-O 120.866 0.365 . . . . 10.0 110.222 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.0 m -106.43 127.07 53.01 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.227 -0.442 . . . . 10.0 110.628 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.07 55.12 0.1 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.72 -0.753 . . . . 10.0 111.996 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.8 m -68.78 155.02 7.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-O 121.154 0.502 . . . . 10.0 111.351 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -99.07 -176.14 3.23 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.201 -0.454 . . . . 10.0 110.571 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.0 m -65.33 -20.11 26.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 121.197 0.522 . . . . 10.0 110.673 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -102.6 56.75 0.78 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.285 0.564 . . . . 10.0 109.812 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -90.44 -12.23 38.04 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.53 -0.759 . . . . 10.0 111.23 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.2 -48.7 80.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.609 -0.723 . . . . 10.0 111.355 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 pp -71.2 -22.5 62.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.161 -0.472 . . . . 10.0 111.993 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.506 ' O ' ' HG2' ' A' ' 43' ' ' GLN . 1.1 m -65.45 -60.1 3.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.356 -0.384 . . . . 10.0 111.421 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -67.4 -27.94 67.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.639 -0.255 . . . . 10.0 111.244 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -58.39 -35.24 71.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.281 -0.418 . . . . 10.0 111.511 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -91.06 -24.61 19.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.394 -0.366 . . . . 10.0 111.44 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.506 ' HG2' ' O ' ' A' ' 39' ' ' THR . 15.9 mm100 -56.47 -36.12 68.72 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.905 0.383 . . . . 10.0 110.856 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.535 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 11.0 t -66.7 -36.84 78.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 10.0 110.615 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.7 ttpm? -65.91 -35.4 80.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.886 -0.597 . . . . 10.0 110.449 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 46.0 mt -74.61 -40.92 48.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.717 -0.674 . . . . 10.0 109.98 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 -63.23 -51.76 64.92 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.345 -0.843 . . . . 10.0 111.514 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -102.35 54.03 0.79 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.282 0.563 . . . . 10.0 110.433 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.74 -41.28 89.3 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.701 -0.681 . . . . 10.0 112.874 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.3 m -92.96 7.93 41.95 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.842 0.321 . . . . 10.0 111.583 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -129.14 89.07 49.38 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.86 0.362 . . . . 10.0 111.241 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.9 -17.66 17.47 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.218 1.946 . . . . 10.0 112.311 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.83 -54.8 22.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.959 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.6 m -69.04 -27.51 65.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.024 0.44 . . . . 10.0 111.049 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -70.19 -41.99 72.99 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.858 0.361 . . . . 10.0 110.677 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -62.57 -42.11 99.35 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.201 -0.454 . . . . 10.0 110.322 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.12 -33.23 86.69 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.933 -0.651 . . . . 10.0 111.723 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.535 ' CZ ' HG21 ' A' ' 44' ' ' VAL . 88.4 t80 -62.2 -37.02 83.71 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.071 0.462 . . . . 10.0 110.07 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 22.7 mt -72.3 -35.87 68.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.68 -0.691 . . . . 10.0 110.901 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -62.04 -34.86 77.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.925 -0.58 . . . . 10.0 111.071 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.4 mt -66.22 -34.31 69.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.114 -0.493 . . . . 10.0 110.959 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.5 mtp -64.5 -33.79 76.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.371 -0.377 . . . . 10.0 110.52 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -61.64 -37.56 84.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.973 -0.558 . . . . 10.0 110.615 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -64.23 -37.92 89.2 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.111 -0.495 . . . . 10.0 110.808 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -78.6 -42.3 29.36 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.728 -0.389 . . . . 10.0 111.15 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -63.25 -34.33 77.44 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.589 -0.278 . . . . 10.0 111.661 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.9 m -84.22 5.38 26.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.733 0.301 . . . . 10.0 111.117 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 63.7 31.92 14.08 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.974 -0.557 . . . . 10.0 111.736 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.4 m -87.71 -48.29 7.98 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.999 0.428 . . . . 10.0 110.303 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 47.9 pt -104.72 146.43 11.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 110.03 -0.359 . . . . 10.0 110.03 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -99.48 -175.54 3.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.802 -0.636 . . . . 10.0 109.956 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.527 ' O ' HG12 ' A' ' 75' ' ' VAL . 0.9 OUTLIER -55.08 -54.09 54.13 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 111.707 0.262 . . . . 10.0 111.707 -179.77 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 72' ' ' THR . 24.2 Cg_endo -63.26 -24.71 72.1 Favored 'Trans proline' 0 C--N 1.358 1.067 0 C-N-CA 121.833 1.689 . . . . 10.0 112.324 178.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.85 -39.26 28.99 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.018 -0.61 . . . . 10.0 112.679 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.53 ' O ' HG23 ' A' ' 79' ' ' VAL . 4.9 p -68.71 -29.86 45.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 O-C-N 122.715 -0.285 . . . . 10.0 111.105 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 72' ' ' THR . 68.0 mt -59.86 -41.37 85.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-O 120.912 0.387 . . . . 10.0 110.052 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -62.13 -40.03 94.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.753 -0.658 . . . . 10.0 109.71 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.2 mmt180 -63.22 -44.89 93.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.754 -0.657 . . . . 10.0 110.739 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 75' ' ' VAL . 47.4 t -61.84 -46.3 96.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.758 -0.655 . . . . 10.0 110.855 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.49 ' HA ' HD13 ' A' ' 90' ' ' ILE . 8.9 m -65.59 -24.32 67.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.893 -0.594 . . . . 10.0 111.661 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -87.43 -24.53 24.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.748 0.309 . . . . 10.0 111.023 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 14.8 tp -86.0 -45.54 11.35 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.08 0.467 . . . . 10.0 110.418 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -103.82 43.77 1.07 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.739 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -63.6 -20.12 65.4 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.001 -0.545 . . . . 10.0 111.491 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -101.36 -0.21 35.91 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.962 0.411 . . . . 10.0 110.613 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -135.27 77.05 55.46 Favored Pre-proline 0 C--O 1.236 0.38 0 CA-C-N 116.246 -0.434 . . . . 10.0 110.208 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.92 -29.25 87.7 Favored 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.301 2.001 . . . . 10.0 112.631 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -62.85 -37.58 87.4 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 116.115 -0.493 . . . . 10.0 110.667 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.1 mt -66.15 -41.34 90.55 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.144 -0.48 . . . . 10.0 110.545 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.49 HD13 ' HA ' ' A' ' 80' ' ' SER . 18.2 mt -66.02 -46.07 89.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.031 -0.532 . . . . 10.0 109.983 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 73.8 t -62.38 -43.91 98.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.637 -0.711 . . . . 10.0 110.383 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.93 -40.62 99.11 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.685 -0.689 . . . . 10.0 112.235 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -66.14 -43.18 87.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.706 0.289 . . . . 10.0 110.726 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -61.79 -32.76 73.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.929 0.395 . . . . 10.0 111.36 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.23 -25.06 27.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.821 0.343 . . . . 10.0 111.365 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.45 -31.59 72.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.014 -0.539 . . . . 10.0 111.511 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 36.4 mt -58.16 115.62 11.94 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.526 -0.306 . . . . 10.0 111.688 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -82.25 -24.82 3.59 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.689 2.259 . . . . 10.0 112.125 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.4 m -91.41 99.82 12.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.157 -0.474 . . . . 10.0 110.58 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -151.55 -115.27 0.66 Allowed Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.955 -0.858 . . . . 10.0 110.955 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -82.32 6.86 5.46 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.407 2.071 . . . . 10.0 111.201 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.33 154.44 23.93 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.408 -0.815 . . . . 10.0 111.765 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.45 126.12 29.07 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.74 -0.664 . . . . 10.0 110.173 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 C-N-CA 120.768 -0.729 . . . . 10.0 112.463 179.682 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 56.3 m . . . . . 0 C--O 1.235 0.3 0 CA-C-O 121.028 0.442 . . . . 10.0 110.258 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.9 m -67.39 148.39 51.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.985 -0.552 . . . . 10.0 111.224 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.49 83.34 1.56 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.742 -0.742 . . . . 10.0 112.42 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 29.5 m -108.14 156.23 8.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 110.159 -0.312 . . . . 10.0 110.159 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -102.35 -177.77 3.5 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.344 -0.389 . . . . 10.0 110.203 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.2 m -65.19 -27.1 41.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.812 0.339 . . . . 10.0 111.485 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -99.53 93.41 5.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.465 -0.334 . . . . 10.0 110.396 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -107.09 -11.56 15.61 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.348 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.09 -50.76 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.649 -0.705 . . . . 10.0 112.404 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.12 -10.99 60.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.129 -0.487 . . . . 10.0 112.052 -178.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.54 -58.46 2.52 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.049 0.452 . . . . 10.0 111.695 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.513 ' O ' HG23 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -67.88 -30.78 70.22 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.896 0.702 . . . . 10.0 112.896 -177.633 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.1 -38.83 73.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.749 0.309 . . . . 10.0 111.59 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -78.92 -35.49 43.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.83 0.348 . . . . 10.0 110.642 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -57.72 -39.9 78.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.981 -0.554 . . . . 10.0 111.383 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 40' ' ' TYR . 26.8 t -65.44 -37.11 79.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.077 0.465 . . . . 10.0 110.207 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.1 ttpm? -69.15 -33.26 73.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.638 -0.71 . . . . 10.0 110.634 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 62.8 mt -73.59 -43.07 55.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.855 -0.612 . . . . 10.0 110.224 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -65.74 -42.24 91.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.864 -0.607 . . . . 10.0 111.203 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -107.4 58.94 0.62 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.33 0.586 . . . . 10.0 110.57 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.62 -43.78 9.94 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.457 -0.792 . . . . 10.0 111.938 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 39.3 m -85.21 -11.05 55.83 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.861 0.362 . . . . 10.0 110.838 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -114.66 92.74 30.35 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.149 -0.478 . . . . 10.0 110.824 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -76.42 -15.84 17.49 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.233 1.956 . . . . 10.0 111.757 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.32 -54.49 32.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.507 -0.77 . . . . 10.0 111.634 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.7 m -65.95 -34.0 77.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.402 -0.363 . . . . 10.0 111.0 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -65.34 -44.23 88.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 10.0 110.719 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -64.6 -41.8 95.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.169 -0.469 . . . . 10.0 110.569 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.61 -39.09 96.91 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 115.948 -0.569 . . . . 10.0 112.09 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -57.98 -40.61 81.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.146 0.498 . . . . 10.0 110.463 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 27.3 mt -71.7 -30.01 65.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.791 -0.641 . . . . 10.0 111.127 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -68.93 -38.65 79.64 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.022 0.439 . . . . 10.0 110.876 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.482 HD13 ' HB3' ' A' ' 78' ' ' ARG . 42.1 mt -67.74 -30.84 49.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.784 -0.644 . . . . 10.0 110.606 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 33.1 mmt -64.94 -28.11 69.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.181 -0.463 . . . . 10.0 110.588 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -63.08 -41.26 99.37 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.154 -0.476 . . . . 10.0 110.26 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -65.31 -42.25 93.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.761 -0.654 . . . . 10.0 110.487 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -65.15 -42.59 93.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.112 -0.495 . . . . 10.0 110.634 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -67.82 -18.56 64.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.89 0.376 . . . . 10.0 111.054 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.1 m -95.92 2.19 53.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.067 -0.515 . . . . 10.0 110.453 178.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 64.79 23.05 12.65 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.714 -0.676 . . . . 10.0 110.758 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.2 m -77.74 -29.34 51.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.508 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 37.8 pt -128.48 153.37 37.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 10.0 111.008 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -105.3 -164.35 1.02 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.902 -0.59 . . . . 10.0 110.432 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.477 ' HB ' ' HD3' ' A' ' 73' ' ' PRO . 24.5 m -55.05 -56.48 27.52 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-N 116.502 -0.317 . . . . 10.0 111.212 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.477 ' HD3' ' HB ' ' A' ' 72' ' ' THR . 36.8 Cg_endo -66.41 -21.77 53.24 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 121.647 1.565 . . . . 10.0 111.822 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.07 -48.15 73.96 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.616 -0.72 . . . . 10.0 112.077 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.461 ' O ' HG23 ' A' ' 79' ' ' VAL . 9.5 p -72.77 -31.88 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 120.882 -0.327 . . . . 10.0 110.161 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 47.0 mt -59.95 -40.82 84.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 109.7 -0.482 . . . . 10.0 109.7 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 30.0 ttp180 -59.28 -42.32 90.97 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.112 -0.699 . . . . 10.0 109.112 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.482 ' HB3' HD13 ' A' ' 61' ' ' ILE . 12.2 mmt180 -67.4 -45.73 75.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.376 -0.829 . . . . 10.0 110.439 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 75' ' ' VAL . 62.7 t -55.64 -43.41 73.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.973 -0.558 . . . . 10.0 111.239 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.9 m -64.69 -30.33 71.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.036 -0.529 . . . . 10.0 112.006 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -87.93 -36.26 17.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.695 0.283 . . . . 10.0 111.381 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 24.1 tp -73.55 -54.14 8.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.92 0.391 . . . . 10.0 111.056 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -91.29 38.9 0.98 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.382 0.611 . . . . 10.0 109.651 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -59.38 -34.39 72.37 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.299 -0.864 . . . . 10.0 112.57 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -94.19 7.0 46.86 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.499 0.185 . . . . 10.0 111.499 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -133.59 72.48 74.03 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-O 120.754 0.311 . . . . 10.0 110.25 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.476 ' O ' HG23 ' A' ' 91' ' ' VAL . 33.4 Cg_exo -60.44 -32.78 94.23 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.026 2.484 . . . . 10.0 111.939 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -58.28 -38.4 76.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.591 -0.731 . . . . 10.0 110.433 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 60.1 mt -73.58 -31.69 63.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.915 -0.584 . . . . 10.0 111.306 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.0 mt -68.88 -45.53 80.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.12 0.486 . . . . 10.0 110.107 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 87' ' ' PRO . 19.4 t -69.34 -35.11 65.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.753 -0.658 . . . . 10.0 110.326 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.39 -46.39 94.42 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.787 -0.72 . . . . 10.0 112.47 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.445 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 64.2 t80 -62.01 -32.11 72.56 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.761 0.315 . . . . 10.0 111.18 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -61.37 -38.03 85.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.099 -0.501 . . . . 10.0 111.781 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.38 -8.25 32.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.895 0.378 . . . . 10.0 111.657 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.46 -19.69 35.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.823 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 93' ' ' PHE . 86.9 mt -58.02 121.66 52.32 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.939 -0.573 . . . . 10.0 111.533 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -77.57 -13.63 16.36 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.708 2.272 . . . . 10.0 112.451 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.7 m -106.45 110.77 23.08 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.336 -0.393 . . . . 10.0 110.651 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -142.05 -146.66 4.7 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.694 -0.765 . . . . 10.0 111.671 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -74.25 -5.99 17.76 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.635 2.223 . . . . 10.0 112.549 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 m -66.92 153.47 43.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.857 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.2 t -59.22 128.83 39.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.243 -0.435 . . . . 10.0 110.556 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.419 0 C-N-CA 120.435 -0.888 . . . . 10.0 112.351 -179.893 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.043 -0.423 . . . . 10.0 112.043 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.99 150.47 36.09 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.771 0.32 . . . . 10.0 110.68 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.7 t -83.47 84.58 7.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.271 0.558 . . . . 10.0 110.523 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -144.28 138.15 7.77 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.698 -0.763 . . . . 10.0 112.264 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.1 m -132.87 108.13 8.76 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.854 -0.424 . . . . 10.0 109.854 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.2 m -92.59 157.73 16.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.461 -0.336 . . . . 10.0 110.637 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.2 82.67 1.12 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.95 -0.643 . . . . 10.0 113.142 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.6 m -88.75 173.37 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.906 -0.405 . . . . 10.0 109.906 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -95.6 176.77 6.03 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.74 -0.209 . . . . 10.0 110.678 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.5 m -67.22 -23.41 30.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-O 120.881 0.372 . . . . 10.0 111.43 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -133.1 87.9 2.45 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.445 -0.576 . . . . 10.0 109.445 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -93.58 13.78 20.9 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.677 -0.692 . . . . 10.0 110.857 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.96 -42.79 94.28 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.767 -0.651 . . . . 10.0 111.412 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.05 -25.8 62.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.257 -0.428 . . . . 10.0 111.526 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.4 m -61.24 -60.35 3.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.22 -0.445 . . . . 10.0 111.519 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.521 ' HB3' ' C4 ' ' A' ' 201' ' ' 8TL . 42.9 t80 -66.22 -31.88 72.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.35 -0.386 . . . . 10.0 111.168 -179.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.09 -52.72 62.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.426 . . . . 10.0 111.48 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -74.74 -27.17 60.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.302 -0.408 . . . . 10.0 111.272 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -58.18 -38.89 77.56 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.251 -0.431 . . . . 10.0 111.662 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.2 t -62.77 -34.83 67.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.122 0.487 . . . . 10.0 110.632 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.7 ttpm? -70.41 -34.74 72.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.857 -0.611 . . . . 10.0 110.762 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 35.1 mt -76.75 -35.57 25.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.701 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -71.21 -43.38 67.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.209 -0.45 . . . . 10.0 111.104 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -106.94 44.18 1.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.184 0.516 . . . . 10.0 110.901 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.55 -30.75 78.18 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.882 -0.675 . . . . 10.0 112.291 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.1 m -92.73 -6.28 49.43 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 122.759 -0.26 . . . . 10.0 111.304 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -123.13 85.03 51.3 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 120.794 0.33 . . . . 10.0 110.847 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.42 -26.32 41.01 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.479 2.119 . . . . 10.0 112.812 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.79 -44.48 93.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.653 -0.249 . . . . 10.0 111.087 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.2 m -65.88 -40.79 91.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.063 -0.517 . . . . 10.0 111.034 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -69.06 -37.73 78.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.547 -0.297 . . . . 10.0 110.835 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -61.23 -43.22 99.23 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.856 0.36 . . . . 10.0 110.616 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.96 -37.82 95.18 Favored Glycine 0 C--N 1.332 0.33 0 N-CA-C 111.529 -0.628 . . . . 10.0 111.529 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -57.51 -42.21 82.36 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.974 0.416 . . . . 10.0 110.181 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 26.6 mt -67.12 -38.04 84.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.811 -0.631 . . . . 10.0 110.887 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -61.61 -44.28 97.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.28 -0.418 . . . . 10.0 110.704 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.9 mt -63.7 -35.78 74.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.306 -0.406 . . . . 10.0 110.304 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 82.6 mtp -64.01 -37.11 86.21 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.106 -0.497 . . . . 10.0 110.219 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -62.53 -37.42 86.0 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.008 -0.542 . . . . 10.0 111.153 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -63.45 -36.58 84.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.09 0.471 . . . . 10.0 110.094 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -73.33 -35.63 66.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.048 -0.524 . . . . 10.0 109.747 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -66.73 -23.96 66.17 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.117 -0.492 . . . . 10.0 110.45 178.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.0 m -94.35 2.74 55.8 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.92 -0.582 . . . . 10.0 110.131 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 56.85 31.63 19.95 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.648 -0.706 . . . . 10.0 111.294 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.7 m -82.2 -22.18 36.07 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.563 0.697 . . . . 10.0 109.846 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 17.6 pt -131.99 158.47 43.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.264 -0.88 . . . . 10.0 109.965 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -110.0 -162.46 0.8 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.557 -0.534 . . . . 10.0 109.557 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.483 ' HB ' ' CD ' ' A' ' 73' ' ' PRO . 1.4 m -56.73 -60.17 10.17 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 116.237 -0.438 . . . . 10.0 111.221 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.483 ' CD ' ' HB ' ' A' ' 72' ' ' THR . 25.1 Cg_endo -61.52 -21.73 72.71 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 121.908 1.739 . . . . 10.0 112.594 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.79 -50.31 11.57 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.931 -0.577 . . . . 10.0 112.674 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.602 ' O ' HG23 ' A' ' 79' ' ' VAL . 14.5 p -65.18 -36.85 78.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.89 0.345 . . . . 10.0 110.898 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.441 HD12 ' HA ' ' A' ' 73' ' ' PRO . 60.5 mt -58.64 -38.99 74.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 116.299 -0.409 . . . . 10.0 111.081 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 -60.87 -39.29 88.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.957 -0.565 . . . . 10.0 110.928 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -69.63 -45.56 68.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.805 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.61 HG12 HG12 ' A' ' 90' ' ' ILE . 13.6 t -61.0 -38.28 79.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.906 -0.588 . . . . 10.0 110.971 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.481 ' HA ' HD13 ' A' ' 90' ' ' ILE . 23.0 m -65.95 -17.38 64.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.469 . . . . 10.0 111.786 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -102.52 -23.84 13.86 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 111.799 0.296 . . . . 10.0 111.799 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 40.3 tp -85.26 -53.08 5.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.929 0.395 . . . . 10.0 110.348 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -94.96 47.61 1.16 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.025 0.44 . . . . 10.0 110.11 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.502 ' CD2' ' HG2' ' A' ' 85' ' ' GLU . 29.2 p-80 -66.08 -25.46 67.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.993 -0.549 . . . . 10.0 110.771 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.502 ' HG2' ' CD2' ' A' ' 84' ' ' HIS . 53.0 mm-40 -91.0 -9.54 45.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.114 -0.494 . . . . 10.0 110.583 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -128.97 72.05 81.91 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.289 -0.414 . . . . 10.0 111.214 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -61.8 -26.91 80.0 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.581 2.187 . . . . 10.0 112.587 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -56.27 -38.8 71.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.865 -0.607 . . . . 10.0 111.964 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 97.7 mt -64.36 -42.83 95.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.381 -0.372 . . . . 10.0 111.208 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.61 HG12 HG12 ' A' ' 79' ' ' VAL . 3.3 mt -73.0 -41.01 59.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.088 -0.506 . . . . 10.0 111.03 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.435 ' O ' ' HB2' ' A' ' 94' ' ' ASN . 78.7 t -67.36 -48.35 77.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.973 -0.558 . . . . 10.0 110.597 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.68 -31.19 77.07 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.002 -0.618 . . . . 10.0 112.45 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -63.93 -24.92 67.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.696 0.284 . . . . 10.0 111.17 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' A' ' 91' ' ' VAL . 2.6 m-80 -63.72 -33.68 76.19 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.031 0.443 . . . . 10.0 110.426 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -95.58 -16.68 21.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.211 0.529 . . . . 10.0 110.343 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -89.35 31.57 0.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.809 -0.632 . . . . 10.0 110.46 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.2 mt -121.35 108.48 35.82 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.4 -0.818 . . . . 10.0 109.178 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -59.7 -49.15 10.82 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.393 2.062 . . . . 10.0 111.849 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.49 118.31 10.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.283 -0.417 . . . . 10.0 110.367 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -168.21 -134.92 1.79 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.55 -0.833 . . . . 10.0 112.53 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -82.83 13.41 2.62 Favored 'Trans proline' 0 CA--C 1.529 0.226 0 C-N-CA 122.88 2.387 . . . . 10.0 113.284 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.2 m -73.65 162.58 29.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.709 0.29 . . . . 10.0 110.261 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.6 m -72.7 104.64 4.0 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.926 0.393 . . . . 10.0 110.532 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.457 0 C-N-CA 120.902 -0.666 . . . . 10.0 112.375 179.698 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 201' ' ' 8TL . . . . . 0.779 ' C11' ' O3 ' ' A' ' 201' ' ' 8TL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.573 0 N-CA-C 112.241 -0.344 . . . . 10.0 112.241 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.8 m -139.27 129.8 25.78 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.852 0.358 . . . . 10.0 110.536 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.9 m -87.86 104.71 16.86 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.405 -0.361 . . . . 10.0 110.422 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -176.81 166.97 38.09 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.113 -0.565 . . . . 10.0 111.965 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 65.7 m -151.74 93.09 1.82 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.102 0.477 . . . . 10.0 110.766 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.56 113.58 24.29 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.947 -0.57 . . . . 10.0 109.907 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 155.08 74.22 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.803 -0.713 . . . . 10.0 111.416 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 28.5 m -84.47 156.54 3.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.094 0.473 . . . . 10.0 111.027 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -112.14 -178.55 3.45 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.585 -0.734 . . . . 10.0 109.321 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.405 HG22 ' H ' ' A' ' 34' ' ' VAL . 1.9 m -67.24 -36.27 76.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.721 0.296 . . . . 10.0 111.73 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -115.05 105.72 13.28 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.882 0.372 . . . . 10.0 110.222 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -139.75 3.51 2.06 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.566 0.58 . . . . 10.0 112.566 -178.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.61 -37.73 87.43 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.122 0.487 . . . . 10.0 110.613 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.493 ' H ' ' HG ' ' A' ' 38' ' ' LEU . 0.7 OUTLIER -64.02 -24.07 67.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.536 -0.756 . . . . 10.0 111.51 179.738 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.3 m -68.36 -47.49 67.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.531 -0.304 . . . . 10.0 111.39 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -67.93 -36.56 80.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.922 0.391 . . . . 10.0 110.323 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 59.0 mt -65.08 -28.67 69.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.909 -0.587 . . . . 10.0 110.736 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -76.85 -38.09 54.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.687 -0.688 . . . . 10.0 110.206 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -59.1 -36.4 75.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.769 -0.65 . . . . 10.0 111.168 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 54.0 t -61.1 -40.92 87.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.982 -0.554 . . . . 10.0 110.911 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.1 pttm -71.09 -24.19 62.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.371 -0.377 . . . . 10.0 111.09 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 81.9 mt -78.01 -48.7 22.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 121.014 0.435 . . . . 10.0 110.087 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -63.68 -40.57 97.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.762 -0.653 . . . . 10.0 111.357 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -103.59 40.02 1.5 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.099 0.476 . . . . 10.0 110.428 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -70.82 -29.36 69.43 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.697 -0.763 . . . . 10.0 112.38 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.4 m -81.74 -31.27 32.08 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.407 0.146 . . . . 10.0 111.04 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -113.56 106.67 53.91 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.791 0.329 . . . . 10.0 110.848 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -81.15 -11.62 12.07 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.473 2.115 . . . . 10.0 112.686 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.95 -48.87 64.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.09 -0.504 . . . . 10.0 110.744 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.5 m -66.29 -32.96 74.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 10.0 110.523 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -72.4 -43.3 64.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 10.0 110.241 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -64.55 -37.75 88.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.066 -0.516 . . . . 10.0 110.248 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.65 -26.83 73.65 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.765 -0.652 . . . . 10.0 111.628 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -68.05 -36.81 80.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.267 0.556 . . . . 10.0 109.681 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 60.5 mt -66.06 -36.81 84.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.687 -0.688 . . . . 10.0 110.606 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -66.54 -31.45 72.17 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.064 -0.516 . . . . 10.0 110.788 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.2 mt -65.29 -42.87 94.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.228 0.537 . . . . 10.0 110.577 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.471 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 67.8 mtp -65.8 -33.56 76.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.039 -0.528 . . . . 10.0 110.657 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.39 -34.6 77.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 10.0 111.421 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -67.97 -31.89 71.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.044 0.45 . . . . 10.0 110.566 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -81.13 -29.7 34.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.636 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 62' ' ' MET . 23.7 mtpp -59.0 -41.21 87.13 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.902 0.382 . . . . 10.0 110.771 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.1 m -88.52 8.37 28.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 10.0 110.967 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 58.33 30.57 19.75 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.656 -0.702 . . . . 10.0 111.038 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.3 m -77.14 -24.71 51.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.086 -0.506 . . . . 10.0 110.844 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 36.1 pt -125.31 162.87 27.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.114 -0.494 . . . . 10.0 110.121 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -112.22 -172.4 2.04 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.939 -0.573 . . . . 10.0 110.055 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.609 ' O ' HG12 ' A' ' 75' ' ' VAL . 2.1 m -54.7 -54.39 49.78 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 116.362 -0.381 . . . . 10.0 111.841 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 72' ' ' THR . 28.7 Cg_endo -63.26 -26.12 72.0 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 121.793 1.662 . . . . 10.0 111.994 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.73 -41.93 72.63 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.759 -0.655 . . . . 10.0 112.571 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.609 HG12 ' O ' ' A' ' 72' ' ' THR . 4.2 p -65.51 -29.95 48.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 120.704 0.287 . . . . 10.0 110.372 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 63.6 mt -63.07 -42.73 97.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 10.0 110.209 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -62.02 -40.06 94.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.533 -0.758 . . . . 10.0 109.934 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -66.63 -46.76 74.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.943 -0.572 . . . . 10.0 110.957 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.1 t -66.3 -43.99 91.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.216 -0.447 . . . . 10.0 111.107 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.554 ' HA ' HD13 ' A' ' 90' ' ' ILE . 0.4 OUTLIER -60.57 -37.98 83.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.122 -0.49 . . . . 10.0 111.196 -179.506 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -79.3 -27.09 42.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.708 -0.223 . . . . 10.0 111.363 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 35.5 tp -76.22 -51.94 11.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.879 0.371 . . . . 10.0 110.346 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 -91.5 48.74 1.5 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.206 0.527 . . . . 10.0 110.212 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -68.7 -8.99 47.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.82 -0.627 . . . . 10.0 111.766 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -110.23 -12.03 14.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.836 0.351 . . . . 10.0 111.047 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -130.46 80.87 69.43 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.385 -0.37 . . . . 10.0 111.001 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -62.31 -28.95 79.23 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.597 2.198 . . . . 10.0 112.298 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -58.5 -36.72 74.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.599 -0.728 . . . . 10.0 111.468 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 95.7 mt -75.72 -30.25 59.2 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.408 -0.36 . . . . 10.0 111.125 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.554 HD13 ' HA ' ' A' ' 80' ' ' SER . 45.4 mt -69.05 -46.17 78.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.347 0.594 . . . . 10.0 109.459 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.411 ' O ' ' HB2' ' A' ' 94' ' ' ASN . 46.3 t -70.11 -37.33 71.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.318 -0.855 . . . . 10.0 109.751 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.32 -40.63 94.31 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.748 -0.66 . . . . 10.0 112.189 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -60.25 -28.91 68.42 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.754 0.311 . . . . 10.0 110.747 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' A' ' 91' ' ' VAL . 28.4 m-80 -69.78 -17.73 63.44 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.44 -0.345 . . . . 10.0 110.662 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.78 -3.47 24.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.89 0.376 . . . . 10.0 111.024 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -112.86 20.19 16.66 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.064 0.459 . . . . 10.0 110.842 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 17.5 mt -80.22 116.15 59.53 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.815 -0.629 . . . . 10.0 109.831 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.32 -18.41 30.06 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.38 2.054 . . . . 10.0 112.74 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.71 158.27 30.47 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.867 -0.42 . . . . 10.0 109.867 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 169.77 -134.32 3.13 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 121.007 -0.616 . . . . 10.0 111.624 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.57 -9.48 18.58 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.755 2.304 . . . . 10.0 111.533 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 m -66.23 152.11 45.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.673 -0.694 . . . . 10.0 111.373 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.56 133.81 55.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.905 -0.589 . . . . 10.0 111.081 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.222 0 CA-C-N 115.967 -0.56 . . . . 10.0 112.463 179.425 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 201' ' ' 8TL . . . . . 0.761 ' C11' ' O3 ' ' A' ' 201' ' ' 8TL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.382 0 N-CA-C 112.051 -0.419 . . . . 10.0 112.051 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -115.56 137.88 51.61 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.753 0.277 . . . . 10.0 110.572 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 19.0 m -101.12 73.17 1.5 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.105 0.478 . . . . 10.0 110.716 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -155.44 137.86 5.79 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.022 -0.609 . . . . 10.0 111.71 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.1 m -106.65 105.25 15.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.901 0.381 . . . . 10.0 110.78 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.4 m -90.56 150.79 21.6 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.76 0.314 . . . . 10.0 110.425 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.88 91.74 2.22 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.695 -0.764 . . . . 10.0 111.643 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.7 m -91.69 164.57 2.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.654 0.264 . . . . 10.0 110.762 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -119.36 177.05 5.05 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.282 -0.417 . . . . 10.0 110.209 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.3 m -81.98 -12.7 12.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.919 0.39 . . . . 10.0 110.856 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -139.95 87.64 2.17 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.185 -0.461 . . . . 10.0 110.111 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.2 p30 -128.61 12.02 6.31 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.25 -0.432 . . . . 10.0 111.037 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.91 -44.69 96.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.261 0.553 . . . . 10.0 111.072 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.541 HD23 ' H ' ' A' ' 38' ' ' LEU . 1.8 pt? -63.24 -31.41 72.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.519 -0.764 . . . . 10.0 111.002 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 m -62.05 -51.42 68.06 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.086 -0.506 . . . . 10.0 111.191 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -70.01 -30.04 67.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.449 -0.341 . . . . 10.0 110.626 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.48 -34.89 78.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.965 0.412 . . . . 10.0 110.528 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -73.87 -32.58 63.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.296 -0.411 . . . . 10.0 110.185 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -60.16 -38.63 83.76 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.092 -0.503 . . . . 10.0 109.782 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 92.9 t -60.35 -39.43 80.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.657 -0.702 . . . . 10.0 109.7 178.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.8 ttpm? -67.04 -38.0 85.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.226 -0.897 . . . . 10.0 110.748 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 57.7 mt -71.0 -43.78 76.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.287 -0.415 . . . . 10.0 110.33 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -62.12 -36.49 81.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 10.0 111.231 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -101.94 36.36 2.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.058 0.456 . . . . 10.0 111.284 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.81 -36.3 89.46 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.855 -0.612 . . . . 10.0 111.984 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.0 m -101.69 13.36 35.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.603 0.24 . . . . 10.0 111.087 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -142.04 74.93 21.18 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.949 0.404 . . . . 10.0 110.752 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -63.71 -26.89 68.36 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.594 2.196 . . . . 10.0 112.476 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.12 -50.03 73.51 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.761 0.315 . . . . 10.0 110.989 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.9 m -63.03 -38.36 90.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.301 -0.409 . . . . 10.0 110.682 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -69.43 -40.11 77.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.412 -0.358 . . . . 10.0 110.791 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -64.65 -41.42 96.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.366 -0.379 . . . . 10.0 110.295 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.83 -27.96 72.77 Favored Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.886 -0.597 . . . . 10.0 111.788 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -64.47 -42.29 95.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.964 0.412 . . . . 10.0 110.393 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.9 mt -64.15 -29.84 70.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.981 -0.554 . . . . 10.0 110.613 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -68.81 -34.2 75.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 10.0 110.259 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.8 mt -67.88 -36.01 74.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.964 -0.562 . . . . 10.0 109.621 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.76 -31.46 72.64 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.591 -0.732 . . . . 10.0 110.156 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -62.36 -39.57 93.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.066 -0.516 . . . . 10.0 111.32 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -63.84 -37.18 86.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.171 -0.468 . . . . 10.0 110.453 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -74.79 -36.5 62.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.123 -0.49 . . . . 10.0 110.474 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -64.28 -41.02 97.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.312 -0.404 . . . . 10.0 110.9 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.7 m -81.8 0.24 40.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.388 -0.369 . . . . 10.0 110.918 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 61.32 32.06 19.24 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.688 -0.687 . . . . 10.0 111.95 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.1 m -78.15 -24.18 47.42 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.193 -0.669 . . . . 10.0 109.193 178.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 45.6 pt -135.91 -179.06 2.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.16 -0.927 . . . . 10.0 109.314 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -136.3 -151.2 0.4 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.927 -0.397 . . . . 10.0 109.927 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.485 HG23 ' C16' ' A' ' 201' ' ' 8TL . 7.1 m -55.72 -57.81 19.29 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 113.167 0.803 . . . . 10.0 113.167 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.459 ' HD3' ' HB ' ' A' ' 72' ' ' THR . 18.8 Cg_endo -61.15 -38.42 67.05 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 121.832 1.688 . . . . 10.0 112.964 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.56 -45.35 93.3 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 116.129 -0.487 . . . . 10.0 113.386 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.45 -39.5 82.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.768 -0.373 . . . . 10.0 111.303 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 81.4 mt -65.57 -43.87 94.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.797 0.332 . . . . 10.0 110.113 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 34.9 ttp-105 -61.58 -37.51 84.14 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.138 -0.483 . . . . 10.0 110.814 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.68 -50.26 58.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.151 -0.477 . . . . 10.0 110.888 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 94.5 t -66.39 -30.95 51.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.111 -0.495 . . . . 10.0 111.869 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 71.0 m -61.19 -27.89 68.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.002 0.429 . . . . 10.0 110.751 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -85.81 -28.97 24.15 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.826 -0.624 . . . . 10.0 110.374 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 25.9 tp -75.67 -45.48 36.78 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.87 -0.604 . . . . 10.0 109.842 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 6.1 m-30 -90.89 41.9 1.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.855 -0.611 . . . . 10.0 109.959 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -65.32 -21.18 66.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.483 -0.326 . . . . 10.0 111.678 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -103.83 5.64 36.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.962 0.411 . . . . 10.0 110.508 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -134.96 69.73 70.74 Favored Pre-proline 0 C--O 1.235 0.341 0 CA-C-N 116.413 -0.358 . . . . 10.0 110.923 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -62.16 -29.74 81.17 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.255 1.97 . . . . 10.0 112.2 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.49 -46.68 83.45 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.009 -0.541 . . . . 10.0 110.703 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 81.0 mt -64.25 -36.29 83.62 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.407 -0.815 . . . . 10.0 111.394 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 94.2 mt -62.57 -47.28 93.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.894 0.378 . . . . 10.0 110.458 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 43.2 t -70.05 -42.72 79.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.293 -0.412 . . . . 10.0 110.649 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.78 -43.84 97.54 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.956 -0.566 . . . . 10.0 112.761 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -62.26 -34.59 76.83 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.699 0.285 . . . . 10.0 111.367 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 -58.59 -38.55 78.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 10.0 111.03 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -91.47 -19.87 22.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.307 -0.406 . . . . 10.0 111.62 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -69.91 -35.32 74.51 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.674 0.274 . . . . 10.0 111.042 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 97' ' ' LEU . 9.3 mt -72.01 126.59 91.24 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 120.848 0.356 . . . . 10.0 111.339 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.72 -18.79 11.65 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.829 2.353 . . . . 10.0 111.984 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.42 130.74 43.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.798 -0.637 . . . . 10.0 111.025 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 161.65 -128.26 1.88 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.094 -0.575 . . . . 10.0 111.758 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -89.35 24.8 0.64 Allowed 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.788 2.325 . . . . 10.0 111.99 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.08 166.99 21.15 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.519 -0.764 . . . . 10.0 111.651 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.17 109.27 1.26 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.823 -0.626 . . . . 10.0 111.024 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.486 0 C-N-CA 120.472 -0.871 . . . . 10.0 112.582 179.596 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 201' ' ' 8TL . . . . . 0.77 ' C11' ' O3 ' ' A' ' 201' ' ' 8TL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.406 0 N-CA-C 112.023 -0.431 . . . . 10.0 112.023 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.67 136.63 32.94 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 117.05 0.425 . . . . 10.0 109.988 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.3 m -82.55 93.47 7.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.856 0.36 . . . . 10.0 110.457 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -150.8 135.99 5.4 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.636 -0.792 . . . . 10.0 112.372 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.2 m -117.98 84.06 2.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.239 0.542 . . . . 10.0 110.493 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.6 m -78.26 147.17 34.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.814 -0.63 . . . . 10.0 110.649 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.08 78.96 0.75 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.826 -0.702 . . . . 10.0 111.486 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.4 m -87.93 160.01 2.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.214 0.531 . . . . 10.0 110.97 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -112.9 174.84 5.7 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.95 -0.568 . . . . 10.0 110.193 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.2 m -68.04 -32.57 56.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.166 0.508 . . . . 10.0 109.826 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -113.07 80.47 1.36 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.27 -0.877 . . . . 10.0 109.211 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -123.83 2.4 8.78 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.035 -0.529 . . . . 10.0 111.547 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.51 -49.8 76.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.375 0.607 . . . . 10.0 111.001 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -66.69 -9.33 35.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.607 -0.724 . . . . 10.0 111.833 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.9 m -72.57 -37.44 68.2 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.58 0.228 . . . . 10.0 111.031 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -74.39 -29.55 61.58 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.788 -0.365 . . . . 10.0 110.615 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -58.0 -43.87 86.86 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.767 -0.457 . . . . 10.0 109.767 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.408 ' O ' HG13 ' A' ' 46' ' ' ILE . 36.6 t70 -64.77 -41.88 95.53 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.696 -0.683 . . . . 10.0 110.81 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -61.19 -38.22 85.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.812 -0.631 . . . . 10.0 111.006 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.62 -40.98 89.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.57 -0.53 . . . . 10.0 109.57 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.06 -29.15 68.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.727 -0.67 . . . . 10.0 110.862 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 42' ' ' ASP . 80.6 mt -75.13 -47.25 36.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.529 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 -62.94 -34.26 77.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.22 -0.446 . . . . 10.0 111.398 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -107.19 41.76 1.43 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.15 0.5 . . . . 10.0 110.506 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -70.75 -27.3 72.6 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.938 -0.648 . . . . 10.0 112.538 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.6 t -100.96 5.32 43.14 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.064 0.459 . . . . 10.0 110.473 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -135.64 86.33 28.67 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.815 -0.63 . . . . 10.0 110.105 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -74.32 -15.74 22.39 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.275 1.983 . . . . 10.0 112.644 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.69 -49.58 61.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.316 -0.402 . . . . 10.0 111.114 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.6 m -66.52 -33.31 75.4 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.318 -0.401 . . . . 10.0 110.779 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -67.64 -41.75 83.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.166 -0.47 . . . . 10.0 110.708 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -62.47 -38.59 90.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.935 0.398 . . . . 10.0 110.567 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.27 -33.25 84.52 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.918 -0.658 . . . . 10.0 111.898 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -61.85 -41.94 98.45 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.947 0.403 . . . . 10.0 110.181 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 24.5 mt -66.71 -36.29 82.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.963 -0.562 . . . . 10.0 110.287 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -62.27 -42.43 99.33 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.665 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.2 mt -66.17 -36.62 77.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.533 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 46.2 mtp -62.12 -34.06 75.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 10.0 110.631 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -62.36 -38.57 90.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.292 -0.413 . . . . 10.0 110.613 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -66.37 -36.83 83.87 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.379 -0.6 . . . . 10.0 109.379 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -68.87 -43.82 74.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.43 -0.805 . . . . 10.0 109.981 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -64.16 -37.17 86.51 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.083 -0.508 . . . . 10.0 111.203 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.7 m -82.5 4.38 24.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.302 -0.408 . . . . 10.0 111.336 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 58.97 28.46 17.67 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.874 -0.603 . . . . 10.0 111.449 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.6 m -75.71 -38.52 58.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.18 0.514 . . . . 10.0 110.143 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.2 pt -120.97 157.73 23.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.689 -0.687 . . . . 10.0 110.106 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -106.85 -163.25 0.9 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.173 -0.467 . . . . 10.0 110.399 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.486 ' O ' HG12 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -55.0 -57.05 21.48 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 112.772 0.656 . . . . 10.0 112.772 -179.724 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 72' ' ' THR . 20.5 Cg_endo -60.94 -29.45 88.05 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.043 1.828 . . . . 10.0 112.666 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.13 -48.17 20.89 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.625 -0.798 . . . . 10.0 112.017 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.486 HG12 ' O ' ' A' ' 72' ' ' THR . 5.6 p -63.91 -30.39 49.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.565 0.221 . . . . 10.0 110.753 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.5 mt -66.2 -49.22 77.73 Favored 'Isoleucine or valine' 0 C--N 1.337 0.053 0 N-CA-C 109.714 -0.476 . . . . 10.0 109.714 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 60.2 ttp180 -61.44 -42.61 99.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.864 -0.607 . . . . 10.0 110.799 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -56.53 -41.62 77.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.88 -0.6 . . . . 10.0 111.568 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.6 p -84.21 -22.36 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 120.826 -0.349 . . . . 10.0 111.625 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.5 m -64.25 -42.42 96.52 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.022 0.439 . . . . 10.0 110.737 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -77.3 -14.25 59.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.121 -0.49 . . . . 10.0 110.316 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 18.3 tp -86.44 -43.5 12.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.862 -0.608 . . . . 10.0 110.065 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -103.62 37.21 2.08 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.897 -0.592 . . . . 10.0 109.935 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -64.16 -24.56 67.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.321 -0.4 . . . . 10.0 111.595 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -92.55 0.26 57.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.467 -0.333 . . . . 10.0 110.895 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 18.4 m170 -136.34 81.03 38.24 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-O 120.675 0.274 . . . . 10.0 110.857 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -65.1 -27.53 57.21 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.483 2.122 . . . . 10.0 112.343 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -57.62 -42.6 83.65 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.8 -0.636 . . . . 10.0 110.96 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 96.1 mt -68.9 -41.04 78.8 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.127 -0.488 . . . . 10.0 111.184 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 59.3 mt -60.6 -48.01 90.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-O 121.116 0.484 . . . . 10.0 110.972 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.4 t -71.5 -42.8 72.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.985 -0.552 . . . . 10.0 110.834 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.77 -45.38 95.84 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.817 -0.629 . . . . 10.0 112.859 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.413 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 39.5 t80 -63.19 -34.42 77.61 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.729 0.3 . . . . 10.0 111.022 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -62.82 -36.09 82.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.406 -0.361 . . . . 10.0 111.149 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.9 -21.22 26.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.865 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -77.17 -25.14 51.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.903 -0.59 . . . . 10.0 110.908 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 93' ' ' PHE . 57.9 mt -52.34 125.55 34.98 Favored Pre-proline 0 C--O 1.235 0.304 0 CA-C-N 116.126 -0.488 . . . . 10.0 112.172 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -67.75 -30.66 33.75 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.586 2.19 . . . . 10.0 111.57 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.83 145.95 38.09 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.65 -0.705 . . . . 10.0 110.494 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 171.29 -169.02 42.15 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.775 -0.726 . . . . 10.0 111.963 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.37 15.89 0.62 Allowed 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 123.535 2.823 . . . . 10.0 113.125 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.81 179.59 2.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.018 0.437 . . . . 10.0 110.702 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.9 t -78.3 116.96 19.1 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.878 -0.416 . . . . 10.0 109.878 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.146 0 C-N-CA 120.882 -0.675 . . . . 10.0 112.346 179.747 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 201' ' ' 8TL . . . . . 0.751 ' C11' ' O3 ' ' A' ' 201' ' ' 8TL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.139 0 N-CA-C 112.47 -0.252 . . . . 10.0 112.47 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.87 117.9 16.38 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.966 -0.383 . . . . 10.0 109.966 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.1 m -68.46 123.47 20.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 10.0 110.792 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 161.27 129.45 1.03 Allowed Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.846 -0.693 . . . . 10.0 111.594 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.57 94.46 5.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.019 0.438 . . . . 10.0 110.882 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.4 m -81.35 149.35 28.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.122 -0.49 . . . . 10.0 109.816 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.37 74.28 1.07 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.019 -0.61 . . . . 10.0 111.972 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.8 m -82.47 161.29 3.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.775 0.322 . . . . 10.0 111.066 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -101.73 178.07 4.73 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.575 -0.528 . . . . 10.0 109.575 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 32.1 m -81.65 4.99 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.155 0.502 . . . . 10.0 111.235 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -153.52 103.45 2.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.87 -0.605 . . . . 10.0 109.763 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 38.6 p-10 -135.57 17.29 3.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.151 0.5 . . . . 10.0 110.733 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.58 -41.79 99.15 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.755 -0.657 . . . . 10.0 111.147 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.584 HD23 ' H ' ' A' ' 38' ' ' LEU . 2.2 pt? -71.17 -30.87 66.96 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.932 -0.577 . . . . 10.0 110.773 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.22 -43.87 93.65 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.209 -0.45 . . . . 10.0 110.876 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -67.45 -38.32 84.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 10.0 110.201 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.64 -41.49 99.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.26 0.552 . . . . 10.0 110.528 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.579 ' O ' HG13 ' A' ' 46' ' ' ILE . 22.1 t70 -66.43 -35.78 81.16 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.369 -0.832 . . . . 10.0 110.874 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -59.53 -45.48 91.64 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.031 0.443 . . . . 10.0 110.712 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 64.7 t -59.51 -35.83 61.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 115.517 -0.765 . . . . 10.0 110.373 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.4 ttpm? -67.51 -35.06 78.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.229 -0.896 . . . . 10.0 110.863 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.579 HG13 ' O ' ' A' ' 42' ' ' ASP . 23.4 mt -76.22 -47.04 32.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.573 -0.285 . . . . 10.0 110.938 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -58.87 -47.14 85.99 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.039 -0.528 . . . . 10.0 111.712 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -104.27 54.65 0.73 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.21 0.528 . . . . 10.0 110.986 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.83 -36.35 29.02 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.709 -0.757 . . . . 10.0 111.521 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.09 4.83 28.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.928 0.394 . . . . 10.0 110.994 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -138.83 87.83 14.25 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.001 -0.545 . . . . 10.0 109.917 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -70.7 -21.0 29.71 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.361 2.041 . . . . 10.0 112.598 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.78 -47.44 83.48 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.499 -0.318 . . . . 10.0 111.328 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.8 m -63.15 -43.27 98.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.077 0.465 . . . . 10.0 110.587 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -65.2 -39.83 93.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.11 -0.495 . . . . 10.0 110.91 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -65.87 -35.97 82.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.985 -0.552 . . . . 10.0 110.705 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -69.53 -33.69 72.52 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.647 -0.706 . . . . 10.0 111.542 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -59.53 -34.82 73.13 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.099 0.476 . . . . 10.0 110.334 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 23.9 mt -62.98 -41.28 99.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.752 -0.658 . . . . 10.0 110.64 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -67.18 -30.39 70.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.97 -0.559 . . . . 10.0 110.637 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.7 mt -65.62 -47.63 85.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.069 -0.514 . . . . 10.0 110.419 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 44.1 mtp -66.07 -27.12 67.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.965 -0.561 . . . . 10.0 111.065 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -63.29 -41.77 99.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.232 -0.44 . . . . 10.0 110.989 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -64.05 -33.32 75.48 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.074 0.464 . . . . 10.0 110.46 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -74.92 -41.27 60.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.7 -0.682 . . . . 10.0 110.466 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -62.63 -34.35 76.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.842 -0.617 . . . . 10.0 111.307 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 68.6 m -82.42 -0.66 47.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.417 -0.356 . . . . 10.0 111.104 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 63.33 23.02 13.58 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.029 -0.532 . . . . 10.0 111.504 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.36 -41.64 39.54 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.845 -0.798 . . . . 10.0 108.845 178.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 31.2 pt -114.87 165.9 9.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.676 -0.693 . . . . 10.0 110.083 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -123.12 -166.48 1.46 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.129 -0.487 . . . . 10.0 109.77 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.478 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 7.1 m -49.02 -55.25 21.6 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 112.029 0.381 . . . . 10.0 112.029 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 72' ' ' THR . 11.5 Cg_endo -55.84 -34.48 91.53 Favored 'Trans proline' 0 C--N 1.358 1.028 0 C-N-CA 122.387 2.058 . . . . 10.0 112.548 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.68 -44.51 62.96 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.778 -0.725 . . . . 10.0 111.939 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.595 ' O ' HG23 ' A' ' 79' ' ' VAL . 82.5 t -60.97 -45.45 98.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.951 -0.388 . . . . 10.0 109.951 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 88.8 mt -55.49 -42.57 68.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.09 -0.504 . . . . 10.0 110.984 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 41.4 ttp180 -59.23 -44.82 92.3 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.137 0.494 . . . . 10.0 109.897 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -63.54 -46.85 84.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.734 -0.666 . . . . 10.0 110.263 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 75' ' ' VAL . 64.3 t -58.46 -43.91 87.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.545 -0.752 . . . . 10.0 111.205 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.429 ' HA ' HD13 ' A' ' 90' ' ' ILE . 9.8 m -66.04 -38.23 87.84 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.182 -0.463 . . . . 10.0 111.59 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -75.84 -20.22 58.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.908 0.385 . . . . 10.0 110.855 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.2 tp -87.55 -53.57 4.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.984 -0.553 . . . . 10.0 110.654 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -97.57 44.52 1.04 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.953 0.406 . . . . 10.0 110.552 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 32.9 p-80 -69.93 -13.59 62.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.321 -0.399 . . . . 10.0 111.424 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -96.95 -12.48 23.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.996 0.426 . . . . 10.0 110.271 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -136.01 77.69 49.11 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 10.0 110.964 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -62.49 -23.41 74.91 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.588 2.192 . . . . 10.0 112.34 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.5 -23.85 67.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.115 -0.493 . . . . 10.0 111.024 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 81.6 mt -87.38 -30.47 20.73 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.459 -0.337 . . . . 10.0 110.49 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.429 HD13 ' HA ' ' A' ' 80' ' ' SER . 55.5 mt -63.48 -51.94 64.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.893 0.378 . . . . 10.0 110.903 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.6 t -63.2 -27.46 43.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.851 -0.613 . . . . 10.0 110.421 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.49 -37.55 92.28 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.431 -0.668 . . . . 10.0 111.431 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -66.67 -39.39 88.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.889 0.376 . . . . 10.0 110.408 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -63.54 -34.87 78.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.585 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -90.24 0.66 57.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.159 -0.473 . . . . 10.0 110.792 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -106.49 2.51 26.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.262 -0.426 . . . . 10.0 110.777 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 53.9 mt -69.96 118.18 61.0 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.276 -0.42 . . . . 10.0 111.069 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -70.79 -41.89 2.69 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.469 2.113 . . . . 10.0 112.536 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.3 m -94.23 149.97 20.74 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 116.321 -0.4 . . . . 10.0 110.232 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -177.9 -141.94 4.41 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.644 -0.789 . . . . 10.0 111.732 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -80.44 0.84 9.73 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.699 2.266 . . . . 10.0 112.424 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.02 157.96 32.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.394 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.2 m -69.19 139.2 54.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.856 0.36 . . . . 10.0 111.426 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.451 0 C-N-CA 120.665 -0.779 . . . . 10.0 112.171 179.912 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 201' ' ' 8TL . . . . . 0.777 ' C11' ' O3 ' ' A' ' 201' ' ' 8TL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.265 0 N-CA-C 112.03 -0.428 . . . . 10.0 112.03 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.39 138.43 50.36 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 110.127 -0.323 . . . . 10.0 110.127 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.0 m -105.3 101.55 11.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.989 0.423 . . . . 10.0 110.368 -179.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -161.32 126.28 1.56 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 121.06 -0.59 . . . . 10.0 112.09 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.75 82.47 2.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.032 0.444 . . . . 10.0 110.529 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.7 m -79.47 134.86 36.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.604 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.58 86.17 1.82 Allowed Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.52 -0.847 . . . . 10.0 112.641 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.9 m -103.62 156.53 5.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 110.068 -0.345 . . . . 10.0 110.068 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -94.63 -164.42 1.17 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.235 -0.438 . . . . 10.0 110.751 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.8 m -78.36 -22.12 13.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.125 0.488 . . . . 10.0 110.929 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -113.59 85.01 2.11 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.414 0.626 . . . . 10.0 110.456 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -113.05 -4.55 13.84 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.541 -0.754 . . . . 10.0 110.402 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.49 -40.13 95.68 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.336 -0.847 . . . . 10.0 112.419 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.15 -9.14 58.81 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.919 0.341 . . . . 10.0 111.919 -178.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.76 -49.55 24.93 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.137 0.494 . . . . 10.0 111.702 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.42 ' HB3' ' C5 ' ' A' ' 201' ' ' 8TL . 64.6 t80 -73.17 -12.9 61.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.07 -0.514 . . . . 10.0 111.499 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.93 -45.81 69.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.007 0.432 . . . . 10.0 110.829 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -69.92 -32.28 70.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.35 -0.386 . . . . 10.0 111.379 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -56.64 -35.13 68.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.929 -0.578 . . . . 10.0 110.885 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 28.7 t -66.02 -42.45 91.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 10.0 110.045 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -63.33 -38.59 91.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.873 -0.603 . . . . 10.0 111.084 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 57.2 mt -73.77 -44.92 51.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 10.0 110.967 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -58.26 -40.96 83.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 10.0 110.894 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -110.13 41.73 1.67 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.335 0.588 . . . . 10.0 110.454 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.87 -28.17 73.41 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.952 -0.642 . . . . 10.0 112.053 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.3 m -96.23 2.38 52.93 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.803 0.335 . . . . 10.0 110.864 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -134.01 86.74 36.62 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 109.591 -0.522 . . . . 10.0 109.591 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -68.27 -17.75 44.77 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.922 2.414 . . . . 10.0 112.582 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.59 -49.28 69.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.058 -0.519 . . . . 10.0 111.122 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.8 m -62.85 -43.19 99.47 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.549 -0.296 . . . . 10.0 111.246 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -65.4 -40.12 93.02 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 110.128 -0.323 . . . . 10.0 110.128 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -60.86 -48.13 83.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 10.0 110.361 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.457 ' O ' HG13 ' A' ' 61' ' ' ILE . . . -60.02 -44.55 97.14 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.93 -0.652 . . . . 10.0 111.828 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -55.78 -43.23 76.59 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.757 0.313 . . . . 10.0 110.891 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 77.8 mt -64.55 -38.03 89.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.932 -0.576 . . . . 10.0 111.26 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -70.71 -39.91 73.13 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.296 -0.411 . . . . 10.0 111.056 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 57' ' ' GLY . 62.4 mt -67.45 -36.5 76.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.024 0.44 . . . . 10.0 110.428 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.93 -31.97 67.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.901 -0.59 . . . . 10.0 111.131 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -63.01 -45.37 92.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.964 -0.562 . . . . 10.0 110.844 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -59.8 -36.34 76.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.916 -0.584 . . . . 10.0 111.663 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -66.73 -42.94 85.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.373 -0.376 . . . . 10.0 110.88 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -74.86 -24.29 58.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.895 -0.593 . . . . 10.0 111.104 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 68.4 m -79.08 5.0 12.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.898 0.38 . . . . 10.0 110.537 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 61.77 33.58 17.75 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.798 -0.637 . . . . 10.0 110.866 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.1 m -93.88 -26.12 17.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.302 -0.408 . . . . 10.0 111.044 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.0 pt -139.85 158.42 26.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.184 -0.462 . . . . 10.0 110.646 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.416 ' HB3' ' H ' ' A' ' 72' ' ' THR . 30.9 m-20 -119.17 -158.93 0.75 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.288 -0.415 . . . . 10.0 110.249 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.428 ' HB ' ' HD3' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -48.21 -59.68 5.58 Favored Pre-proline 0 CA--C 1.542 0.673 0 N-CA-C 112.65 0.611 . . . . 10.0 112.65 -179.6 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.428 ' HD3' ' HB ' ' A' ' 72' ' ' THR . 28.7 Cg_endo -62.91 -35.07 69.18 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 121.554 1.503 . . . . 10.0 112.722 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.1 -44.31 91.52 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 121.099 -0.572 . . . . 10.0 112.256 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.506 ' O ' HG23 ' A' ' 79' ' ' VAL . 8.9 p -74.89 -35.36 35.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 O-C-N 122.853 -0.204 . . . . 10.0 110.906 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 74.0 mt -62.95 -37.92 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.077 0 N-CA-C 110.172 -0.307 . . . . 10.0 110.172 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -59.86 -29.79 68.53 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.287 0.565 . . . . 10.0 110.193 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -81.61 -42.55 19.9 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.716 -0.675 . . . . 10.0 109.656 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 75' ' ' VAL . 97.6 t -59.3 -46.59 92.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.613 -0.721 . . . . 10.0 110.737 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.464 ' HA ' HD13 ' A' ' 90' ' ' ILE . 49.6 m -63.04 -28.85 70.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.952 -0.567 . . . . 10.0 111.512 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -84.91 -40.63 16.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.673 0.273 . . . . 10.0 111.366 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 6.6 tp -64.97 -47.45 77.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.235 0.541 . . . . 10.0 111.056 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -101.18 45.59 0.97 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.013 -0.54 . . . . 10.0 110.076 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -63.93 -29.37 70.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.958 -0.565 . . . . 10.0 111.327 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -98.94 6.37 46.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.964 0.411 . . . . 10.0 110.897 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -137.57 71.11 52.18 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 116.36 -0.382 . . . . 10.0 110.438 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.02 -31.44 76.5 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.338 2.025 . . . . 10.0 112.288 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.78 -32.28 70.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 10.0 110.762 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 89.1 mt -72.11 -42.51 65.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.22 -0.446 . . . . 10.0 110.051 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.464 HD13 ' HA ' ' A' ' 80' ' ' SER . 26.2 mt -65.16 -44.44 95.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 116.036 -0.529 . . . . 10.0 109.805 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 99.1 t -65.11 -37.77 81.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 115.818 -0.628 . . . . 10.0 109.508 178.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -64.18 -38.18 95.58 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.655 -0.783 . . . . 10.0 111.609 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -68.97 -28.1 66.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.96 0.409 . . . . 10.0 110.566 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -62.18 -28.19 69.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.164 0.507 . . . . 10.0 109.926 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.93 8.87 30.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.571 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -117.62 33.35 5.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.831 -0.622 . . . . 10.0 110.072 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.6 mt -106.34 114.68 61.98 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.784 -0.644 . . . . 10.0 110.086 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -71.12 -12.23 30.01 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.626 2.218 . . . . 10.0 112.076 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.3 m -109.93 104.55 13.49 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.029 -0.532 . . . . 10.0 110.563 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -154.49 -149.28 5.21 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.753 -0.737 . . . . 10.0 112.256 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -79.98 39.38 0.83 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.288 2.659 . . . . 10.0 113.232 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 57.9 m -96.35 174.16 7.01 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.147 -0.479 . . . . 10.0 110.228 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.3 m -71.72 95.57 1.49 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.949 0.404 . . . . 10.0 110.252 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.654 0 C-N-CA 120.946 -0.645 . . . . 10.0 111.93 -179.7 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 201' ' ' 8TL . . . . . 0.75 ' C11' ' O3 ' ' A' ' 201' ' ' 8TL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 111.862 -0.495 . . . . 10.0 111.862 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.2 m -118.21 154.65 31.86 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.02 -0.363 . . . . 10.0 110.02 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.3 m -102.26 111.61 23.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.995 0.426 . . . . 10.0 111.0 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -157.04 160.58 30.52 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 121.036 -0.602 . . . . 10.0 111.916 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.3 m -133.98 83.64 2.06 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.055 -0.35 . . . . 10.0 110.055 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.1 m -83.62 99.28 10.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.278 0.561 . . . . 10.0 110.404 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 171.22 66.25 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 111.321 -0.711 . . . . 10.0 111.321 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.4 m -64.85 151.71 9.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.873 0.368 . . . . 10.0 111.294 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 3.2 m170 -116.04 175.68 5.43 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.775 -0.454 . . . . 10.0 109.775 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.7 m -81.26 -23.74 10.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.136 0.493 . . . . 10.0 110.537 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -145.84 88.12 1.81 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.438 0.637 . . . . 10.0 109.936 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -117.87 23.4 11.7 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.682 -0.69 . . . . 10.0 110.254 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.9 -41.95 97.09 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.487 -0.779 . . . . 10.0 110.62 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pp -64.36 -28.47 69.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.534 -0.757 . . . . 10.0 111.303 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.542 ' O ' ' HG2' ' A' ' 43' ' ' GLN . 1.3 m -68.18 -52.78 30.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.068 -0.514 . . . . 10.0 111.358 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.472 ' HB3' ' C4 ' ' A' ' 201' ' ' 8TL . 4.1 t80 -66.38 -28.92 69.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.889 0.376 . . . . 10.0 110.165 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.63 -40.74 96.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.845 -0.616 . . . . 10.0 110.021 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -72.03 -31.27 66.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 10.0 110.554 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.542 ' HG2' ' O ' ' A' ' 39' ' ' THR . 15.9 mm100 -59.21 -40.1 84.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.703 -0.68 . . . . 10.0 110.573 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 92.2 t -59.68 -40.36 82.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.25 0.547 . . . . 10.0 109.863 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.4 ttpm? -62.89 -37.36 86.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.338 -0.846 . . . . 10.0 111.224 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 49.2 mt -73.76 -43.97 52.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.087 0.47 . . . . 10.0 110.795 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -63.66 -37.37 87.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.85 -0.614 . . . . 10.0 111.046 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -110.36 49.81 0.83 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.344 0.592 . . . . 10.0 110.312 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -81.4 -21.67 61.91 Favored Glycine 0 C--O 1.229 -0.156 0 CA-C-N 115.564 -0.744 . . . . 10.0 112.679 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.9 m -86.54 -33.47 20.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.864 0.364 . . . . 10.0 110.522 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -116.85 100.98 53.67 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.067 -0.515 . . . . 10.0 110.71 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -75.12 -15.33 20.54 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.366 2.044 . . . . 10.0 112.256 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.54 -46.83 86.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.7 -0.682 . . . . 10.0 111.067 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.8 m -67.5 -32.61 73.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.008 -0.542 . . . . 10.0 110.331 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -68.74 -43.88 74.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.12 -0.491 . . . . 10.0 110.073 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -62.6 -39.99 95.49 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.845 -0.616 . . . . 10.0 109.972 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.3 -34.19 88.76 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.681 -0.771 . . . . 10.0 111.696 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -63.0 -39.32 94.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.091 0.472 . . . . 10.0 110.657 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 30.1 mt -64.46 -34.61 78.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.877 -0.601 . . . . 10.0 110.433 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -67.39 -37.12 82.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.684 -0.689 . . . . 10.0 110.713 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.7 mt -64.84 -39.96 87.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.166 0.508 . . . . 10.0 110.065 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.73 -31.25 72.37 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.523 -0.762 . . . . 10.0 110.35 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -62.88 -45.15 93.9 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.049 -0.523 . . . . 10.0 109.856 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -61.0 -35.22 76.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.63 -0.714 . . . . 10.0 110.631 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -70.14 -45.61 66.45 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.799 0.333 . . . . 10.0 110.324 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -67.11 -29.83 69.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.013 0.435 . . . . 10.0 110.932 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.83 -3.34 47.39 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.81 -0.632 . . . . 10.0 110.186 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 63.83 31.26 14.17 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.768 -0.651 . . . . 10.0 111.517 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.6 m -91.02 -20.98 21.5 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.1 -0.5 . . . . 10.0 109.75 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 24.3 pt -134.84 150.99 30.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.838 -0.619 . . . . 10.0 109.55 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -107.37 -164.49 0.98 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.878 -0.415 . . . . 10.0 109.878 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.427 ' HB ' ' HD3' ' A' ' 73' ' ' PRO . 0.6 OUTLIER -49.12 -56.64 14.69 Favored Pre-proline 0 CA--C 1.537 0.472 0 O-C-N 123.619 0.574 . . . . 10.0 112.502 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.427 ' HD3' ' HB ' ' A' ' 72' ' ' THR . 40.8 Cg_endo -66.17 -28.59 48.24 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 121.683 1.589 . . . . 10.0 112.733 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.23 -51.99 29.77 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.839 -0.619 . . . . 10.0 113.069 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.9 p -64.52 -40.88 90.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.801 0.334 . . . . 10.0 111.1 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 91.6 mt -62.37 -45.35 98.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.475 -0.33 . . . . 10.0 110.644 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 77' ' ' ARG . 11.4 ttp180 -61.61 -45.65 93.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.395 -0.366 . . . . 10.0 110.936 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -57.87 -49.33 77.05 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.997 0.427 . . . . 10.0 111.095 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.447 HG21 ' C8 ' ' A' ' 201' ' ' 8TL . 86.2 t -68.36 -34.81 68.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.006 -0.543 . . . . 10.0 111.011 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.9 t -61.83 -30.57 70.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.483 -0.326 . . . . 10.0 111.475 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -82.36 -28.97 31.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.009 0.433 . . . . 10.0 110.698 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 23.2 tp -81.96 -40.99 21.42 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.097 -0.501 . . . . 10.0 111.326 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -97.08 32.24 2.21 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.167 -0.469 . . . . 10.0 110.637 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -65.67 -17.65 64.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.895 0.378 . . . . 10.0 111.749 -179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -88.33 -7.78 56.15 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.014 0.435 . . . . 10.0 110.466 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -134.69 71.64 70.31 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.864 -0.607 . . . . 10.0 109.491 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.38 -27.48 84.93 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.953 2.436 . . . . 10.0 112.746 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.07 -31.26 72.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.239 -0.437 . . . . 10.0 110.871 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 67.7 mt -75.21 -35.67 61.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 10.0 110.67 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 58.3 mt -65.41 -52.79 47.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.944 -0.571 . . . . 10.0 110.48 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.1 t -65.49 -38.98 83.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.052 -0.522 . . . . 10.0 109.706 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.98 -36.16 86.92 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.488 -0.778 . . . . 10.0 111.908 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -64.1 -44.03 93.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.716 0.293 . . . . 10.0 110.387 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -60.47 -42.86 97.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.121 -0.49 . . . . 10.0 110.191 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.31 -22.0 59.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.109 -0.496 . . . . 10.0 111.257 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -83.04 -11.6 57.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.258 -0.428 . . . . 10.0 111.171 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 60.2 mt -69.63 119.47 71.13 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.42 -0.355 . . . . 10.0 110.429 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -67.18 -42.59 7.56 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.642 2.228 . . . . 10.0 112.012 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.2 m -79.82 145.32 32.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.71 -0.677 . . . . 10.0 109.967 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 179.92 -131.92 1.73 Allowed Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.563 -0.615 . . . . 10.0 111.563 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -92.26 17.56 1.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.916 2.411 . . . . 10.0 112.16 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.4 m -82.77 176.57 9.22 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.941 -0.572 . . . . 10.0 111.305 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.48 113.97 3.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.994 -0.548 . . . . 10.0 111.598 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.479 0 C-N-CA 121.036 -0.602 . . . . 10.0 112.391 179.404 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 201' ' ' 8TL . . . . . 0.764 ' C11' ' O3 ' ' A' ' 201' ' ' 8TL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.425 0 N-CA-C 112.438 -0.265 . . . . 10.0 112.438 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.0 m -69.55 125.69 27.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.642 0.258 . . . . 10.0 110.767 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.0 t -79.21 137.27 37.35 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.981 -0.554 . . . . 10.0 110.158 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 137.37 176.76 14.6 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 121.096 -0.574 . . . . 10.0 111.794 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.0 m -152.62 133.77 14.24 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 110.0 -0.371 . . . . 10.0 110.0 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.8 m -105.01 136.08 45.15 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.31 -0.404 . . . . 10.0 110.97 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.92 105.23 2.97 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.637 -0.792 . . . . 10.0 112.207 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 17.0 m -115.45 164.56 11.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 110.12 -0.326 . . . . 10.0 110.12 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -104.3 -175.77 2.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.374 -0.376 . . . . 10.0 110.506 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.5 m -79.9 -4.19 6.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.189 0.518 . . . . 10.0 110.869 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -109.56 25.75 11.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.662 -0.699 . . . . 10.0 110.349 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.0 p-10 -68.07 -26.35 65.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.887 -0.597 . . . . 10.0 111.332 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.36 -51.3 62.91 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.586 0.587 . . . . 10.0 112.586 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.453 ' H ' ' HG ' ' A' ' 38' ' ' LEU . 1.4 pp -80.75 -0.87 40.45 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 122.067 -0.396 . . . . 10.0 111.86 -178.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 m -84.25 -34.99 23.72 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.942 0.401 . . . . 10.0 110.46 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -70.58 -21.92 62.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.342 -0.39 . . . . 10.0 111.214 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.54 -47.23 86.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 10.0 110.814 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -64.62 -35.91 82.55 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.957 -0.565 . . . . 10.0 110.61 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -58.41 -48.42 80.72 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.09 -0.505 . . . . 10.0 110.839 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.2 t -64.08 -35.86 75.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 115.65 -0.704 . . . . 10.0 110.549 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.7 tttm -67.77 -35.97 79.65 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.412 -0.813 . . . . 10.0 111.242 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 94.8 mt -77.16 -43.24 31.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.693 0.282 . . . . 10.0 111.295 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -58.3 -36.93 74.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.417 -0.356 . . . . 10.0 111.282 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -110.93 48.05 0.95 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.342 0.591 . . . . 10.0 109.987 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.47 -29.86 74.52 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.642 -0.708 . . . . 10.0 112.788 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.7 m -101.52 1.82 38.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.877 0.339 . . . . 10.0 111.383 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -124.68 94.55 44.26 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 120.908 0.385 . . . . 10.0 110.344 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -77.63 -11.38 17.02 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.481 2.121 . . . . 10.0 112.325 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.44 -51.55 23.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.215 -0.448 . . . . 10.0 110.919 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.5 m -64.48 -31.66 72.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.397 0.618 . . . . 10.0 110.039 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -66.27 -44.44 83.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.657 -0.702 . . . . 10.0 110.265 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -64.36 -37.5 87.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.509 . . . . 10.0 110.828 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.25 -39.45 97.89 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.71 -0.677 . . . . 10.0 112.891 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -60.75 -38.33 84.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.86 0.362 . . . . 10.0 110.702 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.427 ' O ' ' HG3' ' A' ' 63' ' ' LYS . 67.0 mt -65.89 -37.83 87.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.102 -0.499 . . . . 10.0 110.722 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -62.98 -40.38 97.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.114 0.483 . . . . 10.0 109.928 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.3 mt -62.75 -44.66 99.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.786 -0.643 . . . . 10.0 110.198 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.406 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -61.65 -35.75 78.84 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.691 -0.686 . . . . 10.0 110.773 179.853 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 59' ' ' LEU . 92.8 mttt -60.62 -47.22 87.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.753 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -59.58 -40.58 87.85 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.925 0.393 . . . . 10.0 110.885 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -68.24 -42.03 80.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.295 -0.411 . . . . 10.0 110.649 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 62' ' ' MET . 43.8 mtpt -66.12 -33.05 74.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.432 -0.349 . . . . 10.0 111.107 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.1 m -84.67 3.84 35.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.498 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 60.69 32.69 20.3 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.819 -0.628 . . . . 10.0 111.947 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.2 m -81.44 -25.72 35.91 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.329 0.585 . . . . 10.0 109.576 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 15.6 pt -137.84 164.88 27.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.365 -0.834 . . . . 10.0 109.904 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.35 -165.55 1.02 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.935 -0.395 . . . . 10.0 109.935 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.417 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 2.3 m -51.97 -55.57 29.47 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 112.502 0.556 . . . . 10.0 112.502 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 72' ' ' THR . 24.6 Cg_endo -62.35 -22.23 73.8 Favored 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 121.908 1.739 . . . . 10.0 112.59 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -83.26 -44.78 6.85 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.757 -0.735 . . . . 10.0 111.904 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.511 HG22 ' C9 ' ' A' ' 201' ' ' 8TL . 2.5 p -64.79 -34.69 71.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-O 120.817 0.342 . . . . 10.0 110.921 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 77.5 mt -70.11 -41.57 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 110.063 -0.347 . . . . 10.0 110.063 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 26.3 ttp180 -63.62 -40.11 96.06 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.339 -0.391 . . . . 10.0 110.253 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.6 mmt180 -57.76 -43.9 85.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.397 0.618 . . . . 10.0 110.18 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.62 HG21 ' C8 ' ' A' ' 201' ' ' 8TL . 45.9 t -72.9 -29.51 29.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.461 -0.79 . . . . 10.0 111.082 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.404 ' HA ' HD13 ' A' ' 90' ' ' ILE . 69.7 m -61.08 -29.87 70.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.079 0.466 . . . . 10.0 110.785 179.154 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.8 mm-40 -87.82 -26.77 22.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.917 -0.583 . . . . 10.0 110.45 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 29.5 tp -76.53 -53.6 7.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.031 -0.531 . . . . 10.0 110.284 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 18.9 m-30 -93.11 45.27 1.17 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.953 0.406 . . . . 10.0 110.447 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 19.7 p-80 -68.35 -13.01 61.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.035 -0.529 . . . . 10.0 110.948 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -102.99 -10.89 18.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.009 -0.541 . . . . 10.0 110.761 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -133.36 79.53 60.57 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 120.737 0.303 . . . . 10.0 110.855 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.462 ' O ' HG23 ' A' ' 91' ' ' VAL . 18.1 Cg_endo -61.55 -31.47 87.35 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.741 2.294 . . . . 10.0 111.981 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -60.6 -31.81 70.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.744 -0.662 . . . . 10.0 110.987 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.2 mt -74.48 -25.33 59.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.031 -0.532 . . . . 10.0 111.162 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.404 HD13 ' HA ' ' A' ' 80' ' ' SER . 46.1 mt -80.73 -44.56 21.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.125 -0.489 . . . . 10.0 110.023 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 87' ' ' PRO . 17.4 t -67.87 -31.1 50.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.83 -0.623 . . . . 10.0 110.288 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.22 -39.4 97.64 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.805 -0.712 . . . . 10.0 111.759 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.482 ' CZ ' HD21 ' A' ' 97' ' ' LEU . 59.2 t80 -64.28 -36.44 84.13 Favored 'General case' 0 C--O 1.227 -0.117 0 CA-C-O 121.007 0.432 . . . . 10.0 110.216 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -62.63 -27.88 69.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.816 -0.629 . . . . 10.0 110.756 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -93.16 -19.96 20.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.287 -0.415 . . . . 10.0 111.149 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -97.26 44.5 1.05 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.299 -0.41 . . . . 10.0 110.643 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.482 HD21 ' CZ ' ' A' ' 93' ' ' PHE . 40.9 mt -113.01 102.92 55.48 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.083 -0.508 . . . . 10.0 110.444 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -62.19 -42.92 26.23 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.37 2.047 . . . . 10.0 111.873 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.7 94.53 7.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.921 -0.581 . . . . 10.0 110.039 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -134.31 -151.15 6.33 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.559 -0.829 . . . . 10.0 112.55 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -83.11 25.22 0.69 Allowed 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 122.939 2.426 . . . . 10.0 112.385 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.89 171.77 14.72 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.938 -0.574 . . . . 10.0 111.106 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.5 m -61.38 125.44 23.79 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.049 0.452 . . . . 10.0 111.171 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.652 0 C-N-CA 120.814 -0.708 . . . . 10.0 111.806 -179.951 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 201' ' ' 8TL . . . . . 0.783 ' C11' ' O3 ' ' A' ' 201' ' ' 8TL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.423 0 N-CA-C 112.223 -0.351 . . . . 10.0 112.223 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 m -124.8 124.12 41.44 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.591 0.234 . . . . 10.0 110.393 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.1 156.68 33.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.991 -0.55 . . . . 10.0 110.59 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.09 85.26 0.52 Allowed Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.534 -0.841 . . . . 10.0 112.465 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.2 m -73.09 114.97 11.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.866 0.365 . . . . 10.0 110.222 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.0 m -106.43 127.07 53.01 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.227 -0.442 . . . . 10.0 110.628 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.07 55.12 0.1 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.72 -0.753 . . . . 10.0 111.996 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.8 m -68.78 155.02 7.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-O 121.154 0.502 . . . . 10.0 111.351 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -99.07 -176.14 3.23 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.201 -0.454 . . . . 10.0 110.571 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.0 m -65.33 -20.11 26.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 121.197 0.522 . . . . 10.0 110.673 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -102.6 56.75 0.78 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.285 0.564 . . . . 10.0 109.812 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -90.44 -12.23 38.04 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.53 -0.759 . . . . 10.0 111.23 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.2 -48.7 80.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.609 -0.723 . . . . 10.0 111.355 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 pp -71.2 -22.5 62.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.161 -0.472 . . . . 10.0 111.993 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.506 ' O ' ' HG2' ' A' ' 43' ' ' GLN . 1.1 m -65.45 -60.1 3.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.356 -0.384 . . . . 10.0 111.421 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -67.4 -27.94 67.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.639 -0.255 . . . . 10.0 111.244 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -58.39 -35.24 71.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.281 -0.418 . . . . 10.0 111.511 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -91.06 -24.61 19.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.394 -0.366 . . . . 10.0 111.44 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.506 ' HG2' ' O ' ' A' ' 39' ' ' THR . 15.9 mm100 -56.47 -36.12 68.72 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.905 0.383 . . . . 10.0 110.856 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.535 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 11.0 t -66.7 -36.84 78.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 10.0 110.615 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.7 ttpm? -65.91 -35.4 80.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.886 -0.597 . . . . 10.0 110.449 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 46.0 mt -74.61 -40.92 48.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.717 -0.674 . . . . 10.0 109.98 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 -63.23 -51.76 64.92 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.345 -0.843 . . . . 10.0 111.514 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -102.35 54.03 0.79 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.282 0.563 . . . . 10.0 110.433 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.74 -41.28 89.3 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.701 -0.681 . . . . 10.0 112.874 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.3 m -92.96 7.93 41.95 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.842 0.321 . . . . 10.0 111.583 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -129.14 89.07 49.38 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.86 0.362 . . . . 10.0 111.241 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.9 -17.66 17.47 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.218 1.946 . . . . 10.0 112.311 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.83 -54.8 22.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.959 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.6 m -69.04 -27.51 65.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.024 0.44 . . . . 10.0 111.049 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -70.19 -41.99 72.99 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.858 0.361 . . . . 10.0 110.677 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -62.57 -42.11 99.35 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.201 -0.454 . . . . 10.0 110.322 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.12 -33.23 86.69 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.933 -0.651 . . . . 10.0 111.723 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.535 ' CZ ' HG21 ' A' ' 44' ' ' VAL . 88.4 t80 -62.2 -37.02 83.71 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.071 0.462 . . . . 10.0 110.07 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 22.7 mt -72.3 -35.87 68.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.68 -0.691 . . . . 10.0 110.901 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -62.04 -34.86 77.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.925 -0.58 . . . . 10.0 111.071 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.4 mt -66.22 -34.31 69.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.114 -0.493 . . . . 10.0 110.959 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.5 mtp -64.5 -33.79 76.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.371 -0.377 . . . . 10.0 110.52 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -61.64 -37.56 84.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.973 -0.558 . . . . 10.0 110.615 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -64.23 -37.92 89.2 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.111 -0.495 . . . . 10.0 110.808 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -78.6 -42.3 29.36 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.728 -0.389 . . . . 10.0 111.15 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -63.25 -34.33 77.44 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.589 -0.278 . . . . 10.0 111.661 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.9 m -84.22 5.38 26.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.733 0.301 . . . . 10.0 111.117 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 63.7 31.92 14.08 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.974 -0.557 . . . . 10.0 111.736 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.4 m -87.71 -48.29 7.98 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.999 0.428 . . . . 10.0 110.303 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 47.9 pt -104.72 146.43 11.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 110.03 -0.359 . . . . 10.0 110.03 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -99.48 -175.54 3.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.802 -0.636 . . . . 10.0 109.956 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.527 ' O ' HG12 ' A' ' 75' ' ' VAL . 0.9 OUTLIER -55.08 -54.09 54.13 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 111.707 0.262 . . . . 10.0 111.707 -179.77 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 72' ' ' THR . 24.2 Cg_endo -63.26 -24.71 72.1 Favored 'Trans proline' 0 C--N 1.358 1.067 0 C-N-CA 121.833 1.689 . . . . 10.0 112.324 178.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.85 -39.26 28.99 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.018 -0.61 . . . . 10.0 112.679 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.53 ' O ' HG23 ' A' ' 79' ' ' VAL . 4.9 p -68.71 -29.86 45.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 O-C-N 122.715 -0.285 . . . . 10.0 111.105 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 72' ' ' THR . 68.0 mt -59.86 -41.37 85.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-O 120.912 0.387 . . . . 10.0 110.052 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -62.13 -40.03 94.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.753 -0.658 . . . . 10.0 109.71 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.2 mmt180 -63.22 -44.89 93.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.754 -0.657 . . . . 10.0 110.739 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 75' ' ' VAL . 47.4 t -61.84 -46.3 96.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.758 -0.655 . . . . 10.0 110.855 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.49 ' HA ' HD13 ' A' ' 90' ' ' ILE . 8.9 m -65.59 -24.32 67.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.893 -0.594 . . . . 10.0 111.661 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -87.43 -24.53 24.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.748 0.309 . . . . 10.0 111.023 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 14.8 tp -86.0 -45.54 11.35 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.08 0.467 . . . . 10.0 110.418 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -103.82 43.77 1.07 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.739 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -63.6 -20.12 65.4 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.001 -0.545 . . . . 10.0 111.491 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -101.36 -0.21 35.91 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.962 0.411 . . . . 10.0 110.613 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -135.27 77.05 55.46 Favored Pre-proline 0 C--O 1.236 0.38 0 CA-C-N 116.246 -0.434 . . . . 10.0 110.208 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.92 -29.25 87.7 Favored 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.301 2.001 . . . . 10.0 112.631 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -62.85 -37.58 87.4 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 116.115 -0.493 . . . . 10.0 110.667 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.1 mt -66.15 -41.34 90.55 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.144 -0.48 . . . . 10.0 110.545 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.49 HD13 ' HA ' ' A' ' 80' ' ' SER . 18.2 mt -66.02 -46.07 89.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.031 -0.532 . . . . 10.0 109.983 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 73.8 t -62.38 -43.91 98.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.637 -0.711 . . . . 10.0 110.383 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.93 -40.62 99.11 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.685 -0.689 . . . . 10.0 112.235 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -66.14 -43.18 87.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.706 0.289 . . . . 10.0 110.726 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -61.79 -32.76 73.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.929 0.395 . . . . 10.0 111.36 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.23 -25.06 27.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.821 0.343 . . . . 10.0 111.365 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.45 -31.59 72.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.014 -0.539 . . . . 10.0 111.511 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 36.4 mt -58.16 115.62 11.94 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.526 -0.306 . . . . 10.0 111.688 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -82.25 -24.82 3.59 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.689 2.259 . . . . 10.0 112.125 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.4 m -91.41 99.82 12.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.157 -0.474 . . . . 10.0 110.58 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -151.55 -115.27 0.66 Allowed Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.955 -0.858 . . . . 10.0 110.955 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -82.32 6.86 5.46 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.407 2.071 . . . . 10.0 111.201 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.33 154.44 23.93 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.408 -0.815 . . . . 10.0 111.765 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.45 126.12 29.07 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.74 -0.664 . . . . 10.0 110.173 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 C-N-CA 120.768 -0.729 . . . . 10.0 112.463 179.682 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 201' ' ' 8TL . . . . . 0.774 ' C11' ' O3 ' ' A' ' 201' ' ' 8TL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.498 0 N-CA-C 112.093 -0.403 . . . . 10.0 112.093 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.23 140.47 23.13 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.039 -0.356 . . . . 10.0 110.039 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.0 m -74.42 145.18 43.91 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.712 0.291 . . . . 10.0 110.43 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 151.33 151.49 5.61 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.811 -0.709 . . . . 10.0 112.186 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 56.3 m -151.41 85.57 1.33 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.028 0.442 . . . . 10.0 110.258 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.9 m -67.39 148.39 51.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.985 -0.552 . . . . 10.0 111.224 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.49 83.34 1.56 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.742 -0.742 . . . . 10.0 112.42 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 29.5 m -108.14 156.23 8.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 110.159 -0.312 . . . . 10.0 110.159 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -102.35 -177.77 3.5 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.344 -0.389 . . . . 10.0 110.203 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.2 m -65.19 -27.1 41.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.812 0.339 . . . . 10.0 111.485 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -99.53 93.41 5.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.465 -0.334 . . . . 10.0 110.396 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -107.09 -11.56 15.61 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.348 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.09 -50.76 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.649 -0.705 . . . . 10.0 112.404 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.12 -10.99 60.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.129 -0.487 . . . . 10.0 112.052 -178.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.54 -58.46 2.52 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.049 0.452 . . . . 10.0 111.695 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.513 ' O ' HG23 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -67.88 -30.78 70.22 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.896 0.702 . . . . 10.0 112.896 -177.633 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.1 -38.83 73.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.749 0.309 . . . . 10.0 111.59 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -78.92 -35.49 43.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.83 0.348 . . . . 10.0 110.642 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -57.72 -39.9 78.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.981 -0.554 . . . . 10.0 111.383 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 40' ' ' TYR . 26.8 t -65.44 -37.11 79.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.077 0.465 . . . . 10.0 110.207 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.1 ttpm? -69.15 -33.26 73.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.638 -0.71 . . . . 10.0 110.634 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 62.8 mt -73.59 -43.07 55.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.855 -0.612 . . . . 10.0 110.224 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -65.74 -42.24 91.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.864 -0.607 . . . . 10.0 111.203 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -107.4 58.94 0.62 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.33 0.586 . . . . 10.0 110.57 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.62 -43.78 9.94 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.457 -0.792 . . . . 10.0 111.938 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 39.3 m -85.21 -11.05 55.83 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.861 0.362 . . . . 10.0 110.838 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -114.66 92.74 30.35 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.149 -0.478 . . . . 10.0 110.824 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -76.42 -15.84 17.49 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.233 1.956 . . . . 10.0 111.757 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.32 -54.49 32.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.507 -0.77 . . . . 10.0 111.634 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.7 m -65.95 -34.0 77.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.402 -0.363 . . . . 10.0 111.0 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -65.34 -44.23 88.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 10.0 110.719 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -64.6 -41.8 95.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.169 -0.469 . . . . 10.0 110.569 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.61 -39.09 96.91 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 115.948 -0.569 . . . . 10.0 112.09 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -57.98 -40.61 81.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.146 0.498 . . . . 10.0 110.463 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 27.3 mt -71.7 -30.01 65.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.791 -0.641 . . . . 10.0 111.127 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -68.93 -38.65 79.64 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.022 0.439 . . . . 10.0 110.876 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.482 HD13 ' HB3' ' A' ' 78' ' ' ARG . 42.1 mt -67.74 -30.84 49.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.784 -0.644 . . . . 10.0 110.606 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 33.1 mmt -64.94 -28.11 69.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.181 -0.463 . . . . 10.0 110.588 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -63.08 -41.26 99.37 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.154 -0.476 . . . . 10.0 110.26 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -65.31 -42.25 93.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.761 -0.654 . . . . 10.0 110.487 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -65.15 -42.59 93.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.112 -0.495 . . . . 10.0 110.634 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -67.82 -18.56 64.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.89 0.376 . . . . 10.0 111.054 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.1 m -95.92 2.19 53.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.067 -0.515 . . . . 10.0 110.453 178.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 64.79 23.05 12.65 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.714 -0.676 . . . . 10.0 110.758 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.2 m -77.74 -29.34 51.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.508 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 37.8 pt -128.48 153.37 37.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 10.0 111.008 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -105.3 -164.35 1.02 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.902 -0.59 . . . . 10.0 110.432 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.477 ' HB ' ' HD3' ' A' ' 73' ' ' PRO . 24.5 m -55.05 -56.48 27.52 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-N 116.502 -0.317 . . . . 10.0 111.212 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.477 ' HD3' ' HB ' ' A' ' 72' ' ' THR . 36.8 Cg_endo -66.41 -21.77 53.24 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 121.647 1.565 . . . . 10.0 111.822 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.07 -48.15 73.96 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.616 -0.72 . . . . 10.0 112.077 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.461 ' O ' HG23 ' A' ' 79' ' ' VAL . 9.5 p -72.77 -31.88 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 120.882 -0.327 . . . . 10.0 110.161 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 47.0 mt -59.95 -40.82 84.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 109.7 -0.482 . . . . 10.0 109.7 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 30.0 ttp180 -59.28 -42.32 90.97 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.112 -0.699 . . . . 10.0 109.112 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.482 ' HB3' HD13 ' A' ' 61' ' ' ILE . 12.2 mmt180 -67.4 -45.73 75.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.376 -0.829 . . . . 10.0 110.439 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 75' ' ' VAL . 62.7 t -55.64 -43.41 73.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.973 -0.558 . . . . 10.0 111.239 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.9 m -64.69 -30.33 71.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.036 -0.529 . . . . 10.0 112.006 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -87.93 -36.26 17.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.695 0.283 . . . . 10.0 111.381 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 24.1 tp -73.55 -54.14 8.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.92 0.391 . . . . 10.0 111.056 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -91.29 38.9 0.98 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.382 0.611 . . . . 10.0 109.651 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -59.38 -34.39 72.37 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.299 -0.864 . . . . 10.0 112.57 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -94.19 7.0 46.86 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.499 0.185 . . . . 10.0 111.499 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -133.59 72.48 74.03 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-O 120.754 0.311 . . . . 10.0 110.25 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.476 ' O ' HG23 ' A' ' 91' ' ' VAL . 33.4 Cg_exo -60.44 -32.78 94.23 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.026 2.484 . . . . 10.0 111.939 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -58.28 -38.4 76.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.591 -0.731 . . . . 10.0 110.433 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 60.1 mt -73.58 -31.69 63.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.915 -0.584 . . . . 10.0 111.306 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.0 mt -68.88 -45.53 80.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.12 0.486 . . . . 10.0 110.107 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 87' ' ' PRO . 19.4 t -69.34 -35.11 65.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.753 -0.658 . . . . 10.0 110.326 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.39 -46.39 94.42 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.787 -0.72 . . . . 10.0 112.47 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.445 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 64.2 t80 -62.01 -32.11 72.56 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.761 0.315 . . . . 10.0 111.18 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -61.37 -38.03 85.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.099 -0.501 . . . . 10.0 111.781 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.38 -8.25 32.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.895 0.378 . . . . 10.0 111.657 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.46 -19.69 35.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.823 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 93' ' ' PHE . 86.9 mt -58.02 121.66 52.32 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.939 -0.573 . . . . 10.0 111.533 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -77.57 -13.63 16.36 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.708 2.272 . . . . 10.0 112.451 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.7 m -106.45 110.77 23.08 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.336 -0.393 . . . . 10.0 110.651 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -142.05 -146.66 4.7 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.694 -0.765 . . . . 10.0 111.671 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -74.25 -5.99 17.76 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.635 2.223 . . . . 10.0 112.549 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 m -66.92 153.47 43.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.857 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.2 t -59.22 128.83 39.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.243 -0.435 . . . . 10.0 110.556 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.419 0 C-N-CA 120.435 -0.888 . . . . 10.0 112.351 -179.893 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 201' ' ' 8TL . . . . . 0.76 ' C11' ' O3 ' ' A' ' 201' ' ' 8TL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 109.854 -0.424 . . . . 10.0 109.854 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.2 m -92.59 157.73 16.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.461 -0.336 . . . . 10.0 110.637 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.2 82.67 1.12 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.95 -0.643 . . . . 10.0 113.142 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.6 m -88.75 173.37 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.906 -0.405 . . . . 10.0 109.906 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -95.6 176.77 6.03 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.74 -0.209 . . . . 10.0 110.678 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.5 m -67.22 -23.41 30.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-O 120.881 0.372 . . . . 10.0 111.43 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -133.1 87.9 2.45 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.445 -0.576 . . . . 10.0 109.445 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -93.58 13.78 20.9 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.677 -0.692 . . . . 10.0 110.857 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.96 -42.79 94.28 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.767 -0.651 . . . . 10.0 111.412 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.05 -25.8 62.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.257 -0.428 . . . . 10.0 111.526 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.4 m -61.24 -60.35 3.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.22 -0.445 . . . . 10.0 111.519 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -66.22 -31.88 72.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.35 -0.386 . . . . 10.0 111.168 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.09 -52.72 62.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.426 . . . . 10.0 111.48 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -74.74 -27.17 60.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.302 -0.408 . . . . 10.0 111.272 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -58.18 -38.89 77.56 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.251 -0.431 . . . . 10.0 111.662 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.2 t -62.77 -34.83 67.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.122 0.487 . . . . 10.0 110.632 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.7 ttpm? -70.41 -34.74 72.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.857 -0.611 . . . . 10.0 110.762 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 35.1 mt -76.75 -35.57 25.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.701 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -71.21 -43.38 67.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.209 -0.45 . . . . 10.0 111.104 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -106.94 44.18 1.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.184 0.516 . . . . 10.0 110.901 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.55 -30.75 78.18 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.882 -0.675 . . . . 10.0 112.291 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.1 m -92.73 -6.28 49.43 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 122.759 -0.26 . . . . 10.0 111.304 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -123.13 85.03 51.3 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 120.794 0.33 . . . . 10.0 110.847 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.42 -26.32 41.01 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.479 2.119 . . . . 10.0 112.812 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.79 -44.48 93.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.653 -0.249 . . . . 10.0 111.087 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.2 m -65.88 -40.79 91.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.063 -0.517 . . . . 10.0 111.034 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -69.06 -37.73 78.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.547 -0.297 . . . . 10.0 110.835 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -61.23 -43.22 99.23 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.856 0.36 . . . . 10.0 110.616 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.96 -37.82 95.18 Favored Glycine 0 C--N 1.332 0.33 0 N-CA-C 111.529 -0.628 . . . . 10.0 111.529 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -57.51 -42.21 82.36 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.974 0.416 . . . . 10.0 110.181 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 26.6 mt -67.12 -38.04 84.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.811 -0.631 . . . . 10.0 110.887 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -61.61 -44.28 97.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.28 -0.418 . . . . 10.0 110.704 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.9 mt -63.7 -35.78 74.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.306 -0.406 . . . . 10.0 110.304 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 82.6 mtp -64.01 -37.11 86.21 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.106 -0.497 . . . . 10.0 110.219 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -62.53 -37.42 86.0 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.008 -0.542 . . . . 10.0 111.153 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -63.45 -36.58 84.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.09 0.471 . . . . 10.0 110.094 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -73.33 -35.63 66.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.048 -0.524 . . . . 10.0 109.747 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -66.73 -23.96 66.17 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.117 -0.492 . . . . 10.0 110.45 178.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.0 m -94.35 2.74 55.8 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.92 -0.582 . . . . 10.0 110.131 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 56.85 31.63 19.95 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.648 -0.706 . . . . 10.0 111.294 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.7 m -82.2 -22.18 36.07 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.563 0.697 . . . . 10.0 109.846 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 17.6 pt -131.99 158.47 43.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.264 -0.88 . . . . 10.0 109.965 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -110.0 -162.46 0.8 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.557 -0.534 . . . . 10.0 109.557 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.483 ' HB ' ' CD ' ' A' ' 73' ' ' PRO . 1.4 m -56.73 -60.17 10.17 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 116.237 -0.438 . . . . 10.0 111.221 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.483 ' CD ' ' HB ' ' A' ' 72' ' ' THR . 25.1 Cg_endo -61.52 -21.73 72.71 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 121.908 1.739 . . . . 10.0 112.594 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.79 -50.31 11.57 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.931 -0.577 . . . . 10.0 112.674 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.602 ' O ' HG23 ' A' ' 79' ' ' VAL . 14.5 p -65.18 -36.85 78.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.89 0.345 . . . . 10.0 110.898 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.441 HD12 ' HA ' ' A' ' 73' ' ' PRO . 60.5 mt -58.64 -38.99 74.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 116.299 -0.409 . . . . 10.0 111.081 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 -60.87 -39.29 88.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.957 -0.565 . . . . 10.0 110.928 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -69.63 -45.56 68.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.805 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.61 HG12 HG12 ' A' ' 90' ' ' ILE . 13.6 t -61.0 -38.28 79.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.906 -0.588 . . . . 10.0 110.971 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.481 ' HA ' HD13 ' A' ' 90' ' ' ILE . 23.0 m -65.95 -17.38 64.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.469 . . . . 10.0 111.786 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -102.52 -23.84 13.86 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 111.799 0.296 . . . . 10.0 111.799 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 40.3 tp -85.26 -53.08 5.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.929 0.395 . . . . 10.0 110.348 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -94.96 47.61 1.16 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.025 0.44 . . . . 10.0 110.11 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.411 ' CE1' ' HG2' ' A' ' 85' ' ' GLU . 25.8 p80 -66.08 -25.46 67.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.993 -0.549 . . . . 10.0 110.771 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.411 ' HG2' ' CE1' ' A' ' 84' ' ' HIS . 53.0 mm-40 -91.0 -9.54 45.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.114 -0.494 . . . . 10.0 110.583 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -128.97 72.05 81.91 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.289 -0.414 . . . . 10.0 111.214 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -61.8 -26.91 80.0 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.581 2.187 . . . . 10.0 112.587 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -56.27 -38.8 71.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.865 -0.607 . . . . 10.0 111.964 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 97.7 mt -64.36 -42.83 95.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.381 -0.372 . . . . 10.0 111.208 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.61 HG12 HG12 ' A' ' 79' ' ' VAL . 3.3 mt -73.0 -41.01 59.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.088 -0.506 . . . . 10.0 111.03 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.435 ' O ' ' HB2' ' A' ' 94' ' ' ASN . 78.7 t -67.36 -48.35 77.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.973 -0.558 . . . . 10.0 110.597 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.68 -31.19 77.07 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.002 -0.618 . . . . 10.0 112.45 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -63.93 -24.92 67.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.696 0.284 . . . . 10.0 111.17 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' A' ' 91' ' ' VAL . 2.6 m-80 -63.72 -33.68 76.19 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.031 0.443 . . . . 10.0 110.426 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -95.58 -16.68 21.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.211 0.529 . . . . 10.0 110.343 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -89.35 31.57 0.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.809 -0.632 . . . . 10.0 110.46 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.2 mt -121.35 108.48 35.82 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.4 -0.818 . . . . 10.0 109.178 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -59.7 -49.15 10.82 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.393 2.062 . . . . 10.0 111.849 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.49 118.31 10.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.283 -0.417 . . . . 10.0 110.367 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -168.21 -134.92 1.79 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.55 -0.833 . . . . 10.0 112.53 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -82.83 13.41 2.62 Favored 'Trans proline' 0 CA--C 1.529 0.226 0 C-N-CA 122.88 2.387 . . . . 10.0 113.284 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.2 m -73.65 162.58 29.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.709 0.29 . . . . 10.0 110.261 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.6 m -72.7 104.64 4.0 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.926 0.393 . . . . 10.0 110.532 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.457 0 C-N-CA 120.902 -0.666 . . . . 10.0 112.375 179.698 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 65.7 m . . . . . 0 N--CA 1.453 -0.279 0 CA-C-O 121.102 0.477 . . . . 10.0 110.766 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.56 113.58 24.29 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.947 -0.57 . . . . 10.0 109.907 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 155.08 74.22 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.803 -0.713 . . . . 10.0 111.416 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 28.5 m -84.47 156.54 3.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.094 0.473 . . . . 10.0 111.027 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -112.14 -178.55 3.45 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.585 -0.734 . . . . 10.0 109.321 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.405 HG22 ' H ' ' A' ' 34' ' ' VAL . 1.9 m -67.24 -36.27 76.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.721 0.296 . . . . 10.0 111.73 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -115.05 105.72 13.28 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.882 0.372 . . . . 10.0 110.222 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -139.75 3.51 2.06 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.566 0.58 . . . . 10.0 112.566 -178.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.61 -37.73 87.43 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.122 0.487 . . . . 10.0 110.613 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.493 ' H ' ' HG ' ' A' ' 38' ' ' LEU . 0.7 OUTLIER -64.02 -24.07 67.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.536 -0.756 . . . . 10.0 111.51 179.738 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.3 m -68.36 -47.49 67.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.531 -0.304 . . . . 10.0 111.39 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -67.93 -36.56 80.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.922 0.391 . . . . 10.0 110.323 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 59.0 mt -65.08 -28.67 69.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.909 -0.587 . . . . 10.0 110.736 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -76.85 -38.09 54.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.687 -0.688 . . . . 10.0 110.206 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -59.1 -36.4 75.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.769 -0.65 . . . . 10.0 111.168 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 54.0 t -61.1 -40.92 87.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.982 -0.554 . . . . 10.0 110.911 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.1 pttm -71.09 -24.19 62.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.371 -0.377 . . . . 10.0 111.09 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 81.9 mt -78.01 -48.7 22.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 121.014 0.435 . . . . 10.0 110.087 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -63.68 -40.57 97.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.762 -0.653 . . . . 10.0 111.357 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -103.59 40.02 1.5 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.099 0.476 . . . . 10.0 110.428 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -70.82 -29.36 69.43 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.697 -0.763 . . . . 10.0 112.38 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.4 m -81.74 -31.27 32.08 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.407 0.146 . . . . 10.0 111.04 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -113.56 106.67 53.91 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.791 0.329 . . . . 10.0 110.848 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -81.15 -11.62 12.07 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.473 2.115 . . . . 10.0 112.686 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.95 -48.87 64.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.09 -0.504 . . . . 10.0 110.744 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.5 m -66.29 -32.96 74.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 10.0 110.523 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -72.4 -43.3 64.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 10.0 110.241 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -64.55 -37.75 88.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.066 -0.516 . . . . 10.0 110.248 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.65 -26.83 73.65 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.765 -0.652 . . . . 10.0 111.628 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -68.05 -36.81 80.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.267 0.556 . . . . 10.0 109.681 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 60.5 mt -66.06 -36.81 84.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.687 -0.688 . . . . 10.0 110.606 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -66.54 -31.45 72.17 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.064 -0.516 . . . . 10.0 110.788 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.2 mt -65.29 -42.87 94.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.228 0.537 . . . . 10.0 110.577 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.471 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 67.8 mtp -65.8 -33.56 76.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.039 -0.528 . . . . 10.0 110.657 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.39 -34.6 77.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 10.0 111.421 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -67.97 -31.89 71.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.044 0.45 . . . . 10.0 110.566 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -81.13 -29.7 34.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.636 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 62' ' ' MET . 23.7 mtpp -59.0 -41.21 87.13 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.902 0.382 . . . . 10.0 110.771 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.1 m -88.52 8.37 28.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 10.0 110.967 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 58.33 30.57 19.75 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.656 -0.702 . . . . 10.0 111.038 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.3 m -77.14 -24.71 51.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.086 -0.506 . . . . 10.0 110.844 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 36.1 pt -125.31 162.87 27.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.114 -0.494 . . . . 10.0 110.121 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -112.22 -172.4 2.04 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.939 -0.573 . . . . 10.0 110.055 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.609 ' O ' HG12 ' A' ' 75' ' ' VAL . 2.1 m -54.7 -54.39 49.78 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 116.362 -0.381 . . . . 10.0 111.841 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 72' ' ' THR . 28.7 Cg_endo -63.26 -26.12 72.0 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 121.793 1.662 . . . . 10.0 111.994 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.73 -41.93 72.63 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.759 -0.655 . . . . 10.0 112.571 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.609 HG12 ' O ' ' A' ' 72' ' ' THR . 4.2 p -65.51 -29.95 48.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 120.704 0.287 . . . . 10.0 110.372 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 63.6 mt -63.07 -42.73 97.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 10.0 110.209 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -62.02 -40.06 94.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.533 -0.758 . . . . 10.0 109.934 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -66.63 -46.76 74.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.943 -0.572 . . . . 10.0 110.957 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.1 t -66.3 -43.99 91.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.216 -0.447 . . . . 10.0 111.107 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.554 ' HA ' HD13 ' A' ' 90' ' ' ILE . 0.4 OUTLIER -60.57 -37.98 83.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.122 -0.49 . . . . 10.0 111.196 -179.506 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -79.3 -27.09 42.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.708 -0.223 . . . . 10.0 111.363 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 35.5 tp -76.22 -51.94 11.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.879 0.371 . . . . 10.0 110.346 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 -91.5 48.74 1.5 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.206 0.527 . . . . 10.0 110.212 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -68.7 -8.99 47.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.82 -0.627 . . . . 10.0 111.766 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -110.23 -12.03 14.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.836 0.351 . . . . 10.0 111.047 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -130.46 80.87 69.43 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.385 -0.37 . . . . 10.0 111.001 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -62.31 -28.95 79.23 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.597 2.198 . . . . 10.0 112.298 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -58.5 -36.72 74.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.599 -0.728 . . . . 10.0 111.468 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 95.7 mt -75.72 -30.25 59.2 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.408 -0.36 . . . . 10.0 111.125 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.554 HD13 ' HA ' ' A' ' 80' ' ' SER . 45.4 mt -69.05 -46.17 78.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.347 0.594 . . . . 10.0 109.459 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.411 ' O ' ' HB2' ' A' ' 94' ' ' ASN . 46.3 t -70.11 -37.33 71.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.318 -0.855 . . . . 10.0 109.751 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.32 -40.63 94.31 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.748 -0.66 . . . . 10.0 112.189 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -60.25 -28.91 68.42 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.754 0.311 . . . . 10.0 110.747 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' A' ' 91' ' ' VAL . 28.4 m-80 -69.78 -17.73 63.44 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.44 -0.345 . . . . 10.0 110.662 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.78 -3.47 24.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.89 0.376 . . . . 10.0 111.024 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -112.86 20.19 16.66 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.064 0.459 . . . . 10.0 110.842 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 17.5 mt -80.22 116.15 59.53 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.815 -0.629 . . . . 10.0 109.831 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.32 -18.41 30.06 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.38 2.054 . . . . 10.0 112.74 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.71 158.27 30.47 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.867 -0.42 . . . . 10.0 109.867 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 169.77 -134.32 3.13 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 121.007 -0.616 . . . . 10.0 111.624 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.57 -9.48 18.58 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.755 2.304 . . . . 10.0 111.533 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 m -66.23 152.11 45.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.673 -0.694 . . . . 10.0 111.373 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.56 133.81 55.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.905 -0.589 . . . . 10.0 111.081 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.222 0 CA-C-N 115.967 -0.56 . . . . 10.0 112.463 179.425 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.1 m . . . . . 0 C--O 1.234 0.248 0 CA-C-O 120.901 0.381 . . . . 10.0 110.78 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.4 m -90.56 150.79 21.6 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.76 0.314 . . . . 10.0 110.425 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.88 91.74 2.22 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.695 -0.764 . . . . 10.0 111.643 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.7 m -91.69 164.57 2.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.654 0.264 . . . . 10.0 110.762 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -119.36 177.05 5.05 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.282 -0.417 . . . . 10.0 110.209 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.3 m -81.98 -12.7 12.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.919 0.39 . . . . 10.0 110.856 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -139.95 87.64 2.17 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.185 -0.461 . . . . 10.0 110.111 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.2 p30 -128.61 12.02 6.31 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.25 -0.432 . . . . 10.0 111.037 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.91 -44.69 96.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.261 0.553 . . . . 10.0 111.072 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.541 HD23 ' H ' ' A' ' 38' ' ' LEU . 1.8 pt? -63.24 -31.41 72.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.519 -0.764 . . . . 10.0 111.002 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 m -62.05 -51.42 68.06 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.086 -0.506 . . . . 10.0 111.191 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -70.01 -30.04 67.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.449 -0.341 . . . . 10.0 110.626 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.48 -34.89 78.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.965 0.412 . . . . 10.0 110.528 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -73.87 -32.58 63.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.296 -0.411 . . . . 10.0 110.185 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -60.16 -38.63 83.76 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.092 -0.503 . . . . 10.0 109.782 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 92.9 t -60.35 -39.43 80.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.657 -0.702 . . . . 10.0 109.7 178.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.8 ttpm? -67.04 -38.0 85.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.226 -0.897 . . . . 10.0 110.748 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 57.7 mt -71.0 -43.78 76.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.287 -0.415 . . . . 10.0 110.33 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -62.12 -36.49 81.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 10.0 111.231 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -101.94 36.36 2.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.058 0.456 . . . . 10.0 111.284 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.81 -36.3 89.46 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.855 -0.612 . . . . 10.0 111.984 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.0 m -101.69 13.36 35.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.603 0.24 . . . . 10.0 111.087 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -142.04 74.93 21.18 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.949 0.404 . . . . 10.0 110.752 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -63.71 -26.89 68.36 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.594 2.196 . . . . 10.0 112.476 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.12 -50.03 73.51 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.761 0.315 . . . . 10.0 110.989 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.9 m -63.03 -38.36 90.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.301 -0.409 . . . . 10.0 110.682 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -69.43 -40.11 77.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.412 -0.358 . . . . 10.0 110.791 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -64.65 -41.42 96.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.366 -0.379 . . . . 10.0 110.295 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.83 -27.96 72.77 Favored Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.886 -0.597 . . . . 10.0 111.788 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -64.47 -42.29 95.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.964 0.412 . . . . 10.0 110.393 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.9 mt -64.15 -29.84 70.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.981 -0.554 . . . . 10.0 110.613 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -68.81 -34.2 75.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 10.0 110.259 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.8 mt -67.88 -36.01 74.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.964 -0.562 . . . . 10.0 109.621 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.76 -31.46 72.64 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.591 -0.732 . . . . 10.0 110.156 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -62.36 -39.57 93.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.066 -0.516 . . . . 10.0 111.32 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -63.84 -37.18 86.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.171 -0.468 . . . . 10.0 110.453 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -74.79 -36.5 62.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.123 -0.49 . . . . 10.0 110.474 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -64.28 -41.02 97.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.312 -0.404 . . . . 10.0 110.9 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.7 m -81.8 0.24 40.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.388 -0.369 . . . . 10.0 110.918 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 61.32 32.06 19.24 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.688 -0.687 . . . . 10.0 111.95 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.1 m -78.15 -24.18 47.42 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.193 -0.669 . . . . 10.0 109.193 178.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 45.6 pt -135.91 -179.06 2.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.16 -0.927 . . . . 10.0 109.314 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -136.3 -151.2 0.4 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.927 -0.397 . . . . 10.0 109.927 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.459 ' HB ' ' HD3' ' A' ' 73' ' ' PRO . 7.1 m -55.72 -57.81 19.29 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 113.167 0.803 . . . . 10.0 113.167 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.459 ' HD3' ' HB ' ' A' ' 72' ' ' THR . 18.8 Cg_endo -61.15 -38.42 67.05 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 121.832 1.688 . . . . 10.0 112.964 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.56 -45.35 93.3 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 116.129 -0.487 . . . . 10.0 113.386 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.45 -39.5 82.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.768 -0.373 . . . . 10.0 111.303 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 81.4 mt -65.57 -43.87 94.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.797 0.332 . . . . 10.0 110.113 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 34.9 ttp-105 -61.58 -37.51 84.14 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.138 -0.483 . . . . 10.0 110.814 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.68 -50.26 58.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.151 -0.477 . . . . 10.0 110.888 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 94.5 t -66.39 -30.95 51.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.111 -0.495 . . . . 10.0 111.869 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 71.0 m -61.19 -27.89 68.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.002 0.429 . . . . 10.0 110.751 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -85.81 -28.97 24.15 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.826 -0.624 . . . . 10.0 110.374 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 25.9 tp -75.67 -45.48 36.78 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.87 -0.604 . . . . 10.0 109.842 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 6.1 m-30 -90.89 41.9 1.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.855 -0.611 . . . . 10.0 109.959 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -65.32 -21.18 66.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.483 -0.326 . . . . 10.0 111.678 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -103.83 5.64 36.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.962 0.411 . . . . 10.0 110.508 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -134.96 69.73 70.74 Favored Pre-proline 0 C--O 1.235 0.341 0 CA-C-N 116.413 -0.358 . . . . 10.0 110.923 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -62.16 -29.74 81.17 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.255 1.97 . . . . 10.0 112.2 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.49 -46.68 83.45 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.009 -0.541 . . . . 10.0 110.703 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 81.0 mt -64.25 -36.29 83.62 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.407 -0.815 . . . . 10.0 111.394 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 94.2 mt -62.57 -47.28 93.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.894 0.378 . . . . 10.0 110.458 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 43.2 t -70.05 -42.72 79.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.293 -0.412 . . . . 10.0 110.649 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.78 -43.84 97.54 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.956 -0.566 . . . . 10.0 112.761 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -62.26 -34.59 76.83 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.699 0.285 . . . . 10.0 111.367 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 -58.59 -38.55 78.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 10.0 111.03 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -91.47 -19.87 22.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.307 -0.406 . . . . 10.0 111.62 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -69.91 -35.32 74.51 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.674 0.274 . . . . 10.0 111.042 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 97' ' ' LEU . 9.3 mt -72.01 126.59 91.24 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 120.848 0.356 . . . . 10.0 111.339 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.72 -18.79 11.65 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.829 2.353 . . . . 10.0 111.984 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.42 130.74 43.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.798 -0.637 . . . . 10.0 111.025 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 161.65 -128.26 1.88 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.094 -0.575 . . . . 10.0 111.758 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -89.35 24.8 0.64 Allowed 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.788 2.325 . . . . 10.0 111.99 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.08 166.99 21.15 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.519 -0.764 . . . . 10.0 111.651 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.17 109.27 1.26 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.823 -0.626 . . . . 10.0 111.024 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.486 0 C-N-CA 120.472 -0.871 . . . . 10.0 112.582 179.596 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.2 m . . . . . 0 N--CA 1.452 -0.35 0 CA-C-O 121.239 0.542 . . . . 10.0 110.493 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.6 m -78.26 147.17 34.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.814 -0.63 . . . . 10.0 110.649 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.08 78.96 0.75 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.826 -0.702 . . . . 10.0 111.486 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.4 m -87.93 160.01 2.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.214 0.531 . . . . 10.0 110.97 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -112.9 174.84 5.7 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.95 -0.568 . . . . 10.0 110.193 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.2 m -68.04 -32.57 56.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.166 0.508 . . . . 10.0 109.826 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -113.07 80.47 1.36 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.27 -0.877 . . . . 10.0 109.211 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -123.83 2.4 8.78 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.035 -0.529 . . . . 10.0 111.547 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.51 -49.8 76.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.375 0.607 . . . . 10.0 111.001 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -66.69 -9.33 35.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.607 -0.724 . . . . 10.0 111.833 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.9 m -72.57 -37.44 68.2 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.58 0.228 . . . . 10.0 111.031 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -74.39 -29.55 61.58 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.788 -0.365 . . . . 10.0 110.615 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -58.0 -43.87 86.86 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.767 -0.457 . . . . 10.0 109.767 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.408 ' O ' HG13 ' A' ' 46' ' ' ILE . 36.6 t70 -64.77 -41.88 95.53 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.696 -0.683 . . . . 10.0 110.81 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -61.19 -38.22 85.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.812 -0.631 . . . . 10.0 111.006 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.62 -40.98 89.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.57 -0.53 . . . . 10.0 109.57 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.06 -29.15 68.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.727 -0.67 . . . . 10.0 110.862 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 42' ' ' ASP . 80.6 mt -75.13 -47.25 36.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.529 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 -62.94 -34.26 77.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.22 -0.446 . . . . 10.0 111.398 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -107.19 41.76 1.43 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.15 0.5 . . . . 10.0 110.506 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -70.75 -27.3 72.6 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.938 -0.648 . . . . 10.0 112.538 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.6 t -100.96 5.32 43.14 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.064 0.459 . . . . 10.0 110.473 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -135.64 86.33 28.67 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.815 -0.63 . . . . 10.0 110.105 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -74.32 -15.74 22.39 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.275 1.983 . . . . 10.0 112.644 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.69 -49.58 61.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.316 -0.402 . . . . 10.0 111.114 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.6 m -66.52 -33.31 75.4 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.318 -0.401 . . . . 10.0 110.779 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -67.64 -41.75 83.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.166 -0.47 . . . . 10.0 110.708 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -62.47 -38.59 90.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.935 0.398 . . . . 10.0 110.567 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.27 -33.25 84.52 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.918 -0.658 . . . . 10.0 111.898 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -61.85 -41.94 98.45 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.947 0.403 . . . . 10.0 110.181 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 24.5 mt -66.71 -36.29 82.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.963 -0.562 . . . . 10.0 110.287 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -62.27 -42.43 99.33 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.665 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.2 mt -66.17 -36.62 77.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.533 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 46.2 mtp -62.12 -34.06 75.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 10.0 110.631 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -62.36 -38.57 90.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.292 -0.413 . . . . 10.0 110.613 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -66.37 -36.83 83.87 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.379 -0.6 . . . . 10.0 109.379 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -68.87 -43.82 74.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.43 -0.805 . . . . 10.0 109.981 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -64.16 -37.17 86.51 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.083 -0.508 . . . . 10.0 111.203 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.7 m -82.5 4.38 24.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.302 -0.408 . . . . 10.0 111.336 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 58.97 28.46 17.67 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.874 -0.603 . . . . 10.0 111.449 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.6 m -75.71 -38.52 58.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.18 0.514 . . . . 10.0 110.143 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.2 pt -120.97 157.73 23.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.689 -0.687 . . . . 10.0 110.106 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -106.85 -163.25 0.9 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.173 -0.467 . . . . 10.0 110.399 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.486 ' O ' HG12 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -55.0 -57.05 21.48 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 112.772 0.656 . . . . 10.0 112.772 -179.724 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 72' ' ' THR . 20.5 Cg_endo -60.94 -29.45 88.05 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.043 1.828 . . . . 10.0 112.666 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.13 -48.17 20.89 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.625 -0.798 . . . . 10.0 112.017 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.486 HG12 ' O ' ' A' ' 72' ' ' THR . 5.6 p -63.91 -30.39 49.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.565 0.221 . . . . 10.0 110.753 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.5 mt -66.2 -49.22 77.73 Favored 'Isoleucine or valine' 0 C--N 1.337 0.053 0 N-CA-C 109.714 -0.476 . . . . 10.0 109.714 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 60.2 ttp180 -61.44 -42.61 99.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.864 -0.607 . . . . 10.0 110.799 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -56.53 -41.62 77.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.88 -0.6 . . . . 10.0 111.568 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.6 p -84.21 -22.36 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 120.826 -0.349 . . . . 10.0 111.625 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.5 m -64.25 -42.42 96.52 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.022 0.439 . . . . 10.0 110.737 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -77.3 -14.25 59.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.121 -0.49 . . . . 10.0 110.316 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 18.3 tp -86.44 -43.5 12.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.862 -0.608 . . . . 10.0 110.065 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -103.62 37.21 2.08 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.897 -0.592 . . . . 10.0 109.935 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -64.16 -24.56 67.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.321 -0.4 . . . . 10.0 111.595 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -92.55 0.26 57.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.467 -0.333 . . . . 10.0 110.895 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 18.4 m170 -136.34 81.03 38.24 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-O 120.675 0.274 . . . . 10.0 110.857 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -65.1 -27.53 57.21 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.483 2.122 . . . . 10.0 112.343 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -57.62 -42.6 83.65 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.8 -0.636 . . . . 10.0 110.96 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 96.1 mt -68.9 -41.04 78.8 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.127 -0.488 . . . . 10.0 111.184 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 59.3 mt -60.6 -48.01 90.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-O 121.116 0.484 . . . . 10.0 110.972 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.4 t -71.5 -42.8 72.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.985 -0.552 . . . . 10.0 110.834 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.77 -45.38 95.84 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.817 -0.629 . . . . 10.0 112.859 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.413 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 39.5 t80 -63.19 -34.42 77.61 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.729 0.3 . . . . 10.0 111.022 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -62.82 -36.09 82.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.406 -0.361 . . . . 10.0 111.149 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.9 -21.22 26.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.865 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -77.17 -25.14 51.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.903 -0.59 . . . . 10.0 110.908 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 93' ' ' PHE . 57.9 mt -52.34 125.55 34.98 Favored Pre-proline 0 C--O 1.235 0.304 0 CA-C-N 116.126 -0.488 . . . . 10.0 112.172 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -67.75 -30.66 33.75 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.586 2.19 . . . . 10.0 111.57 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.83 145.95 38.09 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.65 -0.705 . . . . 10.0 110.494 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 171.29 -169.02 42.15 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.775 -0.726 . . . . 10.0 111.963 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.37 15.89 0.62 Allowed 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 123.535 2.823 . . . . 10.0 113.125 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.81 179.59 2.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.018 0.437 . . . . 10.0 110.702 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.9 t -78.3 116.96 19.1 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.878 -0.416 . . . . 10.0 109.878 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.146 0 C-N-CA 120.882 -0.675 . . . . 10.0 112.346 179.747 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.235 0.325 0 CA-C-O 121.019 0.438 . . . . 10.0 110.882 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.4 m -81.35 149.35 28.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.122 -0.49 . . . . 10.0 109.816 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.37 74.28 1.07 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.019 -0.61 . . . . 10.0 111.972 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.8 m -82.47 161.29 3.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.775 0.322 . . . . 10.0 111.066 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -101.73 178.07 4.73 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.575 -0.528 . . . . 10.0 109.575 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 32.1 m -81.65 4.99 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.155 0.502 . . . . 10.0 111.235 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -153.52 103.45 2.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.87 -0.605 . . . . 10.0 109.763 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 38.6 p-10 -135.57 17.29 3.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.151 0.5 . . . . 10.0 110.733 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.58 -41.79 99.15 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.755 -0.657 . . . . 10.0 111.147 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.584 HD23 ' H ' ' A' ' 38' ' ' LEU . 2.2 pt? -71.17 -30.87 66.96 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.932 -0.577 . . . . 10.0 110.773 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.22 -43.87 93.65 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.209 -0.45 . . . . 10.0 110.876 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -67.45 -38.32 84.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 10.0 110.201 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.64 -41.49 99.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.26 0.552 . . . . 10.0 110.528 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.579 ' O ' HG13 ' A' ' 46' ' ' ILE . 22.1 t70 -66.43 -35.78 81.16 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.369 -0.832 . . . . 10.0 110.874 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -59.53 -45.48 91.64 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.031 0.443 . . . . 10.0 110.712 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 64.7 t -59.51 -35.83 61.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 115.517 -0.765 . . . . 10.0 110.373 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.4 ttpm? -67.51 -35.06 78.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.229 -0.896 . . . . 10.0 110.863 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.579 HG13 ' O ' ' A' ' 42' ' ' ASP . 23.4 mt -76.22 -47.04 32.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.573 -0.285 . . . . 10.0 110.938 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -58.87 -47.14 85.99 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.039 -0.528 . . . . 10.0 111.712 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -104.27 54.65 0.73 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.21 0.528 . . . . 10.0 110.986 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.83 -36.35 29.02 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.709 -0.757 . . . . 10.0 111.521 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.09 4.83 28.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.928 0.394 . . . . 10.0 110.994 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -138.83 87.83 14.25 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.001 -0.545 . . . . 10.0 109.917 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -70.7 -21.0 29.71 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.361 2.041 . . . . 10.0 112.598 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.78 -47.44 83.48 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.499 -0.318 . . . . 10.0 111.328 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.8 m -63.15 -43.27 98.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.077 0.465 . . . . 10.0 110.587 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -65.2 -39.83 93.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.11 -0.495 . . . . 10.0 110.91 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -65.87 -35.97 82.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.985 -0.552 . . . . 10.0 110.705 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -69.53 -33.69 72.52 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.647 -0.706 . . . . 10.0 111.542 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -59.53 -34.82 73.13 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.099 0.476 . . . . 10.0 110.334 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 23.9 mt -62.98 -41.28 99.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.752 -0.658 . . . . 10.0 110.64 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -67.18 -30.39 70.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.97 -0.559 . . . . 10.0 110.637 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.7 mt -65.62 -47.63 85.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.069 -0.514 . . . . 10.0 110.419 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 44.1 mtp -66.07 -27.12 67.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.965 -0.561 . . . . 10.0 111.065 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -63.29 -41.77 99.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.232 -0.44 . . . . 10.0 110.989 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -64.05 -33.32 75.48 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.074 0.464 . . . . 10.0 110.46 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -74.92 -41.27 60.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.7 -0.682 . . . . 10.0 110.466 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -62.63 -34.35 76.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.842 -0.617 . . . . 10.0 111.307 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 68.6 m -82.42 -0.66 47.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.417 -0.356 . . . . 10.0 111.104 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 63.33 23.02 13.58 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.029 -0.532 . . . . 10.0 111.504 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.36 -41.64 39.54 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.845 -0.798 . . . . 10.0 108.845 178.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 31.2 pt -114.87 165.9 9.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.676 -0.693 . . . . 10.0 110.083 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -123.12 -166.48 1.46 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.129 -0.487 . . . . 10.0 109.77 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.478 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 7.1 m -49.02 -55.25 21.6 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 112.029 0.381 . . . . 10.0 112.029 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 72' ' ' THR . 11.5 Cg_endo -55.84 -34.48 91.53 Favored 'Trans proline' 0 C--N 1.358 1.028 0 C-N-CA 122.387 2.058 . . . . 10.0 112.548 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.68 -44.51 62.96 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.778 -0.725 . . . . 10.0 111.939 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.595 ' O ' HG23 ' A' ' 79' ' ' VAL . 82.5 t -60.97 -45.45 98.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.951 -0.388 . . . . 10.0 109.951 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 88.8 mt -55.49 -42.57 68.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.09 -0.504 . . . . 10.0 110.984 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 41.4 ttp180 -59.23 -44.82 92.3 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.137 0.494 . . . . 10.0 109.897 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -63.54 -46.85 84.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.734 -0.666 . . . . 10.0 110.263 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 75' ' ' VAL . 64.3 t -58.46 -43.91 87.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.545 -0.752 . . . . 10.0 111.205 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.429 ' HA ' HD13 ' A' ' 90' ' ' ILE . 9.8 m -66.04 -38.23 87.84 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.182 -0.463 . . . . 10.0 111.59 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -75.84 -20.22 58.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.908 0.385 . . . . 10.0 110.855 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.2 tp -87.55 -53.57 4.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.984 -0.553 . . . . 10.0 110.654 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -97.57 44.52 1.04 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.953 0.406 . . . . 10.0 110.552 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -69.93 -13.59 62.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.321 -0.399 . . . . 10.0 111.424 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -96.95 -12.48 23.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.996 0.426 . . . . 10.0 110.271 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -136.01 77.69 49.11 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 10.0 110.964 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -62.49 -23.41 74.91 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.588 2.192 . . . . 10.0 112.34 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.5 -23.85 67.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.115 -0.493 . . . . 10.0 111.024 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 81.6 mt -87.38 -30.47 20.73 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.459 -0.337 . . . . 10.0 110.49 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.429 HD13 ' HA ' ' A' ' 80' ' ' SER . 55.5 mt -63.48 -51.94 64.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.893 0.378 . . . . 10.0 110.903 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.6 t -63.2 -27.46 43.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.851 -0.613 . . . . 10.0 110.421 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.49 -37.55 92.28 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.431 -0.668 . . . . 10.0 111.431 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -66.67 -39.39 88.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.889 0.376 . . . . 10.0 110.408 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -63.54 -34.87 78.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.585 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -90.24 0.66 57.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.159 -0.473 . . . . 10.0 110.792 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -106.49 2.51 26.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.262 -0.426 . . . . 10.0 110.777 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 53.9 mt -69.96 118.18 61.0 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.276 -0.42 . . . . 10.0 111.069 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -70.79 -41.89 2.69 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.469 2.113 . . . . 10.0 112.536 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.3 m -94.23 149.97 20.74 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 116.321 -0.4 . . . . 10.0 110.232 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -177.9 -141.94 4.41 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.644 -0.789 . . . . 10.0 111.732 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -80.44 0.84 9.73 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.699 2.266 . . . . 10.0 112.424 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.02 157.96 32.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.394 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.2 m -69.19 139.2 54.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.856 0.36 . . . . 10.0 111.426 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.451 0 C-N-CA 120.665 -0.779 . . . . 10.0 112.171 179.912 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.45 -0.434 0 CA-C-O 121.032 0.444 . . . . 10.0 110.529 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.7 m -79.47 134.86 36.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.604 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.58 86.17 1.82 Allowed Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.52 -0.847 . . . . 10.0 112.641 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.9 m -103.62 156.53 5.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 110.068 -0.345 . . . . 10.0 110.068 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -94.63 -164.42 1.17 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.235 -0.438 . . . . 10.0 110.751 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.8 m -78.36 -22.12 13.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.125 0.488 . . . . 10.0 110.929 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -113.59 85.01 2.11 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.414 0.626 . . . . 10.0 110.456 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -113.05 -4.55 13.84 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.541 -0.754 . . . . 10.0 110.402 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.49 -40.13 95.68 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.336 -0.847 . . . . 10.0 112.419 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.15 -9.14 58.81 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.919 0.341 . . . . 10.0 111.919 -178.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.76 -49.55 24.93 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.137 0.494 . . . . 10.0 111.702 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -73.17 -12.9 61.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.07 -0.514 . . . . 10.0 111.499 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.93 -45.81 69.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.007 0.432 . . . . 10.0 110.829 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -69.92 -32.28 70.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.35 -0.386 . . . . 10.0 111.379 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -56.64 -35.13 68.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.929 -0.578 . . . . 10.0 110.885 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 28.7 t -66.02 -42.45 91.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 10.0 110.045 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -63.33 -38.59 91.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.873 -0.603 . . . . 10.0 111.084 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 57.2 mt -73.77 -44.92 51.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 10.0 110.967 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -58.26 -40.96 83.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 10.0 110.894 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -110.13 41.73 1.67 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.335 0.588 . . . . 10.0 110.454 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.87 -28.17 73.41 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.952 -0.642 . . . . 10.0 112.053 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.3 m -96.23 2.38 52.93 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.803 0.335 . . . . 10.0 110.864 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -134.01 86.74 36.62 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 109.591 -0.522 . . . . 10.0 109.591 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -68.27 -17.75 44.77 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.922 2.414 . . . . 10.0 112.582 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.59 -49.28 69.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.058 -0.519 . . . . 10.0 111.122 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.8 m -62.85 -43.19 99.47 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.549 -0.296 . . . . 10.0 111.246 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -65.4 -40.12 93.02 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 110.128 -0.323 . . . . 10.0 110.128 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -60.86 -48.13 83.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 10.0 110.361 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.457 ' O ' HG13 ' A' ' 61' ' ' ILE . . . -60.02 -44.55 97.14 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.93 -0.652 . . . . 10.0 111.828 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -55.78 -43.23 76.59 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.757 0.313 . . . . 10.0 110.891 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 77.8 mt -64.55 -38.03 89.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.932 -0.576 . . . . 10.0 111.26 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -70.71 -39.91 73.13 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.296 -0.411 . . . . 10.0 111.056 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 57' ' ' GLY . 62.4 mt -67.45 -36.5 76.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.024 0.44 . . . . 10.0 110.428 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.93 -31.97 67.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.901 -0.59 . . . . 10.0 111.131 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -63.01 -45.37 92.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.964 -0.562 . . . . 10.0 110.844 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -59.8 -36.34 76.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.916 -0.584 . . . . 10.0 111.663 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -66.73 -42.94 85.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.373 -0.376 . . . . 10.0 110.88 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -74.86 -24.29 58.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.895 -0.593 . . . . 10.0 111.104 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 68.4 m -79.08 5.0 12.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.898 0.38 . . . . 10.0 110.537 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 61.77 33.58 17.75 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.798 -0.637 . . . . 10.0 110.866 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.1 m -93.88 -26.12 17.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.302 -0.408 . . . . 10.0 111.044 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.0 pt -139.85 158.42 26.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.184 -0.462 . . . . 10.0 110.646 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.416 ' HB3' ' H ' ' A' ' 72' ' ' THR . 30.9 m-20 -119.17 -158.93 0.75 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.288 -0.415 . . . . 10.0 110.249 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.428 ' HB ' ' HD3' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -48.21 -59.68 5.58 Favored Pre-proline 0 CA--C 1.542 0.673 0 N-CA-C 112.65 0.611 . . . . 10.0 112.65 -179.6 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.428 ' HD3' ' HB ' ' A' ' 72' ' ' THR . 28.7 Cg_endo -62.91 -35.07 69.18 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 121.554 1.503 . . . . 10.0 112.722 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.1 -44.31 91.52 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 121.099 -0.572 . . . . 10.0 112.256 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.506 ' O ' HG23 ' A' ' 79' ' ' VAL . 8.9 p -74.89 -35.36 35.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 O-C-N 122.853 -0.204 . . . . 10.0 110.906 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 74.0 mt -62.95 -37.92 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.077 0 N-CA-C 110.172 -0.307 . . . . 10.0 110.172 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -59.86 -29.79 68.53 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.287 0.565 . . . . 10.0 110.193 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -81.61 -42.55 19.9 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.716 -0.675 . . . . 10.0 109.656 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 75' ' ' VAL . 97.6 t -59.3 -46.59 92.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.613 -0.721 . . . . 10.0 110.737 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.464 ' HA ' HD13 ' A' ' 90' ' ' ILE . 49.6 m -63.04 -28.85 70.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.952 -0.567 . . . . 10.0 111.512 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -84.91 -40.63 16.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.673 0.273 . . . . 10.0 111.366 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 6.6 tp -64.97 -47.45 77.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.235 0.541 . . . . 10.0 111.056 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -101.18 45.59 0.97 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.013 -0.54 . . . . 10.0 110.076 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -63.93 -29.37 70.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.958 -0.565 . . . . 10.0 111.327 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -98.94 6.37 46.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.964 0.411 . . . . 10.0 110.897 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -137.57 71.11 52.18 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 116.36 -0.382 . . . . 10.0 110.438 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.02 -31.44 76.5 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.338 2.025 . . . . 10.0 112.288 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.78 -32.28 70.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 10.0 110.762 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 89.1 mt -72.11 -42.51 65.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.22 -0.446 . . . . 10.0 110.051 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.464 HD13 ' HA ' ' A' ' 80' ' ' SER . 26.2 mt -65.16 -44.44 95.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 116.036 -0.529 . . . . 10.0 109.805 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 99.1 t -65.11 -37.77 81.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 115.818 -0.628 . . . . 10.0 109.508 178.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -64.18 -38.18 95.58 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.655 -0.783 . . . . 10.0 111.609 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -68.97 -28.1 66.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.96 0.409 . . . . 10.0 110.566 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -62.18 -28.19 69.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.164 0.507 . . . . 10.0 109.926 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.93 8.87 30.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.571 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -117.62 33.35 5.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.831 -0.622 . . . . 10.0 110.072 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.6 mt -106.34 114.68 61.98 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.784 -0.644 . . . . 10.0 110.086 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -71.12 -12.23 30.01 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.626 2.218 . . . . 10.0 112.076 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.3 m -109.93 104.55 13.49 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.029 -0.532 . . . . 10.0 110.563 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -154.49 -149.28 5.21 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.753 -0.737 . . . . 10.0 112.256 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -79.98 39.38 0.83 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.288 2.659 . . . . 10.0 113.232 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 57.9 m -96.35 174.16 7.01 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.147 -0.479 . . . . 10.0 110.228 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.3 m -71.72 95.57 1.49 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.949 0.404 . . . . 10.0 110.252 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.654 0 C-N-CA 120.946 -0.645 . . . . 10.0 111.93 -179.7 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.3 m . . . . . 0 C--O 1.233 0.201 0 N-CA-C 110.055 -0.35 . . . . 10.0 110.055 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.1 m -83.62 99.28 10.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.278 0.561 . . . . 10.0 110.404 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 171.22 66.25 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 111.321 -0.711 . . . . 10.0 111.321 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.4 m -64.85 151.71 9.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.873 0.368 . . . . 10.0 111.294 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 3.2 m170 -116.04 175.68 5.43 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.775 -0.454 . . . . 10.0 109.775 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.7 m -81.26 -23.74 10.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.136 0.493 . . . . 10.0 110.537 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -145.84 88.12 1.81 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.438 0.637 . . . . 10.0 109.936 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -117.87 23.4 11.7 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.682 -0.69 . . . . 10.0 110.254 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.9 -41.95 97.09 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.487 -0.779 . . . . 10.0 110.62 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pp -64.36 -28.47 69.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.534 -0.757 . . . . 10.0 111.303 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.542 ' O ' ' HG2' ' A' ' 43' ' ' GLN . 1.3 m -68.18 -52.78 30.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.068 -0.514 . . . . 10.0 111.358 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -66.38 -28.92 69.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.889 0.376 . . . . 10.0 110.165 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.63 -40.74 96.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.845 -0.616 . . . . 10.0 110.021 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -72.03 -31.27 66.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 10.0 110.554 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.542 ' HG2' ' O ' ' A' ' 39' ' ' THR . 15.9 mm100 -59.21 -40.1 84.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.703 -0.68 . . . . 10.0 110.573 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 92.2 t -59.68 -40.36 82.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.25 0.547 . . . . 10.0 109.863 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.4 ttpm? -62.89 -37.36 86.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.338 -0.846 . . . . 10.0 111.224 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 49.2 mt -73.76 -43.97 52.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.087 0.47 . . . . 10.0 110.795 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -63.66 -37.37 87.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.85 -0.614 . . . . 10.0 111.046 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -110.36 49.81 0.83 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.344 0.592 . . . . 10.0 110.312 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -81.4 -21.67 61.91 Favored Glycine 0 C--O 1.229 -0.156 0 CA-C-N 115.564 -0.744 . . . . 10.0 112.679 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.9 m -86.54 -33.47 20.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.864 0.364 . . . . 10.0 110.522 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -116.85 100.98 53.67 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.067 -0.515 . . . . 10.0 110.71 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -75.12 -15.33 20.54 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.366 2.044 . . . . 10.0 112.256 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.54 -46.83 86.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.7 -0.682 . . . . 10.0 111.067 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.8 m -67.5 -32.61 73.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.008 -0.542 . . . . 10.0 110.331 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -68.74 -43.88 74.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.12 -0.491 . . . . 10.0 110.073 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -62.6 -39.99 95.49 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.845 -0.616 . . . . 10.0 109.972 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.3 -34.19 88.76 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.681 -0.771 . . . . 10.0 111.696 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -63.0 -39.32 94.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.091 0.472 . . . . 10.0 110.657 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 30.1 mt -64.46 -34.61 78.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.877 -0.601 . . . . 10.0 110.433 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -67.39 -37.12 82.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.684 -0.689 . . . . 10.0 110.713 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.7 mt -64.84 -39.96 87.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.166 0.508 . . . . 10.0 110.065 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.73 -31.25 72.37 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.523 -0.762 . . . . 10.0 110.35 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -62.88 -45.15 93.9 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.049 -0.523 . . . . 10.0 109.856 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -61.0 -35.22 76.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.63 -0.714 . . . . 10.0 110.631 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -70.14 -45.61 66.45 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.799 0.333 . . . . 10.0 110.324 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -67.11 -29.83 69.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.013 0.435 . . . . 10.0 110.932 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.83 -3.34 47.39 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.81 -0.632 . . . . 10.0 110.186 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 63.83 31.26 14.17 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.768 -0.651 . . . . 10.0 111.517 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.6 m -91.02 -20.98 21.5 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.1 -0.5 . . . . 10.0 109.75 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 24.3 pt -134.84 150.99 30.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.838 -0.619 . . . . 10.0 109.55 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -107.37 -164.49 0.98 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.878 -0.415 . . . . 10.0 109.878 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.427 ' HB ' ' HD3' ' A' ' 73' ' ' PRO . 0.6 OUTLIER -49.12 -56.64 14.69 Favored Pre-proline 0 CA--C 1.537 0.472 0 O-C-N 123.619 0.574 . . . . 10.0 112.502 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.427 ' HD3' ' HB ' ' A' ' 72' ' ' THR . 40.8 Cg_endo -66.17 -28.59 48.24 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 121.683 1.589 . . . . 10.0 112.733 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.23 -51.99 29.77 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.839 -0.619 . . . . 10.0 113.069 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.9 p -64.52 -40.88 90.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.801 0.334 . . . . 10.0 111.1 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 91.6 mt -62.37 -45.35 98.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.475 -0.33 . . . . 10.0 110.644 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 77' ' ' ARG . 11.4 ttp180 -61.61 -45.65 93.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.395 -0.366 . . . . 10.0 110.936 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -57.87 -49.33 77.05 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.997 0.427 . . . . 10.0 111.095 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 86.2 t -68.36 -34.81 68.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.006 -0.543 . . . . 10.0 111.011 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.9 t -61.83 -30.57 70.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.483 -0.326 . . . . 10.0 111.475 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -82.36 -28.97 31.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.009 0.433 . . . . 10.0 110.698 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 23.2 tp -81.96 -40.99 21.42 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.097 -0.501 . . . . 10.0 111.326 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -97.08 32.24 2.21 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.167 -0.469 . . . . 10.0 110.637 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -65.67 -17.65 64.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.895 0.378 . . . . 10.0 111.749 -179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -88.33 -7.78 56.15 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.014 0.435 . . . . 10.0 110.466 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -134.69 71.64 70.31 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.864 -0.607 . . . . 10.0 109.491 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.38 -27.48 84.93 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.953 2.436 . . . . 10.0 112.746 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.07 -31.26 72.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.239 -0.437 . . . . 10.0 110.871 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 67.7 mt -75.21 -35.67 61.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 10.0 110.67 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 58.3 mt -65.41 -52.79 47.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.944 -0.571 . . . . 10.0 110.48 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.1 t -65.49 -38.98 83.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.052 -0.522 . . . . 10.0 109.706 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.98 -36.16 86.92 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.488 -0.778 . . . . 10.0 111.908 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -64.1 -44.03 93.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.716 0.293 . . . . 10.0 110.387 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -60.47 -42.86 97.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.121 -0.49 . . . . 10.0 110.191 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.31 -22.0 59.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.109 -0.496 . . . . 10.0 111.257 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -83.04 -11.6 57.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.258 -0.428 . . . . 10.0 111.171 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 60.2 mt -69.63 119.47 71.13 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.42 -0.355 . . . . 10.0 110.429 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -67.18 -42.59 7.56 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.642 2.228 . . . . 10.0 112.012 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.2 m -79.82 145.32 32.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.71 -0.677 . . . . 10.0 109.967 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 179.92 -131.92 1.73 Allowed Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.563 -0.615 . . . . 10.0 111.563 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -92.26 17.56 1.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.916 2.411 . . . . 10.0 112.16 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.4 m -82.77 176.57 9.22 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.941 -0.572 . . . . 10.0 111.305 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.48 113.97 3.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.994 -0.548 . . . . 10.0 111.598 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.479 0 C-N-CA 121.036 -0.602 . . . . 10.0 112.391 179.404 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.0 m . . . . . 0 N--CA 1.451 -0.425 0 N-CA-C 110.0 -0.371 . . . . 10.0 110.0 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.8 m -105.01 136.08 45.15 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.31 -0.404 . . . . 10.0 110.97 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.92 105.23 2.97 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.637 -0.792 . . . . 10.0 112.207 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 17.0 m -115.45 164.56 11.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 110.12 -0.326 . . . . 10.0 110.12 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -104.3 -175.77 2.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.374 -0.376 . . . . 10.0 110.506 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.5 m -79.9 -4.19 6.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.189 0.518 . . . . 10.0 110.869 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -109.56 25.75 11.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.662 -0.699 . . . . 10.0 110.349 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.0 p-10 -68.07 -26.35 65.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.887 -0.597 . . . . 10.0 111.332 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.36 -51.3 62.91 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.586 0.587 . . . . 10.0 112.586 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.453 ' H ' ' HG ' ' A' ' 38' ' ' LEU . 1.4 pp -80.75 -0.87 40.45 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 122.067 -0.396 . . . . 10.0 111.86 -178.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 m -84.25 -34.99 23.72 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.942 0.401 . . . . 10.0 110.46 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -70.58 -21.92 62.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.342 -0.39 . . . . 10.0 111.214 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.54 -47.23 86.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 10.0 110.814 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -64.62 -35.91 82.55 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.957 -0.565 . . . . 10.0 110.61 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -58.41 -48.42 80.72 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.09 -0.505 . . . . 10.0 110.839 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.2 t -64.08 -35.86 75.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 115.65 -0.704 . . . . 10.0 110.549 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.7 tttm -67.77 -35.97 79.65 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.412 -0.813 . . . . 10.0 111.242 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 94.8 mt -77.16 -43.24 31.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.693 0.282 . . . . 10.0 111.295 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -58.3 -36.93 74.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.417 -0.356 . . . . 10.0 111.282 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -110.93 48.05 0.95 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.342 0.591 . . . . 10.0 109.987 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.47 -29.86 74.52 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.642 -0.708 . . . . 10.0 112.788 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.7 m -101.52 1.82 38.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.877 0.339 . . . . 10.0 111.383 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -124.68 94.55 44.26 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 120.908 0.385 . . . . 10.0 110.344 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -77.63 -11.38 17.02 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.481 2.121 . . . . 10.0 112.325 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.44 -51.55 23.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.215 -0.448 . . . . 10.0 110.919 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.5 m -64.48 -31.66 72.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.397 0.618 . . . . 10.0 110.039 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -66.27 -44.44 83.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.657 -0.702 . . . . 10.0 110.265 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -64.36 -37.5 87.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.509 . . . . 10.0 110.828 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.25 -39.45 97.89 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.71 -0.677 . . . . 10.0 112.891 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -60.75 -38.33 84.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.86 0.362 . . . . 10.0 110.702 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.427 ' O ' ' HG3' ' A' ' 63' ' ' LYS . 67.0 mt -65.89 -37.83 87.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.102 -0.499 . . . . 10.0 110.722 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -62.98 -40.38 97.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.114 0.483 . . . . 10.0 109.928 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.3 mt -62.75 -44.66 99.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.786 -0.643 . . . . 10.0 110.198 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.406 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -61.65 -35.75 78.84 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.691 -0.686 . . . . 10.0 110.773 179.853 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 59' ' ' LEU . 92.8 mttt -60.62 -47.22 87.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.753 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -59.58 -40.58 87.85 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.925 0.393 . . . . 10.0 110.885 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -68.24 -42.03 80.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.295 -0.411 . . . . 10.0 110.649 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 62' ' ' MET . 43.8 mtpt -66.12 -33.05 74.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.432 -0.349 . . . . 10.0 111.107 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.1 m -84.67 3.84 35.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.498 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 60.69 32.69 20.3 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.819 -0.628 . . . . 10.0 111.947 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.2 m -81.44 -25.72 35.91 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.329 0.585 . . . . 10.0 109.576 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 15.6 pt -137.84 164.88 27.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.365 -0.834 . . . . 10.0 109.904 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.35 -165.55 1.02 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.935 -0.395 . . . . 10.0 109.935 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.417 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 2.3 m -51.97 -55.57 29.47 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 112.502 0.556 . . . . 10.0 112.502 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 72' ' ' THR . 24.6 Cg_endo -62.35 -22.23 73.8 Favored 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 121.908 1.739 . . . . 10.0 112.59 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -83.26 -44.78 6.85 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.757 -0.735 . . . . 10.0 111.904 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.5 p -64.79 -34.69 71.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-O 120.817 0.342 . . . . 10.0 110.921 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 77.5 mt -70.11 -41.57 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 110.063 -0.347 . . . . 10.0 110.063 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 26.3 ttp180 -63.62 -40.11 96.06 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.339 -0.391 . . . . 10.0 110.253 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.6 mmt180 -57.76 -43.9 85.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.397 0.618 . . . . 10.0 110.18 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 45.9 t -72.9 -29.51 29.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.461 -0.79 . . . . 10.0 111.082 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.404 ' HA ' HD13 ' A' ' 90' ' ' ILE . 69.7 m -61.08 -29.87 70.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.079 0.466 . . . . 10.0 110.785 179.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.8 mm-40 -87.82 -26.77 22.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.917 -0.583 . . . . 10.0 110.45 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 29.5 tp -76.53 -53.6 7.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.031 -0.531 . . . . 10.0 110.284 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 18.9 m-30 -93.11 45.27 1.17 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.953 0.406 . . . . 10.0 110.447 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -68.35 -13.01 61.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.035 -0.529 . . . . 10.0 110.948 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -102.99 -10.89 18.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.009 -0.541 . . . . 10.0 110.761 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -133.36 79.53 60.57 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 120.737 0.303 . . . . 10.0 110.855 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.462 ' O ' HG23 ' A' ' 91' ' ' VAL . 18.1 Cg_endo -61.55 -31.47 87.35 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.741 2.294 . . . . 10.0 111.981 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -60.6 -31.81 70.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.744 -0.662 . . . . 10.0 110.987 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.2 mt -74.48 -25.33 59.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.031 -0.532 . . . . 10.0 111.162 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.404 HD13 ' HA ' ' A' ' 80' ' ' SER . 46.1 mt -80.73 -44.56 21.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.125 -0.489 . . . . 10.0 110.023 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 87' ' ' PRO . 17.4 t -67.87 -31.1 50.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.83 -0.623 . . . . 10.0 110.288 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.22 -39.4 97.64 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.805 -0.712 . . . . 10.0 111.759 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.482 ' CZ ' HD21 ' A' ' 97' ' ' LEU . 59.2 t80 -64.28 -36.44 84.13 Favored 'General case' 0 C--O 1.227 -0.117 0 CA-C-O 121.007 0.432 . . . . 10.0 110.216 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -62.63 -27.88 69.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.816 -0.629 . . . . 10.0 110.756 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -93.16 -19.96 20.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.287 -0.415 . . . . 10.0 111.149 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -97.26 44.5 1.05 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.299 -0.41 . . . . 10.0 110.643 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.482 HD21 ' CZ ' ' A' ' 93' ' ' PHE . 40.9 mt -113.01 102.92 55.48 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.083 -0.508 . . . . 10.0 110.444 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -62.19 -42.92 26.23 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.37 2.047 . . . . 10.0 111.873 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.7 94.53 7.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.921 -0.581 . . . . 10.0 110.039 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -134.31 -151.15 6.33 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.559 -0.829 . . . . 10.0 112.55 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -83.11 25.22 0.69 Allowed 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 122.939 2.426 . . . . 10.0 112.385 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.89 171.77 14.72 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.938 -0.574 . . . . 10.0 111.106 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.5 m -61.38 125.44 23.79 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.049 0.452 . . . . 10.0 111.171 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.652 0 C-N-CA 120.814 -0.708 . . . . 10.0 111.806 -179.951 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.2 m . . . . . 0 C--O 1.235 0.322 0 CA-C-O 120.866 0.365 . . . . 10.0 110.222 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.0 m -106.43 127.07 53.01 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.227 -0.442 . . . . 10.0 110.628 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.07 55.12 0.1 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.72 -0.753 . . . . 10.0 111.996 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.8 m -68.78 155.02 7.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-O 121.154 0.502 . . . . 10.0 111.351 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -99.07 -176.14 3.23 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.201 -0.454 . . . . 10.0 110.571 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.0 m -65.33 -20.11 26.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 121.197 0.522 . . . . 10.0 110.673 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -102.6 56.75 0.78 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.285 0.564 . . . . 10.0 109.812 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -90.44 -12.23 38.04 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.53 -0.759 . . . . 10.0 111.23 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.2 -48.7 80.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.609 -0.723 . . . . 10.0 111.355 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 pp -71.2 -22.5 62.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.161 -0.472 . . . . 10.0 111.993 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.506 ' O ' ' HG2' ' A' ' 43' ' ' GLN . 1.1 m -65.45 -60.1 3.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.356 -0.384 . . . . 10.0 111.421 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -67.4 -27.94 67.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.639 -0.255 . . . . 10.0 111.244 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -58.39 -35.24 71.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.281 -0.418 . . . . 10.0 111.511 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -91.06 -24.61 19.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.394 -0.366 . . . . 10.0 111.44 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.506 ' HG2' ' O ' ' A' ' 39' ' ' THR . 15.9 mm100 -56.47 -36.12 68.72 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.905 0.383 . . . . 10.0 110.856 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.535 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 11.0 t -66.7 -36.84 78.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 10.0 110.615 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.7 ttpm? -65.91 -35.4 80.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.886 -0.597 . . . . 10.0 110.449 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 46.0 mt -74.61 -40.92 48.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.717 -0.674 . . . . 10.0 109.98 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 -63.23 -51.76 64.92 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.345 -0.843 . . . . 10.0 111.514 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -102.35 54.03 0.79 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.282 0.563 . . . . 10.0 110.433 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.74 -41.28 89.3 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.701 -0.681 . . . . 10.0 112.874 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.3 m -92.96 7.93 41.95 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.842 0.321 . . . . 10.0 111.583 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -129.14 89.07 49.38 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.86 0.362 . . . . 10.0 111.241 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.9 -17.66 17.47 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.218 1.946 . . . . 10.0 112.311 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.83 -54.8 22.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.959 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.6 m -69.04 -27.51 65.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.024 0.44 . . . . 10.0 111.049 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -70.19 -41.99 72.99 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.858 0.361 . . . . 10.0 110.677 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -62.57 -42.11 99.35 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.201 -0.454 . . . . 10.0 110.322 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.12 -33.23 86.69 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.933 -0.651 . . . . 10.0 111.723 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.535 ' CZ ' HG21 ' A' ' 44' ' ' VAL . 88.4 t80 -62.2 -37.02 83.71 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.071 0.462 . . . . 10.0 110.07 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 22.7 mt -72.3 -35.87 68.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.68 -0.691 . . . . 10.0 110.901 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -62.04 -34.86 77.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.925 -0.58 . . . . 10.0 111.071 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.4 mt -66.22 -34.31 69.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.114 -0.493 . . . . 10.0 110.959 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.5 mtp -64.5 -33.79 76.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.371 -0.377 . . . . 10.0 110.52 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -61.64 -37.56 84.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.973 -0.558 . . . . 10.0 110.615 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -64.23 -37.92 89.2 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.111 -0.495 . . . . 10.0 110.808 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -78.6 -42.3 29.36 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.728 -0.389 . . . . 10.0 111.15 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -63.25 -34.33 77.44 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.589 -0.278 . . . . 10.0 111.661 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.9 m -84.22 5.38 26.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.733 0.301 . . . . 10.0 111.117 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 63.7 31.92 14.08 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.974 -0.557 . . . . 10.0 111.736 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.4 m -87.71 -48.29 7.98 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.999 0.428 . . . . 10.0 110.303 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 47.9 pt -104.72 146.43 11.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 110.03 -0.359 . . . . 10.0 110.03 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -99.48 -175.54 3.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.802 -0.636 . . . . 10.0 109.956 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.527 ' O ' HG12 ' A' ' 75' ' ' VAL . 0.9 OUTLIER -55.08 -54.09 54.13 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 111.707 0.262 . . . . 10.0 111.707 -179.77 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 72' ' ' THR . 24.2 Cg_endo -63.26 -24.71 72.1 Favored 'Trans proline' 0 C--N 1.358 1.067 0 C-N-CA 121.833 1.689 . . . . 10.0 112.324 178.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.85 -39.26 28.99 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.018 -0.61 . . . . 10.0 112.679 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.53 ' O ' HG23 ' A' ' 79' ' ' VAL . 4.9 p -68.71 -29.86 45.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 O-C-N 122.715 -0.285 . . . . 10.0 111.105 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 72' ' ' THR . 68.0 mt -59.86 -41.37 85.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-O 120.912 0.387 . . . . 10.0 110.052 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -62.13 -40.03 94.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.753 -0.658 . . . . 10.0 109.71 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.2 mmt180 -63.22 -44.89 93.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.754 -0.657 . . . . 10.0 110.739 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 75' ' ' VAL . 47.4 t -61.84 -46.3 96.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.758 -0.655 . . . . 10.0 110.855 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.49 ' HA ' HD13 ' A' ' 90' ' ' ILE . 8.9 m -65.59 -24.32 67.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.893 -0.594 . . . . 10.0 111.661 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -87.43 -24.53 24.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.748 0.309 . . . . 10.0 111.023 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 14.8 tp -86.0 -45.54 11.35 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.08 0.467 . . . . 10.0 110.418 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -103.82 43.77 1.07 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.739 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 13.5 p80 -63.6 -20.12 65.4 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.001 -0.545 . . . . 10.0 111.491 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -101.36 -0.21 35.91 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.962 0.411 . . . . 10.0 110.613 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -135.27 77.05 55.46 Favored Pre-proline 0 C--O 1.236 0.38 0 CA-C-N 116.246 -0.434 . . . . 10.0 110.208 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.92 -29.25 87.7 Favored 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.301 2.001 . . . . 10.0 112.631 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -62.85 -37.58 87.4 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 116.115 -0.493 . . . . 10.0 110.667 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.1 mt -66.15 -41.34 90.55 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.144 -0.48 . . . . 10.0 110.545 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.49 HD13 ' HA ' ' A' ' 80' ' ' SER . 18.2 mt -66.02 -46.07 89.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.031 -0.532 . . . . 10.0 109.983 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 73.8 t -62.38 -43.91 98.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.637 -0.711 . . . . 10.0 110.383 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.93 -40.62 99.11 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.685 -0.689 . . . . 10.0 112.235 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -66.14 -43.18 87.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.706 0.289 . . . . 10.0 110.726 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -61.79 -32.76 73.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.929 0.395 . . . . 10.0 111.36 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.23 -25.06 27.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.821 0.343 . . . . 10.0 111.365 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.45 -31.59 72.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.014 -0.539 . . . . 10.0 111.511 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 36.4 mt -58.16 115.62 11.94 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.526 -0.306 . . . . 10.0 111.688 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -82.25 -24.82 3.59 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.689 2.259 . . . . 10.0 112.125 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.4 m -91.41 99.82 12.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.157 -0.474 . . . . 10.0 110.58 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -151.55 -115.27 0.66 Allowed Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.955 -0.858 . . . . 10.0 110.955 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -82.32 6.86 5.46 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.407 2.071 . . . . 10.0 111.201 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.33 154.44 23.93 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.408 -0.815 . . . . 10.0 111.765 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.45 126.12 29.07 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.74 -0.664 . . . . 10.0 110.173 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 C-N-CA 120.768 -0.729 . . . . 10.0 112.463 179.682 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 56.3 m . . . . . 0 C--O 1.235 0.3 0 CA-C-O 121.028 0.442 . . . . 10.0 110.258 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.9 m -67.39 148.39 51.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.985 -0.552 . . . . 10.0 111.224 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.49 83.34 1.56 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.742 -0.742 . . . . 10.0 112.42 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 29.5 m -108.14 156.23 8.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 110.159 -0.312 . . . . 10.0 110.159 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -102.35 -177.77 3.5 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.344 -0.389 . . . . 10.0 110.203 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.2 m -65.19 -27.1 41.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.812 0.339 . . . . 10.0 111.485 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -99.53 93.41 5.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.465 -0.334 . . . . 10.0 110.396 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -107.09 -11.56 15.61 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.348 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.09 -50.76 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.649 -0.705 . . . . 10.0 112.404 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.12 -10.99 60.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.129 -0.487 . . . . 10.0 112.052 -178.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.54 -58.46 2.52 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.049 0.452 . . . . 10.0 111.695 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.513 ' O ' HG23 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -67.88 -30.78 70.22 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.896 0.702 . . . . 10.0 112.896 -177.633 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.1 -38.83 73.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.749 0.309 . . . . 10.0 111.59 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -78.92 -35.49 43.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.83 0.348 . . . . 10.0 110.642 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -57.72 -39.9 78.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.981 -0.554 . . . . 10.0 111.383 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 40' ' ' TYR . 26.8 t -65.44 -37.11 79.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.077 0.465 . . . . 10.0 110.207 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.1 ttpm? -69.15 -33.26 73.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.638 -0.71 . . . . 10.0 110.634 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 62.8 mt -73.59 -43.07 55.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.855 -0.612 . . . . 10.0 110.224 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -65.74 -42.24 91.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.864 -0.607 . . . . 10.0 111.203 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -107.4 58.94 0.62 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.33 0.586 . . . . 10.0 110.57 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.62 -43.78 9.94 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.457 -0.792 . . . . 10.0 111.938 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 39.3 m -85.21 -11.05 55.83 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.861 0.362 . . . . 10.0 110.838 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -114.66 92.74 30.35 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.149 -0.478 . . . . 10.0 110.824 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -76.42 -15.84 17.49 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.233 1.956 . . . . 10.0 111.757 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.32 -54.49 32.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.507 -0.77 . . . . 10.0 111.634 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.7 m -65.95 -34.0 77.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.402 -0.363 . . . . 10.0 111.0 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -65.34 -44.23 88.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 10.0 110.719 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -64.6 -41.8 95.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.169 -0.469 . . . . 10.0 110.569 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.61 -39.09 96.91 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 115.948 -0.569 . . . . 10.0 112.09 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -57.98 -40.61 81.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.146 0.498 . . . . 10.0 110.463 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 27.3 mt -71.7 -30.01 65.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.791 -0.641 . . . . 10.0 111.127 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -68.93 -38.65 79.64 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.022 0.439 . . . . 10.0 110.876 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.482 HD13 ' HB3' ' A' ' 78' ' ' ARG . 42.1 mt -67.74 -30.84 49.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.784 -0.644 . . . . 10.0 110.606 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 33.1 mmt -64.94 -28.11 69.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.181 -0.463 . . . . 10.0 110.588 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -63.08 -41.26 99.37 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.154 -0.476 . . . . 10.0 110.26 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -65.31 -42.25 93.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.761 -0.654 . . . . 10.0 110.487 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -65.15 -42.59 93.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.112 -0.495 . . . . 10.0 110.634 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -67.82 -18.56 64.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.89 0.376 . . . . 10.0 111.054 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.1 m -95.92 2.19 53.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.067 -0.515 . . . . 10.0 110.453 178.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 64.79 23.05 12.65 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.714 -0.676 . . . . 10.0 110.758 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.2 m -77.74 -29.34 51.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.508 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 37.8 pt -128.48 153.37 37.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 10.0 111.008 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -105.3 -164.35 1.02 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.902 -0.59 . . . . 10.0 110.432 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.477 ' HB ' ' HD3' ' A' ' 73' ' ' PRO . 24.5 m -55.05 -56.48 27.52 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-N 116.502 -0.317 . . . . 10.0 111.212 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.477 ' HD3' ' HB ' ' A' ' 72' ' ' THR . 36.8 Cg_endo -66.41 -21.77 53.24 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 121.647 1.565 . . . . 10.0 111.822 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.07 -48.15 73.96 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.616 -0.72 . . . . 10.0 112.077 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.461 ' O ' HG23 ' A' ' 79' ' ' VAL . 9.5 p -72.77 -31.88 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 120.882 -0.327 . . . . 10.0 110.161 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 47.0 mt -59.95 -40.82 84.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 109.7 -0.482 . . . . 10.0 109.7 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 30.0 ttp180 -59.28 -42.32 90.97 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.112 -0.699 . . . . 10.0 109.112 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.482 ' HB3' HD13 ' A' ' 61' ' ' ILE . 12.2 mmt180 -67.4 -45.73 75.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.376 -0.829 . . . . 10.0 110.439 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 75' ' ' VAL . 62.7 t -55.64 -43.41 73.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.973 -0.558 . . . . 10.0 111.239 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.9 m -64.69 -30.33 71.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.036 -0.529 . . . . 10.0 112.006 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -87.93 -36.26 17.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.695 0.283 . . . . 10.0 111.381 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 24.1 tp -73.55 -54.14 8.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.92 0.391 . . . . 10.0 111.056 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -91.29 38.9 0.98 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.382 0.611 . . . . 10.0 109.651 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -59.38 -34.39 72.37 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.299 -0.864 . . . . 10.0 112.57 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -94.19 7.0 46.86 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.499 0.185 . . . . 10.0 111.499 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -133.59 72.48 74.03 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-O 120.754 0.311 . . . . 10.0 110.25 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.476 ' O ' HG23 ' A' ' 91' ' ' VAL . 33.4 Cg_exo -60.44 -32.78 94.23 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.026 2.484 . . . . 10.0 111.939 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -58.28 -38.4 76.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.591 -0.731 . . . . 10.0 110.433 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 60.1 mt -73.58 -31.69 63.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.915 -0.584 . . . . 10.0 111.306 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.0 mt -68.88 -45.53 80.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.12 0.486 . . . . 10.0 110.107 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 87' ' ' PRO . 19.4 t -69.34 -35.11 65.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.753 -0.658 . . . . 10.0 110.326 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.39 -46.39 94.42 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.787 -0.72 . . . . 10.0 112.47 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.445 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 64.2 t80 -62.01 -32.11 72.56 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.761 0.315 . . . . 10.0 111.18 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -61.37 -38.03 85.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.099 -0.501 . . . . 10.0 111.781 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.38 -8.25 32.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.895 0.378 . . . . 10.0 111.657 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.46 -19.69 35.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.823 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 93' ' ' PHE . 86.9 mt -58.02 121.66 52.32 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.939 -0.573 . . . . 10.0 111.533 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -77.57 -13.63 16.36 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.708 2.272 . . . . 10.0 112.451 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.7 m -106.45 110.77 23.08 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.336 -0.393 . . . . 10.0 110.651 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -142.05 -146.66 4.7 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.694 -0.765 . . . . 10.0 111.671 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -74.25 -5.99 17.76 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.635 2.223 . . . . 10.0 112.549 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 m -66.92 153.47 43.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.857 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.2 t -59.22 128.83 39.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.243 -0.435 . . . . 10.0 110.556 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.419 0 C-N-CA 120.435 -0.888 . . . . 10.0 112.351 -179.893 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.043 -0.423 . . . . 10.0 112.043 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.99 150.47 36.09 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.771 0.32 . . . . 10.0 110.68 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.7 t -83.47 84.58 7.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.271 0.558 . . . . 10.0 110.523 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -144.28 138.15 7.77 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.698 -0.763 . . . . 10.0 112.264 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.1 m -132.87 108.13 8.76 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.854 -0.424 . . . . 10.0 109.854 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.2 m -92.59 157.73 16.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.461 -0.336 . . . . 10.0 110.637 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.2 82.67 1.12 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.95 -0.643 . . . . 10.0 113.142 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.6 m -88.75 173.37 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.906 -0.405 . . . . 10.0 109.906 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -95.6 176.77 6.03 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.74 -0.209 . . . . 10.0 110.678 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.5 m -67.22 -23.41 30.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-O 120.881 0.372 . . . . 10.0 111.43 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -133.1 87.9 2.45 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.445 -0.576 . . . . 10.0 109.445 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -93.58 13.78 20.9 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.677 -0.692 . . . . 10.0 110.857 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.96 -42.79 94.28 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.767 -0.651 . . . . 10.0 111.412 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.05 -25.8 62.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.257 -0.428 . . . . 10.0 111.526 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.4 m -61.24 -60.35 3.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.22 -0.445 . . . . 10.0 111.519 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.521 ' HB3' ' C4 ' ' A' ' 201' ' ' 8TL . 42.9 t80 -66.22 -31.88 72.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.35 -0.386 . . . . 10.0 111.168 -179.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.09 -52.72 62.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.426 . . . . 10.0 111.48 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -74.74 -27.17 60.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.302 -0.408 . . . . 10.0 111.272 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -58.18 -38.89 77.56 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.251 -0.431 . . . . 10.0 111.662 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.2 t -62.77 -34.83 67.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.122 0.487 . . . . 10.0 110.632 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.7 ttpm? -70.41 -34.74 72.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.857 -0.611 . . . . 10.0 110.762 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 35.1 mt -76.75 -35.57 25.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.701 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -71.21 -43.38 67.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.209 -0.45 . . . . 10.0 111.104 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -106.94 44.18 1.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.184 0.516 . . . . 10.0 110.901 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.55 -30.75 78.18 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.882 -0.675 . . . . 10.0 112.291 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.1 m -92.73 -6.28 49.43 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 122.759 -0.26 . . . . 10.0 111.304 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -123.13 85.03 51.3 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 120.794 0.33 . . . . 10.0 110.847 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.42 -26.32 41.01 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.479 2.119 . . . . 10.0 112.812 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.79 -44.48 93.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.653 -0.249 . . . . 10.0 111.087 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.2 m -65.88 -40.79 91.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.063 -0.517 . . . . 10.0 111.034 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -69.06 -37.73 78.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.547 -0.297 . . . . 10.0 110.835 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -61.23 -43.22 99.23 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.856 0.36 . . . . 10.0 110.616 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.96 -37.82 95.18 Favored Glycine 0 C--N 1.332 0.33 0 N-CA-C 111.529 -0.628 . . . . 10.0 111.529 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -57.51 -42.21 82.36 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.974 0.416 . . . . 10.0 110.181 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 26.6 mt -67.12 -38.04 84.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.811 -0.631 . . . . 10.0 110.887 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -61.61 -44.28 97.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.28 -0.418 . . . . 10.0 110.704 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.9 mt -63.7 -35.78 74.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.306 -0.406 . . . . 10.0 110.304 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 82.6 mtp -64.01 -37.11 86.21 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.106 -0.497 . . . . 10.0 110.219 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -62.53 -37.42 86.0 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.008 -0.542 . . . . 10.0 111.153 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -63.45 -36.58 84.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.09 0.471 . . . . 10.0 110.094 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -73.33 -35.63 66.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.048 -0.524 . . . . 10.0 109.747 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -66.73 -23.96 66.17 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.117 -0.492 . . . . 10.0 110.45 178.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.0 m -94.35 2.74 55.8 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.92 -0.582 . . . . 10.0 110.131 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 56.85 31.63 19.95 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.648 -0.706 . . . . 10.0 111.294 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.7 m -82.2 -22.18 36.07 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.563 0.697 . . . . 10.0 109.846 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 17.6 pt -131.99 158.47 43.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.264 -0.88 . . . . 10.0 109.965 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -110.0 -162.46 0.8 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.557 -0.534 . . . . 10.0 109.557 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.483 ' HB ' ' CD ' ' A' ' 73' ' ' PRO . 1.4 m -56.73 -60.17 10.17 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 116.237 -0.438 . . . . 10.0 111.221 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.483 ' CD ' ' HB ' ' A' ' 72' ' ' THR . 25.1 Cg_endo -61.52 -21.73 72.71 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 121.908 1.739 . . . . 10.0 112.594 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.79 -50.31 11.57 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.931 -0.577 . . . . 10.0 112.674 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.602 ' O ' HG23 ' A' ' 79' ' ' VAL . 14.5 p -65.18 -36.85 78.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.89 0.345 . . . . 10.0 110.898 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.441 HD12 ' HA ' ' A' ' 73' ' ' PRO . 60.5 mt -58.64 -38.99 74.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 116.299 -0.409 . . . . 10.0 111.081 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 -60.87 -39.29 88.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.957 -0.565 . . . . 10.0 110.928 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -69.63 -45.56 68.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.805 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.61 HG12 HG12 ' A' ' 90' ' ' ILE . 13.6 t -61.0 -38.28 79.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.906 -0.588 . . . . 10.0 110.971 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.481 ' HA ' HD13 ' A' ' 90' ' ' ILE . 23.0 m -65.95 -17.38 64.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.469 . . . . 10.0 111.786 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -102.52 -23.84 13.86 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 111.799 0.296 . . . . 10.0 111.799 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 40.3 tp -85.26 -53.08 5.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.929 0.395 . . . . 10.0 110.348 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -94.96 47.61 1.16 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.025 0.44 . . . . 10.0 110.11 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.411 ' CE1' ' HG2' ' A' ' 85' ' ' GLU . 25.8 p80 -66.08 -25.46 67.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.993 -0.549 . . . . 10.0 110.771 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.411 ' HG2' ' CE1' ' A' ' 84' ' ' HIS . 53.0 mm-40 -91.0 -9.54 45.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.114 -0.494 . . . . 10.0 110.583 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -128.97 72.05 81.91 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.289 -0.414 . . . . 10.0 111.214 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -61.8 -26.91 80.0 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.581 2.187 . . . . 10.0 112.587 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -56.27 -38.8 71.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.865 -0.607 . . . . 10.0 111.964 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 97.7 mt -64.36 -42.83 95.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.381 -0.372 . . . . 10.0 111.208 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.61 HG12 HG12 ' A' ' 79' ' ' VAL . 3.3 mt -73.0 -41.01 59.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.088 -0.506 . . . . 10.0 111.03 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.435 ' O ' ' HB2' ' A' ' 94' ' ' ASN . 78.7 t -67.36 -48.35 77.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.973 -0.558 . . . . 10.0 110.597 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.68 -31.19 77.07 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.002 -0.618 . . . . 10.0 112.45 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -63.93 -24.92 67.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.696 0.284 . . . . 10.0 111.17 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' A' ' 91' ' ' VAL . 2.6 m-80 -63.72 -33.68 76.19 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.031 0.443 . . . . 10.0 110.426 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -95.58 -16.68 21.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.211 0.529 . . . . 10.0 110.343 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -89.35 31.57 0.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.809 -0.632 . . . . 10.0 110.46 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.2 mt -121.35 108.48 35.82 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.4 -0.818 . . . . 10.0 109.178 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -59.7 -49.15 10.82 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.393 2.062 . . . . 10.0 111.849 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.49 118.31 10.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.283 -0.417 . . . . 10.0 110.367 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -168.21 -134.92 1.79 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.55 -0.833 . . . . 10.0 112.53 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -82.83 13.41 2.62 Favored 'Trans proline' 0 CA--C 1.529 0.226 0 C-N-CA 122.88 2.387 . . . . 10.0 113.284 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.2 m -73.65 162.58 29.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.709 0.29 . . . . 10.0 110.261 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.6 m -72.7 104.64 4.0 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.926 0.393 . . . . 10.0 110.532 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.457 0 C-N-CA 120.902 -0.666 . . . . 10.0 112.375 179.698 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' 8TL . . . . . 0.779 ' C11' ' O3 ' ' A' ' 201' ' ' 8TL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.573 0 N-CA-C 112.241 -0.344 . . . . 10.0 112.241 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.8 m -139.27 129.8 25.78 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.852 0.358 . . . . 10.0 110.536 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.9 m -87.86 104.71 16.86 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.405 -0.361 . . . . 10.0 110.422 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -176.81 166.97 38.09 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.113 -0.565 . . . . 10.0 111.965 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 65.7 m -151.74 93.09 1.82 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.102 0.477 . . . . 10.0 110.766 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.56 113.58 24.29 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.947 -0.57 . . . . 10.0 109.907 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 155.08 74.22 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.803 -0.713 . . . . 10.0 111.416 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 28.5 m -84.47 156.54 3.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.094 0.473 . . . . 10.0 111.027 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -112.14 -178.55 3.45 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.585 -0.734 . . . . 10.0 109.321 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.405 HG22 ' H ' ' A' ' 34' ' ' VAL . 1.9 m -67.24 -36.27 76.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.721 0.296 . . . . 10.0 111.73 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -115.05 105.72 13.28 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.882 0.372 . . . . 10.0 110.222 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -139.75 3.51 2.06 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.566 0.58 . . . . 10.0 112.566 -178.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.61 -37.73 87.43 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.122 0.487 . . . . 10.0 110.613 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.493 ' H ' ' HG ' ' A' ' 38' ' ' LEU . 0.7 OUTLIER -64.02 -24.07 67.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.536 -0.756 . . . . 10.0 111.51 179.738 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.3 m -68.36 -47.49 67.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.531 -0.304 . . . . 10.0 111.39 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -67.93 -36.56 80.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.922 0.391 . . . . 10.0 110.323 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 59.0 mt -65.08 -28.67 69.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.909 -0.587 . . . . 10.0 110.736 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -76.85 -38.09 54.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.687 -0.688 . . . . 10.0 110.206 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -59.1 -36.4 75.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.769 -0.65 . . . . 10.0 111.168 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 54.0 t -61.1 -40.92 87.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.982 -0.554 . . . . 10.0 110.911 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.1 pttm -71.09 -24.19 62.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.371 -0.377 . . . . 10.0 111.09 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 81.9 mt -78.01 -48.7 22.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 121.014 0.435 . . . . 10.0 110.087 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -63.68 -40.57 97.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.762 -0.653 . . . . 10.0 111.357 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -103.59 40.02 1.5 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.099 0.476 . . . . 10.0 110.428 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -70.82 -29.36 69.43 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.697 -0.763 . . . . 10.0 112.38 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.4 m -81.74 -31.27 32.08 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.407 0.146 . . . . 10.0 111.04 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -113.56 106.67 53.91 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.791 0.329 . . . . 10.0 110.848 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -81.15 -11.62 12.07 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.473 2.115 . . . . 10.0 112.686 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.95 -48.87 64.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.09 -0.504 . . . . 10.0 110.744 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.5 m -66.29 -32.96 74.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 10.0 110.523 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -72.4 -43.3 64.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 10.0 110.241 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -64.55 -37.75 88.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.066 -0.516 . . . . 10.0 110.248 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.65 -26.83 73.65 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.765 -0.652 . . . . 10.0 111.628 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -68.05 -36.81 80.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.267 0.556 . . . . 10.0 109.681 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 60.5 mt -66.06 -36.81 84.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.687 -0.688 . . . . 10.0 110.606 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -66.54 -31.45 72.17 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.064 -0.516 . . . . 10.0 110.788 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.2 mt -65.29 -42.87 94.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.228 0.537 . . . . 10.0 110.577 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.471 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 67.8 mtp -65.8 -33.56 76.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.039 -0.528 . . . . 10.0 110.657 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.39 -34.6 77.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 10.0 111.421 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -67.97 -31.89 71.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.044 0.45 . . . . 10.0 110.566 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -81.13 -29.7 34.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.636 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 62' ' ' MET . 23.7 mtpp -59.0 -41.21 87.13 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.902 0.382 . . . . 10.0 110.771 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.1 m -88.52 8.37 28.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 10.0 110.967 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 58.33 30.57 19.75 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.656 -0.702 . . . . 10.0 111.038 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.3 m -77.14 -24.71 51.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.086 -0.506 . . . . 10.0 110.844 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 36.1 pt -125.31 162.87 27.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.114 -0.494 . . . . 10.0 110.121 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -112.22 -172.4 2.04 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.939 -0.573 . . . . 10.0 110.055 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.609 ' O ' HG12 ' A' ' 75' ' ' VAL . 2.1 m -54.7 -54.39 49.78 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 116.362 -0.381 . . . . 10.0 111.841 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 72' ' ' THR . 28.7 Cg_endo -63.26 -26.12 72.0 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 121.793 1.662 . . . . 10.0 111.994 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.73 -41.93 72.63 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.759 -0.655 . . . . 10.0 112.571 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.609 HG12 ' O ' ' A' ' 72' ' ' THR . 4.2 p -65.51 -29.95 48.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 120.704 0.287 . . . . 10.0 110.372 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 63.6 mt -63.07 -42.73 97.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 10.0 110.209 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -62.02 -40.06 94.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.533 -0.758 . . . . 10.0 109.934 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -66.63 -46.76 74.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.943 -0.572 . . . . 10.0 110.957 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.1 t -66.3 -43.99 91.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.216 -0.447 . . . . 10.0 111.107 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.554 ' HA ' HD13 ' A' ' 90' ' ' ILE . 0.4 OUTLIER -60.57 -37.98 83.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.122 -0.49 . . . . 10.0 111.196 -179.506 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -79.3 -27.09 42.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.708 -0.223 . . . . 10.0 111.363 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 35.5 tp -76.22 -51.94 11.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.879 0.371 . . . . 10.0 110.346 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 -91.5 48.74 1.5 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.206 0.527 . . . . 10.0 110.212 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -68.7 -8.99 47.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.82 -0.627 . . . . 10.0 111.766 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -110.23 -12.03 14.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.836 0.351 . . . . 10.0 111.047 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -130.46 80.87 69.43 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.385 -0.37 . . . . 10.0 111.001 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -62.31 -28.95 79.23 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.597 2.198 . . . . 10.0 112.298 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -58.5 -36.72 74.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.599 -0.728 . . . . 10.0 111.468 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 95.7 mt -75.72 -30.25 59.2 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.408 -0.36 . . . . 10.0 111.125 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.554 HD13 ' HA ' ' A' ' 80' ' ' SER . 45.4 mt -69.05 -46.17 78.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.347 0.594 . . . . 10.0 109.459 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.411 ' O ' ' HB2' ' A' ' 94' ' ' ASN . 46.3 t -70.11 -37.33 71.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.318 -0.855 . . . . 10.0 109.751 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.32 -40.63 94.31 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.748 -0.66 . . . . 10.0 112.189 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -60.25 -28.91 68.42 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.754 0.311 . . . . 10.0 110.747 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' A' ' 91' ' ' VAL . 28.4 m-80 -69.78 -17.73 63.44 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.44 -0.345 . . . . 10.0 110.662 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.78 -3.47 24.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.89 0.376 . . . . 10.0 111.024 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -112.86 20.19 16.66 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.064 0.459 . . . . 10.0 110.842 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 17.5 mt -80.22 116.15 59.53 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.815 -0.629 . . . . 10.0 109.831 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.32 -18.41 30.06 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.38 2.054 . . . . 10.0 112.74 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.71 158.27 30.47 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.867 -0.42 . . . . 10.0 109.867 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 169.77 -134.32 3.13 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 121.007 -0.616 . . . . 10.0 111.624 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.57 -9.48 18.58 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.755 2.304 . . . . 10.0 111.533 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 m -66.23 152.11 45.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.673 -0.694 . . . . 10.0 111.373 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.56 133.81 55.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.905 -0.589 . . . . 10.0 111.081 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.222 0 CA-C-N 115.967 -0.56 . . . . 10.0 112.463 179.425 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' 8TL . . . . . 0.761 ' C11' ' O3 ' ' A' ' 201' ' ' 8TL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.382 0 N-CA-C 112.051 -0.419 . . . . 10.0 112.051 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -115.56 137.88 51.61 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.753 0.277 . . . . 10.0 110.572 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 19.0 m -101.12 73.17 1.5 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.105 0.478 . . . . 10.0 110.716 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -155.44 137.86 5.79 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.022 -0.609 . . . . 10.0 111.71 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.1 m -106.65 105.25 15.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.901 0.381 . . . . 10.0 110.78 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.4 m -90.56 150.79 21.6 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.76 0.314 . . . . 10.0 110.425 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.88 91.74 2.22 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.695 -0.764 . . . . 10.0 111.643 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.7 m -91.69 164.57 2.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.654 0.264 . . . . 10.0 110.762 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -119.36 177.05 5.05 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.282 -0.417 . . . . 10.0 110.209 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.3 m -81.98 -12.7 12.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.919 0.39 . . . . 10.0 110.856 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -139.95 87.64 2.17 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.185 -0.461 . . . . 10.0 110.111 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.2 p30 -128.61 12.02 6.31 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.25 -0.432 . . . . 10.0 111.037 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.91 -44.69 96.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.261 0.553 . . . . 10.0 111.072 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.541 HD23 ' H ' ' A' ' 38' ' ' LEU . 1.8 pt? -63.24 -31.41 72.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.519 -0.764 . . . . 10.0 111.002 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 m -62.05 -51.42 68.06 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.086 -0.506 . . . . 10.0 111.191 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -70.01 -30.04 67.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.449 -0.341 . . . . 10.0 110.626 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.48 -34.89 78.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.965 0.412 . . . . 10.0 110.528 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -73.87 -32.58 63.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.296 -0.411 . . . . 10.0 110.185 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -60.16 -38.63 83.76 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.092 -0.503 . . . . 10.0 109.782 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 92.9 t -60.35 -39.43 80.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.657 -0.702 . . . . 10.0 109.7 178.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.8 ttpm? -67.04 -38.0 85.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.226 -0.897 . . . . 10.0 110.748 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 57.7 mt -71.0 -43.78 76.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.287 -0.415 . . . . 10.0 110.33 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -62.12 -36.49 81.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 10.0 111.231 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -101.94 36.36 2.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.058 0.456 . . . . 10.0 111.284 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.81 -36.3 89.46 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.855 -0.612 . . . . 10.0 111.984 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.0 m -101.69 13.36 35.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.603 0.24 . . . . 10.0 111.087 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -142.04 74.93 21.18 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.949 0.404 . . . . 10.0 110.752 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -63.71 -26.89 68.36 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.594 2.196 . . . . 10.0 112.476 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.12 -50.03 73.51 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.761 0.315 . . . . 10.0 110.989 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.9 m -63.03 -38.36 90.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.301 -0.409 . . . . 10.0 110.682 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -69.43 -40.11 77.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.412 -0.358 . . . . 10.0 110.791 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -64.65 -41.42 96.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.366 -0.379 . . . . 10.0 110.295 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.83 -27.96 72.77 Favored Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.886 -0.597 . . . . 10.0 111.788 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -64.47 -42.29 95.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.964 0.412 . . . . 10.0 110.393 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.9 mt -64.15 -29.84 70.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.981 -0.554 . . . . 10.0 110.613 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -68.81 -34.2 75.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 10.0 110.259 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.8 mt -67.88 -36.01 74.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.964 -0.562 . . . . 10.0 109.621 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.76 -31.46 72.64 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.591 -0.732 . . . . 10.0 110.156 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -62.36 -39.57 93.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.066 -0.516 . . . . 10.0 111.32 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -63.84 -37.18 86.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.171 -0.468 . . . . 10.0 110.453 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -74.79 -36.5 62.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.123 -0.49 . . . . 10.0 110.474 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -64.28 -41.02 97.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.312 -0.404 . . . . 10.0 110.9 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.7 m -81.8 0.24 40.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.388 -0.369 . . . . 10.0 110.918 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 61.32 32.06 19.24 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.688 -0.687 . . . . 10.0 111.95 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.1 m -78.15 -24.18 47.42 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.193 -0.669 . . . . 10.0 109.193 178.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 45.6 pt -135.91 -179.06 2.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.16 -0.927 . . . . 10.0 109.314 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -136.3 -151.2 0.4 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.927 -0.397 . . . . 10.0 109.927 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.485 HG23 ' C16' ' A' ' 201' ' ' 8TL . 7.1 m -55.72 -57.81 19.29 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 113.167 0.803 . . . . 10.0 113.167 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.459 ' HD3' ' HB ' ' A' ' 72' ' ' THR . 18.8 Cg_endo -61.15 -38.42 67.05 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 121.832 1.688 . . . . 10.0 112.964 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.56 -45.35 93.3 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 116.129 -0.487 . . . . 10.0 113.386 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.45 -39.5 82.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.768 -0.373 . . . . 10.0 111.303 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 81.4 mt -65.57 -43.87 94.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.797 0.332 . . . . 10.0 110.113 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 34.9 ttp-105 -61.58 -37.51 84.14 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.138 -0.483 . . . . 10.0 110.814 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.68 -50.26 58.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.151 -0.477 . . . . 10.0 110.888 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 94.5 t -66.39 -30.95 51.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.111 -0.495 . . . . 10.0 111.869 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 71.0 m -61.19 -27.89 68.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.002 0.429 . . . . 10.0 110.751 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -85.81 -28.97 24.15 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.826 -0.624 . . . . 10.0 110.374 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 25.9 tp -75.67 -45.48 36.78 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.87 -0.604 . . . . 10.0 109.842 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 6.1 m-30 -90.89 41.9 1.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.855 -0.611 . . . . 10.0 109.959 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -65.32 -21.18 66.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.483 -0.326 . . . . 10.0 111.678 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -103.83 5.64 36.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.962 0.411 . . . . 10.0 110.508 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -134.96 69.73 70.74 Favored Pre-proline 0 C--O 1.235 0.341 0 CA-C-N 116.413 -0.358 . . . . 10.0 110.923 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -62.16 -29.74 81.17 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.255 1.97 . . . . 10.0 112.2 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.49 -46.68 83.45 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.009 -0.541 . . . . 10.0 110.703 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 81.0 mt -64.25 -36.29 83.62 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.407 -0.815 . . . . 10.0 111.394 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 94.2 mt -62.57 -47.28 93.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.894 0.378 . . . . 10.0 110.458 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 43.2 t -70.05 -42.72 79.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.293 -0.412 . . . . 10.0 110.649 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.78 -43.84 97.54 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.956 -0.566 . . . . 10.0 112.761 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -62.26 -34.59 76.83 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.699 0.285 . . . . 10.0 111.367 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 -58.59 -38.55 78.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 10.0 111.03 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -91.47 -19.87 22.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.307 -0.406 . . . . 10.0 111.62 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -69.91 -35.32 74.51 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.674 0.274 . . . . 10.0 111.042 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 97' ' ' LEU . 9.3 mt -72.01 126.59 91.24 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 120.848 0.356 . . . . 10.0 111.339 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.72 -18.79 11.65 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.829 2.353 . . . . 10.0 111.984 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.42 130.74 43.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.798 -0.637 . . . . 10.0 111.025 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 161.65 -128.26 1.88 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.094 -0.575 . . . . 10.0 111.758 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -89.35 24.8 0.64 Allowed 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.788 2.325 . . . . 10.0 111.99 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.08 166.99 21.15 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.519 -0.764 . . . . 10.0 111.651 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.17 109.27 1.26 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.823 -0.626 . . . . 10.0 111.024 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.486 0 C-N-CA 120.472 -0.871 . . . . 10.0 112.582 179.596 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' 8TL . . . . . 0.77 ' C11' ' O3 ' ' A' ' 201' ' ' 8TL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.406 0 N-CA-C 112.023 -0.431 . . . . 10.0 112.023 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.67 136.63 32.94 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 117.05 0.425 . . . . 10.0 109.988 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.3 m -82.55 93.47 7.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.856 0.36 . . . . 10.0 110.457 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -150.8 135.99 5.4 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.636 -0.792 . . . . 10.0 112.372 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.2 m -117.98 84.06 2.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.239 0.542 . . . . 10.0 110.493 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.6 m -78.26 147.17 34.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.814 -0.63 . . . . 10.0 110.649 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.08 78.96 0.75 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.826 -0.702 . . . . 10.0 111.486 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.4 m -87.93 160.01 2.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.214 0.531 . . . . 10.0 110.97 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -112.9 174.84 5.7 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.95 -0.568 . . . . 10.0 110.193 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.2 m -68.04 -32.57 56.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.166 0.508 . . . . 10.0 109.826 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -113.07 80.47 1.36 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.27 -0.877 . . . . 10.0 109.211 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -123.83 2.4 8.78 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.035 -0.529 . . . . 10.0 111.547 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.51 -49.8 76.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.375 0.607 . . . . 10.0 111.001 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -66.69 -9.33 35.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.607 -0.724 . . . . 10.0 111.833 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.9 m -72.57 -37.44 68.2 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.58 0.228 . . . . 10.0 111.031 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -74.39 -29.55 61.58 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.788 -0.365 . . . . 10.0 110.615 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -58.0 -43.87 86.86 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.767 -0.457 . . . . 10.0 109.767 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.408 ' O ' HG13 ' A' ' 46' ' ' ILE . 36.6 t70 -64.77 -41.88 95.53 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.696 -0.683 . . . . 10.0 110.81 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -61.19 -38.22 85.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.812 -0.631 . . . . 10.0 111.006 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.62 -40.98 89.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.57 -0.53 . . . . 10.0 109.57 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.06 -29.15 68.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.727 -0.67 . . . . 10.0 110.862 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 42' ' ' ASP . 80.6 mt -75.13 -47.25 36.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.529 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 -62.94 -34.26 77.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.22 -0.446 . . . . 10.0 111.398 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -107.19 41.76 1.43 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.15 0.5 . . . . 10.0 110.506 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -70.75 -27.3 72.6 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.938 -0.648 . . . . 10.0 112.538 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.6 t -100.96 5.32 43.14 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.064 0.459 . . . . 10.0 110.473 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -135.64 86.33 28.67 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.815 -0.63 . . . . 10.0 110.105 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -74.32 -15.74 22.39 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.275 1.983 . . . . 10.0 112.644 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.69 -49.58 61.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.316 -0.402 . . . . 10.0 111.114 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.6 m -66.52 -33.31 75.4 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.318 -0.401 . . . . 10.0 110.779 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -67.64 -41.75 83.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.166 -0.47 . . . . 10.0 110.708 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -62.47 -38.59 90.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.935 0.398 . . . . 10.0 110.567 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.27 -33.25 84.52 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.918 -0.658 . . . . 10.0 111.898 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -61.85 -41.94 98.45 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.947 0.403 . . . . 10.0 110.181 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 24.5 mt -66.71 -36.29 82.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.963 -0.562 . . . . 10.0 110.287 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -62.27 -42.43 99.33 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.665 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.2 mt -66.17 -36.62 77.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.533 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 46.2 mtp -62.12 -34.06 75.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 10.0 110.631 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -62.36 -38.57 90.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.292 -0.413 . . . . 10.0 110.613 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -66.37 -36.83 83.87 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.379 -0.6 . . . . 10.0 109.379 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -68.87 -43.82 74.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.43 -0.805 . . . . 10.0 109.981 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -64.16 -37.17 86.51 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.083 -0.508 . . . . 10.0 111.203 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.7 m -82.5 4.38 24.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.302 -0.408 . . . . 10.0 111.336 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 58.97 28.46 17.67 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.874 -0.603 . . . . 10.0 111.449 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.6 m -75.71 -38.52 58.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.18 0.514 . . . . 10.0 110.143 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.2 pt -120.97 157.73 23.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.689 -0.687 . . . . 10.0 110.106 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -106.85 -163.25 0.9 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.173 -0.467 . . . . 10.0 110.399 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.486 ' O ' HG12 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -55.0 -57.05 21.48 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 112.772 0.656 . . . . 10.0 112.772 -179.724 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 72' ' ' THR . 20.5 Cg_endo -60.94 -29.45 88.05 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.043 1.828 . . . . 10.0 112.666 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.13 -48.17 20.89 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.625 -0.798 . . . . 10.0 112.017 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.486 HG12 ' O ' ' A' ' 72' ' ' THR . 5.6 p -63.91 -30.39 49.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.565 0.221 . . . . 10.0 110.753 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.5 mt -66.2 -49.22 77.73 Favored 'Isoleucine or valine' 0 C--N 1.337 0.053 0 N-CA-C 109.714 -0.476 . . . . 10.0 109.714 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 60.2 ttp180 -61.44 -42.61 99.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.864 -0.607 . . . . 10.0 110.799 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -56.53 -41.62 77.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.88 -0.6 . . . . 10.0 111.568 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.6 p -84.21 -22.36 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 120.826 -0.349 . . . . 10.0 111.625 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.5 m -64.25 -42.42 96.52 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.022 0.439 . . . . 10.0 110.737 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -77.3 -14.25 59.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.121 -0.49 . . . . 10.0 110.316 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 18.3 tp -86.44 -43.5 12.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.862 -0.608 . . . . 10.0 110.065 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -103.62 37.21 2.08 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.897 -0.592 . . . . 10.0 109.935 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -64.16 -24.56 67.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.321 -0.4 . . . . 10.0 111.595 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -92.55 0.26 57.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.467 -0.333 . . . . 10.0 110.895 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 18.4 m170 -136.34 81.03 38.24 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-O 120.675 0.274 . . . . 10.0 110.857 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -65.1 -27.53 57.21 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.483 2.122 . . . . 10.0 112.343 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -57.62 -42.6 83.65 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.8 -0.636 . . . . 10.0 110.96 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 96.1 mt -68.9 -41.04 78.8 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.127 -0.488 . . . . 10.0 111.184 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 59.3 mt -60.6 -48.01 90.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-O 121.116 0.484 . . . . 10.0 110.972 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.4 t -71.5 -42.8 72.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.985 -0.552 . . . . 10.0 110.834 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.77 -45.38 95.84 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.817 -0.629 . . . . 10.0 112.859 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.413 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 39.5 t80 -63.19 -34.42 77.61 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.729 0.3 . . . . 10.0 111.022 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -62.82 -36.09 82.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.406 -0.361 . . . . 10.0 111.149 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.9 -21.22 26.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.865 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -77.17 -25.14 51.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.903 -0.59 . . . . 10.0 110.908 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 93' ' ' PHE . 57.9 mt -52.34 125.55 34.98 Favored Pre-proline 0 C--O 1.235 0.304 0 CA-C-N 116.126 -0.488 . . . . 10.0 112.172 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -67.75 -30.66 33.75 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.586 2.19 . . . . 10.0 111.57 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.83 145.95 38.09 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.65 -0.705 . . . . 10.0 110.494 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 171.29 -169.02 42.15 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.775 -0.726 . . . . 10.0 111.963 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.37 15.89 0.62 Allowed 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 123.535 2.823 . . . . 10.0 113.125 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.81 179.59 2.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.018 0.437 . . . . 10.0 110.702 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.9 t -78.3 116.96 19.1 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.878 -0.416 . . . . 10.0 109.878 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.146 0 C-N-CA 120.882 -0.675 . . . . 10.0 112.346 179.747 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' 8TL . . . . . 0.751 ' C11' ' O3 ' ' A' ' 201' ' ' 8TL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.139 0 N-CA-C 112.47 -0.252 . . . . 10.0 112.47 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.87 117.9 16.38 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.966 -0.383 . . . . 10.0 109.966 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.1 m -68.46 123.47 20.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 10.0 110.792 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 161.27 129.45 1.03 Allowed Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.846 -0.693 . . . . 10.0 111.594 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.57 94.46 5.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.019 0.438 . . . . 10.0 110.882 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.4 m -81.35 149.35 28.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.122 -0.49 . . . . 10.0 109.816 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.37 74.28 1.07 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.019 -0.61 . . . . 10.0 111.972 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.8 m -82.47 161.29 3.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.775 0.322 . . . . 10.0 111.066 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -101.73 178.07 4.73 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.575 -0.528 . . . . 10.0 109.575 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 32.1 m -81.65 4.99 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.155 0.502 . . . . 10.0 111.235 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -153.52 103.45 2.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.87 -0.605 . . . . 10.0 109.763 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 38.6 p-10 -135.57 17.29 3.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.151 0.5 . . . . 10.0 110.733 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.58 -41.79 99.15 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.755 -0.657 . . . . 10.0 111.147 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.584 HD23 ' H ' ' A' ' 38' ' ' LEU . 2.2 pt? -71.17 -30.87 66.96 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.932 -0.577 . . . . 10.0 110.773 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.22 -43.87 93.65 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.209 -0.45 . . . . 10.0 110.876 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -67.45 -38.32 84.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 10.0 110.201 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.64 -41.49 99.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.26 0.552 . . . . 10.0 110.528 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.579 ' O ' HG13 ' A' ' 46' ' ' ILE . 22.1 t70 -66.43 -35.78 81.16 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.369 -0.832 . . . . 10.0 110.874 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -59.53 -45.48 91.64 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.031 0.443 . . . . 10.0 110.712 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 64.7 t -59.51 -35.83 61.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 115.517 -0.765 . . . . 10.0 110.373 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.4 ttpm? -67.51 -35.06 78.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.229 -0.896 . . . . 10.0 110.863 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.579 HG13 ' O ' ' A' ' 42' ' ' ASP . 23.4 mt -76.22 -47.04 32.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.573 -0.285 . . . . 10.0 110.938 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -58.87 -47.14 85.99 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.039 -0.528 . . . . 10.0 111.712 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -104.27 54.65 0.73 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.21 0.528 . . . . 10.0 110.986 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.83 -36.35 29.02 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.709 -0.757 . . . . 10.0 111.521 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.09 4.83 28.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.928 0.394 . . . . 10.0 110.994 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -138.83 87.83 14.25 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.001 -0.545 . . . . 10.0 109.917 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -70.7 -21.0 29.71 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.361 2.041 . . . . 10.0 112.598 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.78 -47.44 83.48 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.499 -0.318 . . . . 10.0 111.328 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.8 m -63.15 -43.27 98.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.077 0.465 . . . . 10.0 110.587 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -65.2 -39.83 93.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.11 -0.495 . . . . 10.0 110.91 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -65.87 -35.97 82.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.985 -0.552 . . . . 10.0 110.705 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -69.53 -33.69 72.52 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.647 -0.706 . . . . 10.0 111.542 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -59.53 -34.82 73.13 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.099 0.476 . . . . 10.0 110.334 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 23.9 mt -62.98 -41.28 99.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.752 -0.658 . . . . 10.0 110.64 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -67.18 -30.39 70.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.97 -0.559 . . . . 10.0 110.637 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.7 mt -65.62 -47.63 85.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.069 -0.514 . . . . 10.0 110.419 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 44.1 mtp -66.07 -27.12 67.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.965 -0.561 . . . . 10.0 111.065 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -63.29 -41.77 99.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.232 -0.44 . . . . 10.0 110.989 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -64.05 -33.32 75.48 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.074 0.464 . . . . 10.0 110.46 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -74.92 -41.27 60.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.7 -0.682 . . . . 10.0 110.466 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -62.63 -34.35 76.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.842 -0.617 . . . . 10.0 111.307 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 68.6 m -82.42 -0.66 47.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.417 -0.356 . . . . 10.0 111.104 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 63.33 23.02 13.58 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.029 -0.532 . . . . 10.0 111.504 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.36 -41.64 39.54 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.845 -0.798 . . . . 10.0 108.845 178.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 31.2 pt -114.87 165.9 9.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.676 -0.693 . . . . 10.0 110.083 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -123.12 -166.48 1.46 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.129 -0.487 . . . . 10.0 109.77 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.478 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 7.1 m -49.02 -55.25 21.6 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 112.029 0.381 . . . . 10.0 112.029 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 72' ' ' THR . 11.5 Cg_endo -55.84 -34.48 91.53 Favored 'Trans proline' 0 C--N 1.358 1.028 0 C-N-CA 122.387 2.058 . . . . 10.0 112.548 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.68 -44.51 62.96 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.778 -0.725 . . . . 10.0 111.939 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.595 ' O ' HG23 ' A' ' 79' ' ' VAL . 82.5 t -60.97 -45.45 98.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.951 -0.388 . . . . 10.0 109.951 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 88.8 mt -55.49 -42.57 68.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.09 -0.504 . . . . 10.0 110.984 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 41.4 ttp180 -59.23 -44.82 92.3 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.137 0.494 . . . . 10.0 109.897 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -63.54 -46.85 84.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.734 -0.666 . . . . 10.0 110.263 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 75' ' ' VAL . 64.3 t -58.46 -43.91 87.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.545 -0.752 . . . . 10.0 111.205 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.429 ' HA ' HD13 ' A' ' 90' ' ' ILE . 9.8 m -66.04 -38.23 87.84 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.182 -0.463 . . . . 10.0 111.59 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -75.84 -20.22 58.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.908 0.385 . . . . 10.0 110.855 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.2 tp -87.55 -53.57 4.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.984 -0.553 . . . . 10.0 110.654 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -97.57 44.52 1.04 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.953 0.406 . . . . 10.0 110.552 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -69.93 -13.59 62.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.321 -0.399 . . . . 10.0 111.424 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -96.95 -12.48 23.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.996 0.426 . . . . 10.0 110.271 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -136.01 77.69 49.11 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 10.0 110.964 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -62.49 -23.41 74.91 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.588 2.192 . . . . 10.0 112.34 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.5 -23.85 67.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.115 -0.493 . . . . 10.0 111.024 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 81.6 mt -87.38 -30.47 20.73 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.459 -0.337 . . . . 10.0 110.49 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.429 HD13 ' HA ' ' A' ' 80' ' ' SER . 55.5 mt -63.48 -51.94 64.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.893 0.378 . . . . 10.0 110.903 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.6 t -63.2 -27.46 43.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.851 -0.613 . . . . 10.0 110.421 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.49 -37.55 92.28 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.431 -0.668 . . . . 10.0 111.431 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -66.67 -39.39 88.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.889 0.376 . . . . 10.0 110.408 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -63.54 -34.87 78.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.585 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -90.24 0.66 57.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.159 -0.473 . . . . 10.0 110.792 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -106.49 2.51 26.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.262 -0.426 . . . . 10.0 110.777 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 53.9 mt -69.96 118.18 61.0 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.276 -0.42 . . . . 10.0 111.069 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -70.79 -41.89 2.69 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.469 2.113 . . . . 10.0 112.536 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.3 m -94.23 149.97 20.74 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 116.321 -0.4 . . . . 10.0 110.232 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -177.9 -141.94 4.41 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.644 -0.789 . . . . 10.0 111.732 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -80.44 0.84 9.73 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.699 2.266 . . . . 10.0 112.424 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.02 157.96 32.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.394 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.2 m -69.19 139.2 54.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.856 0.36 . . . . 10.0 111.426 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.451 0 C-N-CA 120.665 -0.779 . . . . 10.0 112.171 179.912 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' 8TL . . . . . 0.777 ' C11' ' O3 ' ' A' ' 201' ' ' 8TL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.265 0 N-CA-C 112.03 -0.428 . . . . 10.0 112.03 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.39 138.43 50.36 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 110.127 -0.323 . . . . 10.0 110.127 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.0 m -105.3 101.55 11.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.989 0.423 . . . . 10.0 110.368 -179.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -161.32 126.28 1.56 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 121.06 -0.59 . . . . 10.0 112.09 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.75 82.47 2.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.032 0.444 . . . . 10.0 110.529 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.7 m -79.47 134.86 36.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.604 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.58 86.17 1.82 Allowed Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.52 -0.847 . . . . 10.0 112.641 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.9 m -103.62 156.53 5.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 110.068 -0.345 . . . . 10.0 110.068 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -94.63 -164.42 1.17 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.235 -0.438 . . . . 10.0 110.751 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.8 m -78.36 -22.12 13.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.125 0.488 . . . . 10.0 110.929 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -113.59 85.01 2.11 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.414 0.626 . . . . 10.0 110.456 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -113.05 -4.55 13.84 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.541 -0.754 . . . . 10.0 110.402 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.49 -40.13 95.68 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.336 -0.847 . . . . 10.0 112.419 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.15 -9.14 58.81 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.919 0.341 . . . . 10.0 111.919 -178.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.76 -49.55 24.93 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.137 0.494 . . . . 10.0 111.702 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.42 ' HB3' ' C5 ' ' A' ' 201' ' ' 8TL . 64.6 t80 -73.17 -12.9 61.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.07 -0.514 . . . . 10.0 111.499 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.93 -45.81 69.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.007 0.432 . . . . 10.0 110.829 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -69.92 -32.28 70.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.35 -0.386 . . . . 10.0 111.379 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -56.64 -35.13 68.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.929 -0.578 . . . . 10.0 110.885 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 28.7 t -66.02 -42.45 91.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 10.0 110.045 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -63.33 -38.59 91.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.873 -0.603 . . . . 10.0 111.084 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 57.2 mt -73.77 -44.92 51.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 10.0 110.967 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -58.26 -40.96 83.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 10.0 110.894 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -110.13 41.73 1.67 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.335 0.588 . . . . 10.0 110.454 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.87 -28.17 73.41 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.952 -0.642 . . . . 10.0 112.053 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.3 m -96.23 2.38 52.93 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.803 0.335 . . . . 10.0 110.864 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -134.01 86.74 36.62 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 109.591 -0.522 . . . . 10.0 109.591 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -68.27 -17.75 44.77 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.922 2.414 . . . . 10.0 112.582 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.59 -49.28 69.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.058 -0.519 . . . . 10.0 111.122 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.8 m -62.85 -43.19 99.47 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.549 -0.296 . . . . 10.0 111.246 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -65.4 -40.12 93.02 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 110.128 -0.323 . . . . 10.0 110.128 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -60.86 -48.13 83.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 10.0 110.361 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.457 ' O ' HG13 ' A' ' 61' ' ' ILE . . . -60.02 -44.55 97.14 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.93 -0.652 . . . . 10.0 111.828 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -55.78 -43.23 76.59 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.757 0.313 . . . . 10.0 110.891 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 77.8 mt -64.55 -38.03 89.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.932 -0.576 . . . . 10.0 111.26 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -70.71 -39.91 73.13 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.296 -0.411 . . . . 10.0 111.056 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 57' ' ' GLY . 62.4 mt -67.45 -36.5 76.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.024 0.44 . . . . 10.0 110.428 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.93 -31.97 67.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.901 -0.59 . . . . 10.0 111.131 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -63.01 -45.37 92.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.964 -0.562 . . . . 10.0 110.844 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -59.8 -36.34 76.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.916 -0.584 . . . . 10.0 111.663 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -66.73 -42.94 85.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.373 -0.376 . . . . 10.0 110.88 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -74.86 -24.29 58.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.895 -0.593 . . . . 10.0 111.104 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 68.4 m -79.08 5.0 12.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.898 0.38 . . . . 10.0 110.537 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 61.77 33.58 17.75 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.798 -0.637 . . . . 10.0 110.866 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.1 m -93.88 -26.12 17.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.302 -0.408 . . . . 10.0 111.044 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.0 pt -139.85 158.42 26.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.184 -0.462 . . . . 10.0 110.646 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.416 ' HB3' ' H ' ' A' ' 72' ' ' THR . 30.9 m-20 -119.17 -158.93 0.75 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.288 -0.415 . . . . 10.0 110.249 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.428 ' HB ' ' HD3' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -48.21 -59.68 5.58 Favored Pre-proline 0 CA--C 1.542 0.673 0 N-CA-C 112.65 0.611 . . . . 10.0 112.65 -179.6 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.428 ' HD3' ' HB ' ' A' ' 72' ' ' THR . 28.7 Cg_endo -62.91 -35.07 69.18 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 121.554 1.503 . . . . 10.0 112.722 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.1 -44.31 91.52 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 121.099 -0.572 . . . . 10.0 112.256 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.506 ' O ' HG23 ' A' ' 79' ' ' VAL . 8.9 p -74.89 -35.36 35.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 O-C-N 122.853 -0.204 . . . . 10.0 110.906 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 74.0 mt -62.95 -37.92 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.077 0 N-CA-C 110.172 -0.307 . . . . 10.0 110.172 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -59.86 -29.79 68.53 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.287 0.565 . . . . 10.0 110.193 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -81.61 -42.55 19.9 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.716 -0.675 . . . . 10.0 109.656 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 75' ' ' VAL . 97.6 t -59.3 -46.59 92.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.613 -0.721 . . . . 10.0 110.737 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.464 ' HA ' HD13 ' A' ' 90' ' ' ILE . 49.6 m -63.04 -28.85 70.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.952 -0.567 . . . . 10.0 111.512 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -84.91 -40.63 16.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.673 0.273 . . . . 10.0 111.366 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 6.6 tp -64.97 -47.45 77.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.235 0.541 . . . . 10.0 111.056 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -101.18 45.59 0.97 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.013 -0.54 . . . . 10.0 110.076 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -63.93 -29.37 70.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.958 -0.565 . . . . 10.0 111.327 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -98.94 6.37 46.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.964 0.411 . . . . 10.0 110.897 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -137.57 71.11 52.18 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 116.36 -0.382 . . . . 10.0 110.438 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.02 -31.44 76.5 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.338 2.025 . . . . 10.0 112.288 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.78 -32.28 70.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 10.0 110.762 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 89.1 mt -72.11 -42.51 65.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.22 -0.446 . . . . 10.0 110.051 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.464 HD13 ' HA ' ' A' ' 80' ' ' SER . 26.2 mt -65.16 -44.44 95.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 116.036 -0.529 . . . . 10.0 109.805 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 99.1 t -65.11 -37.77 81.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 115.818 -0.628 . . . . 10.0 109.508 178.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -64.18 -38.18 95.58 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.655 -0.783 . . . . 10.0 111.609 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -68.97 -28.1 66.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.96 0.409 . . . . 10.0 110.566 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -62.18 -28.19 69.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.164 0.507 . . . . 10.0 109.926 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.93 8.87 30.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.571 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -117.62 33.35 5.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.831 -0.622 . . . . 10.0 110.072 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.6 mt -106.34 114.68 61.98 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.784 -0.644 . . . . 10.0 110.086 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -71.12 -12.23 30.01 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.626 2.218 . . . . 10.0 112.076 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.3 m -109.93 104.55 13.49 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.029 -0.532 . . . . 10.0 110.563 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -154.49 -149.28 5.21 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.753 -0.737 . . . . 10.0 112.256 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -79.98 39.38 0.83 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.288 2.659 . . . . 10.0 113.232 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 57.9 m -96.35 174.16 7.01 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.147 -0.479 . . . . 10.0 110.228 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.3 m -71.72 95.57 1.49 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.949 0.404 . . . . 10.0 110.252 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.654 0 C-N-CA 120.946 -0.645 . . . . 10.0 111.93 -179.7 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' 8TL . . . . . 0.75 ' C11' ' O3 ' ' A' ' 201' ' ' 8TL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 111.862 -0.495 . . . . 10.0 111.862 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.2 m -118.21 154.65 31.86 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.02 -0.363 . . . . 10.0 110.02 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.3 m -102.26 111.61 23.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.995 0.426 . . . . 10.0 111.0 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -157.04 160.58 30.52 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 121.036 -0.602 . . . . 10.0 111.916 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.3 m -133.98 83.64 2.06 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.055 -0.35 . . . . 10.0 110.055 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.1 m -83.62 99.28 10.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.278 0.561 . . . . 10.0 110.404 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 171.22 66.25 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 111.321 -0.711 . . . . 10.0 111.321 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.4 m -64.85 151.71 9.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.873 0.368 . . . . 10.0 111.294 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 3.2 m170 -116.04 175.68 5.43 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.775 -0.454 . . . . 10.0 109.775 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.7 m -81.26 -23.74 10.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.136 0.493 . . . . 10.0 110.537 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -145.84 88.12 1.81 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.438 0.637 . . . . 10.0 109.936 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -117.87 23.4 11.7 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.682 -0.69 . . . . 10.0 110.254 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.9 -41.95 97.09 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.487 -0.779 . . . . 10.0 110.62 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pp -64.36 -28.47 69.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.534 -0.757 . . . . 10.0 111.303 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.542 ' O ' ' HG2' ' A' ' 43' ' ' GLN . 1.3 m -68.18 -52.78 30.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.068 -0.514 . . . . 10.0 111.358 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.472 ' HB3' ' C4 ' ' A' ' 201' ' ' 8TL . 4.1 t80 -66.38 -28.92 69.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.889 0.376 . . . . 10.0 110.165 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.63 -40.74 96.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.845 -0.616 . . . . 10.0 110.021 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -72.03 -31.27 66.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 10.0 110.554 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.542 ' HG2' ' O ' ' A' ' 39' ' ' THR . 15.9 mm100 -59.21 -40.1 84.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.703 -0.68 . . . . 10.0 110.573 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 92.2 t -59.68 -40.36 82.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.25 0.547 . . . . 10.0 109.863 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.4 ttpm? -62.89 -37.36 86.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.338 -0.846 . . . . 10.0 111.224 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 49.2 mt -73.76 -43.97 52.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.087 0.47 . . . . 10.0 110.795 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -63.66 -37.37 87.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.85 -0.614 . . . . 10.0 111.046 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -110.36 49.81 0.83 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.344 0.592 . . . . 10.0 110.312 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -81.4 -21.67 61.91 Favored Glycine 0 C--O 1.229 -0.156 0 CA-C-N 115.564 -0.744 . . . . 10.0 112.679 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.9 m -86.54 -33.47 20.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.864 0.364 . . . . 10.0 110.522 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -116.85 100.98 53.67 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.067 -0.515 . . . . 10.0 110.71 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -75.12 -15.33 20.54 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.366 2.044 . . . . 10.0 112.256 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.54 -46.83 86.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.7 -0.682 . . . . 10.0 111.067 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.8 m -67.5 -32.61 73.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.008 -0.542 . . . . 10.0 110.331 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -68.74 -43.88 74.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.12 -0.491 . . . . 10.0 110.073 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -62.6 -39.99 95.49 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.845 -0.616 . . . . 10.0 109.972 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.3 -34.19 88.76 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.681 -0.771 . . . . 10.0 111.696 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -63.0 -39.32 94.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.091 0.472 . . . . 10.0 110.657 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 30.1 mt -64.46 -34.61 78.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.877 -0.601 . . . . 10.0 110.433 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -67.39 -37.12 82.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.684 -0.689 . . . . 10.0 110.713 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.7 mt -64.84 -39.96 87.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.166 0.508 . . . . 10.0 110.065 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.73 -31.25 72.37 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.523 -0.762 . . . . 10.0 110.35 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -62.88 -45.15 93.9 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.049 -0.523 . . . . 10.0 109.856 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -61.0 -35.22 76.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.63 -0.714 . . . . 10.0 110.631 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -70.14 -45.61 66.45 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.799 0.333 . . . . 10.0 110.324 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -67.11 -29.83 69.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.013 0.435 . . . . 10.0 110.932 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.83 -3.34 47.39 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.81 -0.632 . . . . 10.0 110.186 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 63.83 31.26 14.17 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.768 -0.651 . . . . 10.0 111.517 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.6 m -91.02 -20.98 21.5 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.1 -0.5 . . . . 10.0 109.75 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 24.3 pt -134.84 150.99 30.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.838 -0.619 . . . . 10.0 109.55 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -107.37 -164.49 0.98 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.878 -0.415 . . . . 10.0 109.878 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.427 ' HB ' ' HD3' ' A' ' 73' ' ' PRO . 0.6 OUTLIER -49.12 -56.64 14.69 Favored Pre-proline 0 CA--C 1.537 0.472 0 O-C-N 123.619 0.574 . . . . 10.0 112.502 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.427 ' HD3' ' HB ' ' A' ' 72' ' ' THR . 40.8 Cg_endo -66.17 -28.59 48.24 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 121.683 1.589 . . . . 10.0 112.733 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.23 -51.99 29.77 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.839 -0.619 . . . . 10.0 113.069 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.9 p -64.52 -40.88 90.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.801 0.334 . . . . 10.0 111.1 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 91.6 mt -62.37 -45.35 98.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.475 -0.33 . . . . 10.0 110.644 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 77' ' ' ARG . 11.4 ttp180 -61.61 -45.65 93.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.395 -0.366 . . . . 10.0 110.936 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -57.87 -49.33 77.05 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.997 0.427 . . . . 10.0 111.095 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.447 HG21 ' C8 ' ' A' ' 201' ' ' 8TL . 86.2 t -68.36 -34.81 68.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.006 -0.543 . . . . 10.0 111.011 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.9 t -61.83 -30.57 70.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.483 -0.326 . . . . 10.0 111.475 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -82.36 -28.97 31.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.009 0.433 . . . . 10.0 110.698 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 23.2 tp -81.96 -40.99 21.42 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.097 -0.501 . . . . 10.0 111.326 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -97.08 32.24 2.21 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.167 -0.469 . . . . 10.0 110.637 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -65.67 -17.65 64.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.895 0.378 . . . . 10.0 111.749 -179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -88.33 -7.78 56.15 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.014 0.435 . . . . 10.0 110.466 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -134.69 71.64 70.31 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.864 -0.607 . . . . 10.0 109.491 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.38 -27.48 84.93 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.953 2.436 . . . . 10.0 112.746 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.07 -31.26 72.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.239 -0.437 . . . . 10.0 110.871 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 67.7 mt -75.21 -35.67 61.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 10.0 110.67 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 58.3 mt -65.41 -52.79 47.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.944 -0.571 . . . . 10.0 110.48 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.1 t -65.49 -38.98 83.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.052 -0.522 . . . . 10.0 109.706 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.98 -36.16 86.92 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.488 -0.778 . . . . 10.0 111.908 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -64.1 -44.03 93.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.716 0.293 . . . . 10.0 110.387 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -60.47 -42.86 97.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.121 -0.49 . . . . 10.0 110.191 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.31 -22.0 59.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.109 -0.496 . . . . 10.0 111.257 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -83.04 -11.6 57.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.258 -0.428 . . . . 10.0 111.171 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 60.2 mt -69.63 119.47 71.13 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.42 -0.355 . . . . 10.0 110.429 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -67.18 -42.59 7.56 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.642 2.228 . . . . 10.0 112.012 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.2 m -79.82 145.32 32.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.71 -0.677 . . . . 10.0 109.967 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 179.92 -131.92 1.73 Allowed Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.563 -0.615 . . . . 10.0 111.563 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -92.26 17.56 1.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.916 2.411 . . . . 10.0 112.16 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.4 m -82.77 176.57 9.22 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.941 -0.572 . . . . 10.0 111.305 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.48 113.97 3.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.994 -0.548 . . . . 10.0 111.598 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.479 0 C-N-CA 121.036 -0.602 . . . . 10.0 112.391 179.404 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' 8TL . . . . . 0.764 ' C11' ' O3 ' ' A' ' 201' ' ' 8TL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.425 0 N-CA-C 112.438 -0.265 . . . . 10.0 112.438 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.0 m -69.55 125.69 27.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.642 0.258 . . . . 10.0 110.767 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.0 t -79.21 137.27 37.35 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.981 -0.554 . . . . 10.0 110.158 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 137.37 176.76 14.6 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 121.096 -0.574 . . . . 10.0 111.794 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.0 m -152.62 133.77 14.24 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 110.0 -0.371 . . . . 10.0 110.0 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.8 m -105.01 136.08 45.15 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.31 -0.404 . . . . 10.0 110.97 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.92 105.23 2.97 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.637 -0.792 . . . . 10.0 112.207 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 17.0 m -115.45 164.56 11.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 110.12 -0.326 . . . . 10.0 110.12 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -104.3 -175.77 2.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.374 -0.376 . . . . 10.0 110.506 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.5 m -79.9 -4.19 6.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.189 0.518 . . . . 10.0 110.869 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -109.56 25.75 11.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.662 -0.699 . . . . 10.0 110.349 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.0 p-10 -68.07 -26.35 65.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.887 -0.597 . . . . 10.0 111.332 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.36 -51.3 62.91 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.586 0.587 . . . . 10.0 112.586 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.453 ' H ' ' HG ' ' A' ' 38' ' ' LEU . 1.4 pp -80.75 -0.87 40.45 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 122.067 -0.396 . . . . 10.0 111.86 -178.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 m -84.25 -34.99 23.72 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.942 0.401 . . . . 10.0 110.46 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -70.58 -21.92 62.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.342 -0.39 . . . . 10.0 111.214 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.54 -47.23 86.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 10.0 110.814 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -64.62 -35.91 82.55 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.957 -0.565 . . . . 10.0 110.61 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -58.41 -48.42 80.72 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.09 -0.505 . . . . 10.0 110.839 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.2 t -64.08 -35.86 75.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 115.65 -0.704 . . . . 10.0 110.549 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.7 tttm -67.77 -35.97 79.65 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.412 -0.813 . . . . 10.0 111.242 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 94.8 mt -77.16 -43.24 31.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.693 0.282 . . . . 10.0 111.295 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -58.3 -36.93 74.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.417 -0.356 . . . . 10.0 111.282 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -110.93 48.05 0.95 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.342 0.591 . . . . 10.0 109.987 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.47 -29.86 74.52 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.642 -0.708 . . . . 10.0 112.788 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.7 m -101.52 1.82 38.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.877 0.339 . . . . 10.0 111.383 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -124.68 94.55 44.26 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 120.908 0.385 . . . . 10.0 110.344 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -77.63 -11.38 17.02 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.481 2.121 . . . . 10.0 112.325 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.44 -51.55 23.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.215 -0.448 . . . . 10.0 110.919 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.5 m -64.48 -31.66 72.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.397 0.618 . . . . 10.0 110.039 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -66.27 -44.44 83.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.657 -0.702 . . . . 10.0 110.265 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -64.36 -37.5 87.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.509 . . . . 10.0 110.828 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.25 -39.45 97.89 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.71 -0.677 . . . . 10.0 112.891 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -60.75 -38.33 84.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.86 0.362 . . . . 10.0 110.702 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.427 ' O ' ' HG3' ' A' ' 63' ' ' LYS . 67.0 mt -65.89 -37.83 87.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.102 -0.499 . . . . 10.0 110.722 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -62.98 -40.38 97.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.114 0.483 . . . . 10.0 109.928 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.3 mt -62.75 -44.66 99.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.786 -0.643 . . . . 10.0 110.198 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.406 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -61.65 -35.75 78.84 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.691 -0.686 . . . . 10.0 110.773 179.853 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 59' ' ' LEU . 92.8 mttt -60.62 -47.22 87.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.753 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -59.58 -40.58 87.85 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.925 0.393 . . . . 10.0 110.885 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -68.24 -42.03 80.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.295 -0.411 . . . . 10.0 110.649 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 62' ' ' MET . 43.8 mtpt -66.12 -33.05 74.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.432 -0.349 . . . . 10.0 111.107 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.1 m -84.67 3.84 35.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.498 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 60.69 32.69 20.3 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.819 -0.628 . . . . 10.0 111.947 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.2 m -81.44 -25.72 35.91 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.329 0.585 . . . . 10.0 109.576 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 15.6 pt -137.84 164.88 27.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.365 -0.834 . . . . 10.0 109.904 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.35 -165.55 1.02 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.935 -0.395 . . . . 10.0 109.935 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.417 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 2.3 m -51.97 -55.57 29.47 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 112.502 0.556 . . . . 10.0 112.502 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 72' ' ' THR . 24.6 Cg_endo -62.35 -22.23 73.8 Favored 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 121.908 1.739 . . . . 10.0 112.59 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -83.26 -44.78 6.85 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.757 -0.735 . . . . 10.0 111.904 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.511 HG22 ' C9 ' ' A' ' 201' ' ' 8TL . 2.5 p -64.79 -34.69 71.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-O 120.817 0.342 . . . . 10.0 110.921 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 77.5 mt -70.11 -41.57 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 110.063 -0.347 . . . . 10.0 110.063 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 26.3 ttp180 -63.62 -40.11 96.06 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.339 -0.391 . . . . 10.0 110.253 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.6 mmt180 -57.76 -43.9 85.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.397 0.618 . . . . 10.0 110.18 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.62 HG21 ' C8 ' ' A' ' 201' ' ' 8TL . 45.9 t -72.9 -29.51 29.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.461 -0.79 . . . . 10.0 111.082 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.404 ' HA ' HD13 ' A' ' 90' ' ' ILE . 69.7 m -61.08 -29.87 70.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.079 0.466 . . . . 10.0 110.785 179.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.8 mm-40 -87.82 -26.77 22.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.917 -0.583 . . . . 10.0 110.45 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 29.5 tp -76.53 -53.6 7.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.031 -0.531 . . . . 10.0 110.284 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 18.9 m-30 -93.11 45.27 1.17 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.953 0.406 . . . . 10.0 110.447 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -68.35 -13.01 61.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.035 -0.529 . . . . 10.0 110.948 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -102.99 -10.89 18.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.009 -0.541 . . . . 10.0 110.761 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -133.36 79.53 60.57 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 120.737 0.303 . . . . 10.0 110.855 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.462 ' O ' HG23 ' A' ' 91' ' ' VAL . 18.1 Cg_endo -61.55 -31.47 87.35 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.741 2.294 . . . . 10.0 111.981 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -60.6 -31.81 70.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.744 -0.662 . . . . 10.0 110.987 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.2 mt -74.48 -25.33 59.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.031 -0.532 . . . . 10.0 111.162 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.404 HD13 ' HA ' ' A' ' 80' ' ' SER . 46.1 mt -80.73 -44.56 21.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.125 -0.489 . . . . 10.0 110.023 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 87' ' ' PRO . 17.4 t -67.87 -31.1 50.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.83 -0.623 . . . . 10.0 110.288 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.22 -39.4 97.64 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.805 -0.712 . . . . 10.0 111.759 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.482 ' CZ ' HD21 ' A' ' 97' ' ' LEU . 59.2 t80 -64.28 -36.44 84.13 Favored 'General case' 0 C--O 1.227 -0.117 0 CA-C-O 121.007 0.432 . . . . 10.0 110.216 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -62.63 -27.88 69.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.816 -0.629 . . . . 10.0 110.756 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -93.16 -19.96 20.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.287 -0.415 . . . . 10.0 111.149 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -97.26 44.5 1.05 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.299 -0.41 . . . . 10.0 110.643 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.482 HD21 ' CZ ' ' A' ' 93' ' ' PHE . 40.9 mt -113.01 102.92 55.48 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.083 -0.508 . . . . 10.0 110.444 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -62.19 -42.92 26.23 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.37 2.047 . . . . 10.0 111.873 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.7 94.53 7.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.921 -0.581 . . . . 10.0 110.039 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -134.31 -151.15 6.33 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.559 -0.829 . . . . 10.0 112.55 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -83.11 25.22 0.69 Allowed 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 122.939 2.426 . . . . 10.0 112.385 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.89 171.77 14.72 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.938 -0.574 . . . . 10.0 111.106 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.5 m -61.38 125.44 23.79 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.049 0.452 . . . . 10.0 111.171 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.652 0 C-N-CA 120.814 -0.708 . . . . 10.0 111.806 -179.951 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' 8TL . . . . . 0.783 ' C11' ' O3 ' ' A' ' 201' ' ' 8TL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.423 0 N-CA-C 112.223 -0.351 . . . . 10.0 112.223 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 m -124.8 124.12 41.44 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.591 0.234 . . . . 10.0 110.393 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.1 156.68 33.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.991 -0.55 . . . . 10.0 110.59 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.09 85.26 0.52 Allowed Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.534 -0.841 . . . . 10.0 112.465 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.2 m -73.09 114.97 11.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.866 0.365 . . . . 10.0 110.222 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.0 m -106.43 127.07 53.01 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.227 -0.442 . . . . 10.0 110.628 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.07 55.12 0.1 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.72 -0.753 . . . . 10.0 111.996 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.8 m -68.78 155.02 7.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-O 121.154 0.502 . . . . 10.0 111.351 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -99.07 -176.14 3.23 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.201 -0.454 . . . . 10.0 110.571 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.0 m -65.33 -20.11 26.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 121.197 0.522 . . . . 10.0 110.673 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -102.6 56.75 0.78 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.285 0.564 . . . . 10.0 109.812 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -90.44 -12.23 38.04 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.53 -0.759 . . . . 10.0 111.23 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.2 -48.7 80.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.609 -0.723 . . . . 10.0 111.355 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 pp -71.2 -22.5 62.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.161 -0.472 . . . . 10.0 111.993 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.506 ' O ' ' HG2' ' A' ' 43' ' ' GLN . 1.1 m -65.45 -60.1 3.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.356 -0.384 . . . . 10.0 111.421 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -67.4 -27.94 67.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.639 -0.255 . . . . 10.0 111.244 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -58.39 -35.24 71.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.281 -0.418 . . . . 10.0 111.511 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -91.06 -24.61 19.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.394 -0.366 . . . . 10.0 111.44 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.506 ' HG2' ' O ' ' A' ' 39' ' ' THR . 15.9 mm100 -56.47 -36.12 68.72 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.905 0.383 . . . . 10.0 110.856 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.535 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 11.0 t -66.7 -36.84 78.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 10.0 110.615 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.7 ttpm? -65.91 -35.4 80.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.886 -0.597 . . . . 10.0 110.449 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 46.0 mt -74.61 -40.92 48.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.717 -0.674 . . . . 10.0 109.98 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 -63.23 -51.76 64.92 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.345 -0.843 . . . . 10.0 111.514 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -102.35 54.03 0.79 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.282 0.563 . . . . 10.0 110.433 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.74 -41.28 89.3 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.701 -0.681 . . . . 10.0 112.874 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.3 m -92.96 7.93 41.95 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.842 0.321 . . . . 10.0 111.583 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -129.14 89.07 49.38 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.86 0.362 . . . . 10.0 111.241 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.9 -17.66 17.47 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.218 1.946 . . . . 10.0 112.311 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.83 -54.8 22.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.959 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.6 m -69.04 -27.51 65.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.024 0.44 . . . . 10.0 111.049 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -70.19 -41.99 72.99 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.858 0.361 . . . . 10.0 110.677 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -62.57 -42.11 99.35 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.201 -0.454 . . . . 10.0 110.322 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.12 -33.23 86.69 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.933 -0.651 . . . . 10.0 111.723 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.535 ' CZ ' HG21 ' A' ' 44' ' ' VAL . 88.4 t80 -62.2 -37.02 83.71 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.071 0.462 . . . . 10.0 110.07 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 22.7 mt -72.3 -35.87 68.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.68 -0.691 . . . . 10.0 110.901 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -62.04 -34.86 77.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.925 -0.58 . . . . 10.0 111.071 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.4 mt -66.22 -34.31 69.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.114 -0.493 . . . . 10.0 110.959 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.5 mtp -64.5 -33.79 76.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.371 -0.377 . . . . 10.0 110.52 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -61.64 -37.56 84.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.973 -0.558 . . . . 10.0 110.615 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -64.23 -37.92 89.2 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.111 -0.495 . . . . 10.0 110.808 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -78.6 -42.3 29.36 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.728 -0.389 . . . . 10.0 111.15 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -63.25 -34.33 77.44 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.589 -0.278 . . . . 10.0 111.661 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.9 m -84.22 5.38 26.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.733 0.301 . . . . 10.0 111.117 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 63.7 31.92 14.08 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.974 -0.557 . . . . 10.0 111.736 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.4 m -87.71 -48.29 7.98 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.999 0.428 . . . . 10.0 110.303 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 47.9 pt -104.72 146.43 11.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 110.03 -0.359 . . . . 10.0 110.03 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -99.48 -175.54 3.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.802 -0.636 . . . . 10.0 109.956 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.527 ' O ' HG12 ' A' ' 75' ' ' VAL . 0.9 OUTLIER -55.08 -54.09 54.13 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 111.707 0.262 . . . . 10.0 111.707 -179.77 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 72' ' ' THR . 24.2 Cg_endo -63.26 -24.71 72.1 Favored 'Trans proline' 0 C--N 1.358 1.067 0 C-N-CA 121.833 1.689 . . . . 10.0 112.324 178.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.85 -39.26 28.99 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.018 -0.61 . . . . 10.0 112.679 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.53 ' O ' HG23 ' A' ' 79' ' ' VAL . 4.9 p -68.71 -29.86 45.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 O-C-N 122.715 -0.285 . . . . 10.0 111.105 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 72' ' ' THR . 68.0 mt -59.86 -41.37 85.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-O 120.912 0.387 . . . . 10.0 110.052 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -62.13 -40.03 94.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.753 -0.658 . . . . 10.0 109.71 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.2 mmt180 -63.22 -44.89 93.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.754 -0.657 . . . . 10.0 110.739 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 75' ' ' VAL . 47.4 t -61.84 -46.3 96.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.758 -0.655 . . . . 10.0 110.855 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.49 ' HA ' HD13 ' A' ' 90' ' ' ILE . 8.9 m -65.59 -24.32 67.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.893 -0.594 . . . . 10.0 111.661 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -87.43 -24.53 24.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.748 0.309 . . . . 10.0 111.023 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 14.8 tp -86.0 -45.54 11.35 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.08 0.467 . . . . 10.0 110.418 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -103.82 43.77 1.07 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.739 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 13.5 p80 -63.6 -20.12 65.4 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.001 -0.545 . . . . 10.0 111.491 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -101.36 -0.21 35.91 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.962 0.411 . . . . 10.0 110.613 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -135.27 77.05 55.46 Favored Pre-proline 0 C--O 1.236 0.38 0 CA-C-N 116.246 -0.434 . . . . 10.0 110.208 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.92 -29.25 87.7 Favored 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.301 2.001 . . . . 10.0 112.631 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -62.85 -37.58 87.4 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 116.115 -0.493 . . . . 10.0 110.667 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.1 mt -66.15 -41.34 90.55 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.144 -0.48 . . . . 10.0 110.545 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.49 HD13 ' HA ' ' A' ' 80' ' ' SER . 18.2 mt -66.02 -46.07 89.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.031 -0.532 . . . . 10.0 109.983 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 73.8 t -62.38 -43.91 98.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.637 -0.711 . . . . 10.0 110.383 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.93 -40.62 99.11 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.685 -0.689 . . . . 10.0 112.235 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -66.14 -43.18 87.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.706 0.289 . . . . 10.0 110.726 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -61.79 -32.76 73.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.929 0.395 . . . . 10.0 111.36 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.23 -25.06 27.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.821 0.343 . . . . 10.0 111.365 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.45 -31.59 72.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.014 -0.539 . . . . 10.0 111.511 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 36.4 mt -58.16 115.62 11.94 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.526 -0.306 . . . . 10.0 111.688 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -82.25 -24.82 3.59 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.689 2.259 . . . . 10.0 112.125 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.4 m -91.41 99.82 12.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.157 -0.474 . . . . 10.0 110.58 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -151.55 -115.27 0.66 Allowed Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.955 -0.858 . . . . 10.0 110.955 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -82.32 6.86 5.46 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.407 2.071 . . . . 10.0 111.201 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.33 154.44 23.93 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.408 -0.815 . . . . 10.0 111.765 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.45 126.12 29.07 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.74 -0.664 . . . . 10.0 110.173 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 C-N-CA 120.768 -0.729 . . . . 10.0 112.463 179.682 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' 8TL . . . . . 0.774 ' C11' ' O3 ' ' A' ' 201' ' ' 8TL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.498 0 N-CA-C 112.093 -0.403 . . . . 10.0 112.093 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.23 140.47 23.13 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.039 -0.356 . . . . 10.0 110.039 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.0 m -74.42 145.18 43.91 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.712 0.291 . . . . 10.0 110.43 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 151.33 151.49 5.61 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.811 -0.709 . . . . 10.0 112.186 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 56.3 m -151.41 85.57 1.33 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.028 0.442 . . . . 10.0 110.258 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.9 m -67.39 148.39 51.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.985 -0.552 . . . . 10.0 111.224 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.49 83.34 1.56 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.742 -0.742 . . . . 10.0 112.42 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 29.5 m -108.14 156.23 8.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 110.159 -0.312 . . . . 10.0 110.159 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -102.35 -177.77 3.5 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.344 -0.389 . . . . 10.0 110.203 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.2 m -65.19 -27.1 41.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.812 0.339 . . . . 10.0 111.485 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -99.53 93.41 5.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.465 -0.334 . . . . 10.0 110.396 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -107.09 -11.56 15.61 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.348 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.09 -50.76 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.649 -0.705 . . . . 10.0 112.404 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.12 -10.99 60.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.129 -0.487 . . . . 10.0 112.052 -178.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.54 -58.46 2.52 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.049 0.452 . . . . 10.0 111.695 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.513 ' O ' HG23 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -67.88 -30.78 70.22 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.896 0.702 . . . . 10.0 112.896 -177.633 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.1 -38.83 73.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.749 0.309 . . . . 10.0 111.59 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -78.92 -35.49 43.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.83 0.348 . . . . 10.0 110.642 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -57.72 -39.9 78.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.981 -0.554 . . . . 10.0 111.383 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 40' ' ' TYR . 26.8 t -65.44 -37.11 79.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.077 0.465 . . . . 10.0 110.207 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.1 ttpm? -69.15 -33.26 73.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.638 -0.71 . . . . 10.0 110.634 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 62.8 mt -73.59 -43.07 55.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.855 -0.612 . . . . 10.0 110.224 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -65.74 -42.24 91.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.864 -0.607 . . . . 10.0 111.203 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -107.4 58.94 0.62 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.33 0.586 . . . . 10.0 110.57 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.62 -43.78 9.94 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.457 -0.792 . . . . 10.0 111.938 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 39.3 m -85.21 -11.05 55.83 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.861 0.362 . . . . 10.0 110.838 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -114.66 92.74 30.35 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.149 -0.478 . . . . 10.0 110.824 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -76.42 -15.84 17.49 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.233 1.956 . . . . 10.0 111.757 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.32 -54.49 32.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.507 -0.77 . . . . 10.0 111.634 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.7 m -65.95 -34.0 77.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.402 -0.363 . . . . 10.0 111.0 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -65.34 -44.23 88.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 10.0 110.719 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -64.6 -41.8 95.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.169 -0.469 . . . . 10.0 110.569 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.61 -39.09 96.91 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 115.948 -0.569 . . . . 10.0 112.09 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -57.98 -40.61 81.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.146 0.498 . . . . 10.0 110.463 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 27.3 mt -71.7 -30.01 65.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.791 -0.641 . . . . 10.0 111.127 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -68.93 -38.65 79.64 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.022 0.439 . . . . 10.0 110.876 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.482 HD13 ' HB3' ' A' ' 78' ' ' ARG . 42.1 mt -67.74 -30.84 49.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.784 -0.644 . . . . 10.0 110.606 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 33.1 mmt -64.94 -28.11 69.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.181 -0.463 . . . . 10.0 110.588 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -63.08 -41.26 99.37 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.154 -0.476 . . . . 10.0 110.26 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -65.31 -42.25 93.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.761 -0.654 . . . . 10.0 110.487 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -65.15 -42.59 93.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.112 -0.495 . . . . 10.0 110.634 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -67.82 -18.56 64.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.89 0.376 . . . . 10.0 111.054 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.1 m -95.92 2.19 53.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.067 -0.515 . . . . 10.0 110.453 178.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 64.79 23.05 12.65 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.714 -0.676 . . . . 10.0 110.758 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.2 m -77.74 -29.34 51.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.508 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 37.8 pt -128.48 153.37 37.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 10.0 111.008 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -105.3 -164.35 1.02 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.902 -0.59 . . . . 10.0 110.432 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.477 ' HB ' ' HD3' ' A' ' 73' ' ' PRO . 24.5 m -55.05 -56.48 27.52 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-N 116.502 -0.317 . . . . 10.0 111.212 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.477 ' HD3' ' HB ' ' A' ' 72' ' ' THR . 36.8 Cg_endo -66.41 -21.77 53.24 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 121.647 1.565 . . . . 10.0 111.822 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.07 -48.15 73.96 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.616 -0.72 . . . . 10.0 112.077 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.461 ' O ' HG23 ' A' ' 79' ' ' VAL . 9.5 p -72.77 -31.88 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 120.882 -0.327 . . . . 10.0 110.161 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 47.0 mt -59.95 -40.82 84.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 109.7 -0.482 . . . . 10.0 109.7 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 30.0 ttp180 -59.28 -42.32 90.97 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.112 -0.699 . . . . 10.0 109.112 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.482 ' HB3' HD13 ' A' ' 61' ' ' ILE . 12.2 mmt180 -67.4 -45.73 75.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.376 -0.829 . . . . 10.0 110.439 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 75' ' ' VAL . 62.7 t -55.64 -43.41 73.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.973 -0.558 . . . . 10.0 111.239 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.9 m -64.69 -30.33 71.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.036 -0.529 . . . . 10.0 112.006 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -87.93 -36.26 17.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.695 0.283 . . . . 10.0 111.381 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 24.1 tp -73.55 -54.14 8.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.92 0.391 . . . . 10.0 111.056 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -91.29 38.9 0.98 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.382 0.611 . . . . 10.0 109.651 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -59.38 -34.39 72.37 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.299 -0.864 . . . . 10.0 112.57 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -94.19 7.0 46.86 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.499 0.185 . . . . 10.0 111.499 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -133.59 72.48 74.03 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-O 120.754 0.311 . . . . 10.0 110.25 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.476 ' O ' HG23 ' A' ' 91' ' ' VAL . 33.4 Cg_exo -60.44 -32.78 94.23 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.026 2.484 . . . . 10.0 111.939 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -58.28 -38.4 76.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.591 -0.731 . . . . 10.0 110.433 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 60.1 mt -73.58 -31.69 63.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.915 -0.584 . . . . 10.0 111.306 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.0 mt -68.88 -45.53 80.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.12 0.486 . . . . 10.0 110.107 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 87' ' ' PRO . 19.4 t -69.34 -35.11 65.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.753 -0.658 . . . . 10.0 110.326 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.39 -46.39 94.42 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.787 -0.72 . . . . 10.0 112.47 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.445 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 64.2 t80 -62.01 -32.11 72.56 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.761 0.315 . . . . 10.0 111.18 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -61.37 -38.03 85.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.099 -0.501 . . . . 10.0 111.781 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.38 -8.25 32.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.895 0.378 . . . . 10.0 111.657 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.46 -19.69 35.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.823 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 93' ' ' PHE . 86.9 mt -58.02 121.66 52.32 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.939 -0.573 . . . . 10.0 111.533 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -77.57 -13.63 16.36 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.708 2.272 . . . . 10.0 112.451 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.7 m -106.45 110.77 23.08 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.336 -0.393 . . . . 10.0 110.651 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -142.05 -146.66 4.7 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.694 -0.765 . . . . 10.0 111.671 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -74.25 -5.99 17.76 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.635 2.223 . . . . 10.0 112.549 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 m -66.92 153.47 43.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.857 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.2 t -59.22 128.83 39.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.243 -0.435 . . . . 10.0 110.556 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.419 0 C-N-CA 120.435 -0.888 . . . . 10.0 112.351 -179.893 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' 8TL . . . . . 0.76 ' C11' ' O3 ' ' A' ' 201' ' ' 8TL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_